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Abstract 
Anorexia nervosa (AN) is a severe psychiatric illness affecting primarily adolescent females. 
Although prevalence rates are low, the associated morbidity, mortality and reduced quality 
of life result in a severe impact on the individual and thought to incur high societal costs. 
Combining new analyses of a variety of data sources with existing evidence, this thesis 
examines the societal costs of AN for England, including treatment costs and productivity 
impacts, and explores why costs may vary based on individual and service characteristics. 
An estimate of costs for 2010/11 is presented. 
The costs of treating AN and variations in costs associated with individual and service 
characteristics were studied using data from the MCTAAN trial, the Care Pathways Study, 
and three trials from the NIHR-funded Applied Research into Anorexia Nervosa and Not 
Otherwise Specified Eating Disorders (ARIADNE) programme. Education attainment and 
longer-term productivity were studied using data from the ALSPAC and BCS-70, 
respectively. Results were combined with existing evidence to estimate the societal costs of 
AN for England. 
The costs of treatment vary by service type and service characteristics. Individual treatment 
costs were positively associated with age and duration of illness, and vary by care pathway. 
Reporting lifetime incidence of AN was associated with a greater likelihood of being sick 
or disabled at age 30 (economic activity status). The prevalence of AN was estimated at 
approximately 12,000 cases, with around 6,000 Years of Potential Life Lost per year. The 
annual societal costs are estimated at between £80.8 million to £251.8 million. 
Policy recommendations include an emphasis on effective and early treatment, to avoid the 
need for (re-) hospitalisation – a strong predictor of negative patient outcome as well as 
treatment costs. There is a need to improve data quality in mental health services to build 
evaluation capacity. 
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CHAPTER INTRODUCTION 
Anorexia nervosa (AN) is a severe eating disorder (ED) affecting mostly adolescent girls. 
AN is a rare disorder: Two-stage studies of at-risk populations typically find a prevalence 
of up to 1% (Crisp et al. 1976; Hoek & van Hoeken 2003; Szmukler 1985), but owing to 
low overall prevalence as well as differences in methodology and sample population, 
prevalence rates vary significantly between studies. 
Even though prevalence rates are low, the impact on the individual is severe. Patients with 
ED and sub-threshold ED as well as their carers report lower health-related quality of life 
than controls, and this impairment can be considerable (Engel et al. 2009). Moreover, AN 
causes distress to families and carers and may affect their psychological well-being 
(Dimitropoulos et al. 2009; Graap et al. 2008; Kyriacou et al. 2008). 
The outcome of AN is poor, with average rates of recovery around 47% and more than 
20% of cases becoming chronic (Steinhausen 2002). The prognosis is worse for those with 
a longer duration of illness, co-morbidity with other psychiatric illness and older age of 
onset (Berkman et al. 2007). 
Life expectancy in AN is reduced dramatically – by an estimated 24.6 years for age of onset 
of 15 (Harbottle et al. 2008). The corresponding burden of disease is high: EDs are ranked 
4th in terms life years lost to disability in young people aged 15-24 and the metal disorder 
with the second highest number of life years lost in females aged 15-34 (Mathers et al. 2000). 
Suicide-related standard mortality ratios (SMR; the ratio between observed deaths and 
deaths expected given the age and sex of the study population) of up to 58.1 have been 
reported for women with AN (Herzog et al. 2000). In fact, suicide may be the most common 
cause of death in AN, even surpassing the physical consequences of starvation (Pompili et 
al. 2003). 
AN is linked to longer term physical problems, such as decreased bone health and risk of 
fractures, complications at birth and a negative impact on the endocrine and metabolic 
systems, although the latter are often reversed following recovery (Gendall & Bulik 2005). 
There is a high probability of co-morbid disorders such as autistic spectrum disorder and 
attention deficit hyperactivity disorder, obsessive-compulsive disorder, anxiety and 
borderline personality disorder (for a summary, see 15) and adolescent AN is associated 
21 
 
 
with higher odds of anxiety and depressive disorders in early adulthood (Johnson et al. 
2002). 
Treatment of AN is costly, in part because treatment often relies on inpatient care (Gowers 
& Bryant-Waugh 2004). In a census of inpatient beds in England and Wales in 1999, 20% 
of all child and adolescent beds were occupied by ED patients (O’Herlihy et al. 2003b, 
2003a), and ED admissions have the longest median length of stay of all adult psychiatric 
admissions (Thompson et al. 2004). 
Recently, in England and the UK, there has been a shift from inpatient to outpatient 
treatment, driven by several developments. In 1998, only 18% of ED units were managed 
by the NHS, and as a result, inpatient treatment was commissioned to private providers, 
with money flowing from the public to the private sector (Brown 1997; O’Herlihy et al. 
2003a; Palmer & Treasure 1999). In response, NHS services were created, mostly in 
outpatient settings (Palmer & Treasure 1999). At the same time, Specialist ED services are 
concentrated in the South East of England (O’Herlihy et al. 2003b; Tulloch et al. 2008) , and 
25% of the population live in areas without specialist provision (Royal College of 
Psychiatrists 2000), while referral from primary care to specialists services may depend on 
availability of such services within the area (Currin et al. 2006). Consequently, setting up 
outpatient services may facilitate more equitable access to treatment. 
Another aspect is a shift in ‘treatment philosophy’ from a medical view focussing on weight 
restoration to a more ‘holistic’ view that includes the family both as a resource for the 
patient and recipients of support (Eisler 2005; Schmidt et al. 2017), supported by a notion 
that inpatient treatment is associated with negative outcomes and should be avoided except 
in the most severe cases (Meads et al. 2001; National Institute for Clinical Excellence 2004; 
National Institute for Health and Care Excellence 2017a). 
The first (and to my knowledge, so far only) randomised controlled trial in the UK assessing 
the cost-effectiveness of outpatient treatment compared to inpatient treatment found 
specialist outpatient treatment to be more likely to be considered cost-effective than 
inpatient treatment or treatment in general outpatient services on an intention to treat basis 
(Byford et al. 2007a). However, length of psychiatric admissions and costs of secondary 
health care tended to be higher in general outpatient services compared to both inpatient 
and specialist outpatient services, suggesting the relationship between treatment setting and 
costs and outcomes may be more complex. 
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Even though it is clear that AN has a severe impact on the health care system and people’s 
lives – including patients, their carers, families and partners – to date, there are few attempts 
at quantifying the economic impact in monetary terms, and there is a dearth of cost-
effectiveness studies on treatments for AN (Simon et al. 2005; Stuhldreher et al. 2012). Cost-
of-illness (CoI) studies often form the basis for cost-effectiveness analyses (Hodgson & 
Meiners 1982), and they are used to measure the impact of a condition in monetary terms, 
to justify interventions, to assist in the allocation of research funding, to provide a basis for 
prevention policy and to provide a framework for economic evaluation (Rice 2000). Cost-
of-illness studies therefore have the potential to influence both policy and practice, and 
shape the future research agenda. 
While the usefulness of such cost-of-illness studies as an end in themselves has been 
questioned (e.g. Byford et al. 2000; Kennelly 2017; Koopmanschap 1998), they can raise 
awareness of the burden of disease, especially where there is concern about a lack of 
effective interventions or a lack of treatment provision. Analysis of variations in costs is 
particularly useful because this can be used to describe and model trends, and incidence-
based estimates showing the costs associated with a condition over the lifetime of an 
individual can be used in cost-effectiveness studies (Koopmanschap 1998). 
This study is limited to estimating the societal costs of AN for England (2010/11). The 
focus is particularly on filling the gap in information on the costs of treatment in outpatient 
services. Variations in costs are also explored to contribute to the development of 
incidence-based estimates that can facilitate economic evaluations, particularly cost-
effectiveness analyses. Given the available data, the estimates focus on females with AN. 
In this thesis, I contribute towards the effort to establish the costs of mental ill health more 
widely. Often this cost arises not just from treatment, but from a lack of sufficient and 
effective treatment. This lack of treatment and support often leads to problems becoming 
entrenched, resulting in poor outcomes down the line. Showing the costs of a disorder can 
therefore support an argument for prevention, early intervention, and investment in 
effective treatments to prevent a chronic course. The economics of mental health have been 
an area of interest for me for a long time, and I wrote my Master’s thesis on methodological 
issues in estimating the economic costs of suicide (Bonin 2007). Anorexia nervosa and 
suicide share some common features, in that the individual in question may not conform 
to the standard assumptions about ‘rational’ decision making in economic theory. This 
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thesis grew out of my interest in the economics of mental health, and especially in those 
conditions that appear to be ‘irrational’. As part of my role at the Personal Social Services 
Research Unit (PSSRU), I have been involved in research on the economics of ED 
treatment for almost 10 years, and some of the studies in this thesis are the result of this 
work. 
In the remainder of this chapter, I briefly set out the theoretical framework for this thesis 
and present the research questions to be addressed. These are derived from the survey of 
the existing literature in Chapter 2. I then provide an overview of the chapters that form 
the rest of this thesis. 
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THEORETICAL FRAMEWORK: ECONOMIC COSTS AS SOCIAL 
COSTS 
Economics is the science concerned with efficient allocation of resources, and health 
economics is therefore concerned with the efficient allocation of resources in the area of 
health. When considering the efficiency of resource allocation, the perspective of the 
analysis matters. While sometimes evaluations of interventions to improve health take a 
health services perspective, this likely omits relevant impacts on other parts of society, such 
as carers, employers or the patient themselves (Byford & Raftery 1998). Economic 
evaluation therefore should generally take a societal perspective, and economic costs are 
conceptualised as ‘social costs’. Another view is that the perspective should depend on the 
type of decision maker to be informed by the analysis. For example, a health and social care 
perspective may be appropriate for analyses informing decision making within the NHS. 
Commonly, three types of economic costs linked to health conditions are distinguished 
(Hodgson & Meiners 1982): 
• Direct costs arising directly from a condition, such as health care expenditure. These 
should reflect the opportunity cost of a resource. 
• Indirect costs that are related to the condition but are not direct cash expenditure, 
such as productivity losses from lost employment resulting from the condition. 
These are usually estimated using a human capital or friction cost approach 
(Koopmanschapp et al. 1995). 
• Intangible costs1 are those that are not easily quantified in monetary terms, for 
example the value of a life lost due to premature mortality or suicide. These can be 
valued using a human capital approach or willingness to pay methods (Bonin 2007). 
Table 1-1 shows examples of each type of costs as they relate to AN. 
                                                 
1 Please note that many costs that fall under indirect costs, such as productivity losses, are also intangible 
costs. The intangible costs noted here could also be termed “human costs”, see for example (Kennelly 2007) 
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Table 1-1: Types of costs and examples relating to AN 
Type of cost Examples pertaining to AN 
Direct costs 
Health care:  
• Primary care: initial diagnosis and referral; 
• Secondary care: A & E (medical emergencies, self-harm); medical inpatient admissions ( 
• Tertiary care: Specialist ED services 
Other community services:  
• Self-help groups for ED,  
• physiotherapy (support for weight restoration: body image and awareness, addressing compulsive exercise; 
addressing the effects of AN: e.g. osteoporosis; managing anxiety: relaxation and massage) 
Social care:  
• Social worker, as part of a multi-disciplinary team or as a separate service, e.g. to address safeguarding 
concerns, advocate for patients detained under the Mental Health Act. 
• Drug and alcohol services to address addiction 
Education:  
• Tutor, EWO 
Additional expenditure:  
• Special foods, diet aids, child care 
Indirect costs 
Lost output:  
• Education 
• Career choice, unemployment, reduced work productivity 
Intangible costs 
Impact on quality of life:  
• Person with AN,  
• Impact on carers 
Loss of life:  
• Premature mortality from medical complications 
• Suicide 
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RESEARCH QUESTIONS 
The aim of this thesis is to answer the following overarching questions: 
• What are the annual societal costs of AN for England? 
• Why do costs vary between individuals? 
Based on my survey of the literature, I specified concrete research questions that address 
several different aspects of the societal costs of AN. 
Research questions 1 and 2 investigate aspects of direct costs:  
• RQ1: What treatments are provided for AN in an outpatient context, what are the 
associated unit costs, and why do these costs vary? 
• RQ2: What services do people use while being treated for AN on an outpatient 
basis, what are the associated costs, and why do these costs vary? 
Research question 3 addresses indirect costs: 
• RQ3: What is the impact of AN on education, employment, income and related 
outcomes, and for whom? 
Research question 4 addresses intangible costs: 
• RQ4: What is the loss of life associated with AN in England? 
Research question 5 addresses the totality of societal costs: 
• RQ5: What are the annual societal costs of AN in England? 
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THESIS CHAPTER OUTLINE 
The structure of this thesis reflects the concept of economic costs as social costs. The 
overarching goal is to present an estimate of the societal cost of AN that is as comprehensive 
as the available data allow, and why these costs may vary. The literature review revealed that 
there is very little information on the costs associated with AN and at present, no one data 
source provides sufficient information to construct a comprehensive estimate of costs. To 
answer these questions, I synthesise available information and fill gaps in the data needed to 
provide a sound estimate of the costs of AN from a societal perspective using econometric 
and economic modelling techniques. I explore cost variations based on individual and 
service characteristics. This thesis therefore consists of a collection of studies exploring 
different aspects of the societal costs of anorexia nervosa, with a focus on the role of 
outpatient services. 
The empirical chapters (Chapters 4-8) are organised based on the type of cost they explore. 
Chapters 4 and 5 discuss aspects of direct costs of anorexia (unit costs of services and 
individual-level costs associated with service use). Chapter 6 explores some of the indirect 
costs (education and other economic outcomes). In Chapter 7, I estimate the costs 
associated with avoidable mortality due to AN in terms of Years of Potential Life Lost. 
Chapter 8 combines parameters from the data and literature review with estimates from the 
preceding chapters into estimates of the annual costs of AN. 
Figure 1-1 shows how each chapter and each element relates to the research questions, and 
to the components of societal costs: direct costs, indirect costs and intangible costs. This 
figure will be shown at the beginning of each chapter (or part of a chapter) to indicate which 
component of societal costs the studies presented in the chapter relates to. 
28 
 
 
Figure 1-1: Overview of empirical chapters 
 
Chapter 2: Introduction, literature review and research questions 
This chapter briefly introduced the policy framework and service developments relevant to 
the thesis. A structured literature review provides an overview of what is already known on 
the topics that will be explored in the empirical chapters, identifies gaps in our knowledge 
and motivates the derivation of the research questions.  
Chapter 3: Methods and data sources 
Chapter 3 discusses overarching methods used across the empirical studies and describes 
the data sources used in this thesis. 
Chapter 4: Direct cost - Unit costs of ED care 
The focus of this chapter is on the direct costs of AN. I present a unit cost for Multi-family 
Day therapy (MFDT) using data collected for the MCTAAN trial, and unit costs for 
outpatient treatments estimated from data collected as part of the Care Pathways Study 
(CPS), with a focus on variation in treatment costs by service-level characteristics. 
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Chapter 5: Direct costs – Individual-level variations in costs 
In this chapter, I use data from the CPS and three trials that were part of the NIHR-funded 
ARIADNE programme to explore variations in costs associated with service use in people 
with AN based on individual characteristics. 
Chapter 6: Indirect costs - Productivity losses  
Chapter 6 focusses on productivity-related impacts of AN in an analysis of the impact of 
AN on education attainment using ALSPAC data, and a study of longer-term impacts of 
self-reported AN on employment and related outcomes using the BCS-70. 
Chapter 7: Intangible costs – Years of Potential Life Lost 
In this chapter, I use the WHO-distributed DISMOD software model the prevalence of AN 
in England by age and gender, taking into account the incidence and remission from illness 
reported in the literature. I then calculate life expectancy and Years of Potential Life Lost 
from AN in England. 
Chapter 8: Cost of illness  
In Chapter 8, I combine the results of my literature review, publicly available data and the 
results from Chapters 5 to 7 into a cost-of-illness estimate and present the annual societal 
costs of AN in England for 2010/11. 
Chapter 9: Discussion and policy implications 
The final chapter discusses findings from the empirical chapters in the context of existing 
research, and presents policy implications as well as identifying further questions to inform 
the future research agenda. 
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CHAPTER 2  
Survey of the literature 
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CHAPTER INTRODUCTION 
In this chapter, I present an overview of the literature relevant to the studies presented in 
this thesis and highlight some of the conceptual debates and policy questions that frame the 
delivery of services for AN.  
This survey of the literature is not intended to be systematic nor fully comprehensive, but 
to provide a backdrop to the analyses that follow, and to motivate the research questions to 
be answered (see Chapter 1). An initial review was carried out in preparing the thesis 
proposal in 2008 and 2009. This included a scoping search on PubMed and a snowball search 
from key publications, such as the NICE guidance documents on ED (National Institute 
for Clinical Excellence 2004), and the (at the time) most recent review of economic studies 
of AN (CoI, cost-effectiveness and cost studies) available (Simon et al. 2005). This was 
supplemented by a hand search of key journals (International Journal of Eating Disorders 
and European Eating Disorders Review), expert consultation with colleagues at the IoP and 
KCL, and grey literature searches using the Google search engine. These initial searches 
indicated that studies relevant to this thesis were published in journals intended for a clinical 
audience rather than pure economic journals. Following this initial search, a PubMed alert 
was set up to monitor new publications with the broad keywords ‘anorexia’ and ‘eating 
disorder’ in the abstract or title. Snowball searches and expert consultations also continued. 
Additional reviews and systematic reviews were identified, drawn upon and supplemented 
with additional searches, including reverse searches for citations of key papers. Given that 
the evidence base on the costs of AN and ED is reviewed regularly (Ágh et al. 2016; Crow 
2014; National Institute for Clinical Excellence 2004; Simon et al. 2005; Striegel Weissman 
& Rosselli 2017; Stuhldreher et al. 2012), conducting an additional systematic review was 
considered to be a duplication of effort, and would not have made a substantial contribution 
to knowledge. 
In this chapter, I briefly present the aetiology, epidemiology and course of AN, with a view 
to providing an introduction to the topic and providing a definition of AN that can be 
applied throughout this thesis. This is followed by an outline of the consequences of AN in 
terms of health, quality of life, economic outcomes, the effect of families and carers and the 
impact on mortality. I then discuss the literature on the service response to AN in England 
– including availability of services, treatment settings and existing economic evaluations - 
and situate this information in the wider policy context. Finally, I present existing estimates 
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of the societal costs of AN, both in England and internationally, and summarise the literature 
indicating why these costs may vary between individuals. A final section discusses the 
usefulness of cost of illness estimates, identifies gaps in the evidence base to derive my 
research questions, and highlights the policy relevance and contribution to knowledge of 
this thesis. 
WHAT IS ANOREXIA NERVOSA? 
Eating disorders (ED) are severe psychiatric disorders that often become chronic. Anorexia 
nervosa (AN) is generally characterised by a very low body weight and behaviours and 
thoughts centred around the avoidance of weight gain, distorted body image and the 
influence of weight or shape on self-evaluation (American Psychiatric Association 1994; 
Treasure et al. 2010; World Health Organization 1992). Clinical definitions for ED and AN 
can be found in the Diagnostic and Statistical Manual of Mental Disorders versions IV 
(American Psychiatric Association 1994) and V (American Psychiatric Association 2013) 
and the International Classification of Diseases (ICD-10, World Health Organization 1992).  
Two subtypes can be distinguished based on behaviours: the restricting type (AN-R) is 
characterised by low calorie intake, while in the bingeing/purging type (AN-BP), self-
induced vomiting or laxative use may compensate for (perceived) over-eating. It is 
distinguished from the other EDs, bulimia nervosa (BN) and – since their introduction in 
DSM-V – binge eating disorder (BED).  
In addition to these ‘full syndromes’, Eating Disorders Not Otherwise Specified (EDNOS) 
is a diagnostic category intended to cover sub-threshold disorders. A meta-analysis by 
Thomas and colleagues (2009) shows that patients diagnosed with AN-type EDNOS 
(EDNOS-AN) based on DSM-IV criteria, i.e. with a more lenient BMI cut-off and without 
the requirement of amenorrhoea (absence of periods), are very similar to more narrowly 
defined AN. 
DIAGNOSTIC CRITERIA 
The way in which eating disorders are seen has changed over time. Schmidt (2003) describes 
a shifting of aetiological models on a spectrum from the biological to the psychological, that 
eventually locates AN in an ecological framework of risk and protective factors. These 
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include genetic and neurobiological factors, psychological traits, environmental risk factors 
and socio-cultural influences. Life stress can be a precipitating factor in both AN and BN, 
mediated by coping ability and social support. 
The current diagnostic criteria for AN under DSM-V are shown in Figure 1. This is a 
revision of the 1992 DSM-IV criteria, most notably the removal of the criterion of 
amenorrhoea in females, which brings DSM-V more in line with ICD-10 criteria. A strict 
weight criterion of <85% of the expected weight for height was removed, in part because it 
appeared to discourage diagnosis of the full syndrome in practice and inflating the EDNOS 
category (Micali & Hebebrand 2015). 
DSM-IV criteria were subject to several concerns. For example, a study applying DSM-IV 
and ICD 10 classifications to 226 children aged 7-16 found that over 50% were classified as 
EDNOS or could not be classified, casting doubt on the usefulness of these systems for 
children (Nicholls et al. 2000). Similarly, DSM-IV has been criticised as “a poor reflection of 
clinical reality” (Fairburn & Cooper 2011, p. 8) , as an increasing number of cases tended to 
be classified as EDNOS, rather than ‘full syndrome’, i.e. AN or BN (Schmidt 2003). This 
was considered problematic because patients with EDNOS were a diverse population that 
could not easily fit into a diagnosis of AN or BN, but the disorder presented as severe and 
persistent so that a classification of ‘subthreshold’ did not seem appropriate (Fairburn et al. 
2007). DSM-V appears to address this issue to some extent, with a comparison of 
classification of diagnoses for 215 new patients entering an ED service based on DSM-IV 
vs DSM-V finding an increase in proportion of diagnoses of AN from 30% to 40% of 
patients, and a decrease in the number of EDNOS cases from 62.3% to 32.6% of patients 
(Ornstein et al. 2013). 
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Figure 2-1: DSM-V criteria for Anorexia nervosa 
 
Beyond the shifting diagnostic classifications, there has been criticism of the current focus 
on EDs as “socially reinforced behaviours” (Lutter et al. 2016, p. 17), and it has been 
suggested that genetic and other biological research should inform these criteria (Bulik et al. 
2007; Micali & Dahlgren 2016). This reinforces the idea that there shift from a psychosocial 
to a neuropsychiatric or neuropsychological model of AN (Herpertz-Dahlmann et al. 2011), 
and there are calls for research to improve our understanding of the biological causes of AN 
and AN-related behaviours – bingeing, purging, restriction and exercise (Lutter et al. 2016).  
DSM-V criteria for Anorexia nervosa  
• Restriction of energy intake relative to requirements, leading to a significantly low 
body weight in the context of age, sex, developmental trajectory, and physical 
health. Significantly low weight is defined as a weight that is less than minimally 
normal or, for children and adolescents, less than minimally expected. 
• Intense fear of gaining weight or of becoming fat, or persistent behaviour that 
interferes with weight gain, even though at a significantly low weight 
• Disturbance in the way in which one’s body weight or shape is experienced, undue 
influence of body weight or shape on self-evaluation, or persistent lack of 
recognition of the seriousness of the current low body weight 
Two subtypes: 
• Restricting type: During the last three months, the individual has not engaged in 
recurrent episodes of binge eating or purging behaviour (i.e. self-induced 
vomiting, or the misuse of laxatives, diuretics, or enemas). This subtype describes 
presentations in which weight loss is accomplished primarily through dieting, 
fasting and/or excessive exercise 
• Binge-eating/purging type: During the last there months the individual has 
engaged in recurrent episodes of binge eating or purging behaviour (i.e. self-
induced vomiting, or the misuse of laxatives diuretics, or enemas). 
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‘SYNDROME’ OR BEHAVIOURS? 
While diagnostic manuals, such as the DSM-V or the ICD-10 offer strict clinical criteria for 
diagnosis (Schmidt 2003), attention has been paid to these different behaviours associated 
with EDs. For example, a latent class analysis seeking to empirically categorise individuals 
with ED revealed four classes (Keel et al. 2004): 
• Restricting AN 
• AN and BN with multiple methods of purging 
• Restricting AN without obsessive-compulsive behaviours 
• BN with one method of purging (self-induced vomiting) 
Another study of a general cohort of adolescent females revealed six classes (Swanson et al. 
2014b): 
• Asymptomatic; 
• Shape and weight concerns; 
• Overeating without loss of control; 
• Full and subthreshold BED; 
• Full and subthreshold purging disorder; 
• Full and subthreshold BN. 
These studies highlight that classifications may more usefully be broken down along broad 
behaviours than diagnostic classes. Among these behaviours, purging (and vomiting in 
particular) is associated with traits associated with risky behaviours (Reba et al. 2005), 
negative later outcomes (Solmi et al. 2015) and lower quality of life (Engel et al. 2009). Binge 
eating is similarly associated with lower quality of life (Latner et al. 2008). Participants with 
restricting AN, on the other hand, have reported better quality of life, and positive social 
feedback to weight loss and control has been cited as a possible reason (Mond et al. 2005). 
This points to a potential for variation in the societal costs of ED and AN by presence of 
different ED behaviours. 
MODELS OF MAINTENANCE AND TREATMENT 
There are several competing theoretical models for explaining maintenance of ED, and these 
models guide the approach to psychological treatments developed for AN. 
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The transdiagnostic approach to treatment of ED states that EDs (anorexia and bulimia 
nervosa as well as EDs not otherwise specified) share several maintenance factors, even 
though the clinical features may differ (Fairburn et al. 2003). It developed from the model 
of cognitive behaviour therapy for BN, which focussed on over evaluation of eating, shape 
and weight as a core maintaining factor of BN. This theory was extended to include four 
additional maintenance factors: clinical perfectionism, low self-esteem, mood intolerance 
and interpersonal difficulties. It is argued that EDs share the same psychopathology, based 
around over-evaluation of eating, shape and weight, leading to weight control behaviour and 
in some cases compensatory behaviours. In addition, it is common for people to transition 
from one ED to another (Helder & Collier 2010), so that the different ED diagnoses are 
regarded as different states within the ED category. 
In contrast to this model, there is evidence that restricting AN in particular is distinct and a 
maintenance model combining intra- and interpersonal factors has been proposed (Schmidt 
et al. 2006). Four factors in the maintenance of AN are suggested: 
• Obsessive-compulsive personality traits and perfectionism; 
• Avoidance; 
• Pro-anorectic beliefs; 
• Responses of close others. 
The last aspect highlights the reciprocal relationship between carer well-being and ability to 
respond appropriately to the person with AN, and to the severity of the illness and its 
outcomes. The treatment approach therefore focuses on including carers in the process, 
especially for young people. This is the theoretical approach underpinning several of the 
clinical trials that provided data for this thesis. 
RISK FACTORS 
The literature on risk factors of AN is vast (Bulik et al. 2005, 2006; Fairburn et al. 1999; 
Favaro et al. 2006; Fragkos & Frangos 2013; Hinney et al. 2004; Holland et al. 2013; Jacobi et 
al. 2004; Krug et al. 2014; Micali et al. 2014, 2017a; Micali & Hebebrand 2015; Munkholm et 
al. 2016; Nicholls & Viner 2009; Pike et al. 2008; Raevuori et al. 2014; Steiner et al. 2003; 
Sundquist et al. 2016), and while this is an important area of research for prevention science, 
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it is not the main concern of this thesis. In this section, I therefore briefly summarise the 
information presented by Schmidt (2003) and Zipfel and colleagues (2015). 
While it is generally thought that ED arise from or are supported by social and cultural 
pressure, weight and shape concerns are not a feature of all ED, and the interplay of risk 
and protective factors is more complex. Instead, there is a new emphasis on the heritability 
of and genetic risk for ED. Some of these genetic risk factors are shared with other disorders, 
such as depression, while others are unique to ED. The influence of genetic factors may 
increase with age because of the interplay between genetic expression and hormones in 
puberty. Molecular genetics is another field of enquiry, and several genes linked to 
neurotransmitters (serotonin, dopamine) have been identified as potentially relevant in 
determining ED risk. 
Perinatal factors may be important, and premature birth has been identified as a risk factor 
in AN, possibly linked to early feeding problems – another risk factor for AN. 
Childhood risk factors shared with other disorders also included perfectionism, negative 
self-evaluation, as well as adversity including experience of abuse. While dieting was 
associated with later development of BN, this was not the case for AN. Twin and sibling 
studies have confirmed these findings. 
The conclusion to be drawn is that AN and ED are complex disorders with multiple and 
interlinked risk factors, and not all of them may be amenable to preventative efforts. This 
puts an emphasis on effective treatments and interventions to mitigate the potential negative 
impact of AN and ED on those affected. 
EPIDEMIOLOGY 
INCIDENCE 
There is a perception that AN and ED are becoming increasingly common. In a widely 
quoted analysis of incidence of AN in Northern Europe, Hoek and colleagues (Hoek 2006; 
Hoek & van Hoeken 2003) assert an upward trend until the 1970s. The same seems to be 
the result of several longitudinal studies (e.g. Lucas, Beard et al. 1991). On the other hand, 
Fombonne’s meta-analysis of 16 international case-register and community studies (1995) 
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concludes that increasing trends over time can be explained by changes in diagnostic 
methods, availability of services and reporting of incidence. Pawluck and Gorey (Pawluck & 
Gorey 1998) reviewed 12 studies and found that variability in rates over time could to a large 
extent be explained by cohort age and in a recent large-scale study, while Hudson and 
colleagues (2008) fail to find a significant increase in AN over time for the USA. 
The incidence of AN in primary care in Britain appears to have been relatively stable over 
the last 20 years (Currin et al. 2005; Micali et al. 2013; Turnbull et al. 1996). The main source 
of information on incidence in the UK is the Clinical Practice Research Datalink (CPRD, 
formerly known as General Practice Research Database; Walley and Mantgani, 1997), which 
contains data from around 400 GP practices covering approximately 5% of the UK 
population in contact with GPs. The sample of practices is representative in terms of 
geographic distribution and practice size, as well as age and gender of patients (Statistics 
2000). The database contains anonymised information on incidence, number of contacts 
with primary care, prescriptions and referrals. The database has been used to study the 
incidence of ED in England several times (Currin et al. 2005; Micali et al. 2013; Turnbull et 
al. 1996). 
Most recently, Micali and colleagues (Micali et al. 2013) studied the incidence of AN, BN 
and EDNOS in the UK from 2000-2009 and again found the incidence of AN and BN to 
be stable over time, with a statistically significant increase in the age-standardised annual 
incidence rate from 32.3 to 37.2 per 100,000 population driven by an increase in EDNOS. 
The highest incidence group were adolescent females aged 15-19. 
Compared to international estimates from similarly developed countries, the UK incidence 
is low. Hoek and colleagues (1991; 1995) conducted a similar study of general practitioners’ 
records for the Netherlands and found an overall incidence rate of 8.1 per 100 000 person 
years, and in the longitudinal study conducted by Lucas and colleagues (Lucas et al. 1991, 
1999) on the population of Rochester, Minnesota, a similar rate of 8.3 was found for the 
period from 1935-1989. 
However, record-based studies generally do not show the true population incidence, but 
rather the incidence of cases detected by the health care system. Epidemiological studies 
find that over 50% of ED cases in the community are not detected by the health care system 
(Hoek et al. 1995; Keski-Rahkonen et al. 2007). While primary care is often the first point of 
contact with health services for people suffering from ED, due to the tendency to conceal 
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the illness associated with eating disorders and difficulty of diagnosis (especially in children), 
a record-based study is likely underestimate incidence. In 2,881 women from the 1975-179 
birth cohorts of Finnish twins (Keski-Rahkonen et al. 2007), the lifetime prevalence of DSM-
IV AN was 2.2%, and 50% of those cases had not been detected in the health care system. 
Incidence for age 15-19 was 270 per 100,000 person-years. This is a substantially higher 
lifetime prevalence and incidence of AN than previously reported. The accuracy of 
estimated depends on the efficiency and competency of primary care services, and 
availability of specialist services.  
PREVALENCE 
The report on Mental Health of Children and Young People in Great Britain (Green et al. 
2005) estimated a combined prevalence of autistic spectrum disorder and ‘other rare 
disorders’ including ED of ca. 1%. For the analysis, data from the 1999 and 2004 surveys 
were combined to increase the sample base, but a total of only 24 children with eating 
disorders could be identified, and no separate analysis was conducted. In this case, the low 
prevalence leads to a gap in information and research into service use and provision for what 
is a severe disorder associated with high mortality. 
Given the low prevalence in the general population, prevalence studies usually rely on two-
stage designs of at-risk populations, mostly young females. Owing to low overall prevalence 
as well as differences in methodology and sample populations – rates vary significantly: 
Rooney and colleagues (1995) find a rate of 0.1% among females aged 15-29 in a South-west 
London area, identified by hospital and community health workers. In a study of 540 females 
aged 16-35 presenting to their GP in Cambridge, one patient with AN was identified (0.2% 
of the sample). Mann and colleagues (1983) screened schoolgirls aged 15 in a South London 
area for abnormal eating attitudes and behaviour (i.e. not a clinical diagnosis of AN) and 
found these to be present in 6.9% of participants. In a Swedish suburban population that 
asked health and social care personnel to identify patients with ED, the two-year prevalence 
of AN was 258 cases per 100,000 inhabitants for females aged 16-24, while Kjelsas and 
colleagues (Kjelsås et al. 2004) surveyed 1,987 adolescents aged 14 and 15 in 13 secondary 
schools in Norway to find a lifetime prevalence of AN of 0.7%. 
Hoek and van Hoeken (Hoek & van Hoeken 2003) reviewed several of these two stage 
studies from Western Europe and the United States and found an average prevalence rate 
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of 0.3% for young females. This rate has been widely quoted and was used as the basis for 
the King’s Fund report on the societal costs of AN (King’s Fund et al. 2008) which estimated 
that in 2007, there were 26,981 people under 35 with AN in the UK. 
More recently, several large-scale studies of more general populations have been conducted. 
A study in Rochester, Minnesota (Lucas et al. 1991) found an overall sex and age-adjusted 
point prevalence rate of 0.15%, but only 39% of these were confirmed cases of AN. The 
point prevalence for definite cases is only 0.06%. A study of over 30,000 Swedish twins who 
met full DSM-IV criteria, had a hospital discharge diagnosis of AN or a cause-of-death 
including AN found an overall lifetime prevalence of AN of 1.20% for female and 0.29% 
for male participants (Keski-Rahkonen et al. 2006). 
Another recent study of the general population illustrates the problems associated with low 
prevalence: No cases of AN were identified in a study of ED in the general population in a 
South London area (Solmi et al. 2016). 
Prevalence estimates for the number of young girls with partial syndrome, usually defined 
by absence of amenorrhea or sufficient weight loss to meet DSM-IV criteria, fall between 
4-5% (Button et al. 1997; Wakeling 1996). A lifetime prevalence of AN of 1.9% and an 
additional 2.4% for EDNOS-AN (absence of amenorrhea) were found in a study of 1,002 
female Australian twins aged 28-39 (Wade et al. 2006). EDNOS cases accounted for 60% of 
cases in outpatient settings, while AN accounted for only 14.5% (Hoek 2006), indicating 
that there is an even higher need for services at the sub-clinical level. However, Micali and 
colleagues (Micali et al. 2017b) found a weighted lifetime prevalence in a cohort of 5,542 
from the Avon Longitudinal Study of AN of 3.64%, with 1.68% of the binging/purging 
type, and atypical AN of 1.7% - possibly reflecting the implementation of DSM-V criteria 
vs DSM-IV in the previous study. It is likely that the change in diagnostic criteria will be 
reflected in the relative proportions of full syndrome and EDNOS-AN in future studies. 
AN in males is thought to be rare, even though some studies (Carlat et al. 1997; Larsen et al. 
2015; O’Dea & Abraham 2002) suggest that rates may be increasing. Currin and colleagues 
(2005) found a ratio of 1:12 for male to female cases, similar to findings by Hoek and van 
Hoeken (Hoek & van Hoeken 2003) and Beglin and Fairburn (1992) who reported 1:10. 
Button and colleagues (2008) found that approximately 5% of patients of a specialized adult 
ED service in the 21-year period from 1987-2007 were male. In contrast, an American study 
(Hudson et al. 2007) found a lifetime prevalence ratio of 1:3, which is in line with Kjelsås’ 
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figure for adolescents of 2:7 (Kjelsås et al. 2004). A ratio of 1:8 seems to be generally accepted 
in the literature (Zipfel et al. 2015). Given that the prevalence of AN is already low in females, 
prevalence in males is usually estimated via a ratio of male to female cases in two-stage 
studies or from clinical populations rather than from general population studies. As will be 
discussed later in this thesis, the low incidence and prevalence of AN in males means that 
sufficiently large samples for sub-group analyses by gender tend to be unavailable. As a 
result, most analyses presented here are for females only. 
COURSE AND OUTCOME OF ANOREXIA NERVOSA 
Given the low prevalence of AN, most studies are relatively small and it is unclear whether 
they are representative of a wider population with AN. In addition, outcome (improvement, 
remission, relapse and mortality) will at least in part depend on effectiveness of treatment. 
Here I summarise key evidence reviews that combine the results from several studies to 
investigate the course and outcome of AN, supplemented with recent studies relevant to the 
English context, rather than surveying the full field of individual studies. 
One of the most cited studies is a review of 119 English and German language studies 
summarising the outcome of AN (Steinhausen 2002). Results need to be interpreted with 
caution due to the heterogeneity of underlying studies. The study found that outcomes 
differed depending on the length of the follow-up period, with average mortality increasing 
from 0.9% in studies with a short follow to 9.4% in studies with the longest follow-up (see 
Figure 2-2). Outcomes differed by age of onset, with a markedly better prognosis for those 
with adolescent onset (see Figure 2-3). Overall, less than 50% of patients recovered fully, 
and the overall outcome did not vary by time period, indicating that there was no trend of 
improved outcome (for example, through more effective treatments) found in this study.  
Following a cohort of patients with AN over 12 years, Fichter and colleagues (2006)  found 
an improvement post-treatment, an average deterioration in the first two years, and 
improvement between years 3 and 12. Average time to remission in a 12-year follow-up 
study was over 6 years (Herzog et al. 1997). 
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Figure 2-2: Outcome by length of follow-up period1 
 
 
Figure 2-3: Outcome in adolescent onset vs whole group2 
 
                                                 
1 Data from Steinhausen (Steinhausen 2002), p. 1,286. 
2 Data from Steinhausen (Steinhausen 2002), p. 1,286. 
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MORTALITY AND SUICIDE 
Arcelus and colleagues (Arcelus et al. 2011) estimated the standardised mortality ratio3 (SMR) 
associated with AN based on 25 studies with a mean follow-up period of 14.2 years at 5.68 
(95% CI: 4.17-8.26). As the underlying studies did not include male patients, this ratio applies 
to females only. This is lower than SMRs previously found (Hoek 2006), and in particular 
lower than the SMR found in a highly cited study of patients in tertiary care where it was 
10.5 (Birmingham et al. 2005). A more recent study in the UK used HES data linked to death 
registrations to calculate the age and sex-specific SMRs for ED between 2001-2009 (Hoang 
et al. 2014). The SMR for AN in patients aged 15-24 was 11.5 (95% CI 6.0-17.0), and 14.0 
(CI 9.2-18.8) for patients aged 25-44. For EDNOS, the SMR was 1.4 (CI 0-4.0) for younger 
and 4.7 (CI 1.4-8.0) for older adults. The SMR for AN was found to be almost twice as high 
as the SMR for schizophrenia in patients aged 25-44 at 7.3 (CI 6.6-7.9). Overall, the trend 
in mortality from AN in people who received inpatient treatment seems to be decreasing, 
e.g. (Lindblad et al. 2006). 
Mortality from suicide in AN may account for over 50% of deaths (Herzog et al. 2000), and 
the SMR for suicide was 31.0 (CI 21.0-44.0) in a meta-analysis (Preti et al. 2011) – much 
higher than the risk ratio of under 10 found in a previous analysis combining different 
studies (Pompili et al. 2004), and a review of suicide rates in inpatient, outpatient and non-
psychiatric settings which found crude mortality rates ranging from 0% to 5.3%, with a 
combined estimate of 2.5% (Franko & Keel 2006). It follows that the risk of attempted 
suicide is high, with the prevalence in a cohort of patients in Spanish outpatient services of 
8.65% for the restricting type AN, and 25.0% in those with the purging type (Forcano et al. 
2011) – a finding similar to that of Bulik and colleagues (2008), where 7.4% with restricting 
subtype and 26.1 % with the purging subtype as well as 29.3% with AN with binge eating 
had attempted suicide. Measures of depression were elevated in those with suicide attempts. 
These findings are in line with an earlier study from France, where major depressive disorder 
and switching from the restricting to the bingeing/purging subtype were associated with an 
increased risk for suicide attempts (Foulon et al. 2007). 
                                                 
3 The SMR is the ratio between the number of deaths observed in a specific population and the number of 
deaths that would be expected based on age and sex in a standard population. 
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WHAT ARE THE CONSEQUENCES OF ANOREXIA NERVOSA? 
HEALTH CONSEQUENCES AND CO-MORBIDITIES  
The health consequences of AN are wide ranging and complex. Gendall and Bulik (2005) 
reviewed the literature on the long-term biological consequences of AN. The findings of 
their review are summarised below. 
AN affects reproductive and obstetric health. While there was no difference in infertility, 
the rate of miscarriages in women with AN was 30% compared to 16%. Between 10%-
26.5% of women with a history of AN have caesarean sections, compared to 3% in controls. 
Premature birth and low birth weight were found in 20% compared to 6% in those without 
AN. 
There were significant negative impacts on bone health, with a higher risk or more severe 
osteoporosis, osteopenia, premenopausal fracture rates and an increased fracture risk for 
more than 10 years following diagnosis of AN. 
Cancer incidence overall was reduced by 20%, with breast cancer and cervical cancers less 
common. However, gastrointestinal cancers were more common than expected, as were 
types of gastrointestinal disease that tend to resolve with refeeding. Bingeing and purging 
can lead to gastrointestinal bleeding and other problems, while laxative abuse can affect 
pancreatic function and result in renal failure. 
Current AN is associated with endocrine and metabolic problems, such as a reduced resting 
metabolic rate hypothyroidism and increased growth hormone secretion. 
Co-morbid mental health conditions are common in AN. Jordan and colleagues (Jordan et 
al. 2008) report depression in 63% and anxiety in 54% of those affected, while Krug and 
colleagues (2008) reported affective disorders in 52%. Tobacco and substance use were also 
common in the same study (34%), with higher risk in the bingeing/purging type of AN 
compared to the restricting type. There was no increase in alcohol use. Depression is 
common in AN and is associated with lower quality of life (Winkler et al. 2014). 
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QUALITY OF LIFE  
A recent meta-analysis of the health-related quality of life (HR-QoL) in ED (Ágh et al. 2016) 
included 41 studies overall and 18 specifically for AN. Those with ED had lower HR-QoL 
than those with no ED (Fox & Leung 2009), and those with AN had reduced mobility 
compared to those with BN and healthy controls (Keilen et al. 1994). In some comparisons 
of AN with BN and BED, there were no significant differences between diagnostic 
categories but there was a negative relationship between severity of ED symptoms and HR-
QoL (de la Rie et al. 2007; Padierna et al. 2000). A study using a multi-dimensional quality of 
life instrument (Doll et al. 2013) found no differences between the AN group and the 
comparison group without ED. However, those with BN or BED had lower scores on some 
sub-domains. This links with a finding by Mond and colleagues (Mond et al. 2005), who find 
that quality of life is lower in those with BN, BED and purging-type AN compared to 
restricting type AN, and a study by Latner and colleagues (2008), where several purging 
behaviours (bulimic episodes, laxative abuse, self-induced vomiting) were related to lower 
general quality of life. This indicates that purging behaviours may negatively affect QoL. AN 
may also be associated with lower social and physical functioning compared to BN and 
EDNOS (Bamford & Sly 2009; Latner et al. 2008).  
An explanation put forward for the fact that some studies do not find an effect of AN on 
quality of life in patients is that this may be related to positive attitudes towards weight loss 
(Hay et al. 2003). However, a recent meta-analysis finds no evidence for this claim (Winkler 
et al. 2014). The picture of QoL in AN presented by the literature is therefore mixed, but 
there are indications that QoL is related to purging behaviours, and that AN may affect the 
physical and social functioning domains of QoL. 
ECONOMIC OUTCOMES 
AN is associated with long and frequent periods of hospitalisation, where there is alternative 
provision of education (Tulloch et al. 2008). Byford and colleagues (Byford et al. 2007a) 
found that in addition to hospital stays, the young people in their study spent long stretches 
of time out of education. It seems that in the face of severe illness, education often comes 
second, although it is a concern to parents (Tierney 2005) and seen as an important 
determinant of quality of life (de la Rie et al. 2005a). For those who remain within mainstream 
school, special provisions may have to be made to accommodate sickness absences. 
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There is some evidence that the illness does not affect educational outcomes in the longer 
term: there was no statistically significant difference between young women with AN and 
their healthy co-twins 5 years after recovery from AN (Keski-Rahkonen et al. 2007), and a 
greater proportion of patients admitted to hospital with AN had completed post-secondary 
education compared to controls (Hjern et al. 2006). In contrast, Patton and colleagues (2008) 
found young people with EDNOS-AN more likely to be not in education or employment 
than cohort members without ED. However, I am not aware of any previous study looking 
at educational outcomes in AN while controlling for other characteristics, such as socio-
economic status.  
While few studies on the topic exist, there is some evidence to suggest that the impact of 
current AN on productivity in adulthood is severe: In a register study of a national cohort 
of Swedish females born between 1968 and 1977 (N=529,369), 748 inpatients meeting ICD-
9 criteria for a main or co-morbid diagnosis of AN were identified and compared to all other 
participants in terms of health, social and economic outcomes at age 24/25 (Hjern et al. 
2006). In the group with an inpatient stay for AN, 21.4% were financially dependent on state 
benefits, compared to 8.6% in the comparison population (risk ration stratified by birth year, 
socio-economic status, residency and maternal country of birth: 2.6 (95% CI 2.3-3.0). A long 
duration of inpatient treatment and psychiatric co morbidity were significant predictors of 
benefit receipt.  
In a study from British Columbia, Su and Birmingham (2003) collected survey data collected 
from inpatients and outpatients in an adult tertiary care ED service and from 40 ED patients 
throughout the province through a self-help organisation. Of the n=29 respondent recruited 
through the ED service, 6.9% received income support at the time of the survey and 27.6% 
had received it in the past. The corresponding figures are 10% and 25% for the n=20 
respondents recruited through the self-help organisation. In both groups, around 35% 
therefore received disability payments either in the past or presently. The total cost of long-
term disability modelled based on benefit rates and assumptions about the prevalence of 
AN in the female population (assumed to range from 1%-2% between ages 15 to 64) was 
estimated to be in the range of CAD2.5 million to CAD101.7 million per annum, up to 30 
times the total annual cost of tertiary care for EDs.  
A study using five-year data from the US Medical Expenditures Panel Survey, Samnaliev 
and colleagues (2015) compared individuals with a current ED to those without ED in terms 
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of annual health care costs, employment status and earned income. While those with an ED 
incurred higher health care costs, there was no statistically significant difference in 
employment rate (OR = 0.67, 95% CI 0.41-1.09), and no statistically significant difference 
in earnings if employed with a difference in earnings of $2,093 (2011 US$; p=0.48). Results 
for those with ED with another co-morbid mental health condition were similar, except for 
significantly lower earnings (difference $19,374, p<0.01). 
In summary, while the evidence on economic outcomes for AN is sparse, there is some 
evidence that there may be a higher probability of receiving disability benefits, and that this 
is costly when compared on expenditure on treatment. While there is as of yet no evidence 
that ED affects employment status or wage level (and in fact, there is some evidence to 
suggest that these are not affected), is less clear how a history of adolescent AN affects adult 
productivity. 
EFFECT ON CARERS AND FAMILY 
The role of carers is important to this analysis both because the relationship with the carer 
plays an important part in the recovery process and because carers carry much of the burden 
of AN in terms of caregiving. Carers of people with AN experience more distress than carers 
of people with psychosis (Treasure et al. 2001; Whitney et al. 2005) The burden of caregiving 
and other societal costs have not been examined in economic terms. 
Carer distress is driven by self-related strains (strain on the carer), and interpersonal strains 
(strains on relationships) and is higher for mothers than for fathers (Kyriacou et al. 2008).  
Several qualitative studies have looked at the impact of EDs on other family members. 
Changes in children with ED are often described as ‘alarming’, both in personality and 
behaviour (Cottee-Lane et al. 2004) and parents report anxiety about immediate medical 
problems and the child avoiding social activities. 
An ED is often disruptive to family life because it revolves around the disorder to such an 
extent that the needs of carers and other family members cannot be addressed and social 
activities are limited (Cottee-Lane et al. 2004; de la Rie et al. 2005b; Highet et al. 2005). The 
ED can lead to social isolation and put financial strain of the family (Hillege et al. 2006). 
Another factor contributing to carer distress was a lack of support and understanding from 
close others and indeed health service professionals who often failed to respond to parents’ 
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concerns in the early stages of the disorder (Cottee-Lane et al. 2004; de la Rie et al. 2005b; 
Highet et al. 2005). 
Zabala and colleagues (2009) systematically reviewed quantitative studies about expressed 
emotion, caregiving burden and psychological distress of carers. Their analysis included 20 
studies, 5 focussing on AN only, and 9 including all EDs. All studies reporting measures of 
psychological distress showed high levels of psychological distress, depression and anxiety. 
Two studies included in the review compared the caregiving burden of ED carers to carers 
of psychotic patients (Treasure et al. 2001) and compared to healthy controls (Kyriacou et al. 
2008), respectively, and found that ED carers experienced a higher burden. Zabala and 
colleagues (2009) note, however, that in both cases, the comparison groups were not well 
matched. Another study (Santonastaso et al. 1997) found that the subjective caregiving 
burden of carers of AN is higher than for carers of bulimia. In addition, the carers showed 
high levels of expressed emotion, and this was positively associated with age of the patient 
and the duration of illness. 
While the literature clearly shows a severe impact on the family in terms of caregiving, 
financial burden and distress, so far, this impact has not been quantified in monetary terms.  
TREATMENT OF ANOREXIA NERVOSA IN THE CONTEXT OF 
ENGLISH MENTAL HEALTH POLICY 
Treatment and service development of ED and AN is situated in a broader context of mental 
health policy. I summarise trends in service development and mental health policy and relate 
them to service developments in ED. Note that this section does not attempt to detail and 
critique the available treatment approaches for AN. Instead, it focusses on the policy context 
and outlines the organisation of services to provide a framework for the analyses that follow. 
This section highlights some of the major debates regarding the organisation of services for 
ED: 
• A shift from inpatient to outpatient services; 
• The role of specialist services in the treatment of AN; 
• Crisis resolution and home treatment teams to prevent admissions and facilitate 
discharge from hospital. 
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Table 2-1 lists key policy documents and events in the mental health space up to 2017. Key 
documents for the devolved nations are also included. Devolution has led to different 
funding choices and different structures (Greer 2008). While in England, there is more 
increasing emphasis on provider-based competition and patient choice combined with 
performance management, the split between purchaser and provider no longer exists in 
Scotland and Wales. In Northern Ireland, retention of a purchaser/provider split was noted, 
without the elements of encouraging provider competitions or performance management. 
Bevan and colleagues (Bevan et al. 2014) note that this divergence has not led to a 
corresponding divergence in health system performance. 
With regard to ED, NICE guidance documents apply to England, Wales and Northern 
Ireland, therefore setting the context for devolved policy and practice. Both Wales and 
Northern Ireland historically had a lack of specialist ED units, leading to a need for out-of-
area treatment (Royal College of Psychiatrists 2012). 
An early study (Lemouchoux et al. 2001) found that over 20% of the population in Scotland 
did not have access to specialist NHS ED services, so that private providers were funded to 
provide care (Carter & Millar 2004). The first specialist ED inpatient unit in Scotland opened 
in 2009, with other services (including some outpatient services) following suit (Royal 
College of Psychiatrists 2012). While provision has improved, the Royal College of 
Psychiatrists concluded in 2012 that further improvements in service availability and 
improved models of care (such as involvement of GPs, continuity of care and availability of 
treatment in CAMHS) are required to further reduce avoidable mortality from ED in 
Scotland. 
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Table 2-1: Mental health policy in England from 1948 
Year MH policy documents and events Implications 
1948 National Health Service Act Founding of NHS 
1959 Mental Health Act More stringent admission criteria for asylums 
1983 Mental Health Act Duty to provide “aftercare” 
1986 First asylum closed Process of de-institutionalisation begins. 
1990 
‘National Health Service and Community Care 
Act 
Introduces split between purchaser and provider; implements needs assessment and entitlement 
to receiving required services. 
1998 White paper: ‘Modernising mental health services’’ £700 million additional funding 
1999 National Service Framework for MH 
Standards of care, new community-based service models, funding and support for 
implementation. 
 Devolution of NHS Wales  
2000 NHS Plan Standards of care, new community-based service models, funding and support for 
implementation. 2001 ‘National Institute for Mental Health in England’ 
2002 
Bamford review of Mental Health and Learning 
Disability (Northern Ireland) 
 
2003 ‘Every Child Matters’ Provide comprehensive CAMHS services by 200 
 
‘Mental Health (Care and Treatment) (Scotland) 
Act 
Renewed interest in the rights of patients with ED, with guidance on ‘forced feeding’ published 
by the Mental Welfare Commission for Scotland in 2013. 
 
‘National Programme for Improving Mental 
Health and Well-being. Action Plan 2003-2006’ 
(Scotland) 
 
2004 NICE guidance on Eating Disorders  
2004 
‘National Service Framework for Children, Young 
People and Maternity Services’ 
Standard 9: Improve standards of care; access to timely, integrated, high quality, multidisciplinary 
MH services to ensure effective assessment, treatment and support. 
2005 
‘The Mental Health of Children and Young 
People: A Framework for Promotion, Prevention 
and Care’ (Scotland) 
Framework for planning and delivery of integrated approaches to CYP mental health. 
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Year MH policy documents and events Implications 
 
‘Review of Mental Health and Learning Disability’ 
(Northern Ireland) 
Lack of local specialist inpatient units leads to treatment being provided outside the country, 
prompting the prioritisation of development of ED services. 
2006 IAPT established  
 
‘Eating Disorders in Scotland – 
Recommendations for Management and 
Treatment’ 
Published by NHS Quality Improvement Scotland, with recommendations around continuity of 
care, identification in primary care and referral to specialist services. 
 ‘Delivering for Mental Health’ (Scotland)  
2007 ‘Mental Health Act’ Age appropriate care for under 18s. 
 
‘Better Health, Better Care: Action Plan’ 
(Scotland) 
Commitment to faster access to health care locally. 
2009 
‘New horizons: towards a shared vision for mental 
health’ 
Prioritises equality, personalisation, destigmatisation and physical health of people with MH 
problems. 
 
‘Towards a Mentally Flourishing Scotland: Policy 
and Action Plan 2009-2011’ 
 
 ‘Eating Disorders Framework for Wales’ 
Tiered model of service provision implemented for ED. Additional funding of £1m per year for 
two adult specialist services (Wales) 
 
First ‘Bamford’ action plan (2009-11, Northern 
Ireland) 
 
2010 ‘NHS plan for England’ 
Aims: Increase in funding, address geographical inequalities, improve standards of care and 
patient choice. 
 
2011 
‘No Health without Mental Health: Delivering 
better mental health outcomes for people of all 
ages.’ 
Parity of esteem between mental and physical health services. 
2012 
‘Implementation Framework for No Health 
Without Mental Health’ 
 
 ‘Health and Social Care Act’ 
First explicit recognition of “duty towards both physical and mental health” (Parkin & Powell 
2017, p. 6)  
 ‘Mental Health Strategy for Scotland: 2012-2015’  
 ‘Together for Mental Health’ (Wales)  
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Year MH policy documents and events Implications 
 
Second ‘Bamford’ action plan (2012-15, Northern 
Ireland) 
 
2013 
Additional investment in improving CAMHS 
provision for ED (Wales) 
 
2014 
Health and Social Care Information Centre shows 
rise in ED admissions of 8%. 
 
 
‘Closing the Gap: priorities for essential change in 
mental health’ 
Outlines areas for improvement in terms of access to MH services, integrating physical and 
mental health care, prevention and promotion activities, improving quality of life for people with 
MH problems. 
 ‘NHS Five Year Forward View’ 
Proposal to expand access standards to cover eating disorders and a range of other services. 
Goal: achieve parity of esteem by 2020 
 ‘Social Services and Wellbeing Act 2014’ (Wales) 
Change in the provision of services for young people to better meet their needs, such as easier 
access to information, simpler assessments and providing “the right support at the right time”. 
Joint working of the public sector with other organisations. 
 ‘Five year Forward View. Into Action’ Pledge to establish CEDS-CYP. 
2015 
‘Children and Young People’s Eating Disorder 
Access and Waiting Time Commissioning Guide’ 
Standards and requirements for CEDS-CYP and updated referral pathway. 
 ‘Together for Children and Young People’ (Wales) 
Multi-agency, multi-disciplinary programme to improve emotional and mental health services for 
CYP in Wales. 
2016 ‘Five Year Forward View for Mental Health’ 
Recommendations for improving mental health outcomes and achieve parity of esteem by 
2020/21. CEDS pathway to be developed in 2015/16. Call for ED waiting time standard to be 
model for additional standards. Call to end out-of-area placements. 
 ‘Implementing the Five Year Forward View’ £30 million additional funding to implement CEDS-CYP (2015/16-2020/21) 
 
‘Together for Mental Health Delivery plan: 2016-
2019’ (Wales) 
Commitment to access to appropriate and timely services to reduce the number of out-of-area 
placements. 
 Review of the Welsh Eating Disorder Framework 
Key messages arising from the Welsh policy context are summarised: Routine recording of 
outcome measures is needed to enable evidence based service provision.  
2017 
Update of ‘NICE guidance on the recognition and 
treatment of ED’ 
 
 ‘Next steps on the NHS Five Year Forward View’  
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Year MH policy documents and events Implications 
 NHS waiting time standard baseline  
 
Publication of ‘Mental Health Strategy 2017-2027’ 
for Scotland 
Action 22 pledges “support for the development of a digital tool to support young people with 
eating disorders” to “help ensure that young people with an ED are able to access support in a 
way that reflects digital lifestyles”. 
2018 
Review of NHS Eating Disorder treatment in 
Wales 
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PROCESS OF DEINSTITUTIONALISATION AND IMPLICATIONS FOR 
INPATIENT CARE 
Gilburt and Peck (2014) summarise the process transformation of mental health services up 
to the publication of the cross-government paper ‘No Health Without Mental Health’ in 
2011. The publication of ‘No Health Without Mental Health’ prompts and coincides with 
an increased focus on mental health services in general, and on ED in particular. I present 
their argument in what follows. 
A process of de-institutionalisation, driven by advances in psychiatry and pharmacology, and 
changing attitudes towards mental health, started in the late 1980s. This involved moving 
residents into smaller mental health units or into the community. The transition had cost 
implications, as for a period, hospital beds still had to be funded alongside the new 
community services. 
Initially, community mental health teams were the predominant service model, but these 
were found to be insufficiently capable of caring for those with severe and enduring mental 
health problems and younger people. New service models were implemented, overseen by 
the new National Institute for Mental Health and leading to both an increase in the 
workforce and new roles for existing clinicians:  
• Assertive outreach teams providing intensive support to people with complex needs 
living in the community; 
• Crisis resolution and home treatment teams to prevent admissions and facilitate 
discharge from hospital; 
• Early intervention teams for psychosis. 
After the implementation of the National Service Framework for Mental Health (NSF; 
Department of Health 1999), it was recognised that the new service models did not always 
address local requirements –particularly where the new eligibility criteria for community 
services resulted in unmet needs. Local innovation with a view to improving access to 
services is now encouraged by national policy, with funding to support implementation of 
NICE approved treatment for depression and anxiety provided through the flagship 
‘Increasing Access to Psychological Therapies’ programme (IAPT) from 2006. At the same 
time, the severity of illness of those still treated in inpatient settings has increased, while the 
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number of acute beds has fallen, putting cost pressures on providers and leading to local 
concentrations of services. An inability to meet demand for beds has resulted in an increase 
in out-of-area placements. 
AVAILABILITY OF INPATIENT SERVICES FOR AN 
The overarching developments in the organisation of mental health services are seen in the 
service landscape in ED and AN. The severe and often life threatening medical 
consequences of ED often require hospitalisation, and it has been argued that availability of 
specialist services is particularly important in the case of ED because their low prevalence 
means local and general services see too few patients to develop the skills to treat them 
effectively (Palmer & Treasure 1999). At the same time, early and effective treatment is 
important, as duration of illness is a predictor of outcome and can prevent the disorder from 
becoming entrenched (Eisler et al. 1997; Steinhausen 2002). 
ED cases reflect an overall trend of changing admission and discharge criteria and of 
increasing severity in those admitted for inpatient care, in. Average age of admission is now 
higher than in cohorts that pre-date deinstitutionalisation (Collins 2005; Long et al. 2011; 
Morgan & Russell 1975; Russell et al. 1987), and the course of illness of inpatients is more 
severe and enduring. 
In terms of the geographic distribution of services, persistent inequalities are found. A 
survey by the RCP found that in four UK regions covering 25% of the population, there 
was no specialist provision, and 69% of specialist services were clustered in the South East 
of England (Royal College of Psychiatrists 2000). 
The influential 1999 National In-patient Child and Adolescent Psychiatry Study (O’Herlihy 
et al. 2003b, 2003a) mapped the provision of child and adolescent inpatient units in England 
and Wales, covering both public and private sectors. One aim of the study was to describe 
the distribution and characteristics of inpatient mental health units. The study found nine 
inpatient units supplying 98 beds, or 11% of all mental health inpatient beds. These were 
predominantly in London (50 beds), the South East (26 beds) and the East (20 beds). 
The availability of ED services therefore mirrors the picture for all mental health beds, which 
are clustered in London and the South East. Eating disorders were the main diagnosis for 
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almost a quarter (23.3%, Tulloch et al., 2008a) of young people in inpatient units at the time 
of the census.  
The COSI-CAPS study (Tulloch et al. 2008) extended the scope of NICAPS by investigating 
factors related to treatment outcome such as ward environment and staffing, and estimated 
unit costs of inpatient care. Eating disorders accounted for 29% of the cohort. It found a 
55% increase in specialist ED beds (driven largely by an increase in private sector provision), 
and that 66% of beds were located in London. This in turn mirrored a national trend where 
those regions with the highest number of beds per population increased availability more 
compared to other regions. The proportion of overall beds remained stable (see Figure 
2-4).The median admission cost for young people with ED was £37,470 (range £341-
122,100; 2007 prices), and average costs in general units were higher than in specialist ED 
units, with £47,430 compared to £30,370.  
The COSI-CAPS study also included a prospective cohort study of young people admitted 
to general CAMHS units and specialist ED inpatient units. The study found no difference 
in demographic characteristics of young people admitted to an eating disorder unit 
compared to those admitted to a general adolescent unit, but those admitted to an EDU had 
a higher severity of problems and showed a larger improvement from intake to discharge. 
For those with ED, the change in an ED-specific outcome measure was positively correlated 
with costs. The authors concluded that specialist units did not produce better outcomes 
(adjusting for differences at admission), and were not associated with higher levels of patient 
satisfaction. There were no differences in the average cost of admission. 
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Figure 2-4: Percentage of inpatient beds by type of unit/ward, 1999 and 20061  
 
The Royal College of Psychiatrists (RCP) undertook a further mapping exercise of services 
in the UK and Ireland in 2008 (Royal College of Psychiatrists 2012). Questionnaires were 
sent to members of the Section of Eating Disorders and the Faculty of Child and Adolescent 
Psychiatry of the RCP, with the aim of capturing all psychiatrists with an interest in ED, and 
                                                 
1 Data from (O’Herlihy et al. 2007), p. 455.  
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83 valid unique responses from services were received. Of these 83 services, 62 (75%) were 
in the NHS, with 15 (18%) in the independent and 2 (2%) in the voluntary sector.  
Inpatient care for AN was provided by 61 services (74%), while 64 (78%) provided 
outpatient care, and 40 (49%) provided day care. The number of inpatient beds for ED 
across child and adolescent and adult services in the UK was 447, with 226 provided by the 
NHS and 221 by the private sector. Of these, 330 beds (74%) were in specialist EDUs, again 
almost evenly split between the NHS and the private sector with 166 and 164 beds, 
respectively. While services remained clustered around London, the geographical 
distribution improved in England, with an increase in the number of services in the north 
of England and Scotland. Given that the data are reported for children, adolescents and 
adults combined, they do not allow us to compare the number of available beds directly to 
the COSI-CAPS study, which focussed on children and adolescents.  
While bed availability and occupancy data are published for the NHS on a quarterly basis 2, 
these data report on child and adolescent psychiatric beds and adult psychiatric beds overall, 
without providing a breakdown by specialisation. Moreover, these data do not include beds 
in the private sector.  
THE ROLE OF CHILD AND ADOLESCENT MENTAL HEALTH SERVICES 
Child and Adolescent Mental Health Services (CAMHS) are part of the landscape of mental 
health services in England. They operate under a tiered system (Tiers 1-4) designed primarily 
to match levels of specialist skill with levels of need (Royal College of Psychiatrists 2005):  
• Tier 1 services are provided by generalists such as general practitioners, social 
workers or teachers.  
• Tier 2 is provided by mental health professionals not working in a team 
environment.  
• Tier 3 is provided by multidisciplinary teams and is aimed at young people with more 
complex mental health needs.  
• Tier 4 encompasses highly specialised inpatient, day patient and outpatient services. 
                                                 
2 https://www.england.nhs.uk/statistics/statistical-work-areas/bed-availability-and-occupancy/bed-data-
overnight/; retrieved 20/06/2018 
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Recent trends have emphasised local autonomy and choice as well as the integration of child 
and adult mental health services (Callaghan et al. 2017). 
Despite a commitment to providing appropriate CAMHS services by 2006 in ‘Every Child 
Matters’ (2003) and the implementation of the ‘National Service Framework for Children, 
Young People and Maternity Services’ (1999), the 2008 final report on the CAMHS review 
(National CAMHS Review 2008) identified issues around access to services in a timely 
manner and for young people with persistent problems, driven by access criteria and regional 
variations in service provision.  
A 2005 report highlighted that specialist CAMHS lack the capacity to meet demand (Royal 
College of Psychiatrists 2005) and recommended treatment of ED in CAMHS Tiers 2 or 3, 
with Tier 4 reserved for the most severe cases, such as severe ED.  
While the 2011 strategy ‘No Health without Mental Health’ and ‘Closing the Gap: Priorities 
for Essential Change in Mental Health’ focussed on early treatment and created the 
children’s IAPT programme, the ‘Five Year Forward View for Mental Health’ 
recommendations (2016) concluded that models of care are in practice still under-developed, 
with mental health problems not adequately supported in primary care and no clear pathways 
to secondary care in place. In addition, there are efforts to support mental health is schools, 
with guidance on identifying and supporting pupils published by the Department for 
Education in 2014 (Parking & Powell 2017), and mental health support in schools is 
expected to be discussed in a forthcoming Green Paper on mental health. 
DETECTION OF ANOREXIA NERVOSA IN PRIMARY CARE AND ONWARD 
REFERRAL 
Within the tiered CAMHS framework, primary care is an important initial point of contact 
with health services for many people with AN, and often serve as gatekeepers to higher tier 
care, but the problems identified in the Five Year Forward View are found for people with 
ED.  
Ogg and colleagues (1997) reviewed case records of patients diagnosed with ED in primary 
care in Glasgow, 34 with DSM-IV diagnoses of AN. 70% of all patients were referred by 
their GP, and 21% by other specialists. In the five years prior to diagnosis, 71% consulted 
their GP more than 4 times, with common reasons for consultation being gynaecological 
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complaints related to amenorrhea or irregular periods, gastrointestinal problems related to 
ED, or psychological symptoms. Lask and colleagues (2005) also found a high level of 
primary care consultations up to five years prior to an ED diagnosis in a study of three 
groups: 19 girls with AN onset under 14, 19 girls with an emotional disorders and 10 girls 
with no history of mental health problems. Comparisons shown here are made between the 
group with AN and the non-clinical control group without mental health problems. 
On average, those eventually diagnosed with AN had 57.7 consultations (SD 39.5), with 18.6 
(SD 12.9) in the five years before diagnosis, 6.7 (SD 5.2) in the year before and 4.6 (SD 2.8) 
in the six months before diagnosis. The multi-variate analysis of variance showed that there 
was no significant difference between the three groups in terms of the total number of 
lifetime consultations (35.9 with SD = 21.7 in the non-clinical group), but higher than the 
number of consultations in the five years before diagnosis (mean=8.16, SD=6.0), in the year 
before diagnosis (mean = 1.1, SD = 0.9) and in the six months before diagnosis (mean = 
0.58, SD = 0.69). 
Those with AN had a greater number of consultations regarding eating, weight and shape, 
with most of them taking place in the six months before the diagnosis: Over the lifetime, 
those with AN had 2.53 (SD 1.43) consultations for eat, weight and shape concerns, while 
in the last six months, it was 2.5 (SD 1.42). The non-clinical control group, on the other 
hand, reported no such consultations, so that a single consultation about eating, weight and 
shape concerns was a significant predictor of early onset AN. 
But while GPs are likely to see new incident cases of AN first and an increased frequency 
of contact can be a precursor to diagnosis, a vignette study (Currin et al. 2007a) found that 
females were more likely to receive an ED diagnosis than males, even when description of 
symptoms was the same, and that diagnosis did not adhere to guidelines. Possible 
explanations brought forward are a lack of knowledge about ED (Currin et al. 2009), and 
clinical guidelines were often not used in practice (Currin et al. 2007b). Gender of the GP 
also mattered, with female GPs being more likely to diagnose and refer ED to specialist 
services (Feeney et al. 2007). Turnbull and colleagues (Turnbull et al. 1996) analysed the 
GPRD and found that 20% of people presenting with an ED were treated exclusively in 
primary care, while 93% of those with AN were referred on to specialist care. This has been 
interpreted as a lack of confidence in or knowledge of treating AN, possibly due to the 
severity of the illness. 
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Currin and colleagues (2006) surveyed 3,783 GPs in South London, Kent, Sussex and Surrey 
and about 1/3 responded. On average, GPs saw 1.9 new cases and more than 50% of GPs 
had seen a new case in the past year. On average, there were 2.3 consultations before an ED 
was diagnosed. In contrast to the stepped care approach recommended by NICE (National 
Institute for Clinical Excellence 2004), there were two distinct approaches to referral. GPs 
in an area where specialist services existed were both better at identifying ED and tended to 
refer all ED patients. On the other hand, about 27% of new cases were treated exclusively 
in primary care. The most common destinations for referral were ED specialist services 
(22.8% of GP referrals), community mental health services (21.8%), psychiatrists (15.7%) 
and CAMHS (11%). Delay until treatment commenced was on average 7.6 weeks, mainly 
because of waiting lists for specialist services or GP counsellors. The two most common 
suggestions for improving treatment were quick access to specialist services (24%) and 
training opportunities (24%). The perceived role of GPs was to identify cases, offer a 
supportive environment and then make a referral. The referral system was perceived as 
complicated, and there was a concern that specialist care was not available locally. Many GPs 
mentioned that their knowledge of available services was lacking, and referral behaviour may 
depend on the (perceived) availability of specialist care. 
While Currin’s study highlights problems with referrals, Waller and colleagues (2009) found 
that around 35% of those referred on to specialist ED services were never seen, 50% entered 
treatment and only half of those who entered finished treatment. This is similar to a highly 
cited review that found only 34.3% of people with AN were in contact with mental health 
services (Hoek & van Hoeken 2003).  
While some of these studies are now quite dated, it appears from the analysis of current 
policy recommendations that overall, the picture in CAMHS, including Tier 1 CAMHS, may 
be improving only slowly, and it is likely that these problems persist, and the recently 
updated NICE guidance on ED now recommends an immediate referral of suspected ED 
to community-based ED services (National Institute for Health and Care Excellence 2017a). 
OUTPATIENT SERVICES FOR EATING DISORDERS 
Gaps in NHS provision had led young people with acute needs being admitted to adult and 
paediatric wards (Tulloch et al. 2008). With reforms to the NHS, the private sector started 
filling gaps in provision from the 1980s (Treasure 2002).  
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In a 1999 survey, 82% of ED inpatient beds were managed by the private sector (O’Herlihy 
et al. 2003b), While a later study reported an increase of 69% in the number of independent 
sector beds from 1999 to 2006, while in the same period, NHS provision increased by only 
11%, thus widening the gap in provision from 75% to 82% (O’Herlihy et al. 2007). There is 
also a pattern to be observed that private units appear to be less likely to participate in 
research studies (House et al. 2012; Tulloch et al. 2008). 
This ‘mixed economy’, particularly in the area of ED, has led to substantial financial flows 
from the public to the private sector and increases the cost of treatment (Brown 1997; 
Treasure 2002). In response, additional NHS services were created, mostly in outpatient 
settings (Palmer & Treasure 1999). 
At the same time, ‘treatment philosophy’ for AN shifted from a medical view focussing on 
weight restoration, to a more holistic view that includes the family both as a resource for the 
patient and recipients of support (Eisler 2005; House 2011). It is now thought that most 
people with ED can be treated on an outpatient basis (Gowers & Bryant-Waugh 2004). This 
was supported by a notion that inpatient treatment is not associated with better outcomes 
than community-based care (Tulloch et al. 2008) and may even be lead to comparatively 
negative outcomes (Meads et al. 2001; National Institute for Clinical Excellence 2004). 
At the same time, there is a debate around whether the degree of service specialisation 
contributes to treatment outcome. The TOuCAN trial (Gowers et al. 2010) compared the 
costs and outcomes of inpatient treatment, specialist outpatient treatment and treatment as 
usual in CAMHS for 167 adolescents aged 12-18 with AN. There were significant 
improvements after one, two and five years in all three groups, and there was no difference 
in outcomes when controlling for baseline characteristics. The cost-effectiveness analysis 
showed that specialist outpatient treatment had the highest probability of being cost-
effective. One limitation of this study was that only 65% of patients adhered to the allocated 
treatment. 
House (2011) mapped ED services beyond primary care for all Greater London PCTs and 
tracked the care pathways and treatment of young people aged 13-18 with AN over 12 
months. The aim was to explore care pathways with a view to the effect of service 
specialisation. Three distinct care pathways were identified based on the first service contact 
and referral: 1) specialist to specialist service, 2) non-specialist to specialist service and 3) 
non-specialist to non-specialist service. The non-specialist to non-specialist care pathway 
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was associated with a lesser degree of continuity of care and higher inpatient admission rates. 
Participants on this pathway had a higher gain in weight for height, the measure of 
improvement, which may have been driven by inpatient admissions. As the author discusses, 
the study results may not be representative of the situation in England because availability 
of specialist services is higher in London, which may affect the relative importance of the 
non-specialist to specialist pathway. However, given that previously there was little 
knowledge about actual care pathways which the differ considerable from the intended care 
pathway within a PCT, this study is the most comprehensive evidence on service 
organisation and service use of people with AN in the UK to date. 
ECONOMIC EVALUATIONS OF TREATMENTS FOR ANOREXIA NERVOSA 
Despite a keen interest in economic evaluations for treatments of AN, there is little empirical 
evidence available. However, there is no dearth of reviews attempting to identify such 
studies, and several recent systematic reviews are available. I draw on them to summarise 
the available evidence on cost-effective treatments for AN, and on economic evaluations of 
AN treatments more generally. 
Stuhldreher and colleagues (2012) helpfully distinguish between cost-effectiveness analyses 
(CEA) and ‘other cost studies’ (OCS), with the former including studies comparing at least 
two treatment options on both outcomes and costs (encompassing also cost-utility analyses 
and cost-benefit analyses; CUAs and CBAs), and latter being a catch-all term for studies that 
do not fully meet these criteria, e.g., a cost-consequence analysis, or a study presenting both 
costs and outcomes but not formally analysing their joint distribution. The authors further 
pointed to the different approaches available: Conducting an economic analysis or 
evaluation as part of a clinical trial (usually, this will be a CEA) or other empirical data 
(usually, this will be an OCS), or performing a model-based analysis.3 These distinctions will 
be applied in this section to categorise studies identified in the reviews. In addition, a 
distinction is made between ‘prevention’ and ‘treatment’ – with prevention studies usually 
focussing on ED more generally, rather than a single disorder. 
A systematic review of the cost-effectiveness literature was undertaken as part of the recent 
review of the NICE guidance on eating disorders (National Institute for Health and Care 
                                                 
3 More detail on these methods is provided in Chapters 2 and 3. 
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Excellence 2017a) which identified six studies for inclusion (Agras et al. 2014; Byford et al. 
2007a; Crow & Nyman 2004; Egger et al. 2016; Herpertz-Dahlmann et al. 2014; Williamson 
et al. 2001). A slightly more recent systematic review (Le et al. 2017b) identified three 
additional studies for inclusion (Aardoom et al. 2016; Akers et al. 2017; Wright et al. 2014). 
On ad-hoc search of PubMed for additional literature, conducted as part of revisions to the 
thesis in 2018, unearthed a further two studies (Bode et al. 2017; Le et al. 2017a). In addition, 
I drew on several Cochrane reviews to summarise the evidence for different forms of 
treatment: Self-help and guided self-help (Perkins et al. 2006), anti-depressants (Claudino et 
al. 2006), family therapy (Fisher et al. 2010), individual psychological therapy on an outpatient 
basis (Hay et al. 2015) and prevention of eating disorders (Le et al. 2017c; Pratt & 
Woolfenden 2002), which did not add to the list of studies. 
I summarise the findings of these reviews in Table 2-2, based primarily on Le and colleagues 
(2017b) and NICE (National Institute for Health and Care Excellence 2017a), and provide 
more detail on full cost-effectiveness studies of treatments for AN, i.e. those that collect 
individual-level cost data across multiple cost categories (see Chapter 3 for more detail on 
the need to capture all relevant costs in an evaluation). 
In total, there were five CEAs conducted alongside an RCT (Aardoom et al. 2016; Akers et 
al. 2017; Byford et al. 2007a; Egger et al. 2016; Herpertz-Dahlmann et al. 2014), and only two 
of these (Byford et al. 2007a; Egger et al. 2016) were RCTs evaluating an intervention to treat 
AN while also collecting individual-level cost data. Other studies either looked at only 
intervention costs or intervention costs and narrow health care costs or used average (top 
down) cost figures, e.g. cost per inpatient stay, average total societal costs) instead of 
performing bottom-up costing at the individual level and individual-level statistical analyses 
of cost data. 
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Table 2-2: Economic evaluations of AN treatment 
Study and 
analysis type 
Interventions and 
outcome measure 
Country, 
population 
Currency, 
discount rate 
and time 
horizon 
Cost perspective, included 
cost categories 
Main findings 
Aardoom et al 
(2016); CUA 
alongside RCT 
Three variants of 
‘Featback’ intervention vs 
waitlist; 
QALY 
The Netherlands; 
Females >= 16 
with self-reported 
ED symptoms 
2015 € 
No information 
5 months 
Societal; 
Intervention costs, health 
care costs, productivity 
losses 
Intervention without or with low-
intensity therapist support were 
dominant compared to the waitlist 
control. 
Agras el al 
(2014); OCS 
alongside RCT 
Family-based treatment 
(FBT) vs systemic family 
therapy (SyFT); 
Percentage in remission 
USA; 
Adolescents 12-18 
years with AN 
2007 $ (year 
unclear); 
Not applicable 
End of 
treatment (36 
weeks) 
Payer; 
Intervention costs, hospital 
admissions; 
Cost difference FBT vs SyFT -$9,042; 
Difference in remission rates: 8% 
Akers et al 
(2017); CEA 
alongside RCT 
Cognitive dissonance 
interventions vs 
educational brochure; 
meaningful clinical change 
in ED symptoms 
USA; 
Females with 
average age of 21.6 
years 
2012 $ 
No rate applied 
3 years 
Payer (university); 
Intervention costs only 
ICER: US$856 per individual with 
meaningful clinical change 
Bode et al 
(2017); Model-
based OCS 
(cost-offset) 
CBT and focal 
psychodynamic therapy 
(FPT) for AN vs 
optimised TAU; 
No outcome measures. 
Germany; 
General 
population with 
AN. 
2014 or 2015 € 
(year unclear); 
Not applicable; 
12 months 
Societal; 
Individual therapy, inpatient 
treatment, productivity 
losses, sickness benefits, 
early retirement benefits, 
mortality 
Potential savings of € 2.51 and €2.33 
per € invested for CBT and FPT, 
respectively 
The Butterfly 
Foundation 
(2015); Model-
based CUA 
Best practice model vs 
TAU; 
DALYs 
Australia; 
People with ED 
2013 AUS$ 
(year unclear); 
7%; 
10 years 
Societal; 
Intervention cost, health 
care, productivity, 
employment, welfare 
Cost difference: -AUS$57,690 
DALY difference: -1.29 
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Study and 
analysis type 
Interventions and 
outcome measure 
Country, 
population 
Currency, 
discount rate 
and time 
horizon 
Cost perspective, included 
cost categories 
Main findings 
 Best practice model is dominant. 
Savings per participant over 10 years 
of AUS$250,261. 
Byford et al 
(Byford et al. 
2007a); CEA 
alongside RCT 
Specialist outpatient 
treatment (SOP) vs 
inpatient treatment (IT) vs 
general outpatient 
treatment (GOT; 
Morgan-Russel scores 
(MRAOS) 
UK; 
Adolescents aged 
12-18 with DSM-
IV diagnosis of 
AN 
2003/04 £ 
3.5% 
2 years 
Public sector; 
Health care, social care, 
education 
At 2 years: 
Specialist outpatient treatment 
dominant. At WTP £0 per point 
improvement on MRAOS, probability 
of cost-effectiveness is 
78% for SOP, 16% for IP, 6% GOT. 
Crow & Nyman 
(2004), Model-
based CEA 
Adequate care vs usual 
care; 
Years of life saved 
USA; 
Unspecified 
population with 
AN 
2002 or 2003 $ 
(year unclear) 
No discount 
rate 
Lifetime 
Payer; 
Intervention costs only. 
ICER: US$30,180 per year of life 
saved (for adequate care) 
Eggers et al 
(2016); CEA 
alongside RCT 
Focal psychodynamic 
therapy (FPT) vs CBT vs 
optimised TAU; 
Recovery, QALY gained 
Germany; 
Females >=16 
years with DSM-
IV AN and sub-
threshold AN 
2008 €; 
Discount rate 
unclear 
22 months 
Societal; 
Intervention costs, health 
care costs, informal care, 
travel, productivity losses. 
FPT dominant on both outcomes and 
for direct costs only and from a 
societal perspective. 
Probability that FPT is cost-effective 
<68% vs TAU and <67% vs CBT at 
WTP of €50,000 per QALY gained. 
Probability >=85% for cost per 
recovery >= €10,000 compared to 
CBT and >=25,000 for TAU. 
Herpertz-
Dahlmann et al 
(2014); CEA 
alongside RCT 
Day treatment following 
short inpatient care vs 
continued inpatient care; 
Improvement in BMI 
Germany; 
Adolescent 
females aged 11-18 
with AN 
2013 € (year 
unclear); 
Not applicable; 
12 months 
Payer; 
Psychiatrist, psychologist, 
inpatient admissions, 
outpatient visits. 
Day treatment is dominant 
intervention. 
Difference in average costs per 
participant and difference in change in 
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Study and 
analysis type 
Interventions and 
outcome measure 
Country, 
population 
Currency, 
discount rate 
and time 
horizon 
Cost perspective, included 
cost categories 
Main findings 
Note: No individual-level 
cost data collection. 
BMI: -€8,367 (p=0,002), 0.46 
(p<0.0001). 
Le et al (2017a); 
model-based 
CUA 
Family based treatment 
(FBT) vs adolescent-
focussed individual 
therapy (AFT) vs no 
intervention; 
DALY averted 
Australia; 
Adolescents aged 
11-18 with AN of 
short duration 
2013 AUS$; 
N/A; 
6 years 
Payer and carers; 
Intervention cost (including 
training and supervision), 
clinical investigations, GP 
visits, hospitalisation, carer 
time and travel cost 
Mean ICER: 
FBT $5,089 per DALY averted 
AFT $51,891 per DALY averted 
Probability of being cost-effective at 
AUD$ 50,000 per DALY averted: 
100% (FBT) and 45% (AFT). 
Williamson et al 
(2001); OCS 
Partial day hospital care vs 
inpatient care; 
No outcome measure 
beyond hospitalisation 
USA; 
People with 
AN/BN or sub-
threshold AN/BN 
2000 $ (year 
unclear); 
Not applicable; 
12 months 
Payer; 
Intervention cost, inpatient 
admissions 
Cost difference -$9,645, p<0.02 
Wright et al 
(Wright et al. 
2014); Model-
based CUA 
ED screening vs current 
practice; 
Life years with ED 
avoided and QALY 
gained 
USA 
Males and females 
aged 10-17 years 
2012 $ 
3.5% 
10 years 
Payer;  
Intervention costs, health 
care costs 
ICER: US$9,231 per life year with ED 
avoided; US$57,687 per QALY gained 
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The TOuCAN trial (Byford et al. 2007a; Gowers et al. 2010) compared the costs and 
outcomes of inpatient treatment, specialist outpatient treatment and treatment as usual in 
Child and Adolescent Mental Health Services (CAMHS) for 167 adolescents aged 12-18 
with AN. One limitation of this study was that only 65% of patients adhered to the allocated 
treatment. Figure 2-5 illustrates patient movement from allocated treatment (top) over the 
course of the trial (based on Gowers et al. 2010), either due to clinical need or due to patient 
and family preference. It is therefore not surprising that the proportion with a ‘good 
outcome’ in each randomisation group was very similar (around 60-67%), and average costs 
per week over the two-year follow-up period were also similar, ranging from £253 for the 
specialist OP group to £386 in the general CAMHS group (2003/04 costs). 
Figure 2-5: Treatment adherence in the TOuCAN trial 
 
Cost data were collected from clinical records and patient report at the one-year and two-
year follow-up. There were significant improvements on the Morgan-Russel scale (Morgan 
& Hayward 1988), a measure of AN symptoms, after one, two and five years in all three 
groups, and there was no difference in outcomes when controlling for baseline 
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characteristics. The cost-effectiveness analysis showed that specialist outpatient treatment 
had the highest probability of being cost-effective (up to ca. 60%).  
More recently, the ANTOP trial (Anorexia Nervosa Treatment of Outpatients) in Germany 
compared three models of outpatient treatment for adult females with AN: focal 
psychodynamic psychotherapy (FPT), enhanced cognitive-behavioural therapy (CBT-E), 
and optimised treatment as usual (TAU-O). Cost data were collected from monitoring data 
and hospital records (inpatient treatment) over a period of 22 months, and data on other 
health care services and productivity losses were collected using questionnaires covering a 
3-month retrospective period at baseline and at 22 months. Average total costs at 22 months 
in the FPT group were €21,512 (2008 prices), €24,690 in the CBT-E group and €24,827 in 
the TAU-O group. Hospitalisation was required for 19% of patients assigned to FPT, 29% 
of patients in CBT-E and 40% in TAU-O. The contribution of productivity losses from 
absenteeism and presenteeism to total costs at follow-up was 53% in the FPT group, 52% 
in CBT-E and 46% in TAU-O. In the FPT group, 35% of patients were recovered at the 
end of the study, compared to 21% in CBT-E and 12.5% in TAU-O. These results show a 
trend towards higher hospitalisation rates and associated higher service costs in the TAU-
O group, alongside a poorer outcome. Cost-effectiveness analysis employing a net-benefit 
approach adjusting for baseline variables showed a probability that FPT (compared to 
TAU-O) would be considered cost-effective of 95% if an additional recovery is valued at 
€9,825 or more. In a comparison of FPT with CBT-E, the probability reached 85% at a 
valuation of >=€24,550 per recovery. In the comparison of CBT-E with TAU-O, the 
probability that CBT-E would be considered cost-effective did not reach values above 90% 
for valuation values of up to €150,000 per recovery. While the study authors point to 
uncertainty with regard to their cost estimates (e.g. measurement of productivity losses), 
another limitation in the context of economic evaluation is using ‘recovery’ as an outcome, 
as recovery is likely to be associated with discharge or stepping down of care. Recovery 
therefore affects both the cost and outcome side of the cost-effectiveness equation. 
While the evidence base regarding the cost-effectiveness of AN treatments is growing, there 
remains a need for robust empirical studies that consider the full range of relevant costs 
and are able to employ patient-level analysis strategies. Model-based analyses represent an 
alternative where empirical data are lacking, but best practice recommendations, including 
transparency about assumptions and addressing issues of uncertainty, need to be followed. 
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WHAT ARE THE SOCIETAL COSTS OF ANOREXIA NERVOSA? 
COST OF ILLNESS ESTIMATES FOR ANOREXIA NERVOSA 
As above, I apply the definition by Stuhldreher and colleagues (2012), who define CoIs as 
a study aiming to determine the costs due to AN for more than one cost category (e.g., 
inpatient treatment only), and where the analysis is not limited to only one type of 
intervention or treatment. Studies aiming to determine costs but not meeting the other 
criteria are referred to as ‘other cost studies’ (OTCs). 
At the time of inception of this thesis, the literature on CoI of AN had recently been 
reviewed by Simon and colleagues (Simon et al. 2005) who found two ‘full’ CoI studies 
(Krauth et al. 2002; Office of Health Economics 1994), i.e. studies taking a societal 
perspective, and three ‘partial’ cost studies estimating the direct costs of ED treatment for 
inpatient treatment only (Nielsen et al. 1996; Rathner & Rainer 1997) and for inpatient and 
outpatient treatment (Striegel-Moore et al. 2000). 
A later review (Stuhldreher et al. 2012) identified one additional CoI for AN (Mitchell et al. 
2009). Crow (2014) identified two RCTs collecting broader costs in the health domain over 
a three-month retrospective period (Stuhldreher et al. 2015) and a two-year period (Byford 
et al. 2007a) as well as one study looking at inpatient costs only (Haas et al. 2012b). 
A further systematic review (Ágh et al. 2016) identified another two studies looking at 
inpatient costs only (Haas et al. 2012a; O’Brien & Patrick 2008) and a study reporting costs 
associated with outpatient family therapy (Lock et al. 2008). 
Finally, Striegel Weissman and Rosselli (2017) identify a study of the costs associated with 
inpatient treatment that also considers the costs falling on caregivers in terms of lost work 
productivity and lost leisure time (Toulany et al. 2015) and a study of out-of-pocket 
expenditure and its relationship to treatment adherence (Gatt et al. 2014). 
My additional searches, which focussed primarily on full CoI studies for England and 
included searches of the ‘grey’ literature, identified two additional CoI studies for England 
(King’s Fund et al. 2008; ProBono Economics 2012). Another ‘grey’ literature study (The 
Butterfly Foundation 2015) was included in the NICE evidence review on cost-effective 
treatments for ED (National Institute for Health and Care Excellence 2017b). In the UK 
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context, the COSI-CAPS study estimated the costs of inpatient stays for ED (Tulloch et al. 
2008). 
It should be noted that there are of course other ‘partial’ cost studies looking at specific 
aspects of ED treatment, such as Brown (1997), who investigated the ‘mixed economy’ of 
ED treatment, i.e. the growing involvement of the private sector in ED treatment in the 
UK, studies undertaking simple, often ad-hoc cost analyses of one or several treatment 
options or service models (Birchall et al. 2002; Meads et al. 2001). Other studies do not 
distinguish between different types of ED (de Oliveira et al. 2016). There are also studies 
that report a societal cost estimate (for example, Gustavsson et al. 2011), but in fact use data 
from one other study (Krauth et al. 2002) that are used to extrapolate to different contexts. 
Table 2-3 shows an overview of the identified ‘full’ CoI studies, indicating which cost 
categories were included. While not a CoI study, I also show the study by Byford and 
colleagues (Byford et al. 2007a), as although it covers a selected patient population rather 
than attempting to calculate total societal costs, it covers the widest range of services and 
supports and is particularly relevant to the English context.
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Table 2-3: Overview of CoI estimates 
Study Country Direct costs Indirect costs Intangible costs 
Office of Health Economics (1994)  England 
Inpatient treatment 
General practice 
No No 
Striegel-Moore et al (2000) USA 
Inpatient treatment 
Outpatient treatment 
No No 
Krauth et al (2002) Germany 
Inpatient treatment 
Rehabilitation/convalescence 
Pension insurance 
Inability to work 
Premature mortality 
No 
Byford et al (2007a) UK 
Inpatient treatment 
Outpatient treatment 
Primary care 
Social care 
Voluntary sector 
Education 
No No 
King’s Fund (2008) England 
Inpatient treatment 
Outpatient treatment 
Productivity losses No 
Mitchell et al (2009) USA 
Hospital/clinic 
Health care provider 
Prescription medication 
No No 
ProBono Economics (2012) England Inpatient treatment 
Unemployment 
Reduced earnings 
Premature mortality 
Premature mortality 
The Butterfly Foundation (2012) Australia 
Hospital 
Out-of-hospital treatment 
Medication 
Out of pocket expenditure: food, travel 
Carer costs/transfers 
Other indirect costs 
Funeral costs 
For all EDs: 
Loss of income 
Absenteeism 
Lost home production 
Presenteeism 
Premature mortality 
For all EDs: 
Burden of disease 
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While there has been an increase in the number of CoI estimates available, at the time this 
study was conceived, no existing study included all types of costs separately for AN, and 
the spectrum of services and impacts included is often limited. Below, I provide more detail 
on full CoI studies, first presenting the ‘international’ estimates and then focussing on 
estimates for England and the UK, as they are most relevant to this thesis. Prices in 2010/11 
£are provided for comparison purposes. These have been uprated using the appropriate 
GDP deflator to 2010/11 prices and then converted to £1. 
INTERNATIONAL ESTIMATES 
Krauth and colleagues (2002) estimated the annual cost of EDs for Germany based on a 
sample of benefit data from statutory health insurance and statutory pension insurance. The 
cost of inpatient treatment was based on average hospital charges. A projected 4,618 people 
received inpatient treatment at a total cost of €59.1m (£56.9m). Rehabilitation measures in 
convalescence centres (485 cases) cost €2.7 million (£2.6m), rehabilitation (474 cases) €3.1 
million (£3m). Productivity losses were calculated based on 1,155 people each losing 78.4 
days of work (€8 million; £7.7m), and the discounted present value of future earnings for 
214 people who died prematurely due to AN (€122.5 million; £117.9m). The total annual 
cost of AN was estimated at €195.4 million (£188m; range €115.1 million-€297.4 million; 
£110.7m-£286.1m) and €5.3000 per person (£50,990). The authors state that this is 
relatively low compared to the total cost of other conditions such as cardiovascular diseases 
or obesity; however, the proportion of indirect cost is high at 67%, driven by high mortality 
rates in a young patient population. 
Striegel-Moore and colleagues (2008) searched the 1995 MarketScan insurance database to 
quantify the use and cost of services in the US. 517 female and 49 male patients were treated 
for AN (2000). 21.5% of females and 18.4% of males were hospitalized for AN, with an 
average length of stay of 26 days at a cost of $17,384 (females; £15,433) and 15.6 days at a 
cost of $8,799 (males; £7,811). The cost of outpatient treatment was $2,344 for females and 
$1,154 for males (£5,366 and £2,438). The mean annual cost of treatment was $6,045 for 
                                                 
1 Data from https://data.worldbank.org/indicator/ and 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/371079/Avg-year-
20110331.csv/preview 
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females and $2,746 for males (£5,366 and £2,438). According to this estimate, treatment 
costs for females with AN are higher than those for schizophrenia ($4,824; £4,283). 
A partial CoI study of AN from the US covered inpatient costs, outpatient care, and the 
costs of drugs based on a claims database (Mitchell et al. 2009). This study included a non-
ED control group and calculated the additional costs due to AN at $1,288 (£988). 
Deloitte Access Economics estimated the annual costs associated with ED in Australia on 
behalf of the Butterfly Foundation (The Butterfly Foundation 2012). While this estimate 
was ambitious and includes a comprehensive list of cost categories, beyond health care data 
there were few empirical data sources so that a lot of uncertainty around the assumptions 
made to construct the estimate and – except for direct health care costs – it was not possible 
to distinguish between different types of ED. Table 2-4 outlines the components of the 
estimate and shows the resulting costs in 2010/11 GBP. 
Table 2-4: Australian CoI estimate for AN, in original currency and 2010/11 GBP (£) 
Cost category 
Cost for AN/ED in 
2008/09 AUD 
Cost in 2010/11 
GBP 
Hospital (AN only) 57.8m 38.6 m 
Out of hospital medical expenses (AN 
only) 
1.5m 1.0 m 
Prescriptions (AN only) 0.5m 0.3 m 
Loss of income 5.98bn 4.0bn 
Absenteeism and lost home production 1.8bn 1.2bn 
Presenteeism 5.3bn 3.5bn 
Productivity losses from premature death 2bn 1.3bn 
Carer costs 8.54m 5.7m 
Other indirect costs 585m 390.6m 
Funeral costs 9m 6.0m 
Deadweight loss (government transfers 
and revenue forgone) 
9m 6.0m 
Burden of disease (intangible costs) 52.6bn 35.1bn 
 
With the exception of the Deloitte estimate (The Butterfly Foundation 2012), none of the 
international CoI estimates attempt to include intangible costs. The firmest data available 
are those for inpatient treatment, which is arguably the most important health service cost 
to capture as it likely accounts for a large proportion of health care costs. There is more 
uncertainty around estimates of outpatient treatment, and – given the high cost of inpatient 
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treatment and the shift in ‘treatment philosophy’ towards outpatient treatment – there is a 
need to improve data quality with respect to the costs of outpatient services. 
UK ESTIMATES 
An early study of the cost of EDs in the UK (Office of Health Economics 1994) adopted 
a health service provider perspective and used data from the National Survey of Morbidity 
in General Practice and the Hospital Inpatient Enquiry to estimate service use in general 
practice, inpatient bed days and prescriptions. Intangible costs were not included, and while 
the intention was to include the costs of outpatient treatment, no information was available 
so no costs were included. The total cost to the NHS was estimated at £4.2 million per 
annum €6m in 2010/11 prices). This study has a limited perspective, primarily due to a lack 
of data availability. 
The King’s Fund (2008) estimated the service cost and lost employment of AN in the UK. 
Based on the Hospital Episode Statistic, the costs of inpatient care were estimated to be 
£2.5 million in 2007/08 prices (2010/11 £2.65m) for people under age 15 and £8m 
(£8.48m) for people aged 15-34. The cost of outpatient treatment was derived assuming 
that only 34.4% of all people with AN are in contact with mental health services (following 
Hoek and van Hoeken ), and that outpatient costs are 41% of inpatient costs (following 
Striegel-Moore et al (2008), or £4.4 million (£4.54m). Lost employment was calculated on 
the basis that 1,830 people received Incapacity Benefits for EDs. Assuming a weighted 
annual salary of £19,051 (£20,201), the annual cost of unemployment was £33 million 
(£35m). The total cost was £48m (£50.9m) per annum, with 69% due to lost productivity. 
ProBono Economics (2012) put together an estimate of the costs associated with ED. Their 
estimate included the costs of inpatient and outpatient treatment, primary care and private 
healthcare, well as lost earnings, disease burden and premature mortality. Generating a 
highest and lowest estimate, they estimated the range of costs of ED to be between £1.26bn 
and £9.6bn in 2011/12 prices (£1.24bn and £9.47 in 2010/11 prices, respectively); much 
of it due to intangible costs and productivity losses.  
The King’s Fund study and the ProBono Economics study both draw on HES data to 
estimate the number of inpatient days. They then applied assumptions to determine the 
number of days provided to children and adolescents vs adults (King’s Fund: ¾ of inpatient 
days in for people under age 35; ProBono Economics: The total costs of adult admissions 
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are about twice as high as those for children). Unit costs are then applied, and while both 
use PSSRU unit cost data from 2006 and 2009/10 respectively, there was a large difference 
in estimates at £213 and £503 (in 2010/11 prices), respectively. This demonstrates that even 
though similar data sources were used, large differences in estimates can still arise, with a 
King’s Fund estimate of inpatient costs of £11m and a ProBono Economics estimate of 
£49m – although the latter estimate is unable to differentiate between AN and BN (both 
estimates shown in 2010/11 prices). Data quality declines as we move further ‘outward’ 
from inpatient costs, so that productivity losses are estimated purely on assumptions (rather 
than empirical evidence) about unemployment and productivity reductions, and usually 
drawn from different mental health problems such as depression. It is unclear whether these 
data are applicable to AN. 
Similar to the picture presented by the international studies, there is great uncertainty 
around the costs of outpatient treatment. The King’s Fund estimate is based on the ratio of 
outpatient costs to inpatient costs found by Striegel-Moore for the US (Striegel-Moore et al. 
2000), while ProBono Economics base their estimate on unpublished HES data (ProBono 
Economics 2012, p. 19). This points to the large gap in our understanding in the costs of 
outpatient care for AN. 
When looking at estimates from different countries it is important to keep in mind that 
costs depend on the organisation of the specific health care system, prevailing approach to 
treatment and insurance arrangements, so that the results may not necessarily be 
comparable on a like-for-like basis. This explains at least some of the variance between the 
different estimates, although Striegel Weissman and Rosselli (2017) report that even US 
estimates varied from $127 to $8,042 per patient2, and there is a large amount of 
heterogeneity of methods, perspectives and assumptions. As a result, Striegel Weissman 
and Rosselli in 2017 arrive at the same conclusion as Stuhldreher did in 2012:  
“(A) comprehensive evaluation of all costs associated with eating disorders are still 
lacking, as are studies that utilize an appropriate non-disorder comparison group 
for estimating excess costs due to an eating disorder” (Striegel Weissman & Rosselli 
2017, p. 52). 
                                                 
2 As it is unclear what the price years is for these costs, I am unable to uprate these consistently. 
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WHY DO COSTS VARY? 
The production of welfare approach explores whether the level of cost is related to the 
observed change in clinical outcome, adjusting for patient characteristics3. The question this 
approach answers is therefore whether there is a significant relationship between resources 
invested and outcomes achieved.  
One early study of service use in AN, Button and colleagues (1997) tracked 100 consecutive 
patients referred to an eating disorders service; 21 had a diagnosis of AN. There was no 
statistically significant relationship between service consumption, measured as therapy 
sessions, inpatient admissions and correspondence, and outcome at follow-up. Time in 
contact was almost significant, with a longer contact time predicting a poorer outcome. A 
diagnosis of AN and working part time were predictors of longer time in contact with the 
service and more correspondence. 
In the more recent COSI-CAPS study (Tulloch et al. 2008), the costs of inpatient admissions 
were not significantly associated with quality of life or mental health scores, nor were they 
associated with BMI at admission. 
Inpatient care is a significant contributor to the total costs associated with AN. Inter-
individual variation in total hospital costs is typically (and perhaps trivially) driven by length 
of stay. Length of stay appears to vary significantly between international studies, as do 
costs per stay. A US study found an average of 26 days in a system where outpatient 
treatment appeared to be the norm at a cost of $17384 (Striegel-Moore et al. 2000), 
compared to 50 days at a cost of €12800 in a German study (Krauth et al. 2002). 
Recently, studies using micro-costing approaches in costing inpatient stays have made it 
possible to look at variations in cost per day as well as cost per stay.  
Haas and colleagues (2012b) studied the hospital costs associated with ED admissions to a 
Berlin hospital in 2006-2009. AN was associated with higher costs than BN or ED-related 
obesity. A co-morbid personality disorder and a unit decrease in admission BMI in AN 
predicted increased hospital cost. In another study, lower admission BMI and personality 
and behaviour disorders were positively associated with costs (Haas et al. 2012b). These 
                                                 
3 More on the production of welfare approach in Chapter 3. 
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studies were motivated by the impending introduction of a tariff system for reimbursement 
and the question whether a single tariff should apply to all ED. 
Lower BMI was also a significant predictor of higher hospital costs in a recent Canadian 
study (Toulany et al. 2015), where a unit increase in BMI was associated with a 15.7% 
decrease in costs.4 In an analysis of the US Medical Expenditures Panel Survey (Samnaliev 
et al. 2015), comorbid mental health problems were associated with a non-significant trend 
towards higher costs. 
Stuhldreher and colleagues (2015) found that women commencing outpatient treatment 
who reported a hospital stay in the preceding three months had four times higher costs than 
those without a hospital stay. Predictors of total costs in those reporting outpatient 
treatment only were whether the disorder was of the binge-purging type, whether duration 
of illness was greater than six years and whether at least one mental health comorbidity was 
present. BMI was not associated with total costs. For women with a hospital admission, a 
higher BMI at baseline, i.e. after hospitalisation, was associated with higher costs. The 
authors stipulate that an increased weight gain is associated with a longer hospital stay. 
A study using data from the US Medical Expenditure Panel Survey estimated the difference 
in annual health care costs, employment status and income, comparing participants with 
and without ED (Samnaliev et al. 2015). Health care costs were larger for the ED group. 
The impact of mental health comorbidity was significant for annual earnings. 
                                                 
4 This study also investigated variations in caregiver costs in terms of lost work productivity and lost leisure 
time, and found higher BMI and younger age to be negatively associated with these costs. 
79 
 
 
CONCLUSIONS  
ON THE USEFULNESS OF COST OF ILLNESS STUDIES 
Economics is the science concerned with efficient allocation of resources, and health 
economics is therefore concerned with the efficient allocation of resources in the area of 
health. One of our tools is economic evaluation, which involves comparing two alternative 
courses of actions in terms of both their costs and their impact on health (Drummond et al. 
2015). Cost of illness studies (CoI) focus only on the costs, and are therefore not a form of 
evaluation. There is a longstanding debate in the literature about whether their construction 
is a useful pursuit. 
Koopmanschap (1998) summarises the debate around the usefulness of CoI studies in the 
context of health policy. The primary point of criticism is that – as pointed out above – CoI 
studies alone do no aid in the evaluation of healthcare programmes because they themselves 
do not include information on effectiveness. However, CoI studies can be combined with 
information on effectiveness into cost-effectiveness analyses using economic modelling 
techniques that combine information from a variety of sources where no single source (such 
as individual-level data on costs and effects from an RCT) is available (Drummond et al. 
2015). It is further argued that CoI estimates can help to prioritise conditions where future 
economic evaluations may be useful. On the other hand, this may lead to prioritisation of 
programmes for diseases that are already expensive.  
Kennelly (2017) suggests that CoI estimates may simply miss the point, as most health care 
expenditure is effective and there is no compelling reason why there should be less of it. 
In my view, a large cot of illness may be caused by underinvestment in prevention or 
treatment, resulting in a large burden, for example in terms of lost productivity or excess 
mortality, that could be avoided with provision of additional (effective) interventions.  
Moreover, CoI studies can usefully highlight major cost components contributing to total 
costs, and explain trends or project costs as part of scenario analysis. 
Byford and colleagues add that “simply identifying an area of high expenditure does not 
provide enough information to suggest inefficiency and waste and so should not 
automatically take precedence for further scrutiny” (Byford et al., 2000, p. 1135). They 
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further argue that CoI estimates do not help determine how much of the cost could be 
saved, as diseases will not be completely eradicated, and it is unclear whether prevention 
will be cheaper than the CoI. Low prevalence condition with a high cost to individuals that 
are amenable to prevention may result in lower societal CoI than high prevalence 
conditions.  
This argument points us in the direction of perhaps calculating a cost per person with a 
condition, in addition to a societal figure, as the point is well taken and raises important 
questions around equity – particularly where investment in health care is primarily from 
funds raised by general taxation. 
This adds further to the argument that CoI studies – while they may have some intrinsic 
value – are at best a first step towards economic evaluation. As mentioned above, economic 
evaluation such as cost-effectiveness analysis requires information on both costs and 
effectiveness. The distinction between ‘incidence-based’ and ‘prevalence-based CoI 
estimates (see above) is important when discussing the usefulness of CoI estimates.  
Incidence-based CoI studies that model or describe the course of an illness over time for 
an individual and attach costs to ‘health states’ (e.g. the costs associated with service use in 
the year prior to diagnosis of AN, or the costs associated with productivity losses as a 
consequence of early-onset AN) can provide the ‘cost’ side of the cost-effectiveness 
equation. In such a model-based economic evaluation, the costs associated with the course 
of AN without the intervention being evaluated or a second, comparator intervention, 
would be compared to the intervention under study. 
Figure 2- 6 shows a simplified model of the course of illness for AN. A discussion of 
individual-level modelling approaches can be found in Chapter 3. 
Here, three possible ‘states’ are available: 
• Never AN: An individual never goes on to have AN. 
• Current AN: An individual is currently diagnoses with AN. 
• No longer AN: An individual who had AN is no longer affected. 
In a model with ‘Markov periods’, which is a simple form of economic model that is used 
here as an example, individuals are assumed to spend a specified amount of time in a state, 
for example, a one-year period. 
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In addition, there are six ‘transitions’ with their associated ‘transition probabilities’ (where 
pairs such as α and 1-α add up to 100%): 
• Remains healthy: An individual without AN in period t still does not have AN in 
period t+1 (α). 
• Onset of illness: An individual without AN in period t has AN in period t+1 (1-α). 
• Illness persists: An individual with AN in period t still has AN in period t+1 (β). 
• Remission: An individual with AN in period t no longer has AN in period t+1 (1-
β). 
• Remains in remission/recovery: An individual with AN in period t and no AN in 
period t+1 is still without AN in period t+2 (γ). 
• Relapse: An individual who was in remission from AN in period t+1 has AN in 
period t+2 (1-γ). 
Individuals move between ‘states’ via ‘transitions’, from one period to the next. There is a 
‘transition probability’ attached to each transition. In addition, costs are attached to each 
state and each transition.  
For example, the costs associated with individuals never having AN may be assumed to be 
zero, as no additional costs due to AN arise in this case. As shown above, costs increase in 
the year prior to diagnosis due to an increased frequency of GP visits. The transition ‘onset 
of illness’ therefore could be associated with these costs. While no data are available for the 
‘No longer AN’ state, i.e. no empirical cost data are available for those who have are in 
remission or recovery, we can assume for the sake of argument that in this state, costs are 
higher than in the ‘Never AN’ state due to the longer-term consequences of the condition, 
but lower than in the ‘Current AN’ state as there is no need for treatment. 
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Figure 2-6: Schematic state-transition model of the course of illness for AN 
 
The simplest way of approaching model-based economic evaluation would be to determine 
how an intervention changes transition probabilities. A successful treatment, for example, 
might improve the chance of remission, i.e. increase the transition probability for 
‘remission’. Holding all other transition probabilities equal, costs for an individual receiving 
this intervention would be lower, as they are more likely to enter the less costly state (‘No 
longer AN’).  
A preventative intervention, on the other hand, may increase the probability that individuals 
‘remain healthy’, i.e. remain in the ‘Never AN’ state, and therefore reduce the transition 
probability for ‘Onset of illness’. All else remaining equal, costs will again be lower as we 
have assigned a zero cost to the ‘Never AN’ state, and the intervention has increased the 
probability of remaining in this state. 
The example above looks at the potential for using incidence-based CoI estimates for 
model-based economic evaluation for AN, but general CoI studies that cover more than 
one condition can provide comparable estimates and therefore allow for the comparison of 
relative savings from interventions across these conditions (Koopmanschap 1998). 
• Reflecting on the arguments surrounding the usefulness of COI estimates, 
prevalence-based CoI studies have several, but perhaps more limited, uses: 
• Raising awareness for the burden of a specific disease, especially where there is 
concern about a lack of effective interventions or a lack of treatment provision; 
• Prioritising future efforts where the costs of several conditions are estimated on an 
equivalent basis; 
83 
 
 
• Identifying the relative size of contributors to total costs to determine where the 
burden of disease falls. This is relevant both in terms of who might fund additional 
interventions, but also for equity considerations where caregiver burden or personal 
expenditure are concerned in a publicly funded health care system; 
Incidence-based CoI studies on the other hand can be used directly in cost-effectiveness or 
disease modelling studies to describe trends when analysed in the context of demographic 
or technological developments. 
In practice, CoI studies are used to justify interventions, assist in the allocation of research 
funding, provide a basis for prevention policy and to provide a framework for economic 
evaluation. In addition, CoI studies are successfully used by policy and decision makers to 
justify budgets (Rice 2000), suggesting a pragmatic motivation for their continued use. 
As a result, cost-of-illness studies have the potential to influence both policy and practice, 
as well as shape the future research agenda. 
The implementation of cost-effective alternatives to inpatient treatment across the country 
should be a priority to ensure equitable access and adequate treatment (Department of 
Health 1999; Green et al. 2005; Tulloch et al. 2008). One piece of evidence needed to 
facilitate this is a sound CoI estimate, and cost-effectiveness analyses building on it. A CoI 
estimate that can disaggregate costs and consider unmet need can help us understand the 
‘paradox’ (Striegel Weissman & Rosselli 2017) of high costs coupled with infrequent 
treatment and high levels of unmet need in AN. 
POLICY RELEVANCE AND CONTRIBUTION TO KNOWLEDGE 
A lot has been written about Anorexia nervosa, but given the low prevalence, the ethical 
and practical difficulty in conducting clinical trials with a severely ill population, and a 
shifting understanding of the illness and its aetiology, significant gaps in the knowledge 
remain about how best to approach treatment for this severe condition. Economic 
evaluation can play a part in aiding decision making.  
There is a clear demand for a cost of illness estimate for Anorexia nervosa to help in 
understanding the condition and its complex interplay with services (Striegel Weissman & 
Rosselli 2017).  
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Particular gaps in the evidence base have been identified: 
• There is a dearth of information on service use and costs beyond inpatient care. 
• Given a shift from inpatient to outpatient care, information on the costs of different 
forms of outpatient treatment is required. 
• Few existing estimates include indirect costs, such as lost employment, and little is 
known about the impact of AN on these outcomes. 
• Few existing estimates consider the costs of disability and mortality associated with 
AN. 
• Little information is available about why costs vary between individuals. 
The aim of this thesis is to answer the following overarching questions: 
• What are the annual societal costs of AN for England? 
• Why do costs vary between individuals? 
Based on my survey of the literature, I specified concrete research questions that address 
different aspects of the societal costs of AN. 
Research questions 1 and 2 investigate aspects of direct costs:  
• RQ1: What treatments are provided for AN in an outpatient context, what are the 
associated unit costs, and why do these costs vary? 
• RQ2: What services do people use while being treated for AN on an outpatient 
basis, what are the associated costs, and why do these costs vary? 
Research question 3 addresses indirect costs: 
• RQ3: What is the impact of AN on education, employment, income and related 
outcomes, and for whom? 
Research question 4 addresses intangible costs: 
• RQ4: What is the loss of life associated with AN in England? 
Research question 5 addresses the totality of societal costs: 
• RQ5: What are the annual societal costs of AN in England? 
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This thesis contributes knowledge by providing a comprehensive estimate of the societal 
costs of AN for England, with a particular focus on outpatient services. 
It picks up several strands of debate around the treatment of ED, namely how to bring 
about an even greater shift from inpatient to outpatient treatment, and whether there is a 
benefit to service specialisation. Given the recent trends in mental health policy, namely the 
‘Five Year Forward Plan’ and the ‘Five Year Forward Plan for Mental Health’, and the 
resulting commitment to implementing a waiting time standard for ED that will require the 
implementation of (cost-) effective services, this thesis is potentially more relevant now than 
it was upon its inception. 
86 
 
 
CHAPTER 3  
Methods and data 
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CHAPTER INTRODUCTION 
In this chapter, I discuss the methods employed in conducting these studies and describe 
the primary and secondary data sources used in this thesis. Given the wide range of topics 
covered and methods, I focus here on a discussion and critical assessment of the 
overarching methods relevant to the thesis, and justify the choice of approach. Specific 
analysis models and hypotheses are detailed in individual chapters, as appropriate. 
Since no one dataset exists that could be used to meet the aims of this thesis – to present 
an estimate of the societal costs of anorexia in England, and explore why these may vary, 
in this thesis, I draw on a variety of data and employ a range of methods to answer my 
research questions. In addition to feeding into the estimate of societal costs, each study 
contributes to the knowledge base, because it fills a gap in the evidence regarding the costs 
of AN. 
The thesis consists of six empirical studies using seven datasets (Chapters 4-6), in addition 
to three studies applying decision modelling approaches (Chapters 7 and 8). Table 3 1 
provides an overview of the relationship between research questions, chapters, data and 
methods of analysis. 
This thesis builds on work carried out in the context of my employment as a researcher in 
the Personal Social Services Research Unit (PSSRU) at the London School of Economics, 
and particularly as part of the NIHR-funded ARIADNE programme (RP-PG-0606-1043). 
The final report underwent peer review and has now been published (Schmidt et al. 2017). 
This includes versions of the studies presented in Chapter 4 (part 2), Chapter 5, Chapter 6 
(part 2) and Chapter 8 (part 1) that have been revised and extended for this thesis. 
The programme was led by Prof. Ulrike Schmidt at the Institute of Psychiatry (IoP). The 
economic component of this programme was led by Prof. Jeni Beecham (PSSRU) and 
consisted of 
• Cost-effectiveness analysis alongside several clinical trials, 
• Modelling the social costs of AN and 
• Estimating savings to society from changing models of care. 
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Within that programme, I was responsible for developing the cost-of-illness model 
described above, perform analyses of service use, costs and cost-effectiveness, calculate the 
costs associated with current care pathways and develop a prediction model showing the 
impact of the implementation of cost-effective treatments on the social costs of AN.  
Primary data for the ARIADNE programme were collected by researchers at the IoP. I was 
responsible for liaising with the research workers and conducting the analyses as described 
above, in particular building the cost-of-illness model. For the PhD, additional data were 
used to augment the models. 
The Care Pathways Study (CPS) is a health services research and naturalistic cohort study 
that was part of the ARIADNE programme. Data for this study were collected by Dr 
Jennifer House. I was responsible for extracting data and carrying out the analyses presented 
here. 
The MCTAAN trial was led by Ivan Eisler (IoP). Liaison and quality assurance during the 
data collection and entry phase were carried out by myself and Jennifer Beecham. I am 
responsible for the unit cost work and data analysis. 
The analysis of the BCS-70 as part of the ARIADNE project was conceived by Jennifer 
Beecham, but I was responsible for the detailed analysis plan, study design and carrying out 
the analysis. 
Data access for ALSPAC was facilitated by Dr Nadia Micali (University College London) 
through the NIHR-funded project ‘Adolescent eating disorders and related behaviours: 
longitudinal course and risk factors’. I was solely responsible for the design and analysis of 
the study using ALSPAC data presented here.
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Table 3-1: Relating research questions to chapters, data sources and methods 
Research question 
Thesis 
chapter 
Data source Principal method of analysis 
RQ1: What treatments are provided for AN in an outpatient context, 
what are the associated unit costs, and why do these costs vary? 
Chapter 4 
Part 1: MCTAAN study 
Economic costing of intervention 
and descriptive analysis. 
Part 2: Care Pathways Study 
Additionally, analysis of variation 
using regression. 
RQ2: What services do people used while being treated for AN on an 
outpatient basis, what are the associated costs, and why do these costs 
vary? 
Chapter 5 
Part 1: Care Pathways Study 
Regression analysis in an expenditure 
function framework. 
Part 2: Three ARIADNE RCTs 
RQ3: What is the impact of AN on education, employment, income 
and related outcomes, and for whom? 
Chapter 6 
Part 1: ALSPAC Regression analysis using linear, 
logistic and generalised linear 
models. Part 2: BCS-70 
RQ4: What is the loss of life associated with AN in England? Chapter 7 
Life tables for England and 
parameters from literature review. 
Decision-analytic modelling in a 
Markov framework. 
RQ5: What are the annual and lifetime societal costs of AN in 
England? 
Chapter 8 
Results from Chapters 4-7 and 
parameters from literature review. 
Cost-of-illness estimate building on 
decision trees. 
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WORKING DEFINITION OF ANOREXIA NERVOSA 
To estimate the costs associated with AN, it is essential to define what we mean by AN. As 
outlined in Chapter 2, different definitions for AN exist between the two major diagnostic 
classifications, DSM-IV and ICD-10. While most of the studies reviewed predated the 
introduction of DSM-V, evidence is now emerging that uses the new definition. But in 
addition to the shifting classifications used to identify the ‘full syndrome’, the fact that the 
EDNOS group of EDs is much larger than the full syndrome group means that a focus on 
strict criteria risks disregarding a large part of the costs and morbidity associated with AN 
and related disorders. As the literature revealed a heterogeneity of definitions used across 
different studies, in this thesis, what is considered ‘AN’ is any of the following:  
• AN based on DSM-IV criteria; 
• AN based on DSM-V criteria;  
• AN based on ICD-10 criteria; 
• AN-type EDNOS based on the above; 
• Self-report of AN. 
More detail on the most relevant definitions is provided in Chapter 2. 
DATA SOURCES 
Here I describe the datasets that were analysed using statistic and econometric techniques 
to obtain novel results. I do not discuss those data sources that were used to perform basic 
calculations. The latter includes sources such as the Hospital Episode Statistics (HES), data 
obtained from the Department for Work and Pensions (DWP) and other routine data 
sources such as life tables published on an ongoing basis by the Office for National Statistics 
(ONS). 
The data used can be broadly divided into two categories: Those used to analyse service use 
and associated costs, and those used to investigate productivity-related outcomes. The first 
come from four clinical trials and a health services research study (primary data), while the 
latter come from two large UK cohort studies (secondary data). 
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ARIADNE PROGRAMME 
The NIHR-funded programme provided data on three RCTs and a study of care pathways 
for young people with AN. The final report for this programme has undergone peer review 
through NIHR and was recently published (Schmidt et al. 2017). 
The programme included three randomised controlled trials (RCTs), namely, CASIS 
(interventions for carers), MOSAIC (outpatient therapy for adults with AN) and 
iMANTRA (relapse prevention in severe AN) that collected information on participant 
service use. These service use data are used in this thesis to look at the services used by 
people with AN, the associated costs, and variation in costs by patient characteristics 
(Chapter 5, part 2; answering RQ2) 
GUIDED SELF-HELP INTERVENTION FOR CARERS (CASIS) 
The CASIS trial (Carers' Assesment, Skills and Information Sharing; Goddard et al., 2013) 
investigated whether the addition of a guided self-help, skills training intervention for carers 
(Experienced Carers Helping Others; ECHO) to inpatient care provided an additional 
benefit to carers and patients. Patients (aged 12 and over with a primary diagnosis of AN; 
n=178) and their carers (n=268) were recruited from 15 inpatient services in the UK and 
randomised to either ECHO or treatment as usual (TAU). The ECHO intervention 
consisted of self-help materials (book, DVDs) and 10 telephone coaching sessions. Data 
were collected at baseline, 6-months and 12-months. 
The following outcomes relevant to the economic analyses presented here were measured 
in patients: 
Primary: 
• Relapse, defined as readmission to inpatient care or a drop of 2 points from 
discharge BMI (measured monthly) 
• Depression, Anxiety and Stress Scale-21  (DASS-21; Lovibond & Lovibond 1995), 
a 21-item scale measuring the psychological concepts depression, anxiety and stress 
where higher scores represent higher levels of morbidity. 
Secondary: 
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• Wold Health Organization – Quality of Life Questionnaire (short version; WHO-
QoL-100; The Whoqol Group 1998), a self-report measure of quality of life (QoL) 
in four domains: physical health, psychological, social relationships, environment. 
This is measured on 5-point Likert scales in 24 areas. Two additional items ask 
about overall QoL and general health. 
• Eating Disorder Examination (EDE; Fairburn & Cooper 1993), a semi-structured 
interview with four subscales (dietary restraint, eating concern, weight concern, 
shape concern) and a global score (mean of the four subscales). A questionnaire 
version with similar properties to the interview is available (EDE-Q; Luce & 
Crowther 1999). 
To support an economic evaluation, a Client Service Receipt Inventory (CSRI; Beecham & 
Knapp 2001), covering a retrospective 6-month period was completed by patients and 
carers. This thesis is concerned with the patient data only.  
While there were no differences in BMI, patients in the ECHO group experienced lower 
levels of ED symptoms and improved QoL at 6 months. Carers saw a greater reduction in 
caregiving time and a small to moderate reduction in carer burden. Full results for the trial 
have been published (Hibbs et al. 2015). 
OUTPATIENT THERAPY FOR ADULTS WITH BROAD AN (MOSAIC) 
The MOSAIC trial (protocol (Schmidt et al. 2013) compared the Maudsley Model of 
Anorexia Nervosa Treatment for Adults (MANTRA (Schmidt et al. 2006) with Specialist 
Supportive Clinical Management (SSCM) in outpatient with DSM-IV AN or EDNOS-AN 
in a multi-centre RCT. Participants (adults aged 18-65) were recruited from four specialist 
ED services in the south of England. 72 were allocated to MANTRA and 70 to SSCM. 
Both interventions consist of 20 sessions over a 12-month period. 
Data were collected at baseline, 6-months and 12-months. This included the following 
outcome measures that were considered relevant for the analyses in this PhD: 
Primary outcome measure: 
• Body Mass Index (BMI; kg/m2) at 12 months 
Secondary outcome measure: 
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• EDE or EDE-Q 
• DASS 
In addition, a CSRI covering a retrospective 6-month period was developed to support an 
economic evaluation. 
The trial found that there were no differences in clinical outcome between the two 
treatment groups, with patients showing improvements on all measures. However, patients 
found MANTRA to be more acceptable and credible than SSCM. Full details of the trial, 
including measures and results are published in (Schmidt et al. 2017). 
RELAPSE PREVENTION IN SEVERE AN (IMANTRA) 
The final ARIANE study generating data used in this PhD was a feasibility trial that 
randomly allocated 41 inpatients treated for AN aged 16 or above from seven UK specialist 
ED units to receive e-mail guided self-care based on MANTRA (iMANTRA) or treatment 
as usual (TAU). 
Outcome measures included 
• BMI 
• EDE or EDE-Q 
• DASS 
• WHO-QoL 
Again, a CSRI was completed at baseline, 6-months and 12-months. 
While there were no differences between groups at 6 months, the iMANTRA group showed 
higher BMI and lower DASS at 12 months and a slightly lower readmission rate of 22.7% 
compared to 31.2% in the TAU group. Full details of the feasibility study can be found in 
the ARIADNE report (Schmidt et al. 2017). 
CARE PATHWAYS STUDY (CPS) 
The Care Pathways Study investigated the impact of different service contexts on treatment 
outcome (House et al. 2012; House 2011). The study consisted of  
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• A naturalistic health services research study (service-level recruitment and data 
collection), and  
• A retrospective cohort study (patient-level recruitment and data collection). 
A list of potentially eligible services was compiled and key contacts within services were 
identified by IoP researchers. Those contacts were asked to complete a questionnaire 
providing service-level information on service specialisation, service organisation and 
treatment practice with regard to adolescent ED that was designed by researchers at the 
IoP and the PSSRU. 
Services were included if they were: 
• Within the catchment area of a Greater London PCT (GLPCT) 
• Located outside Greater London but accepting referrals from GLPCTs 
• Provides secondary or tertiary mental health care to adolescents (age 13-17) 
• Provided by NHS or private sector 
44 services were identified and 40 agreed to participate but 3 subsequently failed to provide 
the data needed to be included, so that 37 services participated in the study. 
Three main intended care pathways were identified: 
• Specialist Child and Adolescent Eating Disorder Services (CEADs); 
• General CAMHS with a specialisation or special interest in ED (Specialist CAMHS); 
• General CAMHS with no specialisation in ED, referred to as ‘non-specialist 
CAMHS’. 
The analysis of patient-level data revealed that sometimes the actual care pathways differed 
from the intended care pathways. The identified actual care pathways (by specialisation of 
the first service) were: 
• Specialist to specialist 
• Non-specialist to specialist 
• Non-specialist to non-specialist 
• Private services 
Patients identified through participating services were included if they 
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• Had an initial contact or re-contact after a treatment break of at least 6 months with 
a participating service between 01/12/2006 and 30/11/2008 
• Were adolescents (age 13-17) 
• Had a primary diagnosis an eating disorder (ED) 
• Were registered with a GP from a GLPCT 
378 unique cases meeting all inclusion criteria were identified and 93 with a known diagnosis 
of AN or EDNOS-AN consented to be part of the study. Care pathways data were available 
for 90 patients. 
The main finding of the study was that direct access to specialist services led to higher 
referral rates, lower admission rates, and greater consistency of care (Schmidt et al. 2017). 
I use data on services to investigate treatments provided in outpatient services and their 
costs (Chapter 4, part 1; answering RQ 1), and data on 84 participants to explore the 
treatments received and their costs by care pathway as well as variations in costs (Chapter 
5, part 1; answering RQ 2). 
MCTAAN STUDY 
This study is not part of the ARIADNE project but is funded by The Health Foundation 
and lead by Prof Ivan Eisler (IoP). A randomized controlled trial compared Multiple Family 
Day Treatment (MFDT) with manualized outpatient family therapy over a 12 months 
period.  
Outpatient family therapy can in many cases be a substitute for inpatient treatment even 
for severe AN (Eisler et al. 2007) . Multiple family day treatment is an intensive form of 
treatment consisting of a one-week day programme for up to six families, followed by four 
to five further days at four to eight-week intervals. Individual family meetings take place 
between group meetings as required. The focus is to prevent hospitalisation. A randomized 
controlled trial will compare MFDT with manualized outpatient family therapy over a 12 
months period. Primary outcomes are BMI and EDE global score. Outcome and CSRI data 
were collected a baseline (pre-treatment), three months, 12 months (end of treatment) and 
18 months (6 months follow-up). While it was envisaged to recruit 200 patients in total, 
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actual numbers fell short with only 165 entering the study. This study was funded by The 
Health Foundation and lead by Prof. Ivan Eisler. 
UK COHORT STUDIES 
To estimate the productivity-related costs arising from AN, it is necessary to have data on 
people with the condition, as well as a suitable comparison group. Causality is difficult to 
establish in a cohort design. To determine an association between AN and differential 
outcomes relative to this comparison group, the two groups must be as similar as possible 
(and ideally, the same) in all potentially relevant aspects except exposure to the condition, 
or if any differences can be taken into account in the statistical analysis. This means that a 
comparison group should be as similar as possible in terms of demographic and socio-
economic characteristics and other variables relevant to AN and the outcomes under 
investigation, or that at least differences can be assessed based on the available data.  
In addition to suitability for answering the research questions, the following 
considerations went into selecting data sources: 
• Data are freely accessible, or access can be obtained without additional funding 
• Data have not been analysed with respect to the research questions 
It should be noted that the data review was conducted in the early stages of this thesis, and 
the decisions made with regard to data selection reflect availability, quality and publication 
record of the data at the time. 
BRITISH COHORT STUDY 
The British Cohort Study (Centre for Longitudinal Studies 2015) BCS-70 includes over 
17,000 babies born in the UK in one week in April 1970 and is representative of the UK 
population. Currently, data are available for seven sweeps up to age 38, so that people can 
be tracked well into adulthood. The use of the data for this study has been registered with 
the Economic and Social Data Service (UK Data Service 2014) and access is free of charge. 
No formal diagnosis of ED is included in the BCS-70, but at age 30, there is a set of 
questions asking: 
• Whether the participant ever had an ED (lifetime ED); 
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• Age when the participant first had an ED (age of onset); 
• Whether the participant had an ED in the previous 12 months (current ED); 
• Type of ED. 
The BCS-70 data has been successfully used to study risk factors of lifetime ED (Nicholls 
& Viner 2009). In the cohort, 111 women with AN can be identified – a prevalence of 1.9%, 
which is in line with expectations. At the time the study was designed, data were also 
available on outcomes up to age 34 and include information on education and qualifications, 
employment status and income.  
The data allowed me to estimate earnings forgone by those with AN, and this is used in the 
CoI estimate to show the longer-term costs of AN. 
AVON LONGITUDINAL STUDY OF PARENTS AND CHILDREN 
The Avon Longitudinal Study of Parents and Children (Golding et al. 2001) ALSPAC is a 
prospective study of pregnancy and child development, collecting data on mothers, partners 
and children. The initial sample consists of 85-90% of women living in Avon who were 
expected to give birth between April 1991 and December 1992, or 14,472 pregnancies. 
Later, an attempt was made to recruit those who did not initially join the study, and the 
total sample includes 15,224 foetuses. While a representative sample was envisioned, the 
study has a shortfall in less affluent families and ethnic minority mothers compared to the 
population of Britain (Bristol University n.d.). Data are currently available up to age 16, and 
the data for age 18 is expected to become available in early 2012. 
Previous research into AN with the ALSPAC data has focussed on the mothers of the study 
children, specifically on the impact of pregnancy on EDs (Micali et al. 2007b) and the impact 
of maternal EDs on perinatal outcomes (Micali et al. 2007a), post-partum depression (Micali 
et al. 2011)  and breast feeding (Micali et al. 2010). This demonstrates the feasibility of 
researching AN using ALSPAC data.  
The NIHR-funded project ‘Adolescent eating disorders and related behaviours: longitudinal 
course and risk factors’ was carried out by Dr Nadia Micali (King’s College London), and 
data access for the analysis of ALSPAC presented here was facilitated through this study. 
An application for access to the data up to age 16 is was drafted and accepted by the 
ALSPAC team. As part of the project, questions about eating behaviours and BMI were 
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included in the ALSPAC sweeps at ages 14, 16 and 18. The researchers have since used 
these data to obtain clinical diagnoses of ED. The focus of their project was on risk factors 
contributing to adolescent EDs, and particularly the transgenerational effect of maternal 
EDs. At the time of my data application, a study of ED and pregnancy had included 12,252 
mothers, 237 of whom reported a history of AN – a ‘lifetime’ prevalence of 1.7% with an 
average age around 27. This inspired confidence that a sufficient number of young people 
with AN could be identified to conduct this study. 
A NOTE ON SELF-REPORT DATA 
Much of the work in this thesis relies on self-reported data, either in the form of service use 
data collected using CSRIs, or from the large cohort studies.  
When it comes to service use, self-reported data are sometimes considered less reliable than, 
for example, medical records. However, since there is no one central source of service use 
data covering different agencies in the UK, data would have to be collected from each 
agency, potentially in different geographical locations – and the full spectrum of agencies 
that would need to be included may not be known to researchers without consulting with 
participants. A study comparing self-report data and GP records on service contacts and 
found that while GP records were more accurate when it came to GP contacts, they were 
less reliable in reporting contact with other services, such as hospital or community-based 
services (Byford et al. 2007b). Total costs calculated based on the service use reported from 
both sources were similar. Another study found a high level of agreement between self-
report data and GP records(Patel et al. 2005).. 
A practical consideration is that participants are likely to be in contact with a wide range of 
services in diverse geographical areas and that service use patterns will differ between 
individuals. Without asking participants, the specific services will be unknown. For these 
reasons, collecting data from each agency is often not feasible, and the CSRI approach is 
likely to provide similar or at least adequate results with much less resource input (Beecham 
& Knapp 2001). 
Similarly, sometimes concerns are raised about the reliability of self-reported diagnoses or 
symptoms. While for physical health problems with well-defined criteria, such as diabetes, 
there tends to be good agreement between self-reported diagnoses and clinical diagnoses 
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from records (Berg et al. 2012). Self-report can be less successful due to differences between 
(self-) perception and physical measurement, such as in the case of 47% of adolescents 
reporting to be ‘very overweight’ when they were not in one study (Goodman et al. 2000). 
Self-report measures may also lead to misreporting due to carelessness in completing them 
(Kaminska & Foulsham 2016). On the other hand, self-report may reduce socially desirable 
responding, i.e. under-reporting of undesirable behaviours and over-reporting of desirable 
behaviours (Edwards 1958).  
Research specific to reporting of ED has been conducted, and a meta-analysis of studies 
comparing the interview and the (self-report) questionnaire versions of the Eating Disorder 
Examination found that these were correlated, with participants consistently reporting 
higher levels of symptoms on the self-report measure (Berg et al. 2012). Disagreement was 
noted on the binge eating subscale, where more episodes were reported in the interview 
version. The authors suggest that the two instruments measure similar concepts, but are not 
inherently the same. The choice of informant may also matter. A study comparing ED 
symptom reports collected from young people and their parents as part of the ALSPAC 
(Swanson et al. 2014a) concluded that adolescents were more likely than parents to report 
bulimic symptoms, while parents were more likely to report thinness. This suggests a role 
for multiple informants in capturing the range of ED symptoms. While the study above 
compared two versions of the same assessment tool, a comparison of simple questions such 
as “Have you ever had anorexia?” and “Has anybody ever suspected that you might have 
an eating disorder” performed better than clinical subscales in identifying AN in a 
community sample (Keski-Rahkonen et al. 2006).  
On balance, self-reported measures of ED are convenient and less resource intensive than 
clinical interviews, and there is evidence to suggest that they perform adequately, and 
simpler questions may perform better than questionnaire versions of clinical assessments. 
COSTING METHODS 
PERSPECTIVE OF ANALYSIS 
When analysing the economic impact of social policies, a key consideration concerns the 
perspective adopted for the analysis (Drummond et al. 2005). Deciding on a perspective in 
this context means deciding whose views have standing when it comes to decision making 
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about investment of public funds. A common distinction is between public sector costs, 
focussing on public sector budgets, and societal or social costs, which – in the context of 
cost-of-illness studies – include the perspective of everyone who bears a ‘cost’ from an 
illness. 
Due to data limitations and resource constraints, cost analyses often adopt a narrow 
perspective. NICE, for example, generally recommends a health and social care services 
perspective be used in health technology assessment (National Institute for Health and Care 
Excellence 2013, 2014). The thesis however is situated within the theoretical context of 
economic decision analysis, which requires the consideration of full economic costs and 
benefits of each decision option. First formalised by Pigou (1932), the concept of 
externalities is relevant for our choice of cost perspective. An externality occurs when a cost 
or benefit resulting from a choice is borne by a party other than the decision maker. An 
example of an externality in the context of anorexia nervosa might be a choice taken by 
service commissioners to shift the focus of treatment from inpatient treatment for AN to 
outpatient treatment, a health and social care perspective will only take into account the 
impact of this decision on health and social care services. Say this hypothetical decision is 
neutral in terms of patient outcomes such as recovery and survival, and saves money, 
leading analysist to conclude that this is in fact the superior service model. However, a shift 
towards outpatient services means patients will spend more time out of hospital, potentially 
increasing the amount of time requiring informal care provided by parents, family and 
spouses. A societal perspective would incorporate and value this additional burden placed 
on caregivers, and thereby ‘internalise’ the externality into the decision-making process. 
Potential cost savings to the health care system may be outweighed by the increased burden 
to caregivers when taking a societal perspective. 
While the analyses presented in this thesis are limited both by data availability and resource 
constraints, the ambition is to discuss the costs of AN from a societal perspective, and this 
is done wherever possible.  
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DIRECT COSTS 
PRINCIPLES OF UNIT COSTING 
In this thesis, I follow the definition of a ‘unit cost’ used by Beecham (2000), where a unit 
cost is the cost per unit of activity or output. 
Beecham (2000, pp. 12-15) sets out the principles of unit costing, reflecting economic 
theory outlined above. 
• Unit costs should be inclusive, i.e. include resources needed to provide all 
components of a service. This includes both fixed costs, i.e. those costs that do not 
depend on the output or service produced such as overheads, and variable costs, 
i.e. costs that change with outputs produced such as salary costs and on-costs, 
regardless of the budget or source providing these resources. 
• Unit costs should be developed in such a way that they match service use and allow 
for accurate costing of services received. For example, an ED service may provide 
a variety of sessions, ranging from brief weigh-ins with a nurse to one-to-one 
therapy sessions with a consultant. These are very different in terms of resource 
implications, and providing an overall unit cost for a generic intervention with this 
service would not reflect actual resources received by the client. 
• Unit costs should be based on the principle of long-run marginal opportunity costs. 
Economic costs include both ‘accounting costs’ – costs that might be reflected in a 
public-sector budget – and ‘opportunity costs’ – the benefit forgone from not 
investing in the next best alternative. In other words, not only the immediate 
monetary expense needs to be considered, but also the value of the benefit forgone 
by choosing one option over another. ‘Marginal cost’ refers to the cost of 
supporting an additional patient in the service, whereas the focus on ‘long-run’ costs 
such as capital investment in buildings highlights the need to consider the 
implications of service expansion. 
Additionally, Beecham & Knapp (2001) highlight the importance of retaining variations in 
costs between different service users, different facilities or different geographies. 
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MICRO-COSTING: TOP-DOWN VS BOTTOM-UP APPROACHES 
In addition to applying the principles outlined above, there are two broad approaches to 
estimating unit costs: 
In the top-down approach, all relevant expenditure is added and divided by the 
corresponding unit of activity. This approach is comparatively simple to apply and can be 
most appropriate where an average cost – such as the average cost per person receiving 
treatment through an ED service – is required, but does not facilitate analysis of variation 
in costs, for example for patients requiring additional support beyond a standard 
intervention or by patient characteristics, nor does it allow for consideration of regional 
variability. 
In contrast, using the bottom-up all resources required to provide an intervention or service 
are described and costed. The monetary value of those resources is then linked to the unit 
of activity. This approach tends to be more accurate and versatile, as it can be linked to 
individuals, thus retaining variability between patients and between sites.  
Beecham (2000) sets out the process for estimating unit costs for a service or intervention 
using a bottom-up approach: 
• Comprehensively describe all service or intervention elements; 
• Estimate the cost implications (costs) and 
• Identify relevant activities (units); 
• Calculate the total costs and costs per unit (‘unit cost’). 
For the purpose of this thesis, the bottom-up approach is employed where the available 
data allow, namely in the development of unit costs of outpatient treatments and in the 
exploration of variation of individual-level total cost. 
COSTING SERVICE USE 
The costs associated with service use by people with AN were calculated by attaching unit 
costs to instances of service use. The two main sources for unit costs in health and social 
care in England are 
• PSSRU unit cost volume (Curtis 2011) 
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• NHS reference costs (Department of Health 2011) 
These resources were used for convenience, and to maximise consistency across different 
costing studies by using the same source of unit cost data. Where no unit costs were readily 
available, they were estimated using an equivalent approach that employs the principles set 
out above (Beecham 2000; Berridge et al. 2002). 
INDIRECT COSTS: PRODUCTIVITY LOSSES 
Productivity is based on the production function, where output is a function of capital, 
labour and technology. Productivity is a measure of output per unit of input. Productivity 
loss is therefore the value of lost output (Zhang et al. 2011). In this section, I briefly outline 
the concepts related to productivity losses and discuss the main methods available to value 
such losses in economic terms.  
CONCEPTS 
Absenteeism 
Absenteeism is a reduction in output due to work days lost. In AN, this may be due to acute 
illness or hospitalisation, doctor visits or – in the case of carers or parents – due to increased 
time spent providing informal care. Additionally, productivity losses may arise from excess 
mortality, but capturing the ‘value of life’ poses additional challenges, which I discuss below. 
My analysis of BCS-70 data presented in Chapter 6 did not show a significant effect of AN 
on the probability of employment at age 30. However, there was a significant effect on 
economic activity status, with women with AN more likely to be sick or disabled. 
Productivity losses are therefore measured as output foregone due to additional disability 
(see Chapter 8 for details). 
Presenteeism  
Presenteeism measures a reduction in productivity while at work, that is, the difference in 
output in the presence of a condition compared to output in the absence of the condition. 
Given the complexity of many modern jobs, especially in non-manual, non-industrial 
settings where outputs cannot be easily defined nor counted, and the complexity of an 
impairment resulting from a mental health problem, studies of Presenteeism generally rely 
on self-report measures rather than routine data (Schultz & Edington 2007).  
104 
 
 
Losses from presenteeism are then calculated using the same estimate of productivity as for 
the calculation of absenteeism, and applying the average reduction in productivity to this 
estimate. To my knowledge, there is no estimate available for AN, but the loss due to 
depression, sadness or mental illness has been estimated at 15.3% (Goetzel et al. 2004). 
No individual-level data on presenteeism were available for a representative sample of 
people affected by AN, so that an estimate of costs due to presenteeism was not included 
in the estimate of societal cost. 
Underemployment 
Underemployment denotes the fact that illness can lead to changes in employment status, 
such as early retirement, reduced working hours or loss of job (Zhang et al. 2011). In 
addition, an illness may affect choice of job or prevent an individual from working in a job 
at a level matched to their qualifications and skills. Lost output is calculated as the 
differential between expected and actual output.  
As with presenteeism, no data were available to estimate the productivity losses resulting 
from underemployment for this thesis. 
Days of education missed 
If productivity losses can be framed as output forgone, and productivity is related to level 
of education (see below under Valuation methods how productivity can be measured 
through the proxy of wages), then days of education missed are relevant to a full assessment 
of productivity losses arising from AN. The study of ALSPAC data presented in Chapter 
6, Part 2 includes a self-report measure of days of school missed due to illness over a two-
week period. While results are presented for an analysis of whether AN is associated with 
an increased number of school days missed or associated with an increased probability that 
an absence occurred, the valuation challenge outlined below means that these cannot be 
directly measured. 
VALUATION METHODS 
Human capital and friction cost approach 
Productivity losses from absenteeism, presenteeism and underemployment are usually 
valued under the human capital approach. The human capital method places a value on lost 
output by calculating the sum of discounted expected future income. The theoretical 
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justification for this approach is that the market wage is equal to the marginal product of 
labour in a competitive market (Zhang et al. 2011), and therefore represents the opportunity 
cost of lost output to society. 
The approach can be criticised because of its potential to discriminate against groups that 
face structural disadvantages in the labour market, such as the economically inactive, 
women or members of ethnic minorities as well as people with mental health problems. 
Using actual wage rates can, in this case, lead to lower estimates of the societal costs 
associated with an illness, and especially such conditions that are more likely to affect those 
groups. The use of average wage rates has therefore been suggested as a means of assessing 
the loss of productivity that would be averted in the absence of the condition in question. 
Another criticism that led to a refinement of the human capital approach is that, in an 
environment where unemployment is above the frictional level, an absent worker would 
eventually be replaced by another, and the approach therefore over-estimates productivity 
losses due to, for example, diminishing returns to labour at the level of the firm, i.e. other 
employees performing essential tasks during short absences to avoid loss of output 
(Koopmanschap 1998). The friction cost approach (Koopmanschapp et al. 1995) was 
proposed to address this problem. Friction costs include the cost of hiring and training a 
new worker, either from the unemployed or an internal labour pool, as well as lost 
production or the extra cost occurring for maintaining production during the friction 
period. The friction cost approach has itself been subject to criticism, for example in that a 
friction cost that is lower than the wage rate would be at odds with neoclassical theory 
which states that wages equal the marginal product of labour (Johannesson 1996). 
Valuing non-market production 
Another issue that is linked to criticism of the human capital approach is that it disregards 
unpaid work, such as housework and caregiving. The inclusion of informal care in economic 
evaluation can impact on findings to the extent that a conclusion regarding cost-
effectiveness may be reversed upon inclusion alongside a healthcare perspective (Goodrich 
et al. 2012). 
 To determine a ‘shadow price’ for these activities, the opportunity costs of lost time spent 
on unpaid work needs to be developed. Several options have been proposed for an 
approach based on opportunity costs (Francis & McDaid 2009): 
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• Market wage forgone based on an individual’s likely earnings; 
• Average wage; 
• Minimum wage. 
Alternatively, ‘replacement costs’ can be used, i.e. valuing the output produced in terms of 
the cost of purchasing an equivalent service on the market. An example may be the cost of 
child care or the cost of hiring a nurse or caregiver. 
Valuing lost education 
The value of lost education in terms of days of school missed can be conceptualised in 
several ways.  
Lost education can be conceptualised an intermediate outcome in the process of producing 
human capital, measured in terms of education qualifications. With this approach, the 
number of days missed would need to be (causally) linked to education qualifications. While 
absence from school has been found to be a predictor of lower education outcomes (Ou & 
Reynolds 2008), valuing one day of absence in terms of lost income based on a reduction 
in education attainment would require establishing and quantifying a causal relationship of 
the marginal impact of one day missed on education outcome. 
Another valuation approach taken is to measure the value of one day of absence via the 
proxy of productivity losses of a parent or guardian (Smith et al. 1997). Arguably, both 
approaches should be combined, and also include the costs associated with alternative 
school provision and out-of-pocket expenditure, such as childcare. 
INTANGIBLE COSTS: THE ECONOMIC ‘VALUE OF LIFE’ 
Intangible costs are those that cannot be directly measured, and that do not convert into 
monetary values in a straightforward way. This includes impacts of an illness on quality of 
life and on life itself.  
Attempting to measure the ‘value of life’ is sometimes seen as inappropriate, the argument 
being that there is an inherent value to life that cannot and perhaps should not be quantified 
in monetary terms. It is this characteristic of ‘life’ that makes it the prime example of what 
is considered an ‘intangible’ concept. While the debate around whether we should measure 
the value of life lost is interesting and important, for this thesis, I shall simply argue that 
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even considering the potential pitfalls and given the limitations of our methods, it would be 
even more contentious to disregard the loss of life resulting from a condition in any CoI 
estimate, and the value of loss of life averted can be included on the ‘benefit’ side of 
economic evaluations. There are, however, issues around measurement, and I summarise 
the different approaches available below. 
HUMAN CAPITAL APPROACH VS WILLINGNESS TO PAY 
There are two main categories of methods used to measure intangible cost (Bonin 2007; 
Landefeld & Seskin 1982; Mishan 1971):  
• Productivity-based approaches which measure output foregone, usually in terms of 
years of productive life lost combined with estimates of earnings lost – essentially 
the human capital approach. 
• Willingness to pay (WTP) – based approaches which use methods of preference 
elicitation to determine. The latter provide a more general measure of value of life 
and usually employ some kind of risk-wage trade-off setting to obtain an estimate.  
Willingness to pay measures may provide a more general measure and reduce bias. 
However, their application is not without challenge. One criticism that deserves to be 
highlighted is that willingness to pay is not necessarily related to ability or intention to pay 
(Zhang et al. 2011). This means it is conceivable that the sum of all economic losses from 
life years lost can total more than, for example, Gross Domestic Product, nullifying the use 
of CoI estimates in aiding decision making (Kennelly 2017). 
PREFERENCE ELICITATION 
The Treasury Green Book for appraisal and evaluation in central government (HM Treasury 
2003) updated 2011, pp. 57-58 currently recommends the use of ‘willingness to pay’ or 
‘willingness to accept’ approaches, i.e. market based approaches. These break down into 
‘stated preference’ and ‘revealed preference approaches (Fujiwara & Campbell 2011): 
• Stated preference approaches involve presenting participants with different 
scenarios and asking them either how much they would be willing to pay (contingent 
valuation), or to choose a most preferred option among different variations of a 
good or scenario (choice modelling). 
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• Revealed preference approaches elicit valuations by observing market behaviour. 
Please note that there are additional problems around aggregating individual preferences to 
obtain a social value, which are not discussed here. 
VALUE OF PREVENTED FATALITY 
One pragmatic approach to estimating intangible cost is the Value of Statistical Life VSL 
(Viscusi & Aldy 2003). This approach estimates the willingness to pay (WTP) for a 
reduction in risk by analysis. Incremental changes in wages alongside corresponding 
changes in risk of death within the labour market are analysed to determine the Value of 
Prevented Fatality (VPF). Alternatively, stated preference approaches can be employed. It 
is important to note that this is not the ‘value of a life lost’. A VPF of £1 million corresponds 
to a reduction in risk of one in 100,000 being valued at about £10 to an average individual. 
A frequently highlighted problem with these estimates is that market behaviour is not solely 
driven by the avoidance of mortality, and that stated preference approaches require the 
assessment of small incremental changes – something people are known to struggle with 
(Zhang et al. 2011). 
An estimate of VPF for the UK was developed by the Department for Transport 
(Department for Transport 2007). This is a VPF of around £1.43 million (2005 prices) and 
consists of  
• A WTP estimate of the ‘human costs’ of a fatality, both in terms of the loss of 
enjoyment of life and the impact on family and friends - £936,380. 
• Lost output due to injury, including salary oncosts such as national insurance 
contributions – £490,960. 
• Direct costs of the fatality - £840. 
COST PER QUALITY-ADJUSTED LIFE YEAR 
A ‘de-facto’ valuation of life years lost is the WTP threshold applied by National Institute 
for Health and Care Excellence (NICE). We might consider this cost-effectiveness 
threshold, i.e. the highest amount that should be paid per quality adjusted life year (QALY; 
a year of life lived at full health), of £20,000 to £30,000 (Devlin & Parkin 2004; McCabe et 
al. 2008) an example of a ‘stated preference’ at the societal level.  
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While the preference weights for the underlying QALYs were derived using trade-offs 
between years liven in various different health states, the monetary valuation is as (Appleby 
et al. 2007) point out, not based on evidence. Further, in practice the threshold appears to 
be applied inconsistently and a more accurate ceiling value may be £45,000 (Devlin & 
Parkin 2004). Recently, there have been efforts to obtain an empirical estimate of the CE 
threshold based on the argument that there is a relationship between health care expenditure 
and health outcomes (Martin et al. 2008). By relating changes in overall NHS expenditure 
to changes in mortality for different programme budget categories, an empirical CE 
threshold can be estimated (Claxton et al. 2015). Based on 2008 expenditure data and 2008-
2010 mortality data, the central estimate for the CE threshold is £12,936, with an 89% 
chance that it is smaller than £20,000 and a 97% chance that it is under £30,000 – and 
therefore almost certainly lower than the current figures.  
This finding contrasts with the preliminary results from a study attempting to obtain social 
valuations of QALYs (Baker et al. 2010), which find a value around £25,000 per QALY 
using revealed preference methods. This difference in the threshold highlights the 
difference in approach, which represents a move from valuation based on individual 
preferences to a model that values health and life by the proxy of resources required to 
maintain them. The latter approach provides a more ‘rational’ way of valuing health that 
emphasises the trade-offs required – i.e., if more is spent on health, less can be spent 
elsewhere. An avenue for further exploration may be to establish whether the difference 
between the ‘empirical’ valuation and the ‘preference-based’ valuation indicate a potential 
preference for (irrational?) ‘over-spending’ on health care. 
CONCLUSIONS 
It is clear that estimating a monetary value for life itself is conceptually difficult. For the 
purpose of this thesis, which seeks to contribute to the development of economic 
evaluations for interventions for AN, I chose a pragmatic approach in selecting an existing 
estimate to apply to life years lost. Given that the thesis is situated in the field of health 
economics, the most relevant value appears to be the NICE WTP threshold. Even though 
it may be argued that this underestimates the value of what is measured – especially in the 
context of much higher values applied in other areas of appraisal for government policy – 
this is the value that best reflects the preferences of decision makers and funders. While this 
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can be seen as a departure from a strict societal perspective, this will give credibility to the 
estimate and link it directly to decision making within the NHS. 
DATA COLLECTION FOR COST ANALYSIS 
While most of the data used for the analyses presented in this thesis were from secondary 
sources (ALSPAC, BCS-70, public sources such as the Office for National Statistics and 
Department for Work and Pensions), four sets of data were collected as part of clinical trials 
and a cohort study: 
• Service-level information on resources for providing Multi-family Day Therapy 
(MCTAAN trial); 
• Service-level information on resources for providing outpatient ED services as part 
of the Care Pathways Study; 
• Patient-level information on service use from clinical records (Care Pathways 
Study); 
• Information on service use alongside three clinical trials as part of the ARIADNE 
programme. 
The data collection instruments were developed in collaboration with the various clinical 
research teams and Professor Jennifer Beecham. 
1) SERVICE INFORMATION SCHEDULE FOR MCTAAN 
A Service Information Schedule (SIS; Sleed et al. 2004) is used to record information on 
resources needed to provide an intervention or service. This again reflects the principles of 
economic costing above, which require a broad perspective that includes all resources – 
regardless of the budget, or whether these are paid (such as regular staff) or in-kind 
contributions (such as volunteers or trainees).  
The topics covered by the SIS are the same across interventions, as all cost categories need 
to be addressed: 
• What staff are involved in providing the intervention? 
• What are the salaries and on-costs for staff involved? 
• How much time do staff spend on providing the intervention? 
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• How much time is spent preparing for the intervention, in supervision and 
feedback, and travelling to the intervention venue? 
• What non-staff resources are required to provide the intervention? This includes 
additional room hire as well as materials, child care if offered, or snacks provided 
to participants. 
However, implementation of the principles of the SIS will vary depending on the 
intervention or service being costed. Development of the SIS can be described an 
application of the process of unit cost estimation, reflecting step one of the process – 
describing all components of the intervention or service. The SIS for MCTAAN is attached 
as Appendix 1. 
2) SERVICE-LEVEL QUESTIONNAIRE FOR THE CARE PATHWAYS STUDY 
For the Care Pathways Study, a service-level questionnaire for service managers was 
developed by Jennifer Beecham, Eva-Maria Bonin and Jennifer House. This applied the 
principles of the SIS, but aimed to match data that would be collected as part of the routine 
administration of outpatient services to minimize the burden of data collection. 
The questionnaire covered the following information for the 2007-08 financial year: 
• Medical, nursing and other staff working in the service 
• Amount of time dedicated to adolescent ED 
• Referrals of adolescents with a primary diagnosis of ED overall, AN and BN 
• Total number of adolescents assessed and treated by the service (overall) 
• Expenditure on staff salaries and oncosts 
• Other expenditure such as travel and subsistence 
• Clinical and office expenditure,  
• Capital costs and  
• Overheads. 
The full questionnaire is attached as Appendix 2. 
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3) SERVICE USE FROM PATIENT RECORDS 
The main CPS collected patient-level data on a cohort of adolescents from participating 
services.  
The patient-level data provides the following information relevant to the economic analysis: 
• Patient socio-demographic characteristics 
• Patient clinical data (weight and height) 
• Treatment received within each outpatient service along the care pathway:  
• Number of assessments 
• Number of individual or family sessions 
• Number of group, dietic and medical outpatient sessions 
• Number and type of outpatient appointments for physical tests 
• Number of telephone calls 
• Number of psychiatric reviews 
• Number of inpatient days for ED or other reasons 
The data were re-entered to better suit the needs of the economic analysis, showing the 
total number of service contacts for each individual within each service along their care 
pathway. 
4) SERVICE USE FROM CSRI 
Information on patient service use was collected alongside several clinical trials involving 
people with AN. These data were used to describe service use and estimate and analyse 
associated costs. 
The Client Service Receipt Inventory (CSRI; Beecham & Knapp 2001) is an instrument for 
collecting service use data on a broad range of services and participant characteristics and 
can be used to collect self-reported data. This allows services and interventions to be costed 
according to the principles of economic costing, as providing an intervention paid for by 
one agency may reduce the need for services provided by another, and therefore to analyse 
the impact of interventions on different agencies.  
The main sections of the CSRI are as follows:  
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• Background and client information 
• Accommodation and living situation 
• Employment history, earnings and other personal resources 
• Service receipt 
• Informal care and additional expenditure 
While self-report measures are sometimes seen as inferior to medical records, there is no 
one, central source of service use information across different agencies. A study comparing 
patient self-report and GP records showed that the overall costs obtained from both 
sources were similar, but (perhaps not surprisingly) that while GP records are more accurate 
when it comes to GP contacts, they are less reliable than self-report when it comes to the 
use of other resources, such as hospital and community services (Byford et al. 2007b). 
Another study found high agreement between self-report and GP records (Patel et al. 2005). 
A practical consideration is that participants are likely to be in contact with a wide range of 
services in diverse geographical areas and differ between individuals and that without asking 
participants, the specific services will be unknown. For this reason, collecting data from 
each agency is often not feasible, and the CSRI approach is likely to provide similar results 
with much less resource input (Beecham & Knapp 2001). 
DATA ANALYSES 
THE NEED TO INCLUDE CONFOUNDING VARIABLES 
To attempt to establish causality when estimating the impact of AN on later outcomes such 
as education attainment, employment and income using data from individual-level 
observational studies, the methods need to be capable of accounting for any other potential 
influences on the outcome.  
Confounders are factors that impact both on the exposure (AN) and the outcome 
(economic outcome). For example, behavioural difficulties may be associated with a higher 
risk overdeveloping AN, and higher levels of behavioural difficulties could also be 
associated with a higher risk of lower attainment. 
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Covariates are related only to the outcome, without affecting the relationship between the 
exposure and the outcome. These are often genetic or biological factors. For example, 
symptoms of AN may resolve with age, even in the absence of intervention. 
The methods presented here can account for confounders and covariates. The concrete 
confounders and covariates included in the analysis models are detailed in the relevant 
empirical chapters. 
LOGISTIC REGRESSION 
Logistic regression is a suitable choice where outcomes (or dependent variables) are binary, 
i.e. can either take the value zero or one. For example, if the outcome of interest is whether 
a young person has obtained 5 good GCSEs or not, the probability that this is the case 
(meaning the binary variable takes the value one) for any one individual 𝑖 is 𝑝𝑖, and the 
probability that this is not the case (meaning the binary variable takes the value zero) is 
1 − 𝑝𝑖. 
𝑝𝑖, can be written as 
𝑝𝑖 = 𝐹(𝑥𝑖) =
1
1 + ⅇ−(𝛽0+𝛽1𝑥𝑖)
 
Where 𝑋𝑖 represents the vector of factors associated with the outcome – the co-variates 
and confounders in the analysis model. 𝛽0 is the intercept in a linear regression equation, 
and 𝛽1is the regression coefficient on 𝑥. 
The logistic function 𝑔 is a linear combination  
𝑔(𝐹(𝑥)) = ln (
𝐹(𝑥)
1 − 𝐹(𝑥)
) = 𝐵0 + 𝐵1?̅? 
This equation can be exponentiated to yield 
𝐹(𝑥)
1−𝐹(𝑥)
= ⅇ𝛽0+𝛽1𝑥. 
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The value of a binary outcome variable y given X is 
𝑦𝑖 = 𝑝𝑖 + 𝜀 
The error term 𝜀 follows a binominal distribution with a mean of zero and a variance of 
𝑝𝑖(1 − 𝑝𝑖). 
The likelihood function  
𝑙(𝛽) = ∏ 𝑝(𝑥𝑖)
𝑦𝑖[1 − 𝑝(𝑥𝑖)]
(1−𝑦𝑖)
𝑛
𝑖
 
consists of the product of the probability of a positive and the probability of a negative 
outcome and is then maximised for 𝛽 that best fit 
𝑦 = {
1  𝛽0 + 𝛽1𝑥 + 𝜀 > 0
0 𝑒𝑙𝑠𝑒
 
The odds can be described as 
𝑝(𝑥)
1 − 𝑝(𝑥)
= ⅇxp(𝛽0 + 𝛽1𝑥) = ⅇ
𝛽0(ⅇ𝛽1)
𝑥
 
If both outcome (dependent) and predictor (independent) variable are binary, as is the case 
when modelling the impact of anorexia (vs no anorexia) on attainment of 5 good GCSEs 
(vs fewer than 5 good GCSEs), this can be expressed as an odds ratio for a unit change in 
x: 
O𝑅 =
−
𝐹(𝑥 + 1)
1 − 𝐹(𝑥 + 1)
(
𝑓(̅𝑥)
1 − 𝐹(𝑥)
)
=
ⅇ𝛽0+𝛽1(𝑥+1)
ⅇ𝛽0+𝛽1𝑥
= ⅇ𝛽1 
The odds ratio ranges from zero to infinity. An odds ratio of 1 denotes an equal chance of 
the outcome variable taking the value one for both groups (anorexia vs no anorexia), i.e. 
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there is no difference in the chance that members of either group will achieve 5 good 
GCSEs. An odds ratio <1 means that the chance of achieving the outcome is lower for 
people with anorexia, and an odds ratio >1 means that the chance is higher for this group. 
An OR of 0.5 would be interpreted as those with AN being only half as likely as those 
without ED to achieve 5 good GCSEs, while an OR of 2 means they would be twice as 
likely. 
The same principle is applied for categorical/nominal variables with more than two 
categories. One category is chosen as the ‘reference category’, and parameters are estimated 
to denote the odds ratio relative to this reference category. This type of model will be used 
both in Chapter 5 where some explanatory variables are categorical or ordinal (e.g. social 
class at birth), and in Chapter 6 where in addition, the predictor in the ALSPAC study is a 
nominal variable with three levels (no ED, AN, other ED). Where a categorical variable is 
used as a predictor, an F-test is performed post-hoc to determine whether the category of 
interest is different from the reference category (in this case: whether AN cases are different 
from those without ED). 
For continuous independent variables or co-variates, the coefficient denotes the change in 
the log odds related to a one-unit increase in the continuous variable. For example, in 
Chapter 6, the coefficient on the (scale variable) number of days absent from school due to 
illness in a model where 5 good GCSEs is the outcome provides the change in the outcome 
variable for any one-unit change in the scale variable. If the coefficient is 0.9, an additional 
day of absence leads to a 10% reduction in the (relative) chance of achieving 5 good GCSEs. 
In all cases, the interpretation of the parameters 𝛽1 is simple: the odds or odds ratio increase 
by 𝛽1 for each unit increase in 𝑥𝑖 . 
WORKING WITH COST DATA 
EXPLORING VARIATION IN COST DATA 
Theoretical underpinning: Production of welfare approach 
The production of welfare (PoW) approach originates in the evaluation of social care 
services and applies the methods and vocabulary of the general theory of production to the 
area of welfare. This provides a theoretical framework for analysing the relationship 
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between inputs (the means of production) and outputs (in this case, welfare). Or, put 
differently, analysing welfare as a quantifiable production process dependent on a set of 
different ‘inputs’. In the following section, I summarise the salient points of the production 
of welfare (PoW) approach as presented by Davies & Knapp (Davies & Knapp 1981) pp. 
3-19 and point out how it applies to the analysis of treatment and outcomes in AN. 
The term ‘welfare’ in this context is used in a general sense and may refer to a broad range 
of outcomes. Moreover, the ‘production process’ that converts inputs into welfare 
indicators may differ between alternative welfare dimensions examined. One of the 
challenges is therefore to define the distinct (but possibly interacting) factors that constitute 
welfare and are to be measured, and then finding a valid construct to measure them. In the 
context of health care, the output of interest is most likely is a (mental) health outcome or 
quality of life. 
The PoW approach distinguishes between three different types of inputs which explain 
variations in individual outcomes: 
• Resources, or tangible and direct inputs such as staff, buildings and other physical 
elements endogenous to a health service. 
• Non-resources, or intangibles endogenous to the service, such as staff attitudes and 
other characteristics of service environment. 
• Quasi-inputs, or intangibles that are exogenous to the service, such as patient 
characteristics and experiences prior to service contact.  
Table 6: Production of welfare approach and application to AN 
PoW 
(aspect of) 
welfare 
Resources 
(endogenous, 
tangible) 
Non-resources 
(endogenous, 
intangible) 
Quasi-inputs 
(exogenous, 
intangible) 
AN 
Improved 
symptomatology; 
improved quality 
of life 
Hospital bed 
days, staff time 
Ward climate 
Patient characteristics 
(age, personality) 
 
Endogenous inputs are those that can be influenced by a service provider. Quasi-inputs on 
the other hand highlight the role of the patient in the production of her own welfare. The 
basic premise of PoW can be summarised as follows: 
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“Outputs are determined by the levels and modes of combination of resource inputs 
and non resource inputs, given the exogenously determined values of quasi-inputs” 
(Davies & Knapp 1981, p. 8)  
This can be stated in the form of a production function: 
𝑌𝑖 = f(X1i, … , Xni) 
where Yi is the outcome of interest and Xji are the inputs for person i. 
Outcomes, such as improved health, are therefore ‘produced’ by combining resource and 
non-resource inputs. Different resource combinations may produce differential outcomes. 
Where the aim is to link changes in outcomes (here: health) to the resources invested, the 
cost estimate should be as broad as possible and include a wide range of services (Beecham 
2000; Beecham et al. 1991; Knapp 1998), linking back to the principles of economic costing 
described above. 
Cost functions 
A related concept is that of cost and expenditure functions. In economic analysis, the 
relationship of interest is often that between resource use (as measured by costs) and 
outcomes. The model can be re-stated in the form of a cost function because 
“(…) there is an obvious causal link between resource inputs (summarised by costs) 
and the final outcomes (or product) of the care system, but this relationship will be 
mediated by the intermediate outcomes and the different combinations of non-
resource inputs.” (Beecham 2000, p. 32)  
The cost function can be written as 
𝐶𝑖 = f(M1i, … , Mni, Yi) 
where Ci are the costs, Mji are the mediating factors and Yi is the outcome for person i. In 
the cost function approach, the relationship between costs and outcomes can be explored, 
linking back to the production of welfare approach (Beecham et al. 1991; Knapp 1998). 
Here, service costs are used as the dependent and outcome variables are used as explanatory 
variables (controlling for patient characteristics) in a regression-type framework. The cost 
function therefore explores whether cost variations are associated with outcomes. It is often 
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the case that instead, costs vary based on demographic characteristics, or that much of the 
variance in costs remains unexplained due to unobserved variables. 
In this thesis, I use baseline data to explore variations in costs. The analysis cannot claim to 
be a full cost function approach, as an ‘outcome’ in that framework is a change brought 
about by resource investment. Instead, I explore predictors of baseline costs within a 
regression framework to provide information on potential mediators that need to be 
considered in future analyses as well as information on why and for whom baseline costs 
may vary. 
CHARACTERISTICS OF COST DATA 
There are some well-known problems associated with cost data that influence the choice of 
analysis approach and estimation models. Two papers in particular have summarised these 
issues, and provide an overview of the approaches available to address them. 
Dunn and colleagues (2003) write for a general audience wishing to critically assess the 
methods used in economic evaluation, while Kilian and colleagues (2002) provide a more 
technical overview and show the implications of different approaches in a modelling study 
applying them to the same data. The following sections summarise the characteristics of 
cost data, the issues resulting from them and approaches suggested to address them as 
discussed in these papers. 
Distribution of cost data 
While ordinary least squares regression assumes a normal distribution, raw cost data are 
often positively skewed with a long right tail because by definition, the lowest possible value 
is zero and empirically, most participants incur low (or even zero) costs while a small 
number of participants – for example, those with long hospital stays – incur very high costs. 
Heteroscedasticity 
Another feature of cost data is that the assumption of homoscedasticity of residuals is often 
violated, i.e. their variance increases with the value of the observations. In an OLS context, 
the estimator is still unbiased but does not minimise mean square error, and therefore 
variance estimate will be inconsistent. 
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Zero- and low-cost cases 
Another common feature of cost data is a number of participants with zero or very low 
service costs, and a number with markedly higher costs. This suggests that there are often 
two distinct ‘types’ of patients represented in the data, and it may be useful to account for 
this clustering in the analysis. 
Sample size for economic evaluation 
Most clinical studies are powered for the analysis of outcomes rather than an economic 
analysis. Cost data – especially when taking a broad perspective – are usually characterised 
by large standard deviations, which (all things being equal) increases the required sample 
size for a given level of power. As a result, clinical studies are often underpowered with 
regard to the economic evaluation. Given the small sample sizes in some studies presented 
here, and the fact that cost data often do not follow a normal distribution, standard 
parametric methods (t-tests) will be supplemented by non-parametric methods (bootstrap; 
Efron & Tibshirani 1993) to explore cost differences.  
APPROACHES FOR ADDRESSING THE CHARACTERISTICS OF COST DATA 
There are several options for addressing this problem that have been explored in the 
literature by various authors (Kilian et al. 2002; Knapp 1998). 
Ordinary Least Squares with bootstrap 
A common approach for dealing with the problem of heteroscedasticity is to apply the non-
parametric bootstrap to an ordinary least squares regression (Efron & Tibshirani 1993). 
While several approaches to bootstrapping are available, one that is easily implemented 
within STATA and allows for standard errors that are heteroscedasticity consistent is the 
pairs bootstrap, i.e. sampling with direct replacement (Cribari-Neto & Zarkos 1999). 
Log transformation 
A simple way of addressing the non-normality of the distribution of cost data is to model 
the log transformation of the dependent variable: 
𝑙𝑛(𝑦) = 𝛼 + 𝛽𝑥 + 𝜀 
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ⅇxp(ln(𝑦)) = ⅇ𝑥?̂? 
Note that this does not necessarily address the problem of heteroscedasticity (Kilian et al. 
2002). 
Two-stage models 
A common solution is the application of two-stage models (Mullahy 1998). The first part is 
a model predicting whether or not service costs were zero, and the second part contains 
predictors of the costs of care for those with non-zero service costs (here shown in the 
context of a generalised linear model, see below).  
Part 1 
Pr(𝑦𝑖 > 0|𝑥𝑖) =
1
1 + 𝑒−𝐵1−𝐵𝑖𝑋𝑖
 
Part 2 
𝐸(𝑙𝑛(𝑦𝑖)|𝑥𝑖 > 0, 𝑥𝑖) = 𝑋𝑖𝛽𝑖 
Generalised linear models 
The generalized linear model (GLM) extends the linear model and allows for the 
specification not just of a linear predictor  
𝜂𝑖 = 𝑋𝑖𝛽, 
the combination vector of independent variables X and the vector of parameters beta to be 
estimated, but also a probability distribution and a link function that describes how the 
linear predictor relates to the mean of the distribution function: 
𝜇𝑖 = 𝐸(𝑦𝑖) 
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𝑔(𝜇𝑖) = 𝑋𝑖𝛽 
The probability distribution is chosen from a member of the exponential family and 
characterised by the dispersion parameter τ and the parameter θ. The variance function of 
the probability distribution specifies the relationship between the mean of the outcome 
variable and its variance across individuals. 
The mean of the distribution is  
𝐸(𝑦) = 𝜇 = 𝑔−1(𝑋𝛽) 
And the variance is a function of the mean: 
𝑉𝑎𝑟(𝑦) = 𝑉(𝜇) = 𝑉(𝑔−1(𝑋𝛽)) 
The GLM framework accommodates many well-known models. For example, an OLS 
model can be conceptualised as a GLM with a normal distribution and identity link. In 
analysis cost data, a common choice is a gamma distribution with a log link, i.e. the link 
function 
𝑋𝛽 = ln(𝜇) 
The choice of distributional family can be determined using the Park test (Manning & 
Mullahy 2002) by estimating the OLS model 
𝑙𝑛(𝑦𝑖 − ?̂?𝑖)
2 = 𝜆0 + 𝜆1𝑙𝑛(?̂?𝑖) + 𝑣𝑖 
The coefficient on lambda 1 indicates the appropriate distributional family as follows: 
=0: Gaussian/normal distribution 
= 1 : Poisson distribution 
=2 Gamma 
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=3: inverse normal 
MISSING DATA 
It has long been recognised that addressing or at least acknowledging missing data and its 
potential effects is important in any context (Rubin 1976), including health care data (Rubin 
& Schenker 1991) and economic evaluation of health care interventions (Briggs et al. 2003). 
However, reporting of approaches to missing data is not consistent in the field, and 
methods often do not reflect the state of the art (Noble et al. 2012). This is not just the case 
in economics, but also in clinical research (Enders 2016), medicine (Hayati Rezvan et al. 
2015) and epidemiology (Eekhout et al. 2012) – disciplines related to health economics. 
While the following discussion focusses on the application of missing data methods in the 
context of cost-effectiveness analysis, i.e. self-reported survey data with baseline and follow-
up data collection, the same principles apply generally to all missing data, and to all 
longitudinal data such as the BCS-70 or ALSPAC (Spratt et al. 2010). 
MISSING DATA MECHANISMS 
There can be different reasons for missing data (Rubin 1976). 
With 
• Y- Outcome: Y0 observed, Ym missing; 
• X – baseline covariate; 
• W- post-randomisation variable such as hospital stay1; 
• R – missing data indicator (binary). 
the following mechanisms can be distinguished. 
                                                 
1 Note that in the context of non-randomised studies, W could also relate to a post-study entry duration. 
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Missing completely at random (MCAR) 
Missing completely at random is the strongest possible assumption about missing data and 
states that the reasons for data being missing are independent of both observed and 
unobserved factors, i.e. unrelated to Y, X and W: 
P(R|Y, X, W) = P(R) 
If the assumption is met, it is permissible to ignore missing data. The assumption is implicit 
in ad-hoc methods to address missing data, such as complete-case analysis, last value carried 
forward or mean imputation, as otherwise, estimates derived from these methods carry the 
risk of bias.  
Missing at random (MAR) 
Similar to MCAR-CD, here the probability of missingness is unrelated to unobserved 
values, given the observed data:  
P(R|Y, X, W) = P(R| Y0, X, W) 
This means any systematic differences between missing and observed values can be 
explained by differences in observer variables, including baseline co-variates, other co-
variates and confounders, and the observed outcome. An example might be that 
participants with lower socio-economic status are less likely to be retained in a cohort study. 
Missing not at random (MNAR) 
This term describes the situation where missingness is related to unobserved values: 
P(R|Y, X, W) not equal (P(R| Y0, X, W), R depends on Ym 
For example, participants with lower income may be less likely to stay engaged with a cohort 
study and therefore are less likely to provide data on their income down the line – and this 
is not wholly explained by variables that are in the dataset. 
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This is problematic because if we try to estimate the missing outcome variables based only 
on observed data, the estimates will be incorrect if they really depend on unobserved 
variables. The first step in dealing with missing data is therefore to assess whether or not 
they are missing at random. 
MISSING DATA STRATEGIES 
Simple methods 
If data are MCAR, simple methods such as listwise deletion which deletes a participant from 
the analysis, or pairwise deletion, which ignores missing values but includes the participant 
can be employed without the risk of bias – although this still reduces sample size and 
therefore the power to detect changes in outcomes (Scheffer 2002). 
If data are MAR, commonly used methods are to replace missing data with the mean of 
observed cases, or to impute the missing data using a regression model fit to the non-
missing data. Both methods reduce variability in the dataset and therefore lead to smaller 
standard errors. Inverse probability weighting, where each case is included in the analysis 
with a weight that is the inverse of the probability of being missing (based on the observed 
data), can be less efficient because it uses a subset of the available information, and are not 
suitable for non-monotone missing data patterns that are typical for economic evaluation. 
If co-variates are missing, this may lead to extreme weights resulting in high variability of 
the estimates. 
Multiple imputation 
Multiple imputation (MI) addresses the issues raised by other methods. Instead of a single 
imputation, as with a regression model, multiple imputations M are performed that each 
create a plausible version of the missing data. Each dataset 𝑀𝑖 is analysed separately, and 
estimates θ are then combined using Rubin’s Rules (Bo. et al. 2002): 
?̅?𝑀 = ∑
𝜃𝑖
𝑀
𝑀
𝑖=1
 
The variance of the estimate is made up of the within-imputation variance ?̅?𝑀: 
126 
 
 
?̅?𝑀 = ∑
𝑊𝑖
𝑀
𝑀
𝑖=1
 
And the between-imputation variance 𝐵𝑀: 
𝐵𝑀 =
∑ (𝜃𝑖 − 𝜃𝑛)
2M
𝑖
𝑀 − 1
 
The total variance 𝑇𝑀 is therefore: 
𝑇𝑀 = ?̅?𝑀 + 𝐵𝑀 +
𝐵𝑀
𝑀
= ?̅?𝑀 +
𝑀 + 1
𝑀
𝐵𝑀 
Confidence estimates and significance levels can be taken from a t-distribution (Bo. et al. 
2002) 
(𝜃 − ?̅?𝑀)𝑇𝑀
−1 2⁄ ~𝑡𝑣 
With v degrees of freedom: 
𝑣 = (𝑀 − 1) [1 +
1
𝑀 + 1
⋅
?̅?𝑀
𝐵𝑀
]
2
 
Number of imputations 
While (Rubin 1996) showed the relative efficiency (measured in standard deviation units) 
of an estimate to be approximated by the relationship 
(1 +
𝛾
𝑚
)
−1
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with a rate of missingness 𝛾 and a number of imputations m, it has been shown in simulation 
studies that efficiency does not reflect the increase in standard error nor p-value as m gets 
smaller (Graham et al. 2007). This ‘power falloff’ was more pronounced if more than 30% 
of data were missing. The authors recommend a much larger number of imputations to 
avoid unacceptable falloff in power, up to 40 or more imputations. 
Evaluating MI models 
There are two models involved in when using MI procedures: the imputation model and 
the analysis model. (The imputation model should include all variables that will be part of 
the analysis model, and any auxiliary variables that are thought to be important in terms of 
the co-variance matrix. In evaluating whether the model is a ‘good model’, it is therefore 
necessary to determine whether  
• The imputation model is appropriate and 
• Whether the analysis model is appropriate for the data. 
However, there are currently no established guidelines for model checking to determine the 
appropriateness of the imputation model are only emerging, and Nguyen and colleagues 
(2017) provide an overview of existing approaches that I summarise in what follows. 
• Visual inspection of data, e.g. distribution of imputed vs observed data, or 
comparison of summary statistics between observed and imputed data are 
suggested. Options for formal testing are proposed: 
• Ratio of variances of observed and imputed values not between 0.5 and 2, or 
absolute difference in means greater than two standard deviations (Stuart et al. 
2009); 
• Kolmogorov-Smirnov test to compare distributions of observed and imputed data, 
with variables flagged if the p-value was below 0.05 (Abayomi et al. 2008), but results 
were found to be difficult to interpret (Nguyen et al ). 
These methods focus on differences between observed and imputed data. Nguyen and 
colleagues note that such differences in themselves are not problematic, since data are 
assumed to be missing at random. Therefore, the proposed informal methods on their own 
are of limited use, and the authors suggest using external information to determine whether 
imputed data are plausible. One example would be where missingness is related to the value 
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of an imputed variable. The authors use the example of lower socio-economic status being 
associated with missingness in their panel data, with would lead us to expect those with 
missing data to have a lower socio-economic status than those without missing data. 
This approach is extended to comparing observed and imputed distributions including an 
estimated propensity for response (i.e. a logistic regression model on the missingness 
indicator; (Nguyen et al. 2017), and visually inspecting the resulting distributions. A further 
extension proposes grouping individuals based on response probabilities, and performing 
analysis of variance (ANOVA). The imputation model would be rejected if the ANOVA 
test is rejected in 2 out of 5 imputed data sets. 
Another suggestion is to fit a model to the observed data and refining this model before 
the imputation procedure (Marchenko & Eddings 2011). Standard model diagnostics can 
then be applied. 
Another option presented by Nguyen (2017) is cross-validation, where one observation is 
deleted per iteration which is then predicted by the remaining data. The discrepancy 
between observed and predicted values is then assessed. 
Finally, posterior predictive checking is introduced, which compares inference from the 
complete data to the inference from replication data which is based on the imputation 
model. Relevant quantities are tested for similarity between estimates from the complete 
data and the replications, based on the final model to be fitted (He & Zaslavsky 2012) and 
assessed using posterior predictive p-values that should not be too close to zero or one. As 
the authors note, this approach focusses on the appropriateness of the analysis model rather 
than that of the imputation model. 
ADDRESSING MISSING DATA IN THIS THESIS 
There are two main missing data strategies employed in this thesis. Trial data were analysed 
on a complete-case basis, after comparing baseline characteristic for those with and without 
CSRI data. There were no significant differences between the group with data and the full 
sample, and – due to the efforts of the clinical research team to encourage questionnaire 
completion – there were few missing data. 
For the analyses of ALSPAC and BCS-70 in Chapter 5, missing data were analysed and 
multiple imputation was performed using chained equations (Azur et al. 2011) with the -mi 
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impute- command (Royston & White 2011) in Stata 14 (StataCorp 2015) for ALSPAC data 
and Stata 12 (StataCorp. 2011) for BCS-70 data. Following the recommendations by 
(Graham et al. 2007), M=40 sets were imputed for the ALSPAC data, and M=20 sets were 
imputed in the BCS-70 data, where a smaller overall proportion of data were missing. 
As of yet, there is no consensus on the recommended procedure for ensuring a ‘good’ 
performance of the imputation model, and options provided as part of commonly used 
statistical packages are very limited, the choice regarding methods applied in this thesis was 
made with a view to practicality, and to choosing methods that do not simply rely on 
inspecting differences between imputed and observed data. Therefore, models were fit on 
the imputed data and adjusted r-squared – available as part of the STATA command -
mibeta- generated. Following imputation, visual inspection of residuals was performed on 
a sub-set of imputed datasets to asses fit. 
DISEASE MODELLING 
INCIDENCE AND PREVALENCE 
Some of the ad-hoc calculations for the CoI estimate (see below, and Chapter 8) required 
an estimate of prevalence. As the literature review showed, there is no prevalence estimate 
for AN for the general population in England. 
The DISMOD-II disease modelling software (Barendregt et al. 2003) is freely available 
through the World Health Organisation. The software contains a simple disease model with 
three disease-specific states (see Figure 3-1) and general mortality (M): 
• S: Healthy 
• C: With disease 
• D: Disease mortality 
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Figure 3-1: The DISMOD-II disease model from Barendregt et al (2003, p. 3) 
 
In addition, there are three disease-specific transition hazards: 
• i: incidence 
• r: remission 
• f: case fatality 
Fatality from other causes is represented by M (state) and m (transition hazard). Two 
disease-specific parameters are required to calculate the third. 
In addition to the states above, where the probability of being in each state is determined 
by a set of equations which are detailed by Barendregt and colleagues (2003), it is possible 
to enter information on 
• Incidence as a population rate; 
• Prevalence; 
• Duration; 
• Mortality. 
For these inputs, the model is solved using a downhill simplex method, a multi-dimensional 
optimisation method. This optimisation method is also employed where the three transition 
hazards are not consistent with each other, which may be the case where information is 
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taken from different sources – a common occurrence in any kind of modelling. Similarly, 
the procedure will be applied where the model is overidentified, i.e. all three disease-specific 
parameters are available. The procedure then adjusts the values of the input variables to 
ensure internal consistency. 
In the case of AN in England, information on incidence as a population rate, remission and 
disease-specific mortality are available. The objective is to calculate prevalence and (for 
convenience) incident cases by age group for modelling Years of Potential Life Lost (YPLL, 
see Chapter 7). 
LIFE EXPECTANCY 
An estimate of life expectancy for women with AN was required to calculate YPLL. This 
was derived using data from the National Life Tables for England for 2010-2012 (Office 
for National Statistics 2015), and adopting the underlying methods as follows. 
The life tables are constructed in multiple steps. Assuming initially, data on the number of 
people eat each age and the number of people dying in each period are available, mortality 
( xm ) is calculated by dividing the sum of deaths by the sum of the mid-year population.  
The mortality rate between age x and age x+1 ( xq ) is calculated as 
x
x
x
m
m
q


2
2
 
The number dying in each period is 
xxx lqd  , 
where xl  is the number of survivors in the period. 
Accordingly, the number surviving to the next period is 
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xxx dll 1 . 
The next calculation is ‘years alive’ at each age, the average of survivors at ages x and x+1: 
2
1 xxx
ll
L
. 
Summing this number for year x to the final year (100) yields 𝑇𝑥, the total number of years 
lived: 
𝑇𝑥 = ∑ 𝐿𝑖
𝑖=𝑥
100
 
Finally, life expectancy at age x is calculated by dividing this by the number of people at age 
x: 
𝑒𝑥 =
𝑇𝑥
𝑙𝑥
 
To calculate life expectancy for AN, 𝑑𝑥 was multiplied by the standard mortality rate (SMR) 
for AN of 5.86 (Arcelus et al. 2011). The reduction in life expectancy for AN was calculated 
by subtracting the life expectancy for AN at each age from the life expectancy from all-
cause mortality as provided by the ONS data. 
YEARS OF POTENTIAL LIFE LOST AND YEARS LIVED WITH DISABILITY 
Years of Potential Life Lost (YPLL; life years lost due to premature death from AN) and 
Years Lived with Disability (YLD; number of years lived with AN) were calculated to 
estimate the loss to society from AN in terms of excess mortality, the intangible cost of 
AN. 
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YPLL were calculated for the age of onset within each five-year age group for ages 10-49 
by first determining whether a person with age of onset at age x was alive or not alive at a 
given future age up to 82, based on life expectancy at age x. This indicated whether a year 
of life was lost to AN or not. Similarly, YLD were calculated based on the duration of illness 
of AN. Future YPLL and YLD were discounted to present value at age of onset, using a 
discount rate of 3.5%.  
To place a monetary value on the resulting YPLL and YLD estimates, a valuation for a life 
year is required. As discussed above, there are several approaches available to place a 
monetary value on life and none of them are without flaws. YPLL are distinct from QALYs. 
While both one year of life lost and one full QALY (one year lived at full health) cover a 
one-year period, YPLL measures only duration of life without adjusting for quality. For the 
purpose of this CoI estimate, I use the NICE cost-effectiveness threshold to value a YPLL 
at full health. To reflect the discussion around the ‘true’ or appropriate value of the CE 
threshold, I use values of £15,000, £20,000 and £30,000, Since it is unlikely that these 
additional years would have been lived at full health, I employ a disability weight to reflect 
this reduction in QoL. In the absence of an estimate for AN, the disability weight for 
depression (46% reduction, Kruijshaar et al. 2005) was applied to the final figure. 
COST-OF-ILLNESS ESTIMATE 
There is no single data source that would allow the calculation of a cost-of-illness for AN. 
In particular, there is a paucity of data on the short and longer-term patterns of service use 
and associated costs. It is common in economic analysis – especially in cost-effectiveness 
analysis – to make use of modelling techniques to synthesise and analyse in a single 
overarching model evidence from various different sources (Philips et al. 2004)..  
Barton and colleagues (2004, p. 110) provide a useful overview of the reasons justifying the 
use of modelling techniques: 
• Absence of ‘hard data’, where modelling can be used to provide a best estimate to 
inform policy; 
• Need for ‘temporal extrapolation’ beyond the observed data, such as short-term 
data observed in a clinical trial that is used to predict costs or outcomes over a 
longer period of time; 
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• Need for ‘contextual extrapolation’, where data collected in one setting are applied 
in another; 
• Linking of intermediate and final outcomes, such as clinical outcome measures and 
associated health outcomes; 
• Comparisons of interventions where a direct comparison has not been made in a 
clinical trial (relative effectiveness or cost-effectiveness). 
The goal of the modelling process here is to obtain a CoI estimate. CoI studies have been 
conducted at least since the 1950s for a range of conditions, for example for depression 
(Berto et al. 2000; Hodgson & Meiners 1982; Malzberg 1950). Best-practice guidelines have 
been established for their construction and use (Philips et al. 2004). The costs included in 
the model should be estimated using the principles of economic costing described above, 
but in practice the approach taken varies and often depends on data availability (see for 
example, Clabaugh & Ward 2008). 
Use of modelling techniques allows for evidence to be synthesised so that CoI studies are 
possible even for conditions with low prevalence because gaps in the evidence and 
uncertainties arising from small sample sizes can be addressed by the use of sensitivity 
analysis. Examples of the successful use of this approach are estimates of the economic 
cost of autism (Knapp et al. 2009), acquired brain injury (Beecham et al. 2009) and conduct 
problems (Bonin et al. 2011) in the UK. 
Two main approaches are commonly used in economic modelling; both originate in 
decision analysis (Barton et al. 2004): 
• Decision trees illustrate the consequences of decisions (represented by ‘decision 
nodes’) and the associated probabilities that each (mutually exclusive) event or 
outcome will occur. In economic analysis, it is common to associate a cost with 
each outcome. The expected value of a decision is then calculated by calculating the 
probability-weighted cost associated with the decision. Decision trees are 
advantageous for simple models as they require few assumptions but can become 
quite extensive when there are many decision points.  
• Alternatively, a Markov model can be constructed where repeating outcomes can 
be summarised into discrete ‘states’ and ‘transitions’ between states happen on 
135 
 
 
cycles of equal length (‘Markov periods’), e.g. one year. This approach requires more 
data, including transition probabilities for each cycle.  
Both approaches are cohort simulations, where the costs associated with all possible 
outcomes are added, weighted by the probability of an outcome occurring. A Markov model 
additionally takes into account the time spent in each state.  
Beyond these two relatively simple forms, some extensions are possible (Briggs et al. 2006). 
Decision trees and Markov models can be combined, either where state transitions take the 
form of a tree (‘Markov trees’), or where different interventions or strategies are evaluated 
as part of a decision tree leading to an event/outcome, with a Markov model extrapolating 
beyond the event. Another extension is the possibility of building time dependencies into 
Markov models, for example, a change in transition probabilities as the cohort ‘ages’ (e.g. 
differential mortality rates over time), or a varying transition probability, such as the 
mortality rate, depending on how long a patient has spent in a disease state. 
In contrast to the cohort models described above, patient-level simulation models focus on 
individual data and track each patient through the model. This is usually achieved by 
employing Monte Carlo simulation, where a model is run many times on a sample of the 
population. While these models offer more flexibility, e.g. they do not require a fixed cycle 
length, they often require more data to model the future path through the model based on 
patient factors, which is what drives the variation that results from the sampling approach 
(Barton et al. 2004; Briggs et al. 2006). 
While some patient-level models are similar in structure to cohort models in that the 
simulation continuously tracks individuals over time, discrete event simulations focus on 
time in state as an individual moves through a list of well-defined events. An example of 
such discrete events may be admission to inpatient treatment (with an associated time in 
state, the duration of the admission), followed by discharge (Allen et al. 2015). These models 
offer great flexibility in defining rules that can be used to model complex systems. 
System dynamics have a place in modelling where individuals beyond the patient are 
affected. This is usually the case in modelling infectious diseases, or where treatment 
provided to one patient affects the treatment of another (Barton et al. 2004). 
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Given the limited data available to construct a CoI for AN, most calculations in Chapter 8 
use decision trees with one or two sequential decision nodes. A Markov model underpins 
the DISMOD-II disease model, and is used in this thesis to calculate life expectancy and 
YPLL. 
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CHAPTER SUMMARY 
In this chapter, I discussed the methods and data available to answer the research questions 
and to meet the aim of this thesis – to estimate the annual societal costs of AN in England, 
and to explore why costs may vary. Given that such a CoI model requires a wide range of 
information, and no one source is available to derive the estimate, a range of methods and 
data will be used in the empirical chapters that follow. 
This includes: 
• Applying the principles of economic costing to information on resources needed to 
provide treatments for AN in outpatient settings; 
• Using econometric techniques to explore cost variations, accounting for the typical 
characteristics of cost data outlined above; 
• Using econometric modelling techniques to investigate the impact of AN on 
education attainment, employment, income and related outcomes; 
• Using disease modelling software to estimate the prevalence of AN for different 
age groups, given known incidence rates; 
• Applying a simple Markov model to life table data to calculate life expectancy for 
people with AN and determining Years of Potential Life Lost from AN; 
• Using the principles of decision analysis to combine information from a variety of 
sources into a cost of illness estimate for AN; 
• Employing appropriate missing data strategies. 
Chapters 4-8 present the empirical findings, followed by a discussion of results and 
concluding thoughts in Chapter 9. 
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CHAPTER 4  
Direct costs: Unit costs of outpatient treatments 
for Anorexia nervosa 
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CHAPTER INTRODUCTION 
This first empirical chapter focusses on the direct costs associated with AN and on 
answering RQ1: “What treatments are provided for AN in an outpatient context, what are 
the associated unit costs, and why do these costs vary?”  
While this chapter is concerned with unit costs (cost per session or treatment unit) and 
therefore takes a service-level perspective, Chapter 5 will look at service costs and variation 
in service costs at the patient level. 
Mapping studies have found specialist ED services to be concentrated in the South East of 
England (O’Herlihy et al. 2003b; Tulloch et al. 2008), and 25% of the population live in areas 
without specialist provision (Royal College of Psychiatrists 2000) while referral from 
primary care to specialists services may depend on availability of such services within the 
area (Currin et al. 2006). Consequently, setting up outpatient services may facilitate more 
equitable access to treatment. 
But while the Hospital Episode Statistics provide some insight into inpatient treatment 
provided for AN, little is known about the full spectrum of service use and costs associated 
with outpatient treatment of AN. Given the paucity of evidence on cost-effective 
treatments, there is a need for information on the costs of treatment provided in outpatient 
services for AN as a first step towards developing the cost-effectiveness argument. 
In this chapter, I collate information from two different studies, focussing on the unit costs 
of different types of outpatient treatments for people with AN. In Part 1, I present the unit 
costs (cost per day and cost per family per day) of Multi-Family Day Treatment (MFDT), 
calculated based on information obtained alongside the MCTAAN trial. In Part 2, I detail 
the unit costs of other treatments provided in outpatient settings, which is based on 
information from the Care Pathways Study. I also analyse why these costs vary between 
services with different degrees of specialisation with regard to ED treatment. 
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PART 1: UNIT COST OF MULTI-FAMILY DAY TREATMENT 
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INTRODUCTION 
Here I present the unit costs of Multifamily Day Therapy (MFDT) estimated alongside a 
pragmatic multi-centre RCT comparing MFDT to single family therapy (SFT; Eisler et al. 
2016). This was the first trial of MFDT, and the work presented here is the first time the 
costs of this promising form of outpatient treatment for AN have been detailed, using a 
rigorous economic method. Unit costs for SFT and individual therapy (IT) – the control 
treatment and supplementary treatments to MFDT – are also presented. The economic 
analyses conducted for this study are published elsewhere (Bonin et al. 2013) 
While family therapy for AN has a longstanding history (e.g. Russell et al., 1987, but note 
that there are earlier studies), and a growing body of evidence existed that indicated family 
therapy is a promising approach to treating AN in adolescents and can potentially provide 
an alternative to inpatient treatment (Eisler 2005), trials were often underpowered and 
issues of potential bias were identified (Fisher et al. 2010).  
MFDT is a form of the ‘Maudsley method’ of family-based treatment (Rienecke 2017), a 
manualised treatment that is considered suitable for patients who are medically stable and 
which consists of three phases: 
Phase 1: Restoration of physical health, with a focus on avoiding inpatient admissions by 
giving parents responsibility for decisions about eating. 
Phase 2: Once a steady weight gain is achieved, responsibility for decisions about eating is 
gradually transferred back to the patient. 
Phase 3: Review of patient development, identification of future challenges and strategies 
for helping the young person to cope without reverting to the ED behaviours. 
Throughout, MFDT focusses on parental and family input, supported by the therapist. This 
links back to the model of maintenance factors in AN discussed in Chapter 3, which 
highlight the role of carers in AN. Similarly, ‘transdiagnostic’ theories of family therapy have 
been put forward (Loeb et al. 2012). 
MFDT is an intensive form of family therapy. It consists of a one-week intensive 
programme of day-long sessions for up to six families. This is followed by four or five 
additional day-long meetings at 4-8 week intervals, although single-family therapy sessions 
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(SFT) and individual therapy (IT) can be scheduled between group meetings as needed. 
Shared families’ experiences and the group dynamics are key components of the treatment. 
The overall length of the MFDT programme is 12 months. 
A total of 169 moderately ill adolescents with a DSM-IV diagnosis of AN or AN-type 
EDNOS (restricting) were randomised to MFDT or SFT (Eisler et al. 2016). In the SFT 
group, around 60% achieved a good or intermediate outcome as measured on the Morgan-
Russel scale, compared to 75% in the MFDT group – a significantly better improvement 
(Eisler et al. 2016). A qualitative study with five adolescents and 10 parents who participated 
in MFDT found that participants experienced the therapy as positive, and that shared 
experiences and mutual learning and support facilitated change (Voriadaki et al. 2015).I first 
detail the methods used to obtain a description of the MFDT intervention and how 
resources needed to provide the intervention were costed. The data were then analysed 
following the four-stage process proposed by Beecham (2000), I then describe the different 
elements of the intervention, quantify the required resources and associated costs and finally 
present the unit costs of MFDT. Descriptive results are reported and I briefly discuss 
variations in costs across the four intervention sites. Given that the sample consisted of 
only services (services A, B, C and D), no statistical analyses were undertaken. 
This piece of work is an example of costing a complex intervention where an economic 
evaluation was added after the RCT design and implementation was completed, and 
illustrates some of the challenges arising from the need to collect retrospective data. 
However, resources required to provide specific interventions within a service are not 
routinely recorded within CAMHS, and this intervention took place prior to the 
implementation of electronic health records Therefore, this type of retrospective costing 
exercise is the only way of estimating robust intervention costs that adhere to the principles 
of economic costing. 
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METHODS 
COLLECTING INFORMATION ON INTERVENTION ELEMENTS AND RESOURCES 
To calculate the unit costs of MFDT, a Service Information Schedule (SIS) was developed 
to capture all resource inputs related to the intervention so that economic costs could be 
calculated. In accordance with the principles of economic costing detailed in Chapter 1, a 
preliminary SIS was designed to guide an initial interview with Prof. Ivan Eisler to gain a 
better understanding of the intervention and to identify the elements of the MFDT 
intervention. The SIS (attached as Appendix 1) was developed based on this interview. 
Resources needed to provide interventions can generally be broken down into staff time 
and associated salaries, salary on-costs (national insurance, pensions), overheads and other 
resources such as materials and catering, and these elements are reflected in the design of 
the SIS. 
The principles of economic costing prescribe that not just time spent directly on providing 
the intervention, but also ‘indirect’ time spent on related activities needs to be included (see 
also, Barrett & Byford 2008). It is therefore necessary to capture information on all activities 
related to the intervention. Based on the description of the MFDT intervention obtained 
from Prof. Eisler, the final SIS was designed to record information on staff time for the 
following activities:  
• Designing the intervention; 
• Providing an information evening; 
• Training and supervision; 
• Preparation and feedback; 
• Administration; 
• Travel time; 
• Providing the intervention. 
Information on non-staff elements such as room hire and catering were collected for all 
intervention activities combined. 
The resulting SIS was used to structure interviews with clinicians at the four sites where the 
MFDT intervention was provided to participants in the MCTAAN trial. I travelled to the 
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four intervention sites (Services A-D, located in London and surrounding areas) and 
conducted interviews of 30-60 minutes with clinicians to complete the SIS for each service. 
COSTING INTERVENTION RESOURCES 
Once the information had been collected via interview, resources were costed in the 
following way. 
• Staff time: Information was collected on profession, salary grade (where applicable) 
and number of hours spent by each member of staff on each of the activities listed 
above. Based on this information, an appropriate unit cost (cost per hour) for each 
member of staff was drawn from the PSSRU Unit Costs of Health and Social Care 
publication (Curtis 2011). These costs include salaries, employer on-costs and 
capital and non-capital overheads. One site, service C only the provided total 
clinician and administrator time, so that a breakdown into different intervention 
activities was not possible. 
• Rooms: To ensure consistency in the cost estimates and to reflect the integration of 
the intervention into existing service provision within the hospitals, the capital 
overhead charges presented in the PSSRU unit cost volume (Curtis 2011) were used. 
• Travel: Any staff travel to a location other than their usual place of work that is 
related to the normal provision of the intervention (as opposed to being related to 
the requirements of the research design) were included at the rates of 
reimbursement detailed in the NHS Terms and Conditions of Service Handbook in 
force in 20092. Trial participants were asked to provide information on travel time 
and travel expenses relating to their participation in the intervention. Clinicians were 
asked to judge whether or not participant travel costs were related to the 
requirements of the RCT. 
• Other resources: Expenditure on non-staff resources was recorded in currency 
amounts and no separate costing step was required. 
                                                 
2 http://www.nhsemployers.org/your-workforce/pay-and-reward/agenda-for-change/nhs-terms-and-
conditions-of-service-handbook/archive---nhs-terms-and-conditions-of-service-handbook 
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ASSUMPTIONS USED TO ADDRESS MISSING INFORMATION 
Where information on the time spent on an activity was missing, the cost was estimated 
based on information provided by another service. As Service A was where most MFDT 
groups were held and the manualised treatment was considered to be most embedded, 
figures from Service A were used to fill missing information where possible, unless a more 
conservative estimate was available from another service. Given that Service C was unable 
to break down staff time by intervention activity, it was not possible to use data provided 
by this service to replace missing data. Missing information was therefore handled as 
follows: 
• The costs of the information evening for participants from Service B and Service 
D were calculated based on information provided by Service A; 
• Preparation time at Services A and B were calculated based on information provided 
by Service D; 
• The costs of snacks for Service D were assumed to be the same as in Service B, 
which had the lowest cost for this item. 
ASSUMPTIONS ABOUT ATTENDANCE 
Between five and seven families – but typically six – form an MFDT group. Attendance 
was reported to be generally good with full attendance during the intensive phase of the 
intervention and families only occasionally missed sessions during the follow-up phase 
(Eisler et al. 2016). Barrett and Byford (2008) point out that costs of group therapy can be 
estimated either based on the number of sessions allocated to each participant, or the 
number of sessions actually attended, and that the former should be used unless there is 
perfect replacement of those who do not attend, as resources will have been committed 
even if they miss a session.  
While Bonin and Beecham (2012) show that the choice of approach can affect the 
conclusions drawn with regard to cost-effectiveness, in this instance the apparent low level 
of absenteeism justifies the calculation of a cost per session based on allocation, as it will 
be very similar to an estimate based on attendance, and no attendance records were 
available.  
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CALCULATING UNIT COSTS 
The costs of the multi-family groups were calculated for each service. The costs of staff and 
non-staff resources were added to arrive at the total cost for one iteration of the MFDT 
treatment for each service. This total was divided by the number of families participating in 
the groups to calculate the cost per family. Finally, the cost per family was divided by the 
number of days of MFDT, based on 11 days of treatment, which respondents considered 
to be typical and consisted of five days in the intensive phase and six follow-up days. 
RESULTS 
DESCRIPTION OF INTERVENTION COMPONENTS AND RESOURCES 
This section describes the intervention components and resources (staff and non-staff) 
required to provide it. 
Designing the intervention 
The intervention is based on an existing manual and it has not been possible to determine 
what resources went into designing it originally. No adaptation was necessary for the 
MCTAAN study as it was designed specifically for the patient group. Therefore, staff time 
and other resources required for this intervention-related activity were zero. 
Training and supervision 
Three two-hour training workshops on MFDT were held at Service A before the trial 
started, and more were run later in the trial period. Service A plays an important role in 
training new staff; most of the MCTAAN workshops were run there and it appears to be 
the largest provider of MFDT more generally. Staff members from other centres were sent 
to Service A for MFDT training at the workshops. One centre, for example, sends one 
person each year to Service A for training; no charge is made for this. Apart from the 
workshops, which were not attended by every staff member providing the MFDT 
intervention, staff received a few hours’ introduction, but their training mainly consisted of 
helping to run the programme and background reading. 
Trainee family therapists also receive supervision. The arrangements vary between centres. 
In one, supervision takes place approximately once per month. In another, it consists of 
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pre- and post-session discussions. These sessions also vary in length. To add another layer 
of complexity, trainees’ supervision is usually related to the entire course of study in family 
therapy, not just the MFDT. Therefore, only the time trainees spend providing MFDT is 
known and lack of data means that it is not possible to include MFDT-specific supervision. 
Information evenings 
Information evenings for prospective participants were held in at least three services, with 
no information available on Service C. At Service A, this session lasted 2.5 hours. Two staff 
members led the evening supported by four volunteers, and a junior doctor gave a talk 
lasting about an hour.  
Preparation and feedback 
Arrangements for preparation and feedback also vary between sites, and supervision may 
be integrated into these sessions. In one centre, staff members meet for one hour before 
and 1.5 hours after each day’s group session.  
Rooms 
Generally, the intervention takes place within hospital buildings and the type of room used 
depends on availability. If several rooms are available, the groups may split up with the 
young people in one room and the parents in another. If only one room is available, 
partitions may be used to separate the space. One centre which did not have a large enough 
room rented a hall at the local YMCA at a charge of £1,000 for one iteration of the MFDT 
intervention.  
Materials and refreshments 
A variety of materials were used, mostly for arts and crafts such as colouring/drawing, 
collaging and making posters. Estimated costs ranged from approximately £12 to £75 per 
group. The costs of refreshments ranged from £12 to £42 per day. 
Travel 
As the intervention commonly took place at the staff members usual place of work, no 
additional staff travel costs were incurred, unless staff members were acting as key workers. 
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Information about participants’ travel to the MFDT intervention for the intensive phase 
(over the three months following the baseline assessment) is available for 45 young people. 
Most (n=43) travelled with their parents, commonly by car (n=26) or public transport 
(n=17), although some used more than one mode of transport. Average travel time was 
almost an hour but ranged from eight minutes to six hours (n=37), and the average distance 
travelled was 26 miles (range 0.3 miles to 250 miles, n=26). The average public transport 
fare was around £25 but ranged from £0.40 to £200 (n=19). These figures are not included 
in the unit cost of MFDT presented below because they were deemed to be a research cost 
associated with conducting the RCT, rather than the treatment itself, as participants had to 
travel to specific services involved in the trial rather than receiving the intervention at a 
service local to them. 
UNIT COSTS OF MFDT 
Table 4-1 shows the staffing inputs into the intervention provided by each service and 
applies unit costs per hour to these staff hours, as well as other, non-staff costs. Total costs 
for each of the four services are also shown. Then, the following unit costs for the MFDT 
intervention are calculated: 
• Costs per MFDT group, i.e. running one iteration of the group-based intervention, 
including the intensive phase and follow-up sessions over a 12-month period;  
• Costs per participating family over the 12-month period;  
• Costs per family per day of MFDT. 
Table 4-1: The cost of the MFDT intervention, by treatment centre (2008/09 cost) 
 Service A Service B Service C Service D 
 Hrs Cost Hrs Cost Hrs Cost Hrs Cost 
 
Information evening 
Family therapist 5 £220 5 £220 - - 5 £220 
Junior/ward doctor 1 £28 1 £28 - - 1 £28 
Volunteers/trainees 10 £310 10 £310 10 £310 10 £310 
 
MFDT group 
Family therapist 77 £3,388 69 £3,049 - - 92 £4,066 
Psychologist 39 £1,425 77 £3,388 - - - - 
Consultant 39 £4,212 - - - - 77 £8,316 
Junior/ward doctor 39 £1,078 77 £5,313 - - - - 
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 Service A Service B Service C Service D 
 Hrs Cost Hrs Cost Hrs Cost Hrs Cost 
Occupational 
therapist 
- - 69 £1,802 - - - - 
Clinical nurse 
specialist 
- - - - - - 77 £1,925 
Volunteers/trainees 159 £4,937 62 £1,910 116 £3,581 15 £477 
 
Preparation & feedback 
Family therapist 28 £1,210 25 £1,089 - - 21 £924 
Psychologist 14 £509 28 £1,210 - - - - 
Consultant 14 £1,504 - - - - 18 £1,890 
Junior/ward doctor 14 £385 28 £1,898 - - - - 
Occupational 
therapist 
- - 25 £644 - - - - 
Clinical nurse 
specialist 
- - - - - - 18 £438 
Volunteers/trainees 57 £1,763 22 £682 41 £1,279 4 £109 
 
Total staff costs 
Clinician - - - - 187 £9,537 - - 
Administrator - - - - 39 £982 - - 
Total £20,969 £21,543 £15,689 £18,703 
 
Other costs 
        
Materials - £36 - £75 - £13 - £20 
Refreshments - £462 - £138 - £220 - £138 
 
Unit costs 
Total cost per 
group 
£21,466 £21,754 £15,921 £18,860 
Total cost per 
family 
£3,578 £3,626 £2,653 £3,143 
Total cost per 
family per day 
£325 £330 £241 £286 
 
The cost of the MFDT intervention was calculated at £325 per day for Service A, where 
most sessions for this patient group took place. Across the four services, estimates ranged 
from £241 to £330. 
COST VARIATIONS 
Given that MFDT is a manualised intervention, variations in costs between services were 
expected to be small. As can be seen from the results above, Services A and B have roughly 
similar unit costs. Tentatively, cost variations between Services A, B and D seem to result 
from differences in staff providing the intervention. Notably, costs per family per day for 
Service C were lowest by a large margin. This was the service that only provided totals for 
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staff costs and administrator costs, rather than information needed for micro-costing based 
on the principles of economic costing. It is therefore possible that the difference is due to 
different underlying assumptions or inclusion and omission of cost categories, for example 
about the level of overheads or their inclusion in the cost data provided by the service. 
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DISCUSSION 
This is the first study of the costs of MFDT. Data were collected and costs calculated 
following best practice in economic evaluation, giving a high level of confidence in the unit 
costs for those services that were able to provide data in line with the request (Services A, 
B and D). 
The main limitation of this study is the fact that data were collected after the trial had been 
completed, rather than alongside the study which would have allowed staff time use data to 
be collected using diaries, time sheets or other means of real-time recording. One problem 
was that in those services providing the intervention on a ‘routine’ basis it was difficult for 
interviewees to recall at interview which resources had been used specifically for the groups 
run as part of the RCT. This is likely to have biased the information, and it is unclear 
whether this would have increased or decreased the resulting unit costs. However, if the 
interest in the unit cost of MFDT is with a view to rolling out the intervention more widely, 
costs estimated after a ‘bedding down’ phase will be a more useful estimate of costs in the 
longer term, as any set-up issues will have been ironed out. 
Information was missing from some services, and assumptions had to be made to fill those 
gaps. However, the methods used to obtain data and to calculate unit costs follow best 
practice, and any assumptions are clearly stated in the methods section. 
The fact that the estimates for three of the services (A, B and D) are close to each other 
gives confidence that they are reasonably accurate. The unit cost for Service C, which only 
provided data recorded for administrative purposes, is much lower than for other services 
where more detailed information could be obtained. This may be due to a different 
underlying model of calculation, as often services calculate costs not based on long-run 
marginal costs, but on short-term marginal costs, i.e. omitting overheads, or using only a 
partial overhead figure. Given that no authoritative source for these intervention costs 
exists, it is not possible to validate the data collected for this study, and the unit costs 
presented here are the only available estimate for MFDT. 
The cost of one MFDT session for one family was equivalent to around two sessions of 
SFT calculated for the same trial, but less than half the cost per hour. At the same time, 
MFDT treatment costs compare favourably to the cost of one day of inpatient treatment 
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for ED - £330 or less compared to a minimum of £482 per day (Department of Health 
2010). 
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PART 2: UNIT COSTS OF OUTPATIENT TREATMENTS (CARE 
PATHWAYS STUDY) 
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INTRODUCTION 
This second part of Chapter 4 again focusses on the direct costs associated with AN. Again, 
this section takes a service-level approach, but here I attempt to ‘unpack’ the treatment 
components of outpatient services for AN.  
In this study, I analyse data from the Care Pathways Study (CPS) to determine  
• What types of treatment are provided for AN in outpatient ED services,  
• Which staff provide them, and  
• Why costs may vary.  
In particular, I focus on different levels of services specialisation with regard to eating 
disorders: 
• Specialist ED services: NHS child and adolescent ED services (CAEDs) and adult 
ED services; 
• Specialist CAMHS: General CAMHS with ED specialisation; 
• Non-specialist CAMHS: General CAMHS without ED specialisation. 
In addition to being the first study to look at the costs and variations in costs of outpatient 
treatments for AN in England, this study contributes an economic argument to the debate 
on service specialisation, which tries to determine whether specialist services provide more 
effective care for ED than general CAMHS services in terms of treatment outcome. 
While the private sector provided over 80% of inpatient units in 1998 (Brown 1997; 
O’Herlihy et al. 2003b; Palmer & Treasure 1999), there has been a recent effort to increase 
the availability of outpatient services through the NHS. This is considered to be a less costly, 
and potentially cost-effective, mode of treatment compared to inpatient care. However, 
little is known about treatments provided in outpatient settings (Royal College of 
Psychiatrists 2000), and about costs associated with different treatment options. 
To help address the evidence gap with regard to outpatient treatment for AN, the Care 
Pathways Study (House et al. 2012; House 2011) examined different care pathways for 
adolescents aged 13-18 with AN across 4 PCTs in the Greater London Area. Data on 
service contacts and treatment received were collected by House and colleagues from case 
notes and treatment pathways were tracked over 12 months. In addition, data were collected 
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on the types of treatment provided for AN within outpatient services, and the staff involved 
in providing these treatments. These data service-level data are used in the analyses 
presented here. 
METHODS 
DATA COLLECTION 
As part of the main CPS, a service-level questionnaire was given to clinicians to complete 
(see Appendix 3), with the main aim of collecting data for the mapping and analysis of care 
pathways. This questionnaire asked about treatments for AN provided within the service. 
A separate questionnaire for service managers was designed by Jennifer Beecham, Jennifer 
House and myself to address the particular data needs of the economic evaluation (see 
Appendix 2), asking in more detail about the grades and salaries of staff providing ED 
treatments. 
Service managers or other relevant contacts were identified with the research team and 
through internet searches. I then contacted them by e-mail. The request included a letter 
outlining the CPS and the aims of the economic analysis as well as the service questionnaire. 
This initial e-mail was followed-up by one or two telephone calls, either by myself or 
Annette Bauer, another researcher at the PSSRU. This approach proved unsuccessful so a 
follow-up letter was sent to each service, including the questionnaire, a pen and a franked 
return envelope. Despite these efforts, only one completed questionnaire was returned, and 
this had been completed for the wrong period. 
Given this disappointing outcome, the data collected via the service-level questionnaire for 
clinicians for the main study were used to estimate the unit costs presented here. 
From the available data, I created a dataset containing the relevant information. This 
included: 
• Level of service specialisation with regard to ED 
• Service location (hospital or community) 
• Details on ED assessment 
• Typical length of assessment 
• Staff typically involved in assessment 
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• Whether outpatient treatment is provided for AN 
• Type of treatments available 
• Typical length of session 
• Typical number of sessions 
• Staff typically providing the session 
• Details on other treatments provided, e.g. inpatient, day patient 
Data were available for 26 services, with n=5 categorised as specialist ED services, n=6 as 
CAMHS with ED specialisation and n=15 as CAMHS without ED specialisation. 
COSTING SERVICES AND TREATMENTS 
The cost of treatment provided within each service and an average for each group of 
services by level of ED specialisation were calculated using a long-run marginal opportunity 
cost approach (Beecham 2000). For each type of staff member, a unit cost was calculated 
based on relevant schemas in the PSSRU volume Unit Costs of Health and Social Care 
(Curtis 2011), taking into account the likely Agenda for Change pay grade, working hours, 
ratio of client contact to other tasks and overheads based on service location. Unit costs 
used in the calculations are shown in Table 4-2. All costs are presented in 2010/11 prices. 
Table 4-2: Unit costs  
 £per 
hour 
Sources of information 
 
Doctors 
Associate 
specialist 
166 
Curtis (2011), p. 202. Time ratio as per consultant (medical) from 
Curtis (2009), p. 170. 
Consultant 
(assume medical) 
202 
Curtis (2011), p. 203. Time ratio as per consultant (medical) from 
Curtis (2009), p. 170. 
GP (hospital) 229 Curtis (2011), p. 148. 
GP (community) 138 Curtis (2011), p. 148. 
Paediatrician 
(hospital) 
202 As consultant (medical). Curtis (2011), p. 203. 
Paediatrician 
(community) 
138 As GP, Curtis (2011), p. 156. 
Senior house 
officer 
61 
As foundation house officer year 2. Curtis (2011), p. 199. Time 
ratio as per consultant (medical) from Curtis (2009), p. 170. 
Specialist 
registrar 
89 
Curtis (2011), p. 201. Time ratio as per consultant (medical) from 
Curtis (2009), p. 170. 
Staff doctor/ward 
doctor 
117 
Based on consultant (medical), Curtis (2011), p. 203. Time ratio 
as per consultant (medical) from Curtis (2009), p. 170. 
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 £per 
hour 
Sources of information 
 
Nurses 
CAMHS nurse 75 
Based on CAMHS member with band 5 median salary. Curtis 
(2011), p. 173. 
CNS 73 As community mental health nurse, Curtis (2011), p. 142. 
Key nurse 120 Curtis (2011), p. 192. 
Nurse (hospital) 104 Curtis (2011), p. 193. 
Nurse 
(community) 
71 Curtis (2011), p. 141. 
Psychology nurse 104 As specialist nurse. Curtis (2011), p. 193. 
Senior staff nurse 120 Curtis (2011), p. 192. 
Specialist nurse 104 Curtis (2011), p. 193. 
Specialist nurse 
(community) 
89 Based on nurse specialist Curtis (2011), p. 144. 
 
Psychologists and psychiatrists 
Child & 
adolescent 
psychiatrist 
295 As consultant (psychiatric). Curtis (2011), p. 205. 
Child psychiatrist 295 As consultant (psychiatric). Curtis (2011), p. 205. 
Child psychiatrist 
(community) 
293 
As consultant (psychiatric). Curtis (2011), p. 205,  with 
overheads from CAMHS team (Curtis (2011), p. 173). 
Child 
psychologist 
(hospital) 
156 
As clinical psychologist, face-to-face contact, Curtis (2011), p. 
137. Overheads as consultant (psychiatric). Curtis (2011), p. 205. 
Child 
psychologist 
(community) 
152 
As clinical psychologist, face-to-face contact. Curtis (2011), p. 
137. 
Clinical 
psychologist 
(hospital) 
156 
As clinical psychologist, face-to-face contact, Curtis (2011), p. 
137. Overheads as consultant (psychiatric). Curtis (2011), p. 205. 
Clinical 
psychologist 
(community) 
152 Clinical psychologist, face-to-face contact. Curtis (2011), p. 137. 
Consultant 
psychiatrist 
(hospital 
295 Patient-related hour. Curtis (2011), p. 205. 
Psychiatrist 
(community) 
293 
As consultant (psychiatric). Curtis (2011), p. 205,  with 
overheads from CAMHS team (Curtis (2011), p. 173). 
Psychologist 
(hospital 
156 
As clinical psychologist, overheads as consultant (psychiatric). 
Curtis (2011), p. 205. 
Psychologist 
(community) 
152 
As clinical psychologist, face-to-face contact. Curtis (2011), p. 
137. 
psychology 
assistant 
123 
As clinical psychologist, face-to-face contact. Curtis (2011), p. 
137. Median salary grade 6. 
 
Therapists 
Art therapist 
(hospital) 
139 
As clinical psychologist, face-to-face contact. Curtis (2011), p. 
137. Median salary grade 7. 
Art therapist 
(community) 
136 
As clinical psychologist, face-to-face contact. Curtis (2011), p. 
137. Median salary grade 7. 
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 £per 
hour 
Sources of information 
Child 
psychotherapist 
156 
As clinical psychologist, face-to-face contact, Curtis (2011), p. 
137. Overheads as consultant (psychiatric). Curtis (2011), p. 205. 
Cognitive 
analytical 
therapist 
139 
As clinical psychologist, face-to-face contact. Curtis (2011), p. 
137. Median salary grade 7. 
Counselling 
psychotherapist 
156 
As clinical psychologist, face-to-face contact, Curtis (2011), p. 
137. Overheads as consultant (psychiatric). Curtis (2011), p. 205. 
Drama therapist 139 as art therapist 
Family therapist 
(community) 
183 
As clinical psychologist, face-to-face contact. Curtis (2011), p. 
137. Median salary grade 8b. 
Family therapist 
(hospital) 
186 
Clinical psychologist, face-to-face contact. Curtis (2011), p. 137, 
using overheads for hospital-based health care staff (pp. 181-
187) 
Psychotherapist 
(hospital) 
156 
As clinical psychologist, face-to-face contact, Curtis (2011), p. 
137. Overheads as consultant (psychiatric). Curtis (2011), p. 205. 
Psychotherapist 
(community) 
152 
As clinical psychologist, face-to-face contact, Curtis (2011), p. 
137. 
Systemic 
psychotherapist 
156 
As clinical psychologist, face-to-face contact, Curtis (2011), p. 
137. Overheads as consultant (psychiatric). Curtis (2011), p. 205. 
Therapist 156 
As clinical psychologist, face-to-face contact, Curtis (2011), p. 
137. Overheads as consultant (psychiatric). Curtis (2011), p. 205. 
Dieticians 
Dietician 
(hospital) 
36 Curtis (2011), p. 184. 
Dietician 
(community) 
34 
Dietician (hospital). Curtis (2011), p. 184, capital overheads from 
CAMHS teams (pp. 172-175). 
Paediatric 
dietician 
47 Curtis (2011), p. 184, using median salary band 6. 
Specialist 
dietician 
47 Curtis (2011), p. 184, using median salary band 6. 
 
Other 
Behaviourist 156 
As clinical psychologist, face-to-face contact, Curtis (2011), p. 
137. Overheads as consultant (psychiatric). Curtis (2011), p. 205. 
CAMHS 
professional 
(hospital) 
101 
Targeted CAMHS team member. Curtis (2011), p. 175, using 
overheads for hospital-based health care staff (pp. 181-187). 
CAMHS 
professional 
(community) 
98 Targeted CAMHS team member. Curtis (2011), p. 175. 
Occupational 
therapist 
(community) 
35 Curtis (2011), p. 134. No time ratio applied. 
Occupational 
therapist 
(hospital) 
36 Curtis (2011), p. 182. No time ratio applied. 
Occupational 
therapist assistant 
31 
Based on Occupational Therapist. Curtis (2011), p. 182. Median 
salary grade 4 (assistant practitioner). No time ratio applied. 
Physiotherapist 
(community) 
35 Curtis (2011), p. 133. No time ratio applied. 
Physiotherapist 
(hospital) 
37 Curtis (2011), p. 181. No time ratio applied. 
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 £per 
hour 
Sources of information 
Social worker 
(child) 
146 Curtis (2011), p. 157. No time ratio applied. 
Therapeutic carer 104 Curtis (2011), p. 193. 
 
ASSUMPTIONS REGARDING MISSING OR INCONSISTENT INFORMATION 
Given that the information used to generate the dataset for these analyses was not collected 
explicitly with an economic analysis in mind, assumptions needed to be applied where 
required data were not available. The approximate cost of each type of treatment session 
was calculated by applying of the following assumptions: 
• The unit costs for all staff members’ time listed as involved in providing a treatment 
were added together; 
• Where the questionnaire stated that one or another type of staff member provided 
the treatment (e.g. “psychiatrist or psychologist”), an average unit cost was applied; 
• For group treatments, a group size of 6 patients or families was assumed. 
There were some potential inconsistencies where the number of staff members involved in 
a treatment session appeared to be too high to justify the assumption that they were all 
present at the same time. It may be that the question was interpreted as asking for the total 
number of staff who potentially provide the treatment within the service, rather than how 
many people are involved in any one particular treatment session. For example, if it was 
stated on the questionnaire that three psychologists proved individual family therapy, it 
seems unlikely that they all provide the treatment together. Rather, it seems plausible that 
there are three psychologists within the service who can provide family therapy. In these 
cases, it was assumed that one staff member provides a treatment session. 
Calculating the cost of an assessment presented additional difficulties because there were 
often many members of staff involved and it is not clear from the available information 
how much time each staff member spends on the assessment. To explore the range of 
possible cost of an assessment, three estimates were calculated:  
• An ‘average’ unit cost, calculated based on the assumption that each staff member 
spent an equal amount of time with the patient; 
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• A low estimate, assuming the lowest-cost staff member provided the entire 
assessment; 
• A high estimate, assuming the highest-cost staff member provided the entire 
assessment. 
There were four services where the duration of the assessment was given as several months 
(possibly implying ongoing monitoring rather than a formal assessment session) or as 
“variable”. These were treated as missing. After presenting the three estimates described 
above, the base case estimate is used for all further analysis. 
The work presented in this chapter also links with Chapter 5, where the perspective shifts 
from service-level costs and variations in costs to the individual level. The types of 
outpatient treatment reported in the individual-level data are not as fine-grained as those 
available from the service-level analysis presented in this section. To arrive at a unit cost for 
each type of outpatient treatment that could be applied to the individual-level data, a 
weighted average was calculated by applying the proportion of services providing each type 
of treatment as a weight. For example, if 80% of services provide cognitive behaviour 
therapy (CBT) and 12% provide psychodynamic psychotherapy (PDT), the weighted 
average cost of individual treatment (IT) for the service in question is (0.8*(cost CBT) + 
0.12*(cost PDT))/(0.8+0.12).  
In addition to calculating these unit costs for each service, the average unit cost for each 
level of service specialisation was calculated. This average was used to estimate unit costs 
for services where patients received treatment that were not part of the study or that had 
not provided sufficient data to estimate those unit costs.  
ANALYSES 
In presenting the results regarding outpatient treatments and their costs, staff members 
providing the treatment and the unit costs of treatment, outpatient services were grouped 
according to their level of ED specialisation: 
• Specialist ED services: NHS CAEDs and adult ED services; 
• Specialist CAMHS: General CAMHS with ED specialisation; 
• Non-specialist CAMHS: General CAMHS without ED specialisation. 
161 
 
 
The number and percent of services within each service category providing each type of 
treatment and the type of staff involved in the most commonly provided treatments are 
presented. From these data, the costs of different types of treatments were calculated at the 
service level. Differences in the odds that a treatment was provided or a professional 
provided a treatment were tested for statistical significance using univariate logistic 
regression models. Differences in the number of treatments were tested using simple 
regression models (equivalent to a t-test where there are only two predictor categories, and 
extendable to accommodate more than two categories), and the p-value associated with the 
F-test for significance of the overall model is presented. Differences in the mean cost of 
treatments between services were investigated using regression models with 10,000 
bootstrap replications. This model was chosen because the Park test indicated that there 
was no benefit from fitting, for example, a generalised linear model with a log link or a non-
normal distribution, as can be the case for skewed cost data. A 95% significance level was 
used unless indicated otherwise. The analyses use complete data and the number of services 
providing information is presented alongside the results. 
RESULTS 
TREATMENTS PROVIDED 
Table 4-3 shows the number of services that provided treatments for AN on an outpatient 
basis3 and identifies average costs for each treatment, by level of ED specialisation. Across 
all levels of specialisation, cognitive behavioural therapy (CBT), single family therapy (SFT) 
and dietary advice are the most commonly provided treatments.  
I investigated whether level of service specialisation was associated with the number of 
different treatments offered. As Table 4-3 shows, most treatments provided were individual 
treatments (treatments provided one-to-one, as opposed to treatments provided in a group 
setting or to a family). Table 4-4 shows the number of individual treatments provided, the 
total number of treatments offered (including both individual and group or family 
treatments), and number of sessions and length of sessions for the two most commonly 
provided treatments, CBT and SFT. Specialist ED services offered on average 2.6 types of 
                                                 
3 Note that the cost of MFDT shown is based on a re-costing of the MCTAAN data presented in Chapter 
4, Part 1 as I have inflated the costs to 2010/11 prices. 
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individual treatments, while specialist CAMHS offered 2.0, and non-specialist CAMHS 
offered 1.6 (p > 0.01). The total number of treatments offered differed significantly between 
service types.  
Specialist ED services offered more than eight different psychological or psychiatric 
treatments in total, while in specialist CAMHS it was 7.0 and in non-specialist CAMHS it 
was 5.2 (p > 0.01). A (non-significant) trend seems to be that a higher degree of service 
specialisation appears to be related to the likelihood of providing treatments beyond CBT, 
SFT and dietary advice, although there do not appear to be large differences between 
specialist ED services and specialist CAMHS. 
There are no significant differences in the number of sessions or duration of CBT and SFT 
by level of service specialisation, but the data show a large variation within each 
specialisation category.
163 
 
 
Table 4-3: Number of services providing outpatient treatments for AN, by service specialisation 
 Specialist ED services (n = 5) Specialist CAMHS (n = 6) Non-specialist CAMHS (n = 15) 
 Number 
providing (%) 
Mean 
£(SD) 
Valid n 
(cost) 
Number 
providing (%) 
Mean 
£(SD) 
Valid n 
(cost) 
Number 
providing (%) 
Mean 
£(SD) 
Valid n 
(cost) 
Assessment 5 (100%) 
152.79 
(49.53) 
5 6 (100%) 
208.75 
(51.86) 
6 15 (100%) 
152.48 
(67.99) 
13 
CBT 5 (100%) 
135.52 
(20.84) 
5 6 (100%) 
170.72 
(26.46) 
6 10 (67%) 
163.85 
(42.28) 
9 
PDTa 3 (60%) 
123.91 
(10.24) 
3 3 (50%) 
129.82 
(n/a) 
3 5 (33%) 
137.12 
(13.91) 
5 
Nurse 
Counselling 
3 (60%) 
90.60 
(n/a) 
2 1 (17%) 
71.27 
(n/a) 
1 3 (20%) 
82.09 
(n/a) 
2 
Other indiv. 
therapy 
2 (40%) 
129.82 
(n/a) 
1 2 (33%) 
186.17 
(n/a) 
1 5 (33%) 
120.82 
(n/a) 
1 
Group w/o 
parents 
2 (40%) 
40.31 
(11.69) 
2 0 (0%) n/a 0 0 (0%) n/a 0 
Other group 
therapy 
1 (20%) n/a 0 0 (0%) n/a 0 0 (0%) n/a 0 
SFTb 5 (100%) 
204.67 
(37.63) 
4 6 (100%) 
242.26 
(86.03) 
6 12 (80%) 
246.05 
(99.51) 
8 
MFTc 1 (20%) 547 (n/a) 1 2 (33%) 547 (n/a) 1 2 (13%) 547 (n/a) 1 
Other FTd 1 (20%) n/a 0 1 (17%) 
21.55 
(n/a) 
1 2 (13%) 
129.54 
(n/a) 
2 
Refeeding 2 (40%) n/a 0 2 (33%) n/a 0 3 (20%) n/a 0 
Dietary 5 (100%) 
40.55 
(18.55) 
4 5 (83%) 
38.95 
(10.78) 
3 8 (53%) 
108.68 
(n/a) 
2 
(Medical 
monitoring) 
5 (100%) 
121.56 
(89.19) 
2 5 (83%) 
73.85 
(n/a) 
1 10 (67%) 
177.91 
(77.60) 
5 
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 Specialist ED services (n = 5) Specialist CAMHS (n = 6) Non-specialist CAMHS (n = 15) 
 Number 
providing (%) 
Mean 
£(SD) 
Valid n 
(cost) 
Number 
providing (%) 
Mean 
£(SD) 
Valid n 
(cost) 
Number 
providing (%) 
Mean 
£(SD) 
Valid n 
(cost) 
Other 1 (20%) n/a 0 3 (50%) 
115.79 
(n/a) 
1 0 (0%) n/a 0 
a Difference between Specialist ED services and Non-specialist CAMHS statistically significant at the 95% level 
b Difference between Specialist ED services and Specialist CAMHS statistically significant at the 95% level  
c Difference between Specialist ED services and Non-specialist CAMHS statistically significant at the 90% level 
 
Table 4-4: Differences in treatment intensity, by service specialisation 
 Specialist ED services Specialist CAMHS Non-specialist CAMHS  
 Mean SD Range Mean SD Range Mean SD Range p-value (F-test) 
Individual treatments offered 2.60 1.14 1-4 2.00 0.89 1-3 1.64 0.93 0-3 0.182 
Total treatments offered 8.40 1.52 6-10 7.00 2.19 4-10 5.23 1.86 1-8 0.011 
CBT sessions number 17.50 9.85 6-30 12.00 2.83 9-15 17.00 13.06 9-40 0.630 
CBT session length (minutes) 55.00 5.00 50-60 53.33 7.53 45-60 56.5 5.80 45-60 0.616 
SFT sessions number 23.00 13.71 4-40 17.50 8.66 10-30 9.25 4.27 6-15 0.180 
SFT session length (minutes) 56.00 5.48 50-60 67.50 12.55 60-90 67.17 12.68 50-90 0.180 
a Difference between Specialist ED services and Non-specialist CAMHS statistically significant at the 95% level 
b Difference between Specialist ED services and Specialist CAMHS statistically significant at the 95% level  
c Difference between Specialist ED services and Non-specialist CAMHS statistically significant at the 90% level
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VARIATIONS IN COST 
Assessment 
Figure 4-1 shows the average of the three estimates of assessment costs, based on the 
scenarios (‘average’, low and high cost) described above. Data were available for all specialist 
ED services and specialist CAMHS, and 13 of the 15 non-specialist CAMHS services. There 
is a wide variation in the different estimates, resulting in uncertainty. Given that it is not 
possible to determine which estimate is the most appropriate for each service, the average 
cost will be used in the analysis of individual-level data in Chapter 5. 
Figure 4-1: Assessment costs: Averages of three estimates, by service specialisation 
 
CBT and SFT 
Looking more closely at the most commonly provided treatments, CBT and SFT, there are 
differences in average cost per CBT session between service types significant at the 90% 
level (p=0.096), but not in the cost of an SFT session (p=0.667). 
The profession and grade of staff delivering the treatment influences the per session cost 
of that treatment. The percentage of services (by degree of ED specialisation) where specific 
staff members are involved in providing assessment, CBT and SFT are shown in Figure 
4-2. The ‘other professionals’ category includes staff such as occupational therapists, 
CAMHS team members and unspecified staff.  
There are no statistically significant differences in terms of delivery of SFT, but psychiatrists 
are more likely to be involved in CBT in services that are specialist CAMHS compared to 
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non-specialist CAMHS (p < 0.001). No specialist ED service reported that psychiatrists 
delivered CBT. 
Figure 4-2: Staff members involved in assessment and treatment, by service specialisation 
 
Average unit costs of outpatient treatment 
The unit costs for the types of outpatient treatment, summarised by service type to match 
the types of outpatient sessions recorded in the individual-level data set (see Chapter 5 part 
1), are shown in Table 4-5. These averages were used to estimate the cost of treatment for 
patients who were in contact with services not taking part in the study, based on service 
type. 
Table 4-5: Average unit costs of AN outpatient treatment, by level of specialisation for ED 
 Specialist ED 
services 
Specialist 
CAMHS 
Non-specialist 
CAMHS 
 Valid n Mean £ Valid n Mean £ Valid n Mean £ 
Individual 3 £135 6 £163 11 £163 
Group session 1 £32 0 - 0 - 
SFT 3 £187 5 £235 8 £246 
MFT day/session 1 £547 1 £547 1 £114 
Parent session 1 £101 1 £22 1 £98 
Dietic session 3 £33 3 £39 2 £109 
Occupational 
therapy 
0 - 0 - 0 - 
Physiotherapy 0 - 0 - 0 - 
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DISCUSSION 
In this study, I identified the different types of outpatient treatments provided by specialist 
ED services, specialist CAMHS and non-specialist CAMHS in four Greater London PCTs. 
I generated a dataset that allowed me to calculate unit costs for these treatments. I then 
explored variation in costs by degree of service specialisation with regard to ED. While 
service provision in outpatient services has previously been mapped by the Royal College 
of Psychiatrists (Royal College of Psychiatrists 2012), the Care Pathways Study allowed this 
to be broken down by type of eating disorder, and this is the first study reporting in detail 
the costs of these treatments. 
The research identified treatments delivered to a cohort of patients from case notes, rather 
than solely relying on reports from services about what they could provide. Cognitive 
behaviour therapy and single-family therapy were the most common treatments. Mean per 
session unit costs for treatment varied considerably. Average unit costs were lowest in the 
specialist ED services (£136 for CBT and £205 for SFT) with SFT unit costs similar for 
the specialist CAMHS and non-specialist CAMHS services (approx. £245).  
Unit costs are sensitive to the number and profession of staff delivering the intervention, 
as well duration of the session and whether the intervention is provided in a group or 
individual setting. While the small number of services involved poses a challenge to 
statistical analysis, it is reasonable to conclude that differences in unit costs are due to 
variations in staff profession (driven by salary) and staff time. In the case of multi-family 
therapy, specialist services delivered this as whole-day sessions, while in the non-specialist 
CAMHS the sessions lasted only 60-90 minutes (see Table 4-4). The high cost of dietetic 
sessions in non-specialist CAMHS arises because psychiatrists provide dietary advice, while 
in other types of services it is more likely to be provided by dieticians or nurses who receive 
lower salaries. In the case of parent sessions, the variation in unit costs is mainly due to 
group provision of sessions for parents in some services (so staff costs per session are 
shared between several families). 
While there were few differences in the type of professionals providing CBT and SFT, the 
probability that a psychiatrist is involved in providing CBT was significantly higher in 
general CAMHS with ED specialisation than in other service types. In part this may be 
because generic CAMHS teams tend not to include psychiatrists (see Curtis 2011, pp. 172-
174). 
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Specialist skills may also be important. Specialist ED services are likely to include more staff 
with expertise specific to ED, so that staff on lower pay bands (nurses, perhaps) can provide 
treatments that in specialist CAMHS are more likely to be provided by a psychiatrist. The 
belief that specialisation facilitates experience and confidence in treating ED is prominent 
in the literature (Gowers & Bryant-Waugh 2004). Also, as House (House et al. 2012) 
remarks, ED specialisation in general CAMHS is often due to a consultant taking a special 
interest. Part of the explanation for the low number of non-specialist services where 
psychiatrists treat AN may again be that generic CAMHS teams tend not to include 
psychiatrists.  
The analysis of treatment provision indicates that a higher degree of specialisation may be 
associated with offering a wider variety of treatments, and specialist services appear to be 
more likely to provide a specific treatment beyond CBT, SFT and dietary advice. But given 
the small number of services, differences are unlikely to be detected. However, the findings 
regarding the most commonly provided treatments are broadly in line with the results of a 
survey of ED services by the Royal College of Psychiatrists (Royal College of Psychiatrists 
2012). 
Limitations of the study arise from the design and conduct of the Care Pathways Study, 
which are discussed by House (2011, pp. 81-83). The study design in turn reflects the 
difficulties encountered in researching complex and rare conditions generally, and research 
involving CAMHS data in particular (see Batty et al. 2013 for a discussion of measurement 
of routine outcome measures in CAMHS). While a high proportion of eligible services 
(84%) provided data, some key CAMHS services did not agree to participate or agreed but 
failed to provided data. While this is likely to have a greater impact on the individual-level 
data analysis (see Chapter 5, part 2) due to participants not being recruited, it also means 
these services are not represented in the service-level cost data. The focus on Greater 
London, which differs from much of the rest of the UK due to higher concentration of 
specialist NHS and of private ED services, limits generalisability. House stipulates that the 
presence of specialist services may lead to a de-skilling of CAMHS with regard to ED 
treatment. At the same time, those PCTs that are likely to be more comparable to the rest 
of the UK, i.e. those without specialist ED provision, were underrepresented in the study.  
Further limitations arise from the difficulties in collecting data specifically for the economic 
analysis, so that less detailed data had to be used, alongside a set of assumptions (detailed 
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above). The resulting need to use national unit costs means that any variation in salary levels 
and overheads between services is not captured. 
While the small number of specialist services involved in the study means it is difficult to 
draw firm conclusions, this exploratory analysis generates questions that can be addressed 
by future research. 
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CHAPTER SUMMARY 
The literature review highlighted significant gaps in the data on outpatient treatment for 
AN as reflected in the lack of data in previous estimates of the CoI of AN. The review 
further revealed a lack of data on the types of treatments provided and their unit costs. This 
information is required to meet the overall aim of this thesis – to present a comprehensive 
CoI estimate for AN – but also useful to service planners and clinicians alike. This chapter 
therefore explored the types of treatment for AN provided in outpatient settings, their unit 
costs and variations in these costs. The main findings can be summarised as follows: 
• The unit cost of MFDT was estimated at £241-£330 per session (in 2009 prices), 
with £325 in the service providing the largest number of sessions within the RCT. 
• Within Greater London outpatient services, the most commonly provided 
treatments for AN regardless of level of service specialisation were CBT, SFT and 
dietary advice. 
• The average cost of CBT was £136 in specialist ED services, £209 in specialist 
CAMHS and £153 in non-specialist CAMHS. 
• The average cost of SFT was £205 in specialist ED services, £242 in specialist 
CAMHS and £246 in non-specialist CAMHS. 
• The usual duration of CBT and SFT sessions and total number of sessions provided 
were similar across levels of service specialisation. 
• The average cost per CBT session was significantly lower when provided by 
specialist ED services. 
No specialist ED service reported that CBT was provided by psychiatrists, indicating that 
the cost difference stems from differences in the type of staff providing the treatment. 
In conclusion, despite the small sample size and within-group variations, there were some 
significant variations in unit costs that point towards an advantage of service specialisation 
for ED in terms of the costs of treatment, and therefore contributes towards an economic 
argument in the debate around specialist vs non-specialist services for the treatment of AN 
and ED – although this finding deserves further scrutiny. The unit costs calculated here will 
be applied to the analysis of individual-level data from the CPS in Chapter 5. 
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CHAPTER 5  
Direct costs: Variations in individual-level costs 
associated with service use by patients with 
Anorexia nervosa 
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CHAPTER INTRODUCTION 
This chapter contributes to the aims of the thesis – presenting an estimate of the societal 
costs of AN – by addressing RQ1: “What treatments are provided for AN in an outpatient 
context, what are the associated unit costs, and why do these costs vary?” 
 In particular, I explore variations in costs associated with outpatient treatment, where my 
literature review identified a considerable gap in the knowledge. 
Several authors have argued that CoI estimates on their own are of limited use, but that 
looking at variations in costs is a step towards cost-effectiveness analysis and therefore 
economic evaluation. Further, exploring variations in individual-level cost is motivated by 
the production of welfare approach: Are resources directed based on health care need or 
impairment, or do costs vary by demographic features – potentially pointing to issues in 
equity in terms of access or provision of treatment? 
While several studies have looked at resource use in AN in terms of length of inpatient stay 
or number of outpatient contacts both internationally (Krauth et al. 2002; Striegel-Moore et 
al. 2000; Toulany et al. 2015) and in England (Jacobs et al. 2004; ProBono Economics 2012; 
Tulloch et al. 2008), little information is available about the types of treatment received in 
outpatient settings. To my knowledge, to date there is only one RCT in England that reports 
on wider service use and associated costs (Byford et al. 2007a). 
This chapter looks at the service use of individuals with AN, the associated costs and 
variation in costs. I present data from two different studies. First, I show the service use 
and associated costs for a cohort of young people with AN who were in contact with ED 
services in the Greater London Area, over a one-year time period. As Chapter 4, Part 2, this 
again uses data from the Care Pathways Study. Then, I show the service use and costs for 
participants in three clinical trials (part of the ARIADNE programme: MOSAIC (Schmidt 
et al. 2013), CASIS (Goddard et al. 2013b), iMANTRA (Schmidt et al. 2017) prior to 
commencing their allocated treatment in the RCTs. I explore variations in costs due to 
individual characteristics for the Care Pathways cohort, and two of the RCTs. 
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PART 1: INDIVIDUAL-LEVEL COST VARIATIONS AND 
SERVICE SPECIALISATION – EVIDENCE FROM THE CARE 
PATHWAYS STUDY 
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INTRODUCTION 
This first part of Chapter 5 uses data from the Care Pathways Study (CPS; House 2011) to 
investigate the service consumption and associated costs of a cohort of adolescents with 
AN or EDNOS-AN entering ED services in four Greater London PCTSs. I then explore 
variations in costs based on individual characteristics and by care pathway. 
The objective is to illuminate what treatments patients receive within outpatient settings, 
and whether variations in costs are associated with clinical or socio-demographic variables. 
This is part of the effort to contribute to knowledge about costs of treatment in outpatient 
services, where there is currently a major gap. It is also an important contribution to the 
CoI model presented in Chapter 8. 
I describe service use by care pathway, calculate total costs and fit univariate regression 
models to explore variations in costs for this cohort of adolescents. 
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METHODS 
DATA 
In this chapter, I use data from the cohort element of the Care Pathways Study (CPS) 
Patients identified through services participating in the health services research study were 
eligible for inclusion if they 
Had an initial contact or re-contact after a treatment break of at least 6 months with a 
participating service between 01/12/2006 and 30/11/2008 
• Were adolescents (age 13-17) 
• Had a primary diagnosis an eating disorder (ED) 
• Were registered with a GP from a Greater London PCT 
378 unique cases meeting all inclusion criteria were identified and 93 with a known diagnosis 
of AN or EDNOS-AN consented to be part of the study. Care pathways data were available 
for 90 patients.  
The main CPS collected patient-level data on a cohort of adolescents from participating 
services.  
The patient-level data provides the following information relevant to the economic analysis: 
• Patient socio-demographic characteristics 
• Patient clinical data (weight and height) 
• Treatment received within each outpatient service along the care pathway over a 
12-month period:  
• Number of assessments 
• Number of individual or family sessions 
• Number of group, dietic and medical outpatient sessions 
• Number and type of outpatient appointments for physical tests 
• Number of telephone calls 
• Number of psychiatric reviews 
• Number of inpatient days for ED or other reasons 
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The data were re-entered to better suit the needs of the economic analysis, showing the 
total number of service contacts for each individual within each service along their care 
pathway. 
The analysis of service use and costs compared three care pathways identified in the main 
study: 
• Specialist to specialist (S-S): Initial contact with ED services is through a specialist 
service, and onward referral is also to a specialist service. 
• Non-specialist to specialist (NS-S): Initial contact is through a non-specialist service, 
with onward referral to a specialist service. 
• Non-specialist to non-specialist (NS-NS): Initial contact and onward referral are 
both with a non-specialist service. 
The ‘private’ pathway was omitted from the economic analysis presented here because costs 
could not be estimated reliably, as the components required for cost estimation (in particular 
salaries and overheads) were not publicly available. Data for this analysis were available for 
84 out of 90 participants. 
SERVICE USE AND COSTS 
Service use for the cohort was described for the full sample and by care pathway. The costs 
associated with service use were calculated by multiplying instances of services use by the 
unit costs calculated from service-level information and presented in Chapter 4 to arrive at 
individual treatment costs over the one-year period, which are described by repenting 
means, standard deviations and ranges. The unit costs of different outpatient treatments 
were summarised by service type to match the types of outpatient sessions recorded in the 
individual-level data set. These averages were used to estimate the cost of treatment for 
patients who were in contact with services that were not taking part in the study, based on 
degree of service specialisation. In addition to the unit costs estimated from the Care 
Pathways data, unit costs for several other treatments were drawn from publicly available 
sources (Curtis 2011; Department of Health 2011),. Average costs and measures of 
dispersion are shown by care pathway, for each type of treatment and for total costs. The 
contribution of component costs to total costs is also shown. 
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Table 5-1: Additional unit costs for the analysis of care pathways costs 
Treatment Cost Source 
Psychiatric review 
£645 for community-
based services 
ED service ID 1: Duration 60-90 minutes, all 
treating and consulting staff members 
participate. 
£694 for hospital-
based services 
Costed as 75 mins, 1 psychiatrist, 1 
psychologist, 1 nurse. 
Telephone call 
£17.9 for community-
based services 
 7.1 minutes as per GP (Curtis 2011, p. 49), with 
clinical psychologist 
£18.5 for hospital-
based services 
Outpatient 
medical 
£775 
Weighted average for all paediatric outpatient 
contacts (Curtis 2011, p. 73) 
Day patient day £552 
NHS day cases HERG (Department of Health 
2011) 
MFDT £557 Inflating of MCTAAN unit cost (see Chapter 4) 
Medical inpatient 
admission 
£593 per day  
NHS mental health inpatients, children 
(Department of Health 2011) 
ED inpatient 
admission 
£492 per day 
NHS mental health inpatients, ED children 
(Department of Health 2011) 
 
STATISTICAL ANALYSES 
An exploratory analysis of predictors of treatment costs was performed by fitting univariate 
models with total service costs as the dependent variable and patient characteristics and 
measures of clinical severity as explanatory variables. To account for the skewed 
distribution of cost data, after the Park test suggested that different distributional 
assumptions and link functions did not provide a benefit over a linear model, regression 
analysis was performed with 10,000 bootstrap replications. 
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RESULTS 
PARTICIPANT CHARACTERISTICS 
Patient-level data are available for 84 young people. There were no significant differences 
in characteristics between consenters and non-consenters except in the proportion of 
consenters by level of service specialisation: Those on the S-S pathway were more likely to 
consent (55%) than those on the S-NS pathway (26%) and on the NS-NS pathway (23%) 
(see House et al. 2012 for details). 
The main study found that 53 of them were assessed in specialist ED services and remained 
in specialist ED services for treatment (specialist – specialist pathway; S-S). Another 16 
were assessed in non-specialist CAMHS and referred to specialist services for treatment 
(non-specialist – specialist pathway; NS-S), while 15 were assessed in non-specialist 
CAMHS and remained there for treatment or were directly admitted as inpatients (non-
specialist – non-specialist pathway; NS-NS).  
Table 5-2 shows patient demographics, baseline diagnosis, clinical characteristics and 
distribution between care pathways for the entire cohort. Categories with at least five 
participants in the cell were considered in the analysis of cost variations. 
Table 5-2: Patient characteristics (full sample) 
 Variable n (of N) % 
Demographics Female vs male 81 (84) 96% 
 White British vs other 58 (80) 69% 
Parental social class 
Class I or II 
 
56 (70) 80% 
 
Class III or IV 
 
10 (70) 14% 
 Unemployed or inactive 4 (70) 6% 
Parents marital status 
Married or cohabiting vs 
other 
64 (84) 76% 
Living situation 
Living with two parents vs 
other 
64 (84) 76% 
Baseline diagnosis and ED behaviours Anorexia vs EDNOS-AN 36 (84) 43% 
 Dietary restriction 30 (84) 36% 
 Bingeing 6 (84) 7% 
 Vomiting 19 (84) 23% 
 Laxative use 6 (83) 7% 
 Exercise 40 (83) 49% 
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 Variable n (of N) % 
Clinical characteristics (baseline) Other medical condition 11 (84) 13% 
 
Any co-morbid psychiatric 
condition 
24 (84) 29% 
 Co-morbid depression 17 (84) 20% 
 Co-morbid OCD 1 (84) 1% 
 Co-morbid anxiety 5 (84) 6% 
 Self-harm 6 (84) 7% 
 
Other psychiatric 
condition 
7 (84) 8% 
 
Taking psychiatric 
medication 
5 (79) 6% 
 
Previous outpatient 
treatment for ED 
4 (84) 5% 
 
Previous inpatient 
treatment for ED 
1 (84) 1% 
Care Pathway Specialist-specialist 53 (84) 59% 
 Non-specialist-specialist 16 (84) 18% 
 
Non-specialist-non-
specialist 
15 (84) 17% 
 
 
 
Mean (SD) 
 
Range 
Age (years), n = 84 15.0 (1.21) 12-17 
Duration of illness (months), n = 82 7.7 (7.48) 0-36 
Baseline weight/height, n = 83 83.3 (10.29) 63-132 
Number of psychiatric co-morbidities, n=84 0.43 (0.80) 0-3 
 
Most participants were female and white British. Given the young age, most were living 
with parents. The diagnostic split between AN and EDNOS-AN was 44% vs 56%. About 
a third had a co-morbid psychiatric condition, most commonly depression. Restriction was 
present in about a third, with bingeing and purging in 10% and 23%, respectively. The 
average weight for height percentile was 82.8. Average duration of illness was relatively 
short at just over 8 months, but ranged up to three years. Most participants (59%) were in 
the S-S pathway, with just under 20% each in the NS-S and NS-NS pathways. 
TREATMENT RECEIVED 
The number and percentage of participants receiving each type of treatment as well as the 
mean number of contacts for the full sample and by care pathways are shown in Table 5-3 
and Table 5-3, respectively.  
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Table 5-3: Participants receiving outpatient treatments and number of service contacts, full 
sample 
 Full sample (n = 84) 
Type of treatment n (%) Mean contacts (SD) Range 
Assessment 84 100% - - - - 
Individual OP 68 81% 8.3 8.3 0 35 
Family OP 82 98% 13.8 9.7 0 43 
Multi-family OP 13 15% 0.8 2.1 0 8 
Parent only OP 37 44% 1.5 2.9 0 15 
Dietic OP 40 48% 2.0 4.6 0 24 
Medical OP 52 62% 4.2 7.0 0 35 
Telephone calls 52 62% 2.4 3.4 0 17 
Psychiatric review 34 40% 1.7 3.5 0 19 
Day patient 2 2% 0.5 3.9 0 34 
Inpatient (medical) 15 18% 3.0 10.9 0 75 
Inpatient (ED) 17 20% 24.9 59.6 0 280 
.
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Table 5-4: Participants receiving outpatient treatments and number of service contacts, by care pathway 
 Specialist - specialist (n = 53) Non-specialist - specialist (n = 16) Non-specialist - non-specialist (n = 15) 
Type of treatment n % 
Mean contacts 
(SD) 
Range n % 
Mean contacts 
(SD) 
Range n % 
Mean contacts 
(SD) 
Range 
Assessment 53 100%     16 100%     15 100%     
Individual OP 45 85% 9.0 8.3 0 35 9 56% 6.4 8.4 0 24 14 93% 8.1 8.5 0 29 
Family OP 51 96% 14.6 10.3 0 43 16 100% 12.8 9.6 2 37 15 100% 12.0 7.1 2 25 
Multi-family OP 8 15% 0.8 2.0 0 7 2 13% 0.9 2.4 0 8 3 20% 0.9 2.1 0 6 
Parent only OP 23 43% 2.0 3.5 0 15 9 56% 0.9 1.2 0 4 5 33% 0.7 1.5 0 6 
Dietic OP 26 49% 2.8 5.7 0 24 6 38% 0.6 1.1 0 4 8 53% 0.8 1.1 0 4 
Medical OP 32 60% 3.9 6.8 0 35 11 69% 6.3 9.0 0 28 9 60% 3.3 5.2 0 18 
Telephone calls 31 58% 2.4 3.7 0 17 11 69% 2.9 3.6 0 13 10 67% 1.7 1.9 0 6 
Psychiatric review 22 42% 2.0 4.1 0 19 6 38% 1.2 2.1 0 8 6 40% 0.9 1.8 0 7 
Day patient 0 0% 0.0 0.0 0 0 0 0% 0.0 0.0 0 0 2 13% 2.9 9.0 0 34 
Inpatient (medical) 5 9% 1.4 6.1 0 32 6 38% 9.6 21.6 0 75 4 27% 1.3 2.6 0 8 
Inpatient (ED) 8 15% 13.1 36.7 0 149 3 19% 29.5 74.8 0 280 6 40% 61.5 89.8 0 272 
* Medical outpatient appointments include blood tests, bone density scans, pelvic ultrasounds, electrocardiograms and other physical tests.
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Across all care pathways, outpatient single family therapy was the most commonly used 
form of treatment. In the S-S and NS-NS pathways, this was followed by individual 
outpatient therapy and medical outpatient appointments. In the NS-S pathway, the order 
of individual therapy and medical appointments was reversed. 
About one in three in both pathways with assessment in non-specialist services had a 
medical inpatient admission. Those on the NS-NS pathway had the highest proportion of 
inpatient admissions related to their ED. The proportion of people with ED-related 
inpatient admissions was similar for people treated in specialist services regardless of where 
they were initially assessed (15% vs 19%). The average number of inpatient days for ED 
was highest in the NS-NS pathway, and was more than four times as high as in the S-S 
pathway. The analysis of differences in the likelihood of admission and in length of stay can 
be found by House (2011), who found that the NS-NS pathway was associated with a 
significantly higher rate of admission compared to the other pathways. 
TREATMENT COSTS 
Table 5-5 shows the total costs over a one-year period for each pathway (bottom row). 
Mean costs were lowest for the S-S pathway, and highest for the NS-NS pathway. However, 
in each case the SD is larger than the mean suggesting a wide variation in the total cost of 
treatment for the participants who followed each pathway.  
The average costs of individual and family outpatient therapy are roughly similar across all 
pathways, although the average cost of individual outpatient therapy is slightly lower in the 
NS-S group and the cost of family outpatient therapy is slightly higher in the S-S pathway. 
The combined average cost of family treatments (single- and multi-family outpatient 
therapy, outpatient sessions for parents) is highest in the S-S group. Even though dietary 
advice is a treatment reported to be commonly provided, the cost of dietic outpatient 
sessions for this group of young people is actually very low compared to other cost 
categories. The cost of medical outpatient appointments and inpatient admissions for 
medical reasons appears to be higher for patients following the NS-S pathway, possibly 
indicating a higher level of medical complications.  
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Table 5-5: Costs of outpatient treatment, by care pathway 
 Specialist – specialist 
(n = 53) 
Non-specialist – specialist 
(n = 16) 
Non-specialist - non-specialist 
(n = 15) 
Type of treatment Mean £(SD) Range Mean £(SD) Range Mean £(SD) Range 
Assessment 170 (36) 112 - 293 151 (43) 98 - 209 152 (40) 98 - 230 
Individual outpatient (OP) 1,341 (1,195) 0 - 4,206 955 (1,229) 0 - 3,923 1,933 (1,228) 0-4,414 
Family OP 2,976 (2,078) 0 - 8,005 2,998 (2,944) 457-11,786 2,909 (1,135) 965-5,099 
Multi-family OP 443 (1,080) 0 – 3,829 479 (1,323) 0 – 4,376 474 (1,149) 0-3,282 
Parent only OP 174 317) 0 – 1,509 15 (172) 0 – 591 61 (151) 0-585 
Dietic OP 90 (188) 0 – 847 15 (23) 0 – 71 78 (105) 0-382 
Medical OP* 2,998 (5,296) 0 - 27,125 4,892 (6,993) 0 - 21,700 2,583 (4,023) 0 – 13,950 
Telephone calls 43 (68) 0 – 314 53 (67) 0 – 240 37 (38) 0 - 108 
Psychiatric review 1,337 (2,644) 0 - 12,255 784 (1,389) 0 - 5,160 562 (1,166) 0 - 4,515 
Day patient - - - - 1,619 (4,952) 0 – 18,768 
Inpatient (medical) 1,529 (6,520) 0 – 34,112 10,260 (22,998) 0 – 79,950 1,421 (2,752) 0 – 8,528 
Inpatient (ED) 6,452 (18,073) 0 - 73,308 14,514 (36,791) 0 – 137,760 30,242 (44,199) 0 – 133,824 
Total costs 17,544 (28,738) 1,323 - 149,406 35,215 (53,575) 694 -165,656 42,072 (48,277) 3,649 - 168,941 
* Medical outpatient appointments
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While these data capture outpatient treatment and inpatient treatment, there are no 
records of contacts with accident and emergency departments available, which may have 
played a role in, for example, emergency admissions for medical complications. If this 
was a common occurrence in this cohort, there is a potential for under-estimating total 
costs. Please note that the aim of the study was not to consider use of lower-tier health 
services such as primary care. 
Figure 5-1 the distribution of service costs by care pathway. The largest contributor to 
total costs for all care pathways are inpatient admissions for ED, ranging from 37% in 
the S-S pathway and 41% in the NS-S pathway to 72% in the NS-NS pathway. This is 
followed by individual outpatient treatments in the NS-NS and NS-S pathways, and 
family treatments (including individual family therapy, multi-family therapy and sessions 
for parents only) in the S-S pathway. While inpatient stays due to ED make up a large 
proportion of costs in the NS-NS pathway, standard deviations are large – indicating 
considerable variability between individuals. As a result, the difference in inpatient costs 
between pathways is not statistically significant. Together, ED and medical admissions 
account for over 70% of total costs in both pathways where the assessment is in a non-
specialist service. The lower proportion of costs due to inpatient admissions in the S-S 
pathway reflects the lower probability of admissions. 
Figure 5-1: Contributors to total cost of care, by care pathway 
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PREDICTORS OF TREATMENT COST  
Table 5-6 shows the results of the univariate regression analysis identifying whether any 
participants’ characteristics are associated with higher or lower total costs. Costs were 
positively associated with age and duration of illness (significant at the 90% level), and 
negatively associated with having another medical condition and vomiting at baseline. 
There were significant differences by care pathway as a whole, and in pairwise 
comparisons between the S-S and the NS-S pathway (p = 0.088) and the S-S and the NS-
NS pathway (p = 0.016). There was no significant cost difference between the NS-S and 
NS-NS pathway.  
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Table 5-6: Predictors of treatment costs from univariate models 
 
Coef. (contribution 
to total costs) 
SD p 
White British 8,933 8,306 0.285 
Parents married or cohabiting 6,669 9,263 0.474 
Living with parents 10,928 9,213 0.239 
Parental occupational class:    
Class 1 or 2 18,456 17,842 0.305 
Class 3 or 4 20,184 20,937 0.338 
Baseline diagnosis AN vs EDNOS 10,840 7,907 0.174 
Other medical condition - 16,930 11,582 0.148 
Any co-morbid psychiatric condition -5,165 8,742 0.556 
Co-morbid depression -583 9,850 0.953 
Co-morbid anxiety -6,479 16,712 0.699 
Co-morbid self-harm -15,293 15,274 0.320 
Co-morbid other psychiatric condition -9,844 14,278 0.492 
Taking psychiatric medication -15,403 16,187 0.344 
Bingeing -8,090 15,341 0.599 
Dietary restriction 3,223 8,252 0.697 
Vomiting -11,726 9,371 0.214 
Laxative use 2,013 15,455 0.897 
Intense exercise -2,224 8,125 0.785 
Care pathway:    
NS-S 13,638 10,057 0.197 
NS-NS 23,148 10,311 0.027 
Age (years), n = 81 -6,732 3,213 0.039 
Duration of illness (months), n = 79 -864 535 0.111 
Baseline weight/height, n = 80 -543 386 0.163 
Number of psychiatric co-morbidities -3,904 4,984 0.436 
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DISCUSSION 
In this study, I analysed the treatments received and associated costs for a cohort of 
adolescents in four Greater London PCTs. This is the first study to take a comprehensive 
view on the costs of outpatient care in England. I then looked at variations in costs to 
determine if costs are associated with measures of clinical need, or with socio-
demographic factors. 
Across all pathways, inpatient admissions are the main drivers of costs. The composition 
of total costs is slightly different in the S-S pathway, where individual and family 
treatments combined account for almost 36% of costs and there are a lower proportion 
of inpatient admissions. The high percentage of costs due to medical inpatient 
admissions in the NS-S pathway (29%) may point to medical complications arising during 
treatment, leading to referral to specialist services. However, the data do not allow this 
hypothesis to be tested. It should be noted that medical admissions were generally short 
(around seven days), with two cases with exceptionally long admissions (average 63 days), 
and given the small sample size the data are sensitive to such outliers. 
These service use patterns are reflected in the total costs, with the S-S pathway incurring 
the lowest total costs. While this cost difference is statistically significant, the small 
sample and limited data availability mean that it would not be appropriate to conclude 
that this means S-S pathways are the less costly option. Further, it is not possible to adjust 
for individual and service-level factors such as self-selection into the different pathways. 
In addition, there were missing data both at the service and individual level, so that these 
findings should be regarded as indicative rather than definitive. 
Several limitations arise from the design of the Care Pathways study (see (House 2011) 
pp. 81-83): While the study was not an RCT design, these are rare in the study of ED 
services due to small case numbers and difficulties in maintaining adherence to the 
allocated treatment (e.g. (Gowers et al. 2010)). While 37 out of 44 eligible services 
provided data, some key services did not participate. These non-participating services 
were CAMHS services, which increased a bias towards specialist services in the sample. 
Greater London differs from the UK as a whole in terms of service availability, with a 
greater number of specialist NHS and private ED services. According to the study 
authors, this may have resulted in a ‘de-skilling’ of CAMHS services compared to 
CAMHS services in other areas of the country. 
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While this study focussed on one geographical area and transferability to other parts of 
the country is therefore limited, this study makes an important contribution to 
knowledge about the costs of ED treatment in outpatient services. No previous study 
has calculated treatment costs in outpatient services in England using a bottom-up 
approach, and looked at variation in treatment costs by individual characteristics. 
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PART 2: INDIVIDUAL-LEVEL COST VARIATIONS: EVIDENCE 
FROM THREE RCTS 
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INTRODUCTION 
In this section, I extend the analysis from part 1, which covered variations in the costs 
associated with outpatient and inpatient treatment, to encompass a wider range of 
services. I explore service use, associated costs and variations in total costs across 
different agencies and budgets. This is part of my exploration of direct costs of AN and 
links to RQ1: Why do costs vary. 
Using data collected alongside the CASIS (Goddard et al. 2013b), MOSAIC (Schmidt et 
al. 2013) and iMANTRA (Schmidt et al. 2017) trials I present an analysis of baseline data, 
collected from patients before receiving the RCT interventions.  
First, I describe service use for each of the trials. Then, I calculate the associated costs 
by cost category, such as primary care, hospital or social services, and total costs for each 
participant. Finally, I present an exploratory analysis of cost variation for the CASIS and 
MOSAIC trials. This provides insight into the direct costs of treatment for AN Given 
the paucity of evidence regarding service use and costs, this analysis of service use data 
is an important addition to the UK evidence base. 
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METHODS  
DATA SOURCES 
Data were available from three RCTs: 
• CASIS (Goddard et al. 2013b): The populations were patients aged 12 and over 
with a diagnosis of AN (n=178), randomised at the point of admission to 
inpatient care. 
• MOSAIC (Schmidt et al. 2013): This trial recruited female adults aged 18-65 
receiving treatment in specialist ED outpatient services. 
• iMANTRA (Schmidt et al. 2017): Participants in this feasibility study were 
inpatients aged 16 and above recruited at the point of discharge. 
As these were baseline data, data from participants in the intervention and control groups 
were combined for this analysis. 
SAMPLE CHARACTERISTICS AND CLINICAL MEASURES 
Socio-demographic variables and baseline clinical measures are available for these 
samples. Clinical measures included measures of ED symptom severity (EDE and EDE-
Q), depression, anxiety and stress (DASS) and quality of life (WHO-QoL) – although 
not all these measures were collected for all three trials. More detail on each of these 
measures can be found in Chapter 3. 
SERVICE USE AND COSTS 
Participants completed the CSRI (Beecham & Knapp 2001) at baseline. The schedule 
covered a retrospective six-month period and was adapted for each study to include 
hospital services, specialist mental health services, primary care services and community-
based services such as social work and alternative therapy alongside demographic 
information. 
The costs associated with service use for each participant were calculated by identifying 
an appropriate unit cost and duration for each service contact and multiplying these by 
the number of contacts each person reported. They are described by reporting means, 
standard deviations and ranges 
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For most services, unit costs were drawn from publicly available sources (Curtis 2011; 
Department of Health 2011). Others were taken from previous studies or estimated using 
an equivalent method (Beecham 2000; Berridge et al. 2002), and from data collected as 
part of the Care Pathways Study (see Chapter 1, Part 1 for details).  
Where service contacts were reported but the number of contacts was missing, the mean 
for all people in contact with that particular service was entered. 
STATISTICAL ANALYSES 
Service use and costs 
Service use by participants for the 6-month period prior to the baseline assessment are 
described in terms of the number of people in the sample and the percentage of the 
sample using a given service. Service costs are presented as means with standard 
deviations and ranges by service category.  
Cost variations 
The relationship between costs, patient characteristics and clinical measures was explored 
using an expenditure function approach (Beecham et al. 1991; Knapp 1998). The aim was 
to identify if any particular characteristics of people with AN was associated with higher 
or lower costs.  
This was an exploratory analysis using total service costs as the dependent variable, with 
patient characteristics and measures of clinical severity as explanatory variables in a 
regression-type framework. The Park test (see Chapter 3) was applied, with a resulting 
value of zero that suggested that different distributional assumptions did not provide a 
benefit over a linear model. To account for the skewed distribution of cost data, linear 
regression analysis was performed with 10,000 bootstrap replications. Means, standard 
errors and p-values are shown, in addition to the adjusted r-squared. 
Given the exploratory nature of the analysis, all potentially relevant socio-demographic 
and clinical variables available at baseline were used. This includes variables that are 
potentially difficult to interpret when it comes to their relationship to costs over the 
baseline period, such as a current ED diagnosis. However, the main purpose of this 
analysis is to generate hypotheses for further investigation. 
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Table 5-7 shows the predictors used in the analysis of CASIS data, while Table 5-8 shows 
predictors considered in the analysis of MOSAIC data. Details on the clinical measures 
(WHO quality of life scales, DASS and EDE-Q) can be found in Chapter 3. 
Table 5-7: Predictors in the analysis of CASIS data 
Predictor Coding 
Age Scale variable 
Gender male Binary – no/yes 
Ethnicity Binary – Other vs White British 
English is first language Binary – no/yes 
Cohabiting Binary – no/yes 
Has children? Binary – no/yes 
Number of children Scale variable 
Years of education Scale variable 
Has a degree Binary – no/yes 
Economic activity status 
Categorical: 
• Employment 
• Student 
• Economically inactive 
Diagnosis Binary – AN vs other 
BMI (baseline) Scale variable 
Lowest BMI ever Scale variable 
Age of onset Scale variable 
Duration of illness Scale variable 
WHO quality of life rating Scale variable 
WHO health rating  Scale variable 
DASS1 depression score Scale variable 
DASS anxiety subscale Scale variable 
DASS stress subscale Scale variable 
Total DASS score Scale variable 
EDEQ2-Restraint subscale Scale variable 
EDEQ-Eating concern subscale Scale variable 
EDEQ-Shape concern subscale Scale variable 
EDEQ-Weight concern subscale Scale variable 
EDE-Q Global score Scale variable 
Number of hospitalisations Scale variable 
 
Table 5-8: Predictors in the analysis of MOSAIC data 
Predictor Coding 
Age Scale variable 
Ethnicity Binary - Other vs White British 
                                                 
1 Measure of depression, anxiety and stress 
2 Measure of ED symptoms 
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Living with partner Binary – no/yes 
Degree vs no degree Binary – no/yes 
Diagnosis Binary – AN vs other 
BMI (baseline) Scale variable 
Age of onset Scale variable 
Duration of illness Scale variable 
EDEQ-Restraint subscale Scale variable 
EDEQ-Eating concern subscale Scale variable 
EDEQ-Shape concern subscale Scale variable 
EDEQ-Weight concern subscale Scale variable 
EDEQ Global score Scale variable 
Previous hospital admission Binary – no/yes 
Previous treatment for AN Binary – no/yes 
Taking antidepressants Binary – no/yes 
 
Predictors of costs that were statistically significant were selected and a multivariate 
model was fitted by stepwise removal of non-significant predictors from a full model.  
A 90% confidence interval was used to determine statistical significance when identifying 
potential candidates for the multi-variate model because in economic analyses, there is 
less risk associated with type II errors than, for example, in studies of clinical outcomes 
where a false positive may put patients’ health at risk (McCrone et al. 2003).  
Within the set of potential predictors, there are variables that are closely related: duration 
of illness and age of onset, for example, are related to age in that age minus duration of 
illness is age of onset. The highest level of education or qualification achieved will also 
be related to age, and the EDE-Q global score is by definition correlated with its sub-
scales. These cannot be fitted into the same multivariate model, so that in presenting the 
results, I selected the model with the variables that explained the highest proportion of 
variance. 
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RESULTS 
PARTICIPANTS 
Sample characteristics are shown for CASIS (Table 5-9) and MOSAIC (Table 5-10). 
Please note that sample characteristics for the iMANTRA trial are omitted because no 
analysis of costs was performed due to the fact that these would vary based on inpatient 
costs which is driven by length of stay, and it is unclear how variables collected at 
discharge would be related to length of stay. 
Average age in CASIS was 26, the same as in MOSAIC but – given the wider population 
recruited – with a wider range. There was a marked difference in the proportion of 
participants who did not identify as white British (6.6% in CASIS vs 66.7% in MOSAIC). 
This may in part be driven by a more diverse population being treated in outpatient 
compared to inpatient settings, but it is partly due to differences in how response data 
were collected. In the MOASIC data, the ethnicity variable was not a fixed list of 
responses but a free-text response, and participants sometimes responded with “British” 
or “English”, making it difficult to categorise them on the same basis as the CASIS 
sample. Here, only those explicitly identifying as white British are included in that 
category, and results regarding the ethnicity indicator in MOSAIC need to be treated 
with caution. 
Age of onset in MOSAC is older with 17.7 years vs 16.5 years in CASIS. Duration of 
illness is longer in CASIS with an average of 9.8 years, compared to 8.1 years in MOSAIC. 
Average baseline BMI is lower in CASIS (14.3), with 16.6 in MOSAIC. This reflects the 
care pathway for AN, where more severe cases are more likely to be admitted for 
inpatient treatment. 
Overall, the differences between the samples appear to be linked to the different 
recruitment pathways, as the three trials studied different populations. The CASIS trial 
recruited patients at the point of admission to inpatient treatment, while MOSAIC 
studied outpatients and iMANTRA focussed on the period following discharge from 
hospital. 
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Table 5-9: Sample characteristics: CASIS 
Characteristic Available n Mean (SD) or n(%) Range 
Age 156 26.1 (9.04) 13-62 
Gender male 157 7 (4.5%) - 
Ethnicity (Other vs White British) 152 10 (6.6%) - 
English is first language 154 148 (96.1%) - 
Cohabiting 154 32 (20.8) - 
Has children? 143 33 (23.1%) - 
Number of children 143 0.4 (0.84) 0.0-4.0 
Years of education 146 15.2 (2.96) 7.0-25.0 
Degree vs no degree 112 45 (40.2%) - 
Employment  
Employed 
Student 
Inactive 
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26 (16.8%) 
45 (29.0%) 
84 (54.2%) 
- 
Diagnosis AN vs other 157 10 (6.4%) - 
BMI (baseline) 156 14.3 (2.05) 9.0-21.7 
Lowest BMI ever 120 12.8 (1.82) 7.5-18.3 
Age of onset 135 16.5 (5.55) 5.0-45.0 
Duration of illness (months) 135 117.6 (102.69) 9.0-480.0 
WHO QoL rating poor/very poor 150 82 (54.7%) - 
WHO health rating poor/very poor 151 83 (55.0%) - 
DASS depression score 152 28.6 (11.45) 0.0-42.0 
DASS anxiety score 152 19.7 (9.97) 0.0-42.0 
DASS stress score 152 29.0 (9.49) 0.0-42.0 
Total DASS 152 77.3 (27.21) 0.0-126.0 
EDEQ-Restraint 150 3.8 (1.82) 0.0-6.0 
EDEQ-Eating concern 150 3.8 (1.28) 0.0-6.0 
EDEQ-Shape concern 150 5.0 (1.13) 0.25-6.0 
EDEQ-Weight concern 150 4.5 (1.36) 0.0-6.0 
EDE-Q Global score 150 4.3 (1.20) 0.41 – 5.95 
Number of hospitalisations 129 1.8 (2.79) 0.0-18.0 
 
Table 5-10: Sample characteristics: MOSAIC 
Characteristic Available n 
Mean (SD) / 
n (%) 
Range 
Age 141 26.0 (7.48) 18.0-52.0 
Ethnicity (Other vs White British) 87 58 (66.7%) - 
Living with partner 136 27 (19.9%) - 
Degree vs no degree 116 56 (48.3%) - 
Diagnosis AN vs other 141 106 (75.2%) - 
BMI (baseline) 133 16.6 (1.25) 11.0-18.7 
Age of onset 131 17.7 (6.55) 2.0-44.0 
Duration of illness (years) 133 8.1 (7.1) 0.5-37 
EDEQ-Restraint 141 3.7 (1.45) 0.0-6.0 
EDEQ-Eating concern 141 2.9 (1.40) 0.0-6.0 
EDEQ-Shape concern 141 3.5 (1.69) 0.25-6.0 
EDEQ-Weight concern 141 3.2 (1.63) 0.0-6.0 
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Characteristic Available n 
Mean (SD) / 
n (%) 
Range 
EDEQ Global score 141 3.3 (1.28) 0.33-5.6 
Previous hospital admission 140 30 (21.4%) - 
Previous treatment for AN 139 79 (56.8%) - 
Taking antidepressants 139 55 (39.6%) - 
 
SERVICE USE 
Table 5-11 shows the number and percentage of participants in each trial using each type 
of service as well as the average number of contacts with the service and the 
corresponding standard deviations. Participants reported the highest contact rate with 
GPs for their EDs in CASIS, followed by outpatient services and dentists, while in 
MOSAIC, the highest percentage of participants was in contact with outpatient services, 
followed by GPs for EDs and for other reasons. In iMANTRA, where participants were 
recruited from an inpatient population, the high use of inpatient services was followed – 
by a wide margin – by GPs for EDs and psychiatrists/psychologists. 
SERVICE COSTS 
 shows the costs associated with service use, summarising the different services presented 
in Chapter 4 into service categories. Reflecting the pathways of recruitment and the 
location of the interventions to be evaluated in the RCTs, average costs per person were 
highest for inpatient treatment in iMANTRA and CASIS, while outpatient treatment 
costs were the largest contributor to total costs in MOSAIC.
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Table 5-11: Service use in the six months preceding baseline assessment, three trials 
 CASIS MOSAIC iMantra 
Service 
Number using 
(%) 
Mean contacts 
(SD) 
Number using 
(%) 
Mean contacts 
(SD) 
Number using 
(%) 
Mean contacts 
(SD) 
Inpatient ED 79 (49%) 35.56 (67.27) 11 (8%) 6.19 (28.34) 41 (100%) 174.59 (15.33) 
Inpatient other reason 26 (16%) 2.64 (12.43) 15 (11%) 0.67 (3.41) 1 (2%) 0.34 (2.19) 
Outpatient ED 90 (56%) 6.92 (10.37) 126 (89%) 3.75 (8.620) 8 (20%) - 
Outpatient other 23 (14%) 0.72 (2.78) 34 (24%) 0.55 (1.44) 0 (0%) - 
Day hospital 0 (0%) - 0 (0%) - 0 (0%) - 
A&E ED 53 (33%) 0.8 (2.26) 27 (19%) 0.34 (.950) 2 (5%) 0.24 (1.41) 
Gynaecologist 0 (0%) - 0 (0%) - 0 (0%) - 
Psychiatrist 51 (32%) 1.85 (4.74) 32 (23%) 0.96 (2.95) 6 (15%) 2.02 (6.07) 
Psychologist 64 (40%) 2.99 (6.0) 27 (19%) 1.42 (4.72) 0 (0%) - 
Family therapist/MFDT 0 (0%) - 0 (0%) - 4 (10%) 0.56 (1.96) 
Individual 
therapist/CBT/IAPT 
0 (0%) - 0 (0%) - 4 (10%) 0.88 (3.87) 
Psychotherapist 25 (16%) 2.33 (7.04) 10 (7%) 0.53 (2.71) 0 (0%) - 
CPN 40 (25%) 2.38 (7.930) 17 (12%) 0.85 (3.48) 0 (0%) - 
CAMHS/AMHS 0 (0%) - 0 (0%) - 10 (24%) 0.29 (1.33) 
Crisis team 0 (0%) - 0 (0%) - 0 (0%) - 
Residential rehabilitation 0 (0%) - 0 (0%) - 0 (0%) - 
GP ED 137 (86%) 7.44 (7.79) 124 (88%) 4.53 (8.70) 6 (15%) 0.68 (2.14) 
GP other 55 (34%) 1.24 (2.44) 96 (68%) 2.03 (2.64) 3 (7%) 0.41 (1.94) 
Walk-in clinic 0 (0%) - 0 (0%) - 1 (2%) - 
Practice nurse ED 72 (45%) 4.88 (12.36) 32 (23%) 0.81 (2.64) 4 (10%) 0.34 (1.11) 
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 CASIS MOSAIC iMantra 
Service 
Number using 
(%) 
Mean contacts 
(SD) 
Number using 
(%) 
Mean contacts 
(SD) 
Number using 
(%) 
Mean contacts 
(SD) 
Practice nurse other 32 (20%) 0.45 (1.35) 38 (27%) 0.61 (2.24) 0 (0%) - 
Dietician/nutritionist 0 (0%) - 0 (0%) - 6 (15%) 0.78 (3.77) 
Health visitor 0 (0%) - 0 (0%) - 1 (2%) - 
Other community nurse 13 (8%) 0.78 (3.58) 6 (4%) 0.18 (1.14) 0 (0%) - 
Dentist 88 (55%) 0.89 (1.17) 67 (48%) 0.82 (1.28) 4 (10%) 0.37 (1.88) 
Optician 52 (33%) 0.38 (0.59) 36 (26%) 0.34 (0.69) 4 (10%) 0.15 (0.53) 
Counsellor 44 (28%) 2.64 (6.18) 27 (19%) 1.07 (3.07) 0 (0%) - 
Alternative therapist 23 (14%) 0.67 (2.83) 9 (6%) 0.33 (1.64) 0 (0%) - 
Physiotherapist 0 (0%) - 0 (0%) - 1 (2%) 0.07 (0.47) 
Occupational therapist 0 (0%) - 0 (0%) - 0 (0%) - 
Osteopath 0 (0%) - 0 (0%) - 0 (0%) - 
Police 0 (0%) - 0 (0%) - 0 (0%) - 
Solicitor/lawyer 7 (4%) 0.15 (0.87) 7 (5%) 0.09 (.51) 0 (0%) - 
Self-help/support group 18 (11%) 0.51 (2.24) 9 (6%) 0.42 (2.28) 1 (2%) 0.29 (1.87) 
Helplines 7 (4%) 0.38 (2.22) 4 (3%) 0.16 (1.21) 0 (0%) - 
CAB 0 (0%) - 0 (0%) - 1 (2%) 0.02 (0.16) 
Voluntary 
organisations/churches 
0 (0%) - 0 (0%) - 0 (0%) - 
Websites 24 (15%) 1.12 (4.11) 12 (9%) 1.97 (15.63) 0 (0%) - 
Social worker 17 (11%) 0.33 (1.36) 14 (10%) 0.26 (1.36) 0 (0%) - 
Outreach/ family support 
worker 
12 (8%) 0.11 (0.4) 5 (4%) 0.04 (.24) 0 (0%) - 
Family centre 0 (0%) - 0 (0%) - 0 (0%) - 
Carer 0 (0%) - 0 (0%) - 0 (0%) - 
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 CASIS MOSAIC iMantra 
Service 
Number using 
(%) 
Mean contacts 
(SD) 
Number using 
(%) 
Mean contacts 
(SD) 
Number using 
(%) 
Mean contacts 
(SD) 
Extra help at school 23 (14%) 0.14 (0.35) 18 (13%) 0.13 (0.33) 0 (0%) - 
* In iMANTRA, these professionals were combined into one question 
 
Table 5-12: Service costs in the six months preceding baseline assessment, three trials 
 CASIS MOSAIC iMANTRA 
Service category Mean £ SD £ Range £ Mean £ SD £ Range £ Mean £ SD £ Range £ 
Hospital 21,045 30,370 0-215,172 4,547 14,403 0-87,794 81,304 12,029 21,672-87,651 
Mental health 1,687 2,261 0-11,232 709 1,564 0-11,458 1,062 2,894 0-13,224 
Primary care 1,650 1,409 0-7,360 1,046 1,304 85-12,272 229 493 0-2,076 
Community services 286 489 0-1,752 115 247 0-1,460 3 16 0-105 
Social work 95 397 0-3,780 70 383 0-3,549 49 293 0-1,872 
Self-help and advice 32 99 0-673 59 394 0-4,500 0 n/a n/a 
Total costs 24,795 31,121 318-224,025 6,546 15,316 138-96,287 82,647 11,296 25,200-95,124 
Note: Hospital includes: Inpatient, outpatient, A & E. Mental health includes: Psychiatrist, psychologist, CPN, psychotherapist, family therapist, MFDT, individual therapist, CBT, 
CAMHS, AMHS, crisis team, residential rehabilitation. Primary care includes: GP, practice nurse, community nurses, dentist, optician, dietician/nutritionist. Community services 
includes: Counsellor, alternative therapy, solicitor/lawyer, physiotherapy, occupational therapy, osteopathy, police. Self-help and advice includes: Self-help group, support group, 
CAB, helplines, websites. Social care includes: Social worker, outreach worker, family support worker, family centre, carer. 
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The proportion of total cost absorbed by each cost category for each trial is shown in Figure 
5-2.  
Figure 5-2: Costs by service category, three trials 
MOSAIC 
 
CASIS 
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iMANTRA 
 
Total costs over the six months prior to baseline were highest for the iMANTRA group in 
which all participants had used inpatient care over the previous six months; hospital costs 
accounted for 99% of total costs. In the CASIS group, who were also recruited from an 
inpatient population, hospital costs still accounted for 85% of total costs, and only around 
6% of this was due to outpatient visits, reported by over 60% the participants. In the 
MOSAIC group – recruited through outpatient services – only 16% reported a hospital 
admission for ED or other reasons in the six months prior to the intervention. For all three 
studies, community, self-help and social work services contributed a very small proportion 
to total costs even though some of these services were used by over 10% of the study 
samples. 
PREDICTORS OF SERVICE COSTS 
I explored predictors of service costs in the MOSAIC and CASIS groups. Table 5-13 and 
Table 5-14 show the results of univariate regression models, relating participant 
characteristics to total costs, as well as a ‘full’ model with all predictors significant at the 
90% level, and a ‘fitted’ model which maximises the proportion of variance in total costs 
explained (adjusted r-squared).Note that even though the number of previous 
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hospitalisations was statistically significant in the univariate models, this predictor has been 
omitted in the following models to avoid issues of endogeneity. 
For the univariate models using CASIS data, there were significant positive associations 
with total costs for having English as a first language (coefficient 21,426), WHO health 
rating (coefficient 12,206), DASS stress score (coefficient 614), total DASS score 
(coefficient 179) and the number of previous hospitalisations (coefficient 3,723). There 
were significant negative associations between total costs and having children (coefficient-
11,184), the number of children (coefficient -4,783), having a degree (coefficient -4,790), 
having a diagnosis of AN vs another diagnosis (coefficient -17,193), lowest BMI ever (-
4,640) and age of onset (-635). 
This points to patients not from a background of recent migration, higher stress and 
possibly a more protracted or severe course of illness as indicated by a higher number of 
hospitalisations, lowest ever BMI and earlier age of onset, and those with EDNOS incurring 
higher costs.  
Those with children, a higher level of education, a later age of onset and a potentially less 
severe course of illness (as measured by the lowest BMI ever) incurred lower costs, pointing 
perhaps to less engagement with services for those with later or adult onset AN. 
The largest coefficients are found for English as a first language, WHO health rating and a 
diagnosis of EDNOS, but some scale variables (previous hospitalisations, number of 
children, and lowest BMI also carry high coefficients that indicate the need for further 
investigation. Perhaps surprising is that a better WHO health rating is also associated with 
higher costs, and the relationship between WHO health rating and previous treatment and 
current severity of illness should be explored, especially since this is one of the largest 
coefficients. 
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Table 5-13: Predictors of service costs (CASIS) 
 Univariate models Full model Fitted model 
Predictor Coef. se p Coef. se p Coef. se p 
Age -118 235 0.615       
Gender male 7,615 9,121 0.404       
Ethnicity (Other vs White British) 3,054 15,637 0.845       
English is first language 21,426 28,11 <0.001 26,723 10,390 0.010 27,175 7,039 <0.001 
Cohabiting 1,998 5,033 0.691       
Has children? -11,184 5,060 0.027       
Number of children -4,783 1,879 0.011       
Years of education 704 996 0.480       
Degree vs no degree -4,790 2,696 0.076 8,790 7,997 0.272    
Employment 
• Student 
• Economically inactive 
 
-6,288 
-2,397 
 
6,376 
6,343 
 
0.324 
0.706 
      
Diagnosis AN vs other -17,193 3,836 <0.001 -20,352 11,125 0.067    
BMI (baseline) -1,010 951 0.288       
Lowest BMI ever -4,640 1,567 0.003 -7,155 1,989 >0.001 -7,997 2,031 <0.001 
Age of onset -635 681 0.096 -684 452 0.130    
Duration of illness -27 18 0.138       
WHO quality of life rating 7,929 5,025 0.115       
WHO health rating  13,206 4,812 0.006 18,090 6,933 0.009 18,267 6,726 0.007 
DASS depression score 355 264 0.178       
DASS anxiety score 287 193 0.137       
DASS stress score 614 171 <0.001 920 1,026 0.369 603 267 0.024 
Total DASS score 179 73 0.015       
EDEQ-Restraint 17 1,203 0.989       
EDEQ-Eating concern 1,835 2,057 0.372       
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 Univariate models Full model Fitted model 
Predictor Coef. se p Coef. se p Coef. se p 
EDEQ-Shape concern 714 2,346 0.761       
EDEQ-Weight concern 1,665 1,713 0.331       
EDE-Q Global score 1,239 1,861 0.505       
Number of hospitalisations 3,723 1,246 0.003       
 
Adjusted R2 
        
 
0.197 
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Table 5-14: Predictors of service costs (MOSAIC)- 
 Univariate models Full model Fitted model 
Predictor Coef. se p Coef. se p Coef. se p 
Age -243 137 0.075 -83 130 0.524    
Ethnicity (Other vs White British) 3,142 3,586 0.381       
Living with partner -3,371 1,693 0.047 18 1,671 0.991    
Degree vs no degree -4,790 2,696 0.076 -2,425 1,665 0.145    
Diagnosis AN vs other -5,563 1,781 0.002 2,331 1,173 0.047 4,031 1,318 0.002 
BMI (baseline) -850 614 0.166       
Age of onset -317 147 0.031 -100 127 0.433    
Duration of illness -23 99 0.815       
EDEQ-Restraint -1,448 1,306 0.271       
EDEQ-Eating concern 617 847 0.466       
EDEQ-Shape concern -401 1,005 0.690       
EDEQ-Weight concern -965 881 0.273       
EDEQ Global score -850 1,305 0.521       
Previous hospital admission 16,254 5,137 0.002       
Previous treatment for AN 5,120 2,018 0.011       
Taking antidepressants 5,433 2,543 0.033 5,286 2,601 0.042 4,847 1,875 0.010 
 
Adjusted R2 
        
 
0.041 
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In the final fitted model, the only predictors retained are English as a first language 
(coefficient 27,175), lowest BMI ever (coefficient -7,997), WHO health rating (coefficient 
18,267) and DASS stress score (coefficient 603). While the coefficient on the DASS stress 
score is approximately the same as in the univariate model, the size of the other 
coefficients has increased as is perhaps expected, with the coefficient for lowest BMI ever 
increasing from -4,640 to -7,997. It should be noted that the fitted model explains less 
than 20% of variation (adjusted R2=0.197), leaving much of the variation in cost 
unexplained. 
In the models for MOSAIC, there is a significant positive association between total costs 
and taking antidepressants (coefficient 5,433), and there are significant negative 
associations with age (coefficient -243), living with a partner (coefficient -3,371), having 
a degree (coefficient -4,790), a diagnosis of AN vs another diagnosis (coefficient -5,563) 
and age of onset (coefficient -317). 
These are similar trends to what we see in CASIS, with psychiatric co-morbidity 
(depression) and a potentially longer duration of illness (age of onset) associated with 
higher costs. Negative associations with age, living with a partner and having a degree are 
potentially related, as the latter two are more likely to be true for older people.  
The final fitted model only retains the variable for diagnosis (coefficient 4,031) and taking 
antidepressants (coefficient 4,847). Note that the former switches sign in the multivariable 
models, pointing to missing explanatory variables missing from these models. This is 
further supported by the adjusted R2 of 0.041, i.e. explained variation of only 4.1%. 
Further analysis should explore whether there are separate effects for level of education 
and having a family (children or partner), and which aspects of severity of illness and 
illness duration are likely to contribute to higher costs. 
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DISCUSSION 
This section contributes to the evidence base by a) describing the service use by patients 
with ED before commencing an evidence-based treatment and associated costs and b) 
analysing why these costs vary between individuals. Aside from the TOUCAN study 
(Byford et al. 2007a), to my knowledge these are the largest datasets of wider service use 
associated with AN in England that have been analysed to date. 
The data presented were taken from three studies each with a different recruitment 
pathway. This was reflected in both the service use data and the costs, as, for example, all 
participants in iMANTRA (who were recruited from inpatient units) predictably reported 
inpatient stays. The MOSAIC group, recruited through outpatient services, was the most 
diverse in terms of the range of service use, and also reported the lowest average costs. 
While the literature on cost variations is only starting to emerge, some trends can be 
observed: 
• Health care costs associated with ED are higher than for those without ED 
(Samnaliev et al. 2015). 
• Hospital costs associated with AN are higher than for other ED (Haas et al. 
2012a). 
• The presence of bingeing/purging behaviours is associated with higher outpatient 
costs (Stuhldreher et al. 2015). 
• Longer duration of illness is associated with higher outpatient costs (Stuhldreher 
et al. 2015). 
• Lower BMI at admission is associated with higher costs in AN and vice versa 
(Haas et al. 2012b, 2012a; Toulany et al. 2015). 
• Higher BMI following hospitalization is associated with higher retrospective 
costs, i.e. a longer inpatient stay is associated with a higher BMI (Stuhldreher et al. 
2015). 
• Co-morbid mental health problems and conditions are associated with higher 
costs in inpatients (Haas et al. 2012b, 2012a) and outpatients (Stuhldreher et al. 
2015), although some studies do not find this effect. 
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Factors associated with poor outcomes in the AN literature (Steinhausen 2002; Treasure 
& Russell 2011) , such as low BMI, a diagnosis of AN vs EDNOS and longer duration 
of illness, were also associated with higher treatment costs in this study, in line with 
previous literature summarized above. These findings suggest that patients with the 
highest needs in these domains are receiving the most intensive service response when 
presenting to secondary or tertiary care. 
There were some differences between the studies. Higher age was associated with slightly 
lower treatment costs in MOSAIC. Previous treatment for AN (number of previous 
hospital admissions in CASIS and a binary indicator of previous hospital admissions in 
MOSAIC) were associated with higher treatment costs – the latter being in line with other 
literature (Stuhldreher et al. 2015). Interpretation is difficult, as it is unclear whether this 
simply reflects treatment costs immediately prior to the study, or a prolonged engagement 
with services due to severity or chronicity of AN, and these predictors have therefore 
been omitted from the multivariate models.  
English as a first language was also associated with higher treatment costs in CASIS, 
which may point to differences in treatment uptake among minority population groups 
(House 2011) – but in the univariate models, this is not reflected in a significant cost 
impact of the variable. 
The findings in this study broadly reflect the existing literature but identifies additional 
potentially relevant predictors of costs: age and English as a first language. Notably, 
mental health co-morbidity - a significant predictor of costs in several previous studies – 
was not significant in the multi-variate model. 
210 
 
 
 
CHAPTER SUMMARY 
Little is known about the treatment received in outpatient services, the associated costs 
and whether those costs vary by clinical need or by other characteristics. There is a 
particular gap in the knowledge of costs of treatment for AN provided by outpatient 
services, especially in community-based services. In this chapter, I explored treatments 
received by a cohort entering outpatient treatment in four Greater London PCTs (CPS) 
and participants in two large RCTs (CASIS, MOSAIC). I then analysed the associated 
costs and explored variations based on individual level characteristics, and additionally 
based on level of service specialisation for the former. 
Key findings with regard to treatment in the CPS received can be summarised as follows: 
• Single-family therapy was the most commonly received treatment, followed by 
individual outpatient and medical outpatient treatment. 
• Other forms of treatment, such as day patient or parent-only sessions were much 
less common.  
• The S-S and N-S pathways had similar rates of inpatient admissions. 
• The NS-NS pathway had the highest rate of admissions and the highest average 
length of stay. 
• Prior to inpatient admission GP consultations and outpatient services for ED and 
dentist were the most reported services (CASIS). 
• Prior to commencing outpatient treatment, the most commonly seen services 
were outpatient services and GPs for ED and other reasons (MOSAIC). 
The following key findings relate to service-level variations in costs: 
• Patients on the S-S pathway had the lowest average cost, while those on the NS-
NS pathway had the highest, but this difference was not statistically significant 
• Costs associated with inpatient treatment for ED were the largest contributor to 
total costs for all pathways, with 37% in the S-S pathway, 41% in the NS-S 
pathway and 72% in the NS-NS pathway. 
• In both NS-S and NS-NS pathways, total inpatient costs accounted for over 70% 
of total costs, compared to 46% in the S-S pathway. 
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At the individual level, costs were positively associated with: 
• Age and duration of illness in the CPS; 
• English as a first language, WHO health rating and DASS stress scale in CASIS; 
• Previous hospital admission in MOSAIC. 
Costs were negatively associated with: 
• Vomiting and co-morbid medical condition in the CPS; 
• The S-S pathway compared to the NS-NS pathway in the CPS; 
• Lowest BMI in CASIS; 
• Age and a diagnosis of AN vs other diagnosis in MOSAIC. 
The largest contributors to costs in the RCT groups were 
• Inpatient admissions in CASIS, with 50% reporting an admission; 
• Outpatient services in MOSAIC, with inpatient costs accounting for only 8%. 
In conclusion, costs appeared to be driven by care pathway and the associated risk of 
admission, although the direction of causality is unclear and cannot be tested with the 
available data. In the RCTs, the recruitment pathway is reflected in reported service use. 
Cost variations are related to some indicators of severity (e.g. low BMI, duration of illness, 
vomiting) and some demographic characteristics (age, English as a first language). 
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CHAPTER 6  
Indirect costs: Evidence on the productivity-
related impacts of Anorexia nervosa from two 
British cohorts 
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CHAPTER INTRODUCTION 
The previous two chapters focussed on the direct costs of AN. In this chapter, I focus 
on some of the indirect costs associated with AN to answer RQ3: “What is the impact of 
AN on education, employment, income and related outcomes?” 
Productivity losses – productivity not realised as a result of an illness – are an important 
aspect of these indirect costs, and often make up a large percentage of the overall cost of 
illness. The theoretical framework for the two studies presented here is the human capital 
approach, where productivity is seen as a dividend from a “stock” of capital that can be 
built and maintained by productivity-enhancing activities. One such activity (or indicator 
of activity) is education attainment. Productivity itself is measured in terms of output and 
the market valuation of this output. Wages and income can be used as a proxy measure 
of productivity, although it is an imperfect one. 
This chapter first explores the impact of AN on human capital accumulation, measured 
by education attainment at GCSE-level using data from the ALSPAC, and secondly the 
impact of AN on productivity and related outcomes as measured by employment status, 
income, disability and benefit receipt in adulthood using BCS-70 data. 
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PART 1 – THE EFFECT OF ANOREXIA NERVOSA ON GCSE 
ATTAINMENT. EVIDENCE FROM THE ALSPAC COHORT. 
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INTRODUCTION 
AN is associated with long and frequent periods of hospitalisation. While there is 
commonly some on-site education, such long hospitalisations can mean that young 
people spend long stretches of time out of education (Byford et al. 2007a). Byford and 
colleagues (Byford et al. 2007a) found that in addition to hospital stays, the young people 
in their study spent long stretches of time out of education. It seems that in the face of 
severe illness, education often comes second, although it is a concern to parents (Tierney 
2005) and seen as an important determinant of quality of life (de la Rie et al. 2007). For 
those who remain within mainstream school, special provisions may have to be made to 
accommodate sickness absences. 
School absences are likely to characterise the education pathway of young people with 
AN. Usually, however, absences are a policy concern because they are linked to truancy 
and associated behavioural difficulties and crime (National Audit Office 2005). 
At the same time, some features of AN may mitigate any detrimental impact on 
attainment. People with the disorder are thought to have a higher than average IQ (Lopez 
et al. 2010) and better working memory (Kothari et al. 2012), and may have higher 
achievement than those with a comparable IQ (Dura & Bornstein 1989). Higher levels of 
perfectionism are also associated with AN (Lloyd et al. 2014), although it is not clear 
whether this would necessarily lead to improved school performance. 
There is some evidence that the illness does not affect educational outcomes in the longer 
term: there was no statistically significant difference between young women with AN and 
their healthy co-twins five years after recovery from AN (Keski-Rahkonen et al. 2007), 
and a greater proportion of patients admitted to hospital with AN had completed post-
secondary education compared to controls (Hjern et al. 2006). In contrast, Patton and 
colleagues (Patton et al. 2008) found young people with EDNOS-AN more likely to be 
not in education or employment than cohort members without ED. However, I am not 
aware of any study looking at educational outcomes controlling for other characteristics, 
such as parental socio-economic status.  
Persistent purging behaviours are associated with lower education attainment (Allen et al. 
2013), and patients falling into the purging subtype of AN may experience lower quality 
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of life than the restricting type (Mond et al. 2005) – although this has more recently been 
challenged as the result of a review of the literature (Baiano et al. 2014). In this chapter, I 
explore whether sickness absence and purging behaviour have a detrimental effect on 
education outcomes for young people with AN. 
I use ALSPAC data to test the following hypotheses: 
• Young people with anorexia nervosa will not differ from non-disordered controls 
in terms of GCSE attainment, controlling for confounding factors such as socio-
economic status and parental level of education. 
• Young people with anorexia nervosa with bingeing/purging have lower GCSE 
attainment than non-disordered controls. 
• Level of school absences due to sickness will not affect GCSE attainment of 
young people with AN more than those without disordered eating patterns. 
• Absences will negatively affect GCSE outcomes in those with bingeing/purging 
behaviours, but not those where these behaviours are absent. 
While a recent Swedish study found that school achievement was positively related to the 
risk of AN in both females and males (Sundquist et al. 2016), I am not aware of a study 
of education outcomes in AN for England. 
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METHODS 
DATA AVAILABILITY AND ACCESS 
This is a longitudinal prospective study with comparison groups and inclusion of potential 
confounders. It uses data from the ALSPAC (Golding et al. 2001), a longitudinal birth 
cohort study, which enrolled all pregnant women living within Avon, England, due to 
give birth between the 1st April 1991 and 31st December 1992. It is estimated that 
approximately 85-90% of those eligible for inclusion chose to participate and the sample 
has been shown to be representative of the UK population, although deprived 
households are under-represented in the sample (Bristol University 2014). The core 
ALSPAC sample consists of 14,541 pregnancies, and data were obtained on 14,272 with 
a known birth outcome via postal questionnaires. 13,988 children survived the first year, 
and at age 7, another 713 children were enrolled.  
Data access was facilitated by Dr Nadia Micali, University College London, through the 
NIHR-funded project ‘Adolescent eating disorders and related behaviours: longitudinal 
course and risk factors’17. Questions about eating behaviours that will enable the 
researchers to obtain DSM-IV diagnoses have been included in the sweeps at ages 16 and 
18. The focus is on risk factors contributing to adolescent EDs, and particularly the 
transgenerational effect of maternal EDs. 
For the present study, eligibility criteria were aligned with Dr Micali’s study. Participants 
were considered eligible if they had not withdrawn consent and could be contacted for 
data collection at ages 14 and 16. Where there was more than one participant from the 
same family (i.e. in case of a multiple birth), one twin was randomly removed to preserve 
independence. At age 14, 6,140 out of 10,581 eligible participants returned questionnaires 
on ED behaviours, with 5,069 out of 9,702 at age 16.  
In addition, availability of GCSE outcome data determined whether participants were 
included in this analysis. GCSE data were available through linked data so that they were 
not reliant on survey responses. Given the high amount of missing data in the ED 
variables and the hypothesised causal relationship between ED and GCSE performance, 
                                                 
17 http://www.iop.kcl.ac.uk/sites/edu/?id=191 
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the outcome variable was used in the multiple imputation model to utilise the information 
in the outcome variable (GCSE) about the predictor variable, AN status (Sterne et al. 
2009). 
PREDICTORS 
Data on eating behaviours were available at ages 14 and 16. At age 14, there was evidence 
of AN for n=102 females, while at age 16, there was evidence for n=69. For a small 
number (n=13), there was evidence of AN at both time points.  
For this analysis, a combined indicator was calculated that reflected whether the study 
participant had a diagnosis of anorexia nervosa, derived by the researchers based on 
DSM-IV criteria (Micali et al. 2017a) at either age 14 or age 16. Data on self- and parent 
reported bingeing and purging behaviours were collected at the same time. Additionally, 
school absences due to illness over the last two weeks were available at age 16. Data were 
re-coded to suit the analysis (see Table 6-1). Those with a diagnosis of AN at either age 
14 or age 16 are of primary interest to this study, while those with no ED formed the 
comparison group. 
Table 6-1: Coding of eating behaviours and ED diagnosis at age 14 and age 16 
Characteristic Coding 
Bingeing or purging at age 14 or age 16 Binary – no/yes 
ED diagnosis at age 14 or age 16 
Categorical 
• No ED 
• Anorexia 
• Other ED 
Days absence due to illness last two weeks Scale  
 
OUTCOMES 
The main outcome measure was educational attainment at Key Stage 4, measured as a) 
the total point score and b) whether 5 or more ‘good’ GCSEs (grades A*-C) were 
achieved. The latter is a commonly used indicator of good educational attainment and the 
total point score is useful for comparison with other studies. 
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CONFOUNDERS AND CO-VARIATES 
The literature on education research is vast and there are many potential predictors of 
educational attainment. An analysis of attainment in the Chicago Longitudinal Study (Ou 
& Reynolds 2008) found the strongest predictors to be maternal educational attainment, 
school absences and mobility, grade retention and the young person’s educational 
expectations. Student characteristics such as gender (Arnot et al. 1998; Gray et al. 2004), 
ethnicity (Demack et al. 2000), (parental) socio-economic status or occupational class 
(Connolly 2006; Demack et al. 2000; Power & Manor 1992), mental health problems 
including depression and psychological distress (Fergusson & Woodward 2002; Rothon 
et al. 2010; Shahar et al. 2006; Wilson & Marcotte 1996), learning disabilities, for example 
ADHD (Wilson & Marcotte 1996) as well as ability or intelligence (Furnham et al. 2009) 
are possible predictors of educational achievement. At the school level, characteristics 
such as school sector (Smith & Naylor 2005), school size (Newman et al. 2006), school 
resources (Steele et al. 2007) and the proportion of poor students (Noden & West 2009) 
may be associated (positively or negatively) with achievement. There is also evidence that 
school-level characteristics, such as the proportion of parents in higher occupational 
classes, influence the chance of developing eating disorders, independent of individual-
level characteristics (Bould et al. 2016). 
Three sets of confounders and co-variates were identified, following an analysis presented 
by Vignoles and colleagues (2010), and a review and analysis of risk factors by Nicholls 
and Viner (2009). The first includes ALSPAC core variables that provide demographic 
information on parents and child, household characteristics and key information related 
to pregnancy and birth outcome (see Table 6-2). 
Table 6-2: Set 1 - ALSPAC core variables 
Characteristic Coding 
Mother’s age at delivery Scale variable 
Preterm birth or low birth weight, defined 
as born at gestational age <37 weeks or 
born at gestational age >= 37 weeks with 
a birth weight <2,500 grams. 
Binary – no/yes 
Parity Binary – single vs multiple birth 
Gender of child Binary – female/male 
Child ethnicity Binary – white/other 
Smoking in pregnancy Binary – ever smoked no/yes 
Housing tenure Categorical: 
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Characteristic Coding 
• Owner-occupied 
• Social housing 
• Private rented 
• Other 
Marital status 
Categorical: 
• Never married 
• Married (regardless of number of 
marriage) 
• No longer married (regardless of reason) 
Occupational class 
Categorical: Lowest occupational class, 
combining data on mother and father. 
• I  
• II 
• III non-manual 
• IV manual 
• V 
Maternal education 
Categorical: Mother’s highest educational 
qualification 
• CSE 
• Vocational 
• O-level 
• A-level 
• Degree 
 
The second set of predictor variables includes additional child and family characteristics 
(see Table 6-3). 
Table 6-3: Set 2 - Child and family characteristics 
Characteristic Coding 
Number of children in household Scale 
Pupil eligibility for FSM (KS4) Binary – no/yes 
IDACI deprivation indicator Scale (range 0-1) 
YP expectation of obtaining 5+ good 
GCSEs 
Categorical 
• Very likely 
• Fairly likely 
• Not very likely 
• Not at all likely 
Emotional and behavioural difficulties Binary – ever, no/yes 
School Action or School Action Plus 
(KS4) 
Binary – no/yes 
School absences due to sickness last 2 
weeks 
Scale – range 0-14 
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The final set of variables includes school-level characteristics (see Table 6-4). 
Table 6-4: Set 3 - School-level characteristics 
Characteristic Coding 
School reputation (parent report) 
Categorical 
• Very good 
• Good 
• Poor 
• Very poor 
• Don’t know (recoded to missing) 
Sex of school 
Binary 
• Mixed 
• Single sex 
School identifier Nominal variable, used for clustering 
 
Additional characteristics, such as institution type, were considered for analysis, but there 
was a perfect correlation with independent schools and single-sex schools. Given that the 
literature suggests that the proportion of females in a school is positively related to the 
risk of developing eating disorders (Bould et al. 2016), preference was given to the sex of 
school indicator, which was re-coded from a categorical variable (mixed, male only, 
female only) to a binary variable (mixed vs single sex). 
MISSING DATA 
Missing data were analysed and multiple imputation was performed using chained 
equations with the - mi impute - command (Royston & White 2011) in Stata 14 (StataCorp 
2015). M=40 sets were imputed.  
Scale variables were imputed using the predictive mean matching procedure (-pmm-), 
considering the three next neighbours. Truncated regression (-truncreg-) was used for 
scale variables with a limited range, such as the IDACI, which has a range of zero to one. 
Logistic regression (logit) was used for binary variables, ordered logit (-ologit-) for ordinal 
variables, and multinomial regression (-mlogit-) for nominal variables. The augment 
option was used selectively where perfect prediction was encountered. 
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ANALYSIS MODELS 
Analysis models were developed by first identifying sets of variables representing 
characteristics with a theoretical backing for their impact on education outcomes and 
anorexia nervosa. The model can be described as 
𝐴𝑖 = 𝑓(𝐸𝑖 , 𝑋𝑖, 𝐼𝑖, 𝑆𝑖, 𝑈𝑖) 
Where 𝐴𝑖 is individual GCSE attainment, as a function of 
• 𝐸𝑖 , representing the individual’s eating behaviours and diagnosis; 
• 𝑋𝑖, a set of demographic and socio-economic characteristics from the ALSPAC 
core variable set; 
• 𝐼𝑖, a set of child and parent characteristics shown to be linked to both eating 
behaviours and attainment;  
• 𝑆𝑖, a set of school characteristics;  
• 𝑈𝑖, an error term. 
Starting with a simple linear model 
Model 1: 𝐴𝑖 = 𝛼 + 𝛽𝐸𝑖 + 𝑈𝑖 , 
the analysis is extended by adding additional sets of variables: 
𝑀𝑜𝑑𝑒𝑙 2: 𝐴𝑖 = 𝛼 + 𝐸𝑖 + 𝑋𝑖 + 𝑈𝑖 , 
𝑀𝑜𝑑𝑒𝑙 3: 𝐴𝑖 = 𝛼 + 𝛽𝐸𝑖 + 𝑋𝑖 + 𝐼𝑖 + 𝑈𝑖 , 
𝑀𝑜𝑑𝑒𝑙 4: 𝐴𝑖 = 𝛼 + 𝛽𝐸𝑖 + 𝑋𝑖 + 𝐼𝑖 + 𝑆𝑖 + 𝑈𝑖. 
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Similarly, for the binary outcome denoting whether a young person achieved 5 good 
GCSEs, and where 𝑉𝑖 represents the three sets of variables, the logit regression equivalent 
is as follows: 
𝑝(𝐴𝑖 = 1|𝑉𝑖) =  
𝑒(𝛽0+𝛽1𝐸𝑖+𝛽1𝑋𝑖+𝛽2𝐼𝑖+𝛽3𝑆𝑖)
𝑒(𝛽0+𝛽1𝐸𝑖+𝛽1𝑋𝑖+𝛽2𝐼𝑖+𝛽3𝑆𝑖) + 1
 
With 𝑝(𝑌 = 1|𝑋) interpreted as the probability of a positive outcome conditional on X, 
written as the odds ratio 
ln (
𝑝
1 − 𝑝
) = 𝛽0 + 𝛽1𝐸𝑖 + 𝛽1𝑋𝑖 + 𝛽2𝐼𝑖 + 𝛽3𝑆𝑖 
Analyses for Model 4 were run with the -vce(cluster)- option, with KS4 school ID as the 
clustering variable. 
Model fit is assessed by comparing the four resulting models for each of the two outcome 
variables on the adjusted 𝑅2 for linear regression models using the user-written -mibeta- 
command in STATA 14. The selected model was used in the following logit regression 
to ensure comparability. Residual plots (-qqnorm-) were inspected to confirm 
assumptions about normality of residuals for 10 imputed datasets. 
Following selection of the most efficient model to address hypothesis 1, hypotheses 2-4 
are tested by extending this model to include interactions between the AN indicator 
variable and bingeing/purging behaviours, absences, or both, as appropriate to answering 
the respective research question. 
SUB-GROUP ANALYSES 
To ensure consistency with other estimates in the literature and throughout this thesis, 
analyses were repeated for females only. In addition, I tested whether the imputation of 
the predictor variable (ED diagnosis) changed the results (Sterne et al. 2009) – as presence 
of an ED could conceivably be related to missingness – and ran the analysis for females 
including only those cases that provided data on the ED behaviour questions (n=1,024).  
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RESULTS 
SAMPLE 
Overall, data on KS4 attainment (whether has attained 5 good GCSEs; GCSE total point 
score) is available for n=11,997. No data were available for 3,087. After removal of 
participants without data on GCSE total score, whether they had achieved 5 ‘good’ 
GCSEs and missing information on sex, 9,511 cases remained, and 9,492 had information 
on KS4 school ID which was used for clustering. These 9,511 cases form the sample for 
analysis without the clustering variable, and n=9,492 form the sample for analyses with 
clustering. There are n=4,751 and n= 4,745 in the samples for the analysis relating to 
females only. 
DESCRIPTIVES 
In the unimputed data set, data on absences in the last two weeks due to sickness were 
available for n=2,831. Information on ED diagnosis was available for 2,452, with n=195 
in the group with AN. Data on bingeing and purging behaviours were available for 2,273, 
with 114 experiencing these at either age 14 or age 16. 
Sample information for the group without an ED and the group with AN is shown in 
Table 6-5. 
There are differences in several sample characteristics. Those with AN are more likely to 
be female, and less likely to be a member of an ethnic minority. Findings regarding socio-
economic status are difficult to interpret. While those with AN are less likely to live in 
social housing (defined as either rented from a council or a housing association) and more 
likely to have parents whose lowest combined occupational class is I, they appear to be 
under-represented in occupational classes II and III-non-manual, and over-represented 
in class III-manual. Eligibility for free school meals is low across the sample, and 25% 
lower in the group with AN than in the group without ED.
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Table 6-5: Sample characteristics and data availability 
 No ED With AN 
 % available n % available n 
Parity - Multi 51.61% 1,953 54.44% 180 
Sex of child - female 44.31% 1,995 76.92% 182 
Child ethnicity - not white 4.24% 1,933 3.37% 178 
Mother ever smoked - yes 61.11% 1,978 59.22% 179 
Housing tenure  2,008  184 
• Owner-occupied 84.96%  84.24%  
• Social housing 7.87%  5.43%  
• Private rented 4.73%  5.98%  
• Other 2.44%  4.35%  
Maternal marital status  2,028  184 
• Never married 12.82%  14.13%  
• Married 82.64%  80.43%  
• No longer married 4.54%  5.43%  
Occupational class  1,877  175 
• I 2.88%  3.43%  
• II 12.31%  8.57%  
• III nm 29.94%  25.71%  
• III m 27.38%  29.71%  
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 No ED With AN 
 % available n % available n 
• IV 28.72%  28.00%  
• V 4.10%  4.57%  
Maternal education  1,959  181 
• CSE 11.84%  10.50%  
• Vocational 7.45%  9.39%  
• O-level 33.84%  33.70%  
• A-level 28.13%  30.94%  
• Degree 18.73%  15.47%  
Pupil eligibility for FSM (KS4) - yes 3.51% 2,106 2.67% 187 
YP expectation of obtaining 5+ 
good GCSEs 
 1,686  146 
• Very likely 62.93%  60.96%  
• Fairly likely 31.14%  32.88%  
• Not very likely 4.39%  4.79%  
• Not at all likely 1.54%  1.37%  
Emotional and behavioural 
difficulties – yes 
4.32% 1,320 0.87% 115 
School Action or School Action Plus 
(KS4) – yes 
9.65% 2,052 8.65% 185 
School reputation (parent report)  1,747  156 
• Very good 39.15%  30.13%  
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 No ED With AN 
 % available n % available n 
• Good 57.18%  67.31%  
• Poor 3.32%  1.92%  
• Very poor 0.34%  0.64%  
Sex of school  2,171  191 
Mixed 94.80%  93.72%  
Male only 1.70%  0.52%  
Female only 3.50%  5.76%  
     
 Mean (SD) available n Mean (SD) available n 
Mother’s age at delivery 29.35 (4.45) 1,995 29.52 (4.90) 182 
Gestation period 39.48 (1.81) 1,995 39.63 (1.68) 182 
Birthweight 3,437.87 (535.56) 1,971 3,348.79 (464.57) 181 
IDACI deprivation indicator 0.13 (0.13) 2,222 0.14 (0.15) 195 
Number of children in household 2.24 (0.80) 1939 2.29 (0.84) 182 
Days school absences due to 
sickness last 2 weeks 
-0.04 (0.89) 1579 -0.01 (0.96) 136 
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Those in the AN group were less likely to have report experiencing emotional and 
behavioural difficulties, with only one person reporting problems for every five reporting 
them in the comparison group.  
Perceived school quality differed between groups, presenting a mixed picture. Fewer 
participants in the group with AN attended a ‘very good’ school, but more attending a 
‘good’ school. While they were less likely to attend a ‘poor’ school, they were more likely 
to attend a ‘very poor’ school – although the proportion in these categories was small 
across the sample. Plausibly linked to the distribution of sex between the groups, 
participants with AN were more likely to attend a female only school, and less likely to 
attend a male only school.  
On the (mean-centred) variable showing days of absences from school due to illness, 
those with AN had a lower average deviation from the mean than the comparison group. 
However, this variable is highly skewed, with 4,249 out of 4,928 participants with data 
available reporting zero days absence due to illness. 
REGRESSION ANALYSES 
In the following section, I present summary results for the various models. The fully 
expanded models can be found in Appendix 4. 
Table 6-6 shows a summary of models 1-4, estimating the effect of reporting AN vs 
reporting no ED on GCSE total score, where  
• Model 1 is a model including only the AN/no ED dummy variable; 
• Model 2 additionally includes variables from set 1 above; 
• Model 3 additionally includes variables from set 2 above and  
• Model for additionally includes variables from set 3 above. 
Table 6-6: Impact of anorexia on GCSE total score (full sample) 
 Model 1 – coeff. (SE) Model 2 Model 3 Model 4 
Anorexia  0.45 (14.25) -9.38 (11.41) -1.66 (7.80) -1.18 (7.97) 
Prob > F 0.976 0.413 0.831 0.88 
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The coefficient on the AN category is not significant in any of the four models, as 
indicated by the result of the F-test. To facilitate choice between these models, the 
adjusted R-squared was analysed and while this increases most between models 1 and 2, 
there is still an increase to model 3 upon the inclusion of school variables. There is little 
change between models 3 and 4, which is perhaps expected given the limited number of 
variable added to the model, and model 3 is selected for the analyses that follow. 
Table 6-7 shows the results of this model, corresponding to the hypotheses stated above: 
• Model 3a is Model 3 above and includes variables from sets 1 and 2 alongside the 
AN indicator; 
• Model 3b additionally includes the indicator for bingeing and purging behaviours 
(BP) and an interaction term between the AN and the BP indicators; 
• Model 3c includes the AN indicator, the variable reporting days of sickness 
absence from school, and the interaction term between the two and 
• Model 3d includes the AN and BP indicators, the absence variable and a three-
way interaction term. 
Table 6-7: Impact of anorexia, binging/purging and absences on GCSE total score (full 
sample) 
 
Model 3a– coeff. 
(SE) 
Model 3b Model 3c Model 3d 
Anorexia -1.66 (7.80) -2.49 (8.47) -1.51 (7.76) -1.08 (7.83) 
Bingeing/purging - 
-11.90 
(18.11) 
- -1.76 (4.96) 
AN x BP - 14.30 (22.86) - - 
Absences - - 
-5.41 
(2.25)* 
-5.23** 
(1.81) 
AN x Absences - - 0.49 (1.36) - 
AN x BP x 
Absences 
- - - 0.57 (1.32) 
Prob > F 0.831 0.59 0.90 0.948 
* p<0.05 
** p<0.01 
The only significant coefficient in these models is on the variable for absences in Models 
3c and 3d. Note that GCSE score ranges from 0-1,281, so that a 5-point difference per 
day of absence above the mean is judged to be a small effect. 
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The same process is repeated for the logit modelling the impact of AN on whether a 
study participant achieved 5 or more good GCSEs.  
Table 6-8: Impact of anorexia on 5 good GCSEs 
 
Model 1 – OR 
(se) 
Model 2 – OR 
(se) 
Model 3 – OR 
(se) 
Model 4 – OR 
(se) 
Anorexia 
(OR) 
1.13 (0.19) 1.02 (0.18) 1.20 (0.25) 1.20 (0.25) 
Prob > F 0.464 0.889 0.401 0.403 
 
The findings in Table 6-8 show the same pattern observed above, and again model 3 is 
selected for the investigation that follows. 
In Table 6-9, results of the logit models are shown. None of the coefficients reach 
statistical significance, with the exception of absences (without the interaction with AN) 
in Model 3d, meaning that a relationship between AN, BP, absences and their interactions 
with the odds of achieving 5 or more good GCSEs cannot be shown in this model. 
Table 6-9: Impact of anorexia, binging/purging and absences 5 good GCSEs (full 
sample) 
 
Model 3a – 
OR (se) 
Model 3b – 
OR (se) 
Model 3c – 
OR (se) 
Model 3d – 
OR (se) 
Anorexia 1..20 (0.25) 1.21 (0.28) 1.20 (0.25) 1.22 (0.26) 
Bingeing/purging - 0.76 (0.37) - 0.93 (0.11) 
AN x BP - 1.25 (0.71) - - 
Absences - - 0.92 (0.05) 0.93* (0.038) 
AN x Absences - - 1.01 (0.04) - 
AN x BP x 
Absences 
- - - 1.01 (0.37) 
Prob>F 0.401 0.454 0.376 0.3485 
*p<0.1 
SUB-GROUP ANALYSES 
The sub-group analysis using the sample of females only shows essentially the same 
results, with the only difference that the absence variable is no longer significant in Model 
3d for the ‘5 good GCSEs’ outcome (see Table 6-11). 
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Table 6-10: Impact of anorexia, binging/purging and absences on GCE total score 
(females only) 
 
Model 3a– coeff ( 
SE) 
Model 3b Model 3c Model 3d 
Anorexia -0.65 (9.27) -1.51 (10.78) 
-0.61 
(9.22) 
-0.49 (9.38) 
Bingeing/purging - 
-11.55 
(32.10) 
- -0.37 (5.51)) 
AN x BP - 
13.72 
(36.37) 
- - 
Absences - - 
-4.80 
(3.74) 
-5.00 (2.88)* 
(2.58) 
AN x Absences - - 
10.07 
(2.16) 
- 
AN x BP x 
Absences 
- - - 0.27 (1.90) 
* p<0.1 
Table 6-11: Impact of anorexia, binging/purging and absences 5 good GCSEs (females 
only) 
 
Model 3a – 
OR (se) 
Model 3b – 
OR (se) 
Model 3c – 
OR (se) 
Model 3d – 
OR (se) 
Anorexia 1.13 (0.33) 1.26 (0.41) 1.23 (0.33) 1.25 (0.35) 
Bingeing/purging - 0.81 (0.63) - 0.96 (0.12) 
AN x BP - 1.14 (1.01) - - 
Absences - - 0.94 (0.09) 0.92 (0.06) 
AN x Absences - - 0.99 (0.06) - 
AN x BP x 
Absences 
- - - 1.15 (0.67) 
 
For the sample including only females for whom information on the predictor variable 
was available, there were no significant associations between AN and education in the 
models.  
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DISCUSSION 
To my knowledge, this is the first study of the impact of AN on GCSE attainment. In 
accordance with my hypotheses, young people with AN did not differ from controls 
without ED in terms of their GCSE achievement. However, counter to my hypotheses, 
the presence of bingeing/purging behaviours did not affect GCSE attainment. These 
results held when the analysis was repeated for females only, and for those who provided 
data on ED behaviours. The latter analysis was performed to see whether the imputation 
changed the direction of results, as in the unimputed data, there was a trend towards 
higher GCSE scores in young people with AN. 
The process of model fitting shows that, in terms of r-squared, socio-demographic 
variables and characteristics in childhood that are predictive of AN and education are 
more important than the school-level variables tested, and more important than the 
presence of ED behaviours. 
There are several limitations to this study. Data on ED behaviours and diagnoses was 
available for ages 14 and 16, and these were combined in the predictor variable to increase 
sample size. This may dilute any effect of current AN on education. Across all variables 
in the analysis, including in the cross-tabulations of predictors and outcomes, there was a 
fair amount of missing data. This was addressed using multiple imputation procedures. 
The main finding from this study will inform my estimate of productivity losses associated 
with AN. Based on these analyses, there is no evidence of an impact of AN on GCSE 
attainment, nor evidence of an effect of bingeing and purging behaviours. No costs 
associated with lover attainment will therefore be included in the CoI estimate. 
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PART 2 – LONGER-TERM ECONOMIC OUTCOMES 
ASSOCIATED WITH ANOREXIA NERVOSA IN THE BCS-70 
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INTRODUCTION 
This section delves further into the indirect costs associated with AN and contributes 
towards answering RQ3: “What is the impact of AN on education, employment, income 
and related outcomes?”. To my knowledge, this is the first study of long-term economic 
outcomes in AN using UK cohort data. 
As described in Chapter 3, a common way of valuing productivity losses is to determine 
the amount of lost employment and applying a wage rate to estimate total productivity 
lost. I use BCS-70 data to investigate the association of self-reported AN with economic 
outcomes in adulthood, including employment and income to estimate excess 
unemployment and income forgone due to AN. This information can then be used to 
calculate productivity losses due to AN. 
The following hypotheses are tested: 
• Women with lifetime AN will have a lower chance of being in employment 
compared to women with no ED; 
• Women with lifetime AN will have a lower income (conditional on being in 
employment); 
• Women with lifetime AN will have a higher chance of being disabled and  
• Women with lifetime AN will have a higher chance of being in receipt of benefits. 
I describe those with AN and those without an ED in terms of their long-term economic 
outcomes and develop logistic regression and general linear models to estimate the effect 
of AN, controlling for a range of risk factors identified by Nicholls and Viner (2009) in 
the same dataset. 
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METHODS  
DATA 
The British Cohort Study (BCS-70) includes over 17,000 babies born in the UK in one 
week in April 1970 and is representative of the UK population. At the time the analysis 
was undertaken, data were available for seven sweeps up to age 38, so participants could 
be tracked well into adulthood. Use of the data is free of charge, and this study has been 
registered with the Economic and Social Data Service.  
PREDICTOR 
No formal diagnosis of ED is included in the BCS-70, but at age 29/30, there is a set of 
questions about self-reported lifetime ED, age of onset and type of ED.  
Table 6-12: Questions relating to eating disorders in the BCS-70 (age 29/30 sweep) 
Characteristic Coding 
Ever had eating problems Binary – no/yes 
Name of eating problem (up to 4 problems) 
Categorical: 
Bulimia or compulsive eating 
Anorexia nervosa 
Problems with swallowing 
Some other kind of eating problem 
Don’t know 
Age first had ED Scale variable 
Eating disorder in last 12 months Binary – no/yes 
Seen a doctor about ED in last 12 months Binary – no/yes 
 
From these data, it is possible to determine: 
• Lifetime ED: Whether the cohort member ever had an ED, and the type of ED 
(multiple EDs possible); 
• Age of onset of ED; 
• Current ED: Whether the cohort member had an ED in the last 12 months. 
• Whether the cohort member has seen a doctor about the ED in the last 12 
months. 
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The analysis presented here was modelled on a study by Nicholls and Viner (2009), who 
reviewed the literature on childhood risk factors for AN and reported whether these risk 
factors predicted self-reported lifetime AN in the BCS-70.  
I used the same case definition as Nicholls and Viner, comparing those with AN only 
(i.e., no other ED reported) to those with no self-reported ED. Participants were 
therefore included in this study if they had answered the question about lifetime ED at 
age 29/30 and either reported AN only (AN group) or no eating problems (comparison 
group).  
OUTCOMES 
The economic outcomes in adulthood considered in this analysis were related to 
education, employment and benefit receipt. Table 6-13 describes these outcomes and 
how they were coded for the analysis. With the exception of income (scale variable), 
outcomes were categorical variables in the original BCS-70 data and were re-coded as 
binary variables to ensure a sufficient number of participants with AN were available in 
each cell. These binary categories were developed in preliminary analyses of the outcome 
variables to ensure there were sufficient which is presented below. 
Table 6-13: Characteristics and coding 
Characteristic Coding 
Education outcomes  
High level of education, defined as having a degree (undergraduate or 
postgraduate qualification; 2004 sweep) 
Binary – 
no/yes 
Employment-related outcomes  
Participation in paid employment and other activities that build skills 
and human capital, e.g. participation in education and training. (2000 
sweep) 
Binary – 
no/yes 
Whether cohort member is an employee (2000 sweep) 
Binary – 
no/yes 
Whether cohort member is employed full-time (conditional on being 
employed; 2000 sweep) 
Binary – 
no/yes 
Whether cohort member is employed part-time (conditional on being 
employed; 2000 sweep) 
Binary – 
no/yes 
High social class (class I or II), based on occupation (conditional on 
being employed; 2000 sweep) 
Binary – 
no/yes 
Economic activity status is ‘sick’ or ‘disabled’ (2000 sweep) 
Binary – 
no/yes 
Self-reported weekly wage at age 29/30 (2000 sweep) 
Scale 
variable 
Benefit receipt  
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Characteristic Coding 
Income-related benefits: Whether cohort member receives income 
support, council tax benefit or housing benefit 
Binary – 
no/yes 
Family-related benefits: Whether cohort member receives child benefit 
or family tax credit not paid as lump sum 
Binary – 
no/yes 
CONFOUNDERS 
In developing the analytical approach, I used a recent paper looking at risk factors for 
AN in the BCS-70 (Nicholls & Viner 2009) as a starting point. This looked at risk factors 
identified in the literature and tested whether there was a significant relationship in the 
data. 
As much as possible, I replicated the coding used in the Nicholls & Viner analyses, 
informed by discussions with the authors and the researchers who conducted the analyses 
that were the basis for some of their coding choices. The variables and their coding are 
shown in table 6-13. 
Table 6-14: Characteristics and coding of confounders. 
Characteristic Coding 
Female sex Binary – no/yes 
Mother report of frequent feeding problems in first 6 
months (1975 sweep) 
Binary – no/yes 
Maternal psychological morbidity, defined as scoring 
>=7 on the Malaise Inventory18 (1975 sweep) 
Binary – no/yes 
Ever separated from mother for longer than one 
month (1975 sweep) 
Binary – no/yes 
Child BMI, defined as weight divided by height 
squared (1980 sweep) 
Categorical: 
Overweight – one SD or more 
above mean 
Normal weight – within one 
SD above or below mean 
Underweight – one SD or 
more below mean 
Under-eating age 10  
Self-esteem measured on LAWSEQ (Lawrence 1981) 
(1980 sweep) 
Categorical: 
High – one SD or more above 
mean 
Average – within one SD 
above or below mean 
Low – one SD or more below 
mean 
                                                 
18 https://www.ukdataservice.ac.uk/teaching-resources/malaise/background 
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Characteristic Coding 
Conduct and hyperactivity domains of the Rutter Scale 
(Rutter 1967), based on teacher report (1980 sweep) 
Categorical: 
High – one SD or more above 
mean 
Average – within one SD 
above or below mean 
Low – one SD or more below 
mean 
Attention problems domain of the Rutter Scale, based 
on teacher report (1980 sweep) 
Categorical: 
High – one SD or more above 
mean 
Average – within one SD 
above or below mean 
Low – one SD or more below 
mean 
 
Table 6-15 shows those predictors that were identified as being significant in univariate 
models: 
Table 6-15: Significant predictors of AN in the BCS-70 cohort (adapted from Nicholls & 
Viner 2009, p. 794) 
Predictor n 
Adjusted odds 
ratio* 
p 
Female sex 10,340 34.8 (8.0-143) <0.0001 
Report of frequent feeding problems in first 6 
months 
9,023 2.1 (1.32-3.7) 0.01 
Maternal psychological morbidity (Malaise 
Inventory high scorer >=7) 
9,036 2.1 (1.3-3.6) 0.004 
Separation from mother >1 month 9,150 2.5 (1.1-5.8) 0.04 
Child BMI Overweight >1 SD Age 10 (3 cats) 8,675 0.4 (0.2-1.1) 0.08 
Under-eating age 10 9,668 3.0 (1.5-6.6) 0.003 
Self-esteem high >=1SD above mean 8,408 0.7 (0.5-0.9) 0.02 
Conduct and hyperactivity problems teacher 
report >=1 SD above mean 
8,598 2.0 (1.0-4.0) 0.05 
Attention problems teacher report >=1 SD above 
mean 
8,276 1.9 (1.0-3.7) 0.06 
*Odds ratios adjusted for “sex, occupational class, maternal education at 5 or 10 years as appropriate, and 
occupational class at 30 years.” (Nicholls & Viner 2009, p. 794) 
Confounders to be included in a model should be associated with both treatment and 
outcome, and the literature on the BCS-70 suggests that this is the case for the variables 
identified as significant predictors of AN (Dearden et al. 2004; Knapp et al. 2011). 
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ANALYSIS APPROACH 
The Nicholls & Viner analysis showed female sex to be highly predictive of AN status. 
The literature on AN suggests that (maybe because male cases are so rare) treatment and 
outcomes for males tend to be very different to females, indicating that an analysis for 
males and females likely to be worthwhile – especially in the context of exploring 
variations in societal costs of AN. However, only 5 male participants with a self-reported 
lifetime AN were found in this sample. A decision was therefore made to exclude males 
from this analysis. 
Another issue to be considered was the choice of analytical approach. Nichols and Viner 
employed a multi-variate regression model (Cepeda et al. 2003). However, I was 
concerned about the potential for multicollinearity, given the relatively large number of 
binary and categorical variables on one hand, and the small number of cases in the AN 
group on the other hand. It has been suggested that in this situation, a propensity score 
can be calculated that is a summary indicator of the likelihood of an outcome being 
achieved, without needing to worry about overfitting the propensity score model 
(Shepherd 2001). 
The propensity score is calculated using a logistic regression model with the treatment 
allocation as the dependent variable. In this case, whether or not the cohort member 
reported AN vs no ED. The variables thought to be associated with both predictor and 
outcome are used as predictors. The model estimates 
𝑝(𝑥) ≝ Pr (𝑇 = 1|𝑋 = 𝑥), 
Where p(x) is the propensity score, T is the binary outcome variable and X are the 
confounders. This score is then used as a co-variate in in a second stage regression. 
I calculated a propensity score based on the risk factors for anorexia identified by Nicholls 
and Viner (see above). I attempted to use k-3 nearest neighbour matching, but matches 
could not be found for all participants in the AN group, further reducing the analysis 
sample. I therefore employed a simpler model, using the propensity score as a co-variate 
in logistic regression models to estimate the effects of AN on economic outcomes at age 
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29/30. This approach has been applied successfully to BCS-70 data before (Dearden et 
al. 2004) and reduces bias in the estimate of the treatment effect (D’Agostino 1998)., 
The models were estimated using the logit command in STATA v.12 (StataCorp. 2011) 
and STATA v. 14 (StataCorp 2015) with the  - vce(cluster) - option to reflect the clustering 
within individuals across several time points typical for longitudinal data. The difference 
in weekly income was estimated using a generalised linear specification with a gamma 
family and log link, as suggested by the Park test. 
MISSING DATA 
Missing data patterns in longitudinal data take a specific form and have received a lot of 
attention, both in epidemiology and in relation to, for example, clinical trials. 
Consequently, the development of multiple imputation procedures has led to their 
application to longitudinal data. Questions that arise are whether multiple imputation is 
in fact necessary (Twisk et al. 2013), whether outcomes (i.e. the dependent variable) should 
be imputed e.g. (Groenwold et al. 2012), and which imputation model is (structurally) the 
most appropriate (Ferro 2014). However, as discussed in the Chapter 3, imputation is 
generally preferred. 
Missing values imputed using chained equations and 20 imputations. The chained 
equations procedure was chosen because of the inter-relatedness of the various predictor 
variables. I tested relationships between predictors and constructed the imputation model 
accordingly. The imputation was performed prior to constructing the propensity score. 
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RESULTS 
SAMPLE 
At age 29/30, 11,261 cohort members were followed up. Information on eating problems 
is available for 11,211 (99.6%). Overall, 407 reported having had eating problems, and 
116 participants reported lifetime AN. Of these, 101 reported AN only. The proportion 
of males with AN was very small, with only 5 male participants reporting AN. 
Consequently, the AN group consists of 96 female participants reporting lifetime AN. In 
the comparison group (i.e. cohort members reporting no ED), there are 5,070 
participants.  
Descriptives are reported for the original (i.e. unimputed) data. The average age of onset 
was 17.82 years (SD 4.42, range 7-28) with a median of 17 and a mode of 18. Early onset 
anorexia (age of onset <13 years) was reported by 6 women. A large proportion (n=44) 
reported onset between 13 and 17, and 46 between 18 and 28. Figure 6-1 shows the 
distribution of age of onset.  
Figure 6-1: Distribution of age of onset of self-reported AN in the BCS-70 cohort 
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Of the 96 women, 22 had anorexia in the past 12 months. Of these women with a current 
ED, 13 had seen a doctor about the eating disorder. The average age of onset for this 
group was 20.0 years (SD 5.72). There were seven women with a current ED who 
reported age of onset at 23 years or older, i.e. report a duration of illness of 6 years or less 
and could therefore be considered to have a short-term experience of AN. The average 
age of onset for this group was 26.4 years (SD 1.72). Those with a current ED and age of 
onset younger than 23 years (n=14) reported an average age of onset of 16.8 (SD 3.95). 
Figure 6-2 shows the distribution of the cohort member’s father’s or mother’s 
occupational class at birth (of the cohort member), while Figure 6-3 shows the highest 
level of maternal education at age 5. 
Figure 6-2: Distribution of father’s or mother’s occupational class at CM birth 
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Figure 6-3: Level of maternal education at age 5 
 
ANALYSES OF OUTCOMES 
Unadjusted results 
This section shows simple comparisons in outcomes between the group with AN and the 
group without ED, i.e. not adjusting for the propensity score. 
The distribution of father’s or mother’s occupational class at birth of the cohort member19 
and level of maternal education at age 5 (considered to be relevant confounders) are 
shown in Figure 6-2 and Figure 6-3. There were no statistically significant differences 
between cohort members with and without self-reported AN. 
Education attainment 
Data on highest educational qualification is available at ages 30 and 34. Summary 
information (including age the participant left full-time education) is shown in Table 6-16 
and Table 6-17. The only significant difference is that those with anorexia left full time 
education at age 20, compared to age 18 among those with no anorexia.  
                                                 
19 Mother’s social class was used where the father’s was not available. 
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Table 6-16: Highest educational qualification at age 30 
 No ED Anorexia 
 Mean (SD) Range n Mean (SD) Range n 
Number of O-levels 6.09 (3.04) 0-15 2,490 6.57 (2.95) 0-12 42 
Number of CSEs 3.97 (2.89) 0-12 865 3.35 (2.80) 0-12 17 
Number of a-levels 2.65 (1.07) 0-7 1,083 2.38 (0.97) 1-4 24 
Age left full-time education* 18.71 (3.87) 14-34 4,504 20.0 (4.77) 15-34 77 
*Difference significant at the 95% level 
Table 6-17: Highest educational attainment at age 34 
  
No ED 
(n=4,500) 
Anorexia (n=77) 
 n % n % 
None 343 8% 9 12% 
CSE 675 15% 9 12% 
GCE/O-level/GCSE 1,479 33% 17 22% 
A/SSCE/AS 425 9% 7 9% 
Degree etc. 1,297 29% 28 36% 
Higher degree/PGCE 281 6% 7 9% 
 
As shown in Table 6-16 and Table 6-17, there are a lot of missing cases for these particular 
questions. Given the small numbers, data were plotted in a graph (see Figure 6-4), and 
visual inspection suggested that there may be differences between those with and without 
reporting anorexia in terms of those obtaining a highest qualification that is below and 
above A-levels (or equivalents). Please note that while line graphs are not usually an 
appropriate choice for these type of data, they were chosen because they effectively 
highlight differences between the two groups as the level of education increases. 
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Figure 6-4: Highest educational attainment age 34 
 
There were 1,578 (35%) in the comparison group with a degree or higher degree, and 34 
(45%) in the anorexia group. This difference was significant at the 90% level (p=0.058 
for Chi-square and p=0.071 for Fisher’s exact test). 
Employment status 
Employment status at age 29/30 was explored in a similar way. The original variable had 
12 categories, with very few people with anorexia in each cell. Table 6-18 shows the 
original variable, and the same variable recoded into  
• ‘Economically active’ vs not 
• Employed (full-time or part-time) vs other 
• Employed vs unemployed vs other 
This reflect different theoretical and practical distinctions. None of the distinctions 
showed a significant difference between those with and without AN. Those with anorexia 
were no more likely than those without to be in part-time employment (see Table 6-18). 
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Table 6-18: Employment status at age 29/30 
 
No ED 
(n=5,449) 
Anorexia 
(n=95) 
Category n % n % 
Full-time paid employment 2,647 49% 43 45% 
Part-time paid employment 1,150 21% 17 18% 
Full-time self-employed 153 3% 3 3% 
Part-time self-employed 87 2% 3 3% 
Unemployed seeking work 116 2% 0 0% 
Full-time education 73 1% 3 3% 
Government training scheme 5 0% 0 0% 
Temporarily sick/disabled 17 0% 0 0% 
Permanently sick/disabled 84 2% 10 11% 
Looking after home/family 1,030 19% 14 15% 
Wholly retired 1 0% 0 0% 
Other 86 2% 3 3% 
Not economically active 1,334 24% 27 28% 
Employed 4,037 74% 66 69% 
Full-time work 2,800 51% 46 48% 
Part-time work 1,237 23% 20 21% 
 
Employment-based occupational class 
Another possible impact beyond the probability of employment or working time is on 
choice of the type of job, which determines occupational class in some classification 
systems. As a result, data on occupational class is only for those who are in paid 
employment or self-employed. The breakdown is shown in Table 6-19. 
Table 6-19: Employment-based occupational class, age 29/30 
 
No ED 
(n=4,033) 
Anorexia 
(n=65) 
Category n % n % 
I - Professional 179 4% 3 5% 
II- Managerial – technical 1,430 35% 32 49% 
III.i - Skilled, non-manual 1,579 39% 17 26% 
III.ii - Skilled, manual 304 8% 4 6% 
IV - Partly skilled 451 11% 7 11% 
V - Unskilled 84 2% 2 3% 
Others 6 0% 0 0% 
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Figure 6-5 plots these data as a simple graph, showing potential differences in Class II 
and Class IIIn. Figure 6-6 shows the same data, but cumulates them over time. It appears 
that a useful cut-off might be after Class II. 
Figure 6-5: Occupational class at age 29/30 
 
Figure 6-6: Occupational class at age 29/30, cumulative 
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The proportion of those with anorexia (35/65) is Classes I and II is significantly greater 
(at the 95% level; add p-value) than for those without anorexia (1,609/4,033). 
Benefit receipt 
Benefit receipt at age 29/30 is detailed in Table 6-20. Given the large number of available 
benefits, the most commonly received benefits were pragmatically divided into income-
related benefits (income support, council tax benefit and housing benefit) vs family-
related benefits (child benefit, family tax-credit not paid as lump sum). Those with 
anorexia were more likely to receive income-related benefits, potentially pointing to a 
lower income. 
Table 6-20: Benefit receipt, age 29/30 
 
No ED 
(n=5,449) 
Anorexia 
(n=96) 
Category n % n % 
Statutory sick pay 32 1% 0 0% 
Child benefit 2,853 52% 48 50% 
JSA 110 2% 0 0% 
Income support* 444 8% 16 17% 
Family tax credit (non-lump) 391 7% 8 8% 
Family tax credit (lump sum) 35 1% 0 0% 
Council tax benefit 523 10% 13 14% 
Housing benefit* 536 10% 16 17% 
Maternity allowance 37 1% 0 0% 
Statutory maternity pay 102 2% 0 0% 
Income-related benefits* 780 14% 21 22% 
Family-related benefits 2,905 53% 48 50% 
*difference in proportion significant at 95% level 
 
Income 
Self-reported mean weekly income at age 29/30 was £298 for those with and £279 for 
those without AN, a non-significant difference. The income variables in the BCS-70 are 
problematic. While the data provider has promised to share a cleaned version of the 
variable in the near future, at the time of this analysis, only an ‘informal’ and incomplete 
fix was available. This fix is based on work by Lorraine Dearden and Alissa Goodman, 
who reviewed the earnings data in the BCS-70 and tried to address problems and 
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inconsistencies (Appendix 4 to Shepherd 2001). The results presented here are based on 
this fix, which its authors acknowledge is incomplete, and results relating to the income 
variable therefore need to be interpreted with caution. 
Multi-variate models 
Propensity score 
The result of the propensity score model is shown in Table 6-21. While the purpose of a 
propensity score model is not to maximise explained variance or to retain only significant 
co-variates in a final model, but to incorporate as much relevant information as possible, 
some large (significant) contributors to the chance of being in the AN group can be 
highlighted. Early Feeding problems, early separation from the mother and high maternal 
malaise scores are the largest contributors to an increased risk of being in the AN group, 
followed by high scores on the conduct problems and hyperactivity scale. High self-
esteem on the other hand is the largest contributor to a decreased risk of being in the AN 
group. 
Table 6-21: Propensity score model. 
 Coef. SE p-value 
Social class at birth    
• III 1.13 0.33 0.675 
• IV, V or other 1.19 0.45 0.633 
Maternal qualifications    
• Qualification – not degree 1.32 0.34 0.280 
• Degree 1.73 0.79 0.229 
Frequent feeding problems in first 6 months 1.74 0.47 0.041 
Separated from mother >1 month 1.76 0.80 0.216 
Under-eating 1.67 0.65 0.188 
Malaise Inventory    
• Low scorer 1.30 0.50 0.503 
• High scorer 1.87 0.53 0.027 
Child BMI category age 10    
• Low BMI 0.70 0.24 0.305 
• High BMI 0.64 0.26 0.277 
Maternal BMI 0.97 0.03 0.299 
Self-esteem    
250 
 
 
 
 Coef. SE p-value 
• Low self-esteem 0.81 0.26 0.505 
• High self-esteem 0.61 0.22 0.178 
Conduct problems and hyperactivity    
• Low scorer 1.01 0.53 0.992 
• High scorer 1.60 0.44 0.082 
Ethnicity 0.53 0.54 0.538 
 
Economic outcomes 
Table 6-22 shows economic outcomes in adulthood for those with and without AN. 
There is a statistically significant difference between those with and without AN for three 
of the eight outcomes. The statistically significant difference in income-related benefits 
reflects the higher probability of those with AN receiving income support (17% vs 8%) 
and housing benefit (17% vs 10%).  
Table 6-22: Overview of economic outcomes for people with and without anorexia, age 
29/30 or 34 
 No ED 
Anorexia 
(n=96) 
Category % Available n % Available n 
Degree vs not* 29% 5,449 35% 96 
Economically active vs not 76% 5,449 72% 96 
Employed vs other 74% 5,449 69% 96 
Full-time work vs not 51% 5,449 48% 96 
Sick/disabled vs not* 2% 5,449 10% 96 
Occupational class I or II vs lower* 40% 4,033 54% 65 
Receiving income-related benefit vs not* 14% 5,449 22% 96 
Family-related benefits vs not 53% 5,449 50% 96 
*Difference statistically significant at 95% level 
 
Table 6-23 shows the odds ratio for each of these outcomes, adjusting for AN risk factors 
(the propensity score). The only significant difference between those reporting AN and 
the group with no ED is that those with AN were 6.32 times as likely to be long-term 
sick or disabled. For those in employment, there was no difference in weekly income. 
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Table 6-23: Odds ratios for economic outcomes of anorexia, adjusted for propensity score 
Outcome Age measured Odds ratio (SE) p-value 
Long-term sick/disabled** 30 6.32 (2.33) <0.01 
Employed 30 0.75 (0.17) 0.19 
Occupational class I or II if employed 30 1.02 (0.36) 0.960 
Receives income-related benefits 30 1.30 (0.34) 0.31 
Has a degree 34 1.29 (0.53) 0.533 
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DISCUSSION 
The current evidence base on the economic circumstances of people with AN and the 
potential adult consequences of a severe disorder is small. This study is the first to look 
at the longer-term economic consequences of AN in England, and therefore adds 
considerably to the knowledge base in this area.  
While there were significant differences between those with AN and those with no ED 
in terms of the (unadjusted) proportion in employment, the proportion in a high social 
class if employed, the proportion receiving income-related benefits and the proportion 
with a degree, these differences did not carry through in the multi-variate analysis. In 
those surviving into adulthood, a lifetime occurrence of AN did not appear to affect 
employment prospects or wages – a similar finding to a study in the US that found no 
statistically significant impact of ED on chance of employment or wages (Samnaliev et al. 
2015). These findings highlight the need to adjust for potential confounders. 
One possible explanation for the lack of impact only those participants provide data who 
a) survive into adulthood and b) did not drop out of the cohort study, potentially due to 
the severity of their illness. This calls into question the missing at random assumption 
underlying the MI procedure. 
The advantage of using a cohort that is representative of the general population, rather 
than a ‘clinical’ sample recruited, for example, through specialist ED services, is that it 
does not capture just the top end (in terms of need) of the affected population. This could 
potentially disguise a significant result that might have been found if only those with a 
strict clinical diagnosis were considered. But while sometimes concerns are raised about 
the reliability of self-reported diagnoses, simple questions such as have been shown to be 
as good as more elaborate screening instruments in identifying ED in community samples 
(Keski-Rahkonen et al. 2006). 
Those with AN did have much higher odds of being sick or disabled (adjusted OR 6.32). 
While another study found that 35% of those with AN received benefits in a Canadian 
study (Su & Birmingham 2003), in this sample, only 10% were sick or disabled. 
Further work is needed to determine why AN does not appear to affect employment 
prospects in this cohort with high levels of disability. 
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CHAPTER SUMMARY 
The evidence for the impact of AN on economic outcomes is mixed. The studies 
presented here were the first to use the respective dataset to investigate productivity-
related outcomes in adulthood for people with AN. In summary, the studies showed that: 
• There was no impact of AN on GCSE attainment. 
• There was no interaction between AN and absences. 
• The presence of bingeing/purging behaviours did not alter these relationships. 
• Those with AN were not more likely to be unemployed. 
• They were not more or less likely to be in a higher occupational class (classes I or 
II) if employed. 
• They were more likely to be long-term sick or disabled. 
• They were not more likely to receive income-related benefits. 
• There was no difference in weekly wages for those in employment. 
These findings are broadly in line with the existing literature. A previous study from 
Finland did not find an impact of AN on education in the long term (Keski-Rahkonen et 
al. 2007). In contrast to these findings, a sample with AN was found to have a higher 
chance of having a degree (Hjern et al. 2006). The same study showed the rate benefits 
receipt to be high, as was the chance of disability in a Canadian study (Su & Birmingham 
2003). Finally, a recent US study found no impact of AN on the likelihood of employment 
or on wages (Samnaliev et al. 2015). 
These findings will be used in Chapter 8 to inform the CoI estimate of AN: If no impact 
on education, employment or wages can be found, no costs should be included, as there 
will be no impact on productivity. However, there was a significant impact on disability, 
which will be explored in terms of costs to the public sector and in terms of productivity. 
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CHAPTER 7  
Intangible costs: Years of Potential Life Lost 
from Anorexia nervosa 
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CHAPTER INTRODUCTION 
This chapter shows disease modelling results estimating the annual prevalence and case 
fatalities from AN for England and therefore contributes to answering RQ4: “What is 
the loss of life associated with AN in England?” 
While many studies have estimated the prevalence of AN, most focus on at risk 
populations because general population studies typically find few cases of AN (Solmi et 
al. 2016). This makes it difficult to obtain an empirical prevalence figure for AN. 
I use the DisMod-II disease modelling software to combine information on the English 
population (distribution, mortality rate) and information on AN (incidence, duration of 
illness and SMR) to estimate prevalence by 5-year age group and case fatalities. I apply 
the method suggested by Harbottle and colleagues (Harbottle et al. 2008) to English data 
to estimate the life expectancy of women with AN at various ages of onset. I calculate 
years lived with disability (YLD) and Years of Potential Life Lost (YPLL) and discount 
them to age of onset so that a monetary value to calculate intangible costs associated with 
AN can be applied in Chapter 8. 
A previous iteration of this study was recently published (Schmidt et al. 2017). I have since 
updated the model and provide two additional scenarios, exploring the impact of a) a 
higher incidence to reflect the population not in contact with health services and b) a 
lower mortality rate to simulate more effective treatments. 
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METHODS 
DISMOD-II MODEL 
The DisMod-II software (Barendregt et al. 2003) is publicly available and contains a set 
of equations for a simple disease model. The equations relate the following disease 
parameters to each other: 
• Incidence 
• Prevalence 
• Case fatality 
• Time to remission 
At least three of the above are required as inputs to generate the remaining as model 
outputs. In addition, information on the underlying population (number of people, all-
cause mortality) are required to populate the model. The software allows the user to 
estimate a more complete picture of a disease where full information is not available. 
POPULATION DATA 
Data on the English population was drawn from the Office for National Statistics mid-
year estimate for 2011. Given the lack of data on AN in males, only data on females were 
used. 
INCIDENCE 
Incidence rates for females were entered in 5-year age groups, based on the most recent 
estimate from an analysis of the GPRD by Micali (2013), as rates per 100,000.  
MORTALITY RATE AND SMR 
The general population mortality rate between age x and age x+1 was taken from National 
Life Tables (ONS) for 2010-2012. The SMR for AN of 5.86 was taken from a review of 
36 studies (Arcelus et al. 2011).  
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LIFE EXPECTANCY IN AN 
Life expectancy at ages 10-100 was calculated by applying the SMR for anorexia to the 
mortality rate for England. Applying the method for constructing life tables provided by 
the ONS, the number of deaths at each age was calculated by multiplying the mortality 
rate by the population. Life expectancy at each age was then calculated by first calculating 
years alive at each age, then summing years alive from age x to the oldest age (in this case, 
100), and dividing this by the population at age x. Full details of the calculations can be 
found in Chapter 3. 
DURATION OF ILLNESS 
In a widely cited study by Herzog and colleagues (1997), 50% of those admitted to 
hospital for AN recovered after 6 years. This input parameter was used for the median 
duration of ED. 
SCENARIO ANALYSIS 
To model the impact of unmet treatment need on mortality, I re-ran the base scenario 
but doubled the incidence rate. In a second variation, I assumed that mortality from 
medical complications is reduced by 50%, i.e. an overall reduction of 25%. 
YEARS OF POTENTIAL LIFE LOST AND YEARS LIVED WITH DISABILITY 
YPLL were calculated for the age of onset within each 5-year age group (by first 
determining whether a person with age of onset at age x was alive or not alive at a given 
future age up to 82, based on life expectancy at age x. Future YPLL were discounted to 
age of onset, using a discount rate of 3.5%. 
Years lived with disability were calculated by multiplying the model output for duration 
of illness for each five-year age group by the number of incident cases in that age group. 
Future years lived with disability were discounted to age of onset, using a discount rate of 
3.5%. 
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RESULTS 
OVERVIEW OF SCENARIOS 
Table 7-1 shows the results of the DISMOD II analysis, estimating a prevalence of 
approximately 13,000 cases and an incidence of ca. 2,000 new cases in the base scenario. 
The largest proportion of cases is at ages 20-24 (21%), given that most cases have their 
onset between ages 15-19. Table 7-2 and Table 7-3 show the same information for the 
two additional scenarios. 
PREVALENCE RATE 
The prevalence rate for the three scenarios is plotted in Figure 7-1. The high incidence 
scenario doubles prevalence. The highest prevalence is found between age 20-24, given 
that the highest incidence rate is in the age 15-19 age group. 
Figure 7-1: Estimated prevalence per 100,000, three scenarios 
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Table 7-1: Prevalence, morbidity and mortality for AN in England, base case 
Age group Incidence per 100k 
Number new 
cases 
Prevalence per 100k 
Total 
cases 
% of total 
cases 
Duration of 
illness 
Age of 
onset 
Case 
fatalities 
10-14 21.5 322 31.6 474 4% 4.5 13 0 
15-19 44.5 722 117.5 1,907 15% 5.4 18 2 
20-24 23.3 415 150.6 2,681 21% 6.6 22 4 
25-29 17.7 324 128.0 2,344 18% 7.6 27 4 
30-34 5.6 99 103.7 1,830 14% 8.5 31 5 
35-39 2.5 44 63.6 1,124 9% 9.4 38 5 
40-44 1.5 29 45.7 896 7% 9.7 42 6 
45-49 1.0 19 33.3 655 5% 8.9 47 7 
50-54 0.5 8 23.5 405 3% 8.0 53 6 
55-59 0.4 6 16.0 243 2% 7.3 57 6 
60-64 0.3 5 9.6 155 1% 5.7 64 6 
65-69 0.4 5 6.8 89 1% 5.1 66 5 
70+ 0.2 12 3.5 73 1% 3.4 74 12 
All ages 7.5 2,036 47.8 12,899 100% 6.1 22 69 
 
Table 7-2: Prevalence, morbidity and mortality for AN in England, high incidence case 
Age group Incidence per 100k 
Number new 
cases 
Prevalence per 100k 
Total 
cases 
% of total 
cases 
Duration of 
illness 
Age of 
onset 
Case 
fatalities 
10-14 43.0 644 63.2 946 4% 4.5 13 1 
15-19 89.1 1446 235.2 3,818 15% 5.4 18 5 
20-24 46.6 830 301.5 5,368 21% 6.6 22 7 
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Age group Incidence per 100k 
Number new 
cases 
Prevalence per 100k 
Total 
cases 
% of total 
cases 
Duration of 
illness 
Age of 
onset 
Case 
fatalities 
25-29 35.4 648 256.3 4,694 18% 7.6 27 9 
30-34 11.3 199 207.7 3,664 14% 8.5 31 10 
35-39 4.9 87 127.3 2,249 9% 9.4 38 9 
40-44 3.0 59 91.6 1,794 7% 9.7 42 12 
45-49 2.0 39 66.6 1,310 5% 8.9 47 14 
50-54 0.7 12 46.7 806 3% 8.1 52 12 
55-59 0.4 6 30.1 456 2% 7.3 57 11 
60-64 0.3 5 17.6 283 1% 5.8 64 11 
65-69 0.4 5 11.0 144 1% 5.1 67 9 
70+ 0.2 12 5.4 100 0% 3.4 74 15 
All ages 15.0 4,033 95.1 25,665 100% 6.2 22 126 
 
Table 7-3: Prevalence, morbidity and mortality for AN in England, low mortality case 
Age group Incidence per 100k 
Number new 
cases 
Prevalence per 100k 
Total 
cases 
% of total 
cases 
Duration of 
illness 
Age of 
onset 
Case 
fatalities 
10-14 21.5 322 31.7 474 4% 4.5 13 0 
15-19 44.5 722 117.6 1,909 14% 5.4 18 1 
20-24 23.3 415 150.9 2,687 20% 6.7 22 1 
25-29 17.7 324 128.6 2,354 18% 7.8 27 2 
30-34 5.6 99 104.6 1,844 14% 8.8 31 2 
35-39 2.5 44 64.6 1,142 9% 10.0 38 2 
40-44 1.5 29 47.0 921 7% 10.5 42 2 
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Age group Incidence per 100k 
Number new 
cases 
Prevalence per 100k 
Total 
cases 
% of total 
cases 
Duration of 
illness 
Age of 
onset 
Case 
fatalities 
45-49 1.0 19 34.9 686 5% 9.9 47 3 
50-54 0.5 8 25.4 437 3% 9.2 53 3 
55-59 0.4 6 18.1 275 2% 8.6 57 3 
60-64 0.3 5 11.8 191 1% 7.2 64 3 
65-69 0.4 5 9.0 118 1% 6.7 66 3 
70+ 0.2 12 5.6 131 1% 4.9 74 10 
All ages 7.5 2,035 48.9 13,195 100% 6.3 22 35 
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TOTAL CASES 
Similarly, total cases are highest in the high incidence scenario (see Error! Not a valid 
bookmark self-reference.), and slightly higher in the low mortality scenario  
Figure 7-2: Total cases, three scenarios 
 
MORTALITY RATE 
Figure 7-3 plots mortality rates. The impact of higher incidence while constraining other 
parameters means that the mortality rate has to adjust in the high incidence scenario. 
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Figure 7-3: Mortality rate, three scenarios 
 
CASE FATALITIES 
Finally, Figure 7-4 shows case fatalities. In the base scenario, there are an estimated 69 
fatalities per year. 
Figure 7-4: Case fatalities, three scenarios 
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DURATION OF ILLNESS 
Duration of illness was modelled to retain the average of around six years, while also 
reflecting a likely shorter duration in the case of a younger age of onset. Here, we see the 
impact of the lower mortality rate, which - all else being equal – leads to a longer duration 
of illness (see Figure 7-5). 
Figure 7-5: Duration of illness, three scenarios 
 
YEARS OF POTENTIAL LIFE LOST 
Table 7-4 shows estimated life expectancy and average YPLL by age of onset. Combining 
the results of the base case with an analysis by Harbottle & Birmingham (Harbottle et al. 
2008) and recent projections for life expectancy in England, I estimate that 6,000 life years 
are lost to AN each year (discounted to present value; see Table 7-5). The present value 
of YPLL across all age groups is on average 3 years. As expected, for the low mortality 
scenario, the estimate is halved, while it is doubled for the high incidence scenario.
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Table 7-4: Life expectancy and YPLL 
Age Chance of death age x Life expectancy age x YPLL for AN onset age x 
10 0.0004 55.0 17.8 
11 0.0005 54.0 17.8 
12 0.0006 53.1 17.8 
13 0.0005 52.1 17.8 
14 0.0007 51.1 17.7 
15 0.0008 50.2 17.7 
16 0.0010 49.2 17.7 
17 0.0012 48.2 17.6 
18 0.0012 47.3 17.6 
19 0.0014 46.4 17.6 
20 0.0013 45.4 17.5 
21 0.0014 44.5 17.5 
22 0.0013 43.5 17.4 
23 0.0015 42.6 17.4 
24 0.0014 41.7 17.3 
25 0.0016 40.7 17.3 
26 0.0017 39.8 17.2 
27 0.0020 38.8 17.2 
28 0.0020 37.9 17.1 
29 0.0020 37.0 17.1 
30 0.0023 36.1 17.0 
31 0.0024 35.2 17.0 
32 0.0027 34.2 16.9 
33 0.0029 33.3 16.8 
34 0.0032 32.4 16.8 
35 0.0036 31.5 16.7 
36 0.0038 30.6 16.6 
37 0.0041 29.8 16.5 
38 0.0045 28.9 16.4 
39 0.0047 28.0 16.3 
40 0.0055 27.1 16.2 
41 0.0061 26.3 16.1 
42 0.0063 25.4 16.0 
43 0.0070 24.6 15.9 
44 0.0078 23.8 15.8 
45 0.0084 23.0 15.6 
46 0.0093 22.1 15.5 
47 0.0096 21.3 15.4 
48 0.0107 20.5 15.2 
49 0.0119 19.8 15.1 
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Table 7-5: Reduction in life expectancy and present value of YPLL 
Age 
group 
Age of 
onset 
New 
cases 
Reduction in life 
expectancy 
Present value 
YPLL 
10-14 13 322 17.77 735 
15-19 18 722 17.61 1,957 
20-24 22 415 17.42 1,196 
25-29 27 324 17.19 1,109 
30-34 31 99 16.96 359 
35-39 38 44 16.42 203 
40-44 42 29 16.02 154 
45-49 47 19 15.37 101 
50-54 53 8 14.37 52 
55-59 57 6 13.52 37 
60-64 64 5 11.78 28 
65-69 66 5 11.24 26 
70+ 74 12 8.80 38 
Total  2,010  5,995 
 
YEARS LIVED WITH DISABILITY 
Years lived with disability is closely related to duration of illness, but is shown here to 
include discounting of future years of life. As with duration of illness, years lived with 
disability is not affected by assumptions about incidence, but is increased by assuming a 
lower mortality rate for AN (see Figure 7-5). The total number of years lived with 
disability (discounted to present value) in the base case is 47,131, with 48,460 in the low 
mortality case. The small difference in estimates arises from the distribution of age of 
onset, where incident cases are more likely to fall into age brackets with shorter durations 
of illness. 
267 
 
 
 
Figure 7-6: Years lived with disability, three scenarios 
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DISCUSSION AND SUMMARY 
In this short chapter, I present the results of a disease modelling study with the aim of 
calculating life years lost from AN in England. I then apply a valuation and discount to 
present value to obtain an estimate of the annual intangible costs associated with AN. 
This estimate will be combined with estimates of direct costs and indirect costs to 
calculate the CoI of AN in England. 
In the base case, 
• New cases per year are estimated at 2,036; 
• Prevalence is estimated at 48.9 cases per 100,000; 
• Total cases are estimated at 12,895; 
• Fatalities are estimated at 69 per year; 
• The reduction of life expectancy is up to 17 years; 
• The total present value of YPLL is around 6,000; 
• The total present value of YLD is around 47,000. 
While the incidence figure is based on the most recent estimate available and therefore 
rooted in the literature, although it is lower than incidence figures derived from 
calculations based on incidence rates for the population as a whole. In contrast, the King’s 
Fund estimated that in 2007, here were nearly 27,000 people with AN.  
The scenarios reflecting a) higher incidence and b) lower mortality illustrate that changing 
any one parameter will alter the model to accommodate this change. Given that incidence 
is fixed and even a large reduction in SMR does not seem to affect prevalence by much, 
it is possible that the estimate of duration of illness – around six years – is too low. The 
low mortality scenario also illustrates how a lower mortality rate can increase duration of 
illness. While mortality is avoided, the number of years lived with an illness will be higher. 
This small study aimed to produce an estimate of prevalence, life years lost and years lived 
with disability. 
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CHAPTER 8  
The annual costs of Anorexia nervosa to 
English society, 2010/11 
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CHAPTER INTRODUCTION 
This chapter pulls together information from the preceding empirical chapters (Chapters 
4-7) to estimate the annual societal costs of AN for England. The chapter draws on data 
collected alongside the various RCTs from the ARIADNE programme, the Care 
Pathways Study, the analyses of BCS-70 data as well as publicly available data and 
parameters from the literature review. 
Previous estimates of the cost of AN in England have adopted a perspective limited to 
the cost of inpatient care (Office of Health Economics 1994) or relied on assumptions 
drawn from international cost estimates when it comes to estimating the costs of 
outpatient treatment (King’s Fund et al. 2008).  
More recently, the charity ProBono Economics estimated the annual cost of EDs to be 
between £1.26 and £9.6 billion (ProBono Economics 2012). This estimate does not 
distinguish between different types of ED and is to a large extent based on the previous 
work by the King’s Fund (2008). It includes a burden of disease figure associated with 
disability from AN of £950m in the lower-cost scenario, so that approximately £80m are 
due to increased health care costs and £230m due to productivity losses. 
The study presented here endeavours to address some of the shortcomings of previous 
estimates. A particular gap was the lack of data on the costs of outpatient treatment. In 
the context of a shift in the focus of treatment from inpatient towards outpatient 
treatment, this was a significant blind spot. Providing estimates from English data reduce 
the reliance on international figures, which allows me to better reflect the English health 
care context. This is important because as we have seen, service consumption such as 
length of stay can vary significantly between countries, and it is reasonable to assume that 
the ratio of inpatient to outpatient costs will vary as well. 
 There is no single data source that would allow the calculation of a cost-of-illness for 
AN. In particular, there is a paucity of data on the short- and longer-term patterns of 
service use and associated costs. It is common in economic analyses to make use of 
modelling techniques to synthesise and analyse evidence from various different 
sources(Philips et al. 2004). Use of modelling approaches allows for evidence to be 
synthesised so that CoI studies are possible even for conditions with low prevalence 
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because gaps in the evidence, and uncertainties arising from small sample sizes can be 
addressed by the use of sensitivity analysis. 
In this chapter, I present a ‘conservative estimate’ based on publicly available data that 
provides a touch stone for comparisons with previous estimates, and a ‘high estimate’ 
incorporating additional potential costs where assumptions and recourse to non-routine 
data sources were necessary. Given the limited availability of reliable data sources, I have 
combined top-down estimates (breaking down total figures to arrive at a per-case figure) 
and bottom-up estimates (starting with the individual case and aggregating up). Judging 
by my review of the existing literature, this study is the most comprehensive estimate of 
the costs associated with AN in England to date. 
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METHODS 
LITERATURE AND DATA REVIEW 
A literature and data review was performed at the outset of the project to identify known 
costs of AN, and any gaps in the existing research.  
I reviewed available datasets to identify potential sources of parameters for the cost of 
illness estimate. This included routine datasets and large population surveys. 
In particular, I searched for sources of data on: 
• Incidence of AN and related disorders for England; 
• Detection rates in primary care; 
• Referrals to secondary/tertiary care; 
• Care pathways; 
• Treatments provided for AN; 
• Service use; 
• Economic outcomes, including education attainment, employment and income. 
Where no current figures for England were available, estimates from the studies presented 
in this thesis were used, and several of the studies (see Chapters 6 and 7) were designed 
specifically to address gaps in the data. 
Any remaining gaps were filled using parameters from a literature search. This search had 
several elements, and formed the basis of Chapter 2 as well as this CoI estimate: 
• A scoping search on PubMed; 
• Snowball search from recent key publications, such as the NICE guidance 
documents on eating disorders, and the most recent review of cost-of-illness 
studies available; 
• Search of indexes of key journals (International Journal of Eating Disorders and 
European Eating Disorders Review); 
• Expert consultation with colleagues at the IoP and KCL; 
• Grey literature searches using the Google search engine. 
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Following this initial search, a PubMed alert was set up to monitor new publications with 
the keywords anorexia and eating disorder in the abstract or title. 
SENSITIVITY ANALYSIS 
To address the uncertainty arising from the fact that data from different sources are 
combined, and the uncertainty surrounding individual parameters, perform deterministic 
sensitivity analysis by presenting two scenarios:  
• A ‘conservative estimate’, based on publicly available data sources such as the 
Hospital Episode Statistics (HES) and data on benefit receipt from the 
Deportment for Work and Pensions (DWP). Productivity losses are based on 
DWP claimants data. The approach of using publicly available data means that 
this estimate is (to some extent) comparable to previous work by The King’s Fund 
(2008) and ProBono Economics (ProBono Economics 2012). 
• A high cost estimate’ that incorporates assumptions and parameters from the 
literature and data from studies that were part of the ARIADNE programme to 
account for other potential costs that may not be reflected in the publicly available 
data. This ‘high cost estimate’ includes potential additional admissions and 
outpatient contacts due to AN recorded under different diagnoses, family 
expenditure on private sector inpatient provision (either out of pocket or funded 
by insurance), estimates of A&E visits and primary care costs. 
Additionally, productivity losses are calculated from estimated lost earnings associated 
with disability based on  
• DWP claimants data and 
• An estimated number based on results from Chapter 6. 
Finally, estimated losses associated with Years Lived with Disability (YLD) are calculated 
for possible valuations of a year at full health of £15,000, £20,000 and £30,000. 
Therefore, I present two scenarios each for service costs and productivity losses, and 
three scenarios for losses associated with loss of life and reduction in quality of life. 
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DATA SOURCES 
PREVALENCE OF AN 
The likely prevalence of AN by age group was estimated based on the most recent analysis 
of incidence in the General Practice Research Database (Micali et al. 2013) and parameters 
for the average duration (Steinhausen 2009) and mortality rates from AN based on a 
review of the recent literature (Arcelus et al. 2011) using the freely available DISMOD II 
software (Barendregt et al. 2003). These results are presented in Chapter 7. 
PRIMARY CARE COSTS 
The conservative estimate of primary care costs draws on estimates from the ProBono 
Economics report (ProBono Economics 2012), which combined information on the 
number of GP contacts by patients with AN presented by NICE (National Institute for 
Clinical Excellence 2004) – in turn based on the Third National Survey of Morbidity in 
General Practice – and a prevalence estimate for AN to arrive at a figure of three GP 
visits per year for each prevalent case of AN. Little is known about the service use of 
people with AN prior to entering treatment, but there is some evidence on elevated 
service use up to five years prior to diagnosis (Lask et al. 2005; Ogg et al. 1997). For the 
higher cost estimate, this study draws on baseline information from the three trials 
presented in Chapter 5 to estimate a plausible range of primary care costs (GP services, 
nurses, dieticians) incurred prior to an inpatient admission or outpatient treatment. Where 
treatment is provided exclusively in primary care, it is assumed that each person is in 
contact with their GP three times per year, as in the conservative estimate. National unit 
costs for GP visits were applied (Curtis 2011). 
SECONDARY AND TERTIARY CARE 
The Hospital Episode Statistics (HES) provides information on admissions to NHS 
hospitals in England and outpatient treatment in hospitals. Summary data are routinely 
published on an annual basis, so that no analysis of HES data was undertaken for this 
thesis. Classification is based on ICD-10 diagnostic codes. Summary data are publicly 
available by primary diagnosis, and since 2013/14 also by all diagnosis, i.e. including 
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additional diagnoses. It includes non-residents treated in English hospitals and private 
patients treated in the NHS. 
 HES include data on the number of inpatient, outpatient and A&E contacts at NHS 
hospitals in England (HESonline 2011). The proportion of cases treated primarily on an 
inpatient and outpatient basis were calculated by combining HES data with the prevalence 
estimate (number of cases) and information from the literature review as follows: I 
assume that around a third of AN cases are treated exclusively in primary care (Currin et 
al. 2006). Based on the number of episodes recorded in HES, I estimate that around 11% 
of prevalent cases are treated as inpatients each year. This suggests that 56% are treated 
primarily on an outpatient basis. 
COST OF INPATIENT AND OUTPATIENT TREATMENT 
The number of inpatient admissions, number of bed days and outpatient contacts 
recorded under a primary diagnosis of AN were obtained from the publicly available data 
from the Hospital Episode Statistic for 2010/1120 and the Special Interest Topic on ED 
for the same year (HESonline 2011). Since a detailed breakdown by age was not available, 
the ratio of adult (63%) to child (37%) of Finished Consultant Episodes (FCEs) from the 
Special Interest Topic report was applied when costing inpatient stays. This served as a 
lower-bound estimate for inpatient costs because admissions that are causally related to 
AN may not be recorded under a primary diagnosis of AN, but under the primary 
presenting problem such as cardiac problems. To obtain a higher bound estimate, the 
ratio of costs for medical inpatient admissions to ED admissions from the Care Pathways 
Study was applied. The higher estimate also includes potential additional outpatient care 
costs, based on the ratio of the costs of ED-related and medical outpatient appointments 
to ED inpatient costs from the Care Pathways Study, across all three pathways (38% and 
27%, respectively). This includes treatment provided in community settings. An ad-hoc 
analysis of data relating to patients treated in the private sector (also from the Care 
Pathways Study) indicates that outpatient treatment makes up a much smaller proportion 
of costs than in the public sector. I therefore apply this additional cost only to NHS beds 
(51% of ED inpatient costs). 
                                                 
20 Note that this was not an analysis of individual-level HES data. 
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COST OF INDEPENDENT SECTOR PROVISION 
The likely cost to the NHS of inpatient treatment provided by the independent sector, 
and additional costs of privately funded treatment are calculated based on the assumption 
that 49% of ED beds are provided by the private sector (Royal College of Psychiatrists 
2012), and 90% of independent beds are NHS funded (O’Herlihy et al. 2003b). The 
remaining 10% were assumed to be funded privately or through private insurance. 
BENEFIT RECEIPT 
Social security benefit payments made to people due to ED were obtained from the 
Department for Work and Pensions. There were on average 810 female claimants of 
Employment Support Allowance (ESA) for ED per quarter, with an average weekly 
amount of £90.25. Incapacity Benefit (IB) or Severe Disablement Allowance (SDA) was 
paid to 1,308 females each quarter, with a weighted average weekly amount of £56.04. As 
the statistic does not distinguish between different EDs, I assumed that the proportion 
of benefits paid to people with AN corresponded to the proportion of ED admissions 
for AN in HES (71% of FCEs). For the high cost scenario, the number of people 
receiving benefits for AN were estimated based on the finding from my analysis of the 
BCS-70 (see Chapter 6) that showed people with AN to be 6.3 times as likely to be 
disabled in adulthood. This resulted in 824 claimants for ESA and 2,399 for IB or SDA.  
LOST PRODUCTIVITY 
Lost productivity from an increased risk of disability (see Chapter 7) was calculated based 
on the number of claimants as above. For those claiming ESA, the amount forgone was 
calculated as the difference between median full time and median part time annual wages 
for females, while for those on IB and SDA, it was calculated as the median full-time 
wage from the Annual Survey of Hours and Earnings (ASHE, table 1.7a). Assumptions 
for discounting to present value were an average age of women with AN of 26, based on 
my prevalence calculations (see Chapter 7), and a retirement age of 62.3. This was adjusted 
for the average probability of unemployment for women, the average between the 
estimate from the Census and the Labour Force Survey of 4.1%. Lost earnings for 
someone claiming ESA is therefore estimated at £13,892, and for someone claiming IB 
or SDA at £22,492. 
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YEARS LIVED WITH DISABILITY AND YEARS OF POTENTIAL LIFE LOST  
YLD and YPLL were calculated based on based a survival analysis by Harbottle and 
colleagues (2008), an average life expectancy of 82 a standardised mortality rate of 5 and 
a discount rate of 3.5%. YPLL were valued at £30,000 (with sensitivity values of £15,000 
and £20,000), and a 46% reduction was applied to account for the likely disability weight 
of AN. Details on the methods and full results of the disease modelling study used to 
generate these data can be found in Chapter 7. 
OVERVIEW OF PARAMETERS AND ASSUMPTIONS 
Table 8-1 provides an overview of parameters and assumptions for the ‘conservative’ and 
the ‘high’ estimate.
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Table 8-1: Parameters and assumptions used in the CoI estimate 
Parameter Assumptions conservative estimate Assumptions high estimate 
ED inpatient costs children 1,370 admissions for females with AN (HESonline 2011) (71% of 
ED admissions, HESonline 2011)  
Average length of stay 55.1 days (HESonline 2011)  
37% of FCEs for AN in people < age 18 (HESonline 2011)  
Unit costs: £473 adults, £491 children 
Additionally: 
Medical inpatient costs were 29% of ED inpatient 
costs (Care Pathways Study; Chapter 5) 
ED inpatient costs adults 
Private sector NHS funded N/A 
90% of independent beds are NHS funded 
(O’Herlihy et al. 2003b) 
Privately funded treatment N/A 
• 49% of beds provided by the independent 
sector (Royal College of Psychiatrists 2012) 
• 90% of independent beds are NHS funded 
(O’Herlihy et al. 2003b)  
Outpatient costs children 110 first appointments (HESonline 2011)  
8,025 subsequent appointments (HESonline 2011)  
78 telephone appointments (HESonline 2011)  
Unit costs:  
• Ratio: Outpatient costs due to ED are 38% of 
inpatient costs (Care Pathways Study) 
• Ratio: Medical outpatient sessions are 27% of 
inpatient costs (Care Pathways Study) 
Outpatient costs adults 
A & E N/A 
Distribution of treatment assumption from A&E 
contacts in CASIS and MOSAIC: 
• 32% of later inpatients with average 2.5 
contacts for ED 
• 19% of later outpatients with average 1.8 
contacts for ED 
Primary care 
3 GP visits per person with AN (prevalence based, from ProBono 
Economics 2012) 
Unit costs:  
Distribution of treatment assumption (Currin, 
Schmidt et al. 2006, HESonline 2011) 
GP (CASIS, MOSAIC): 
• 86% of later inpatients, average 8.9 contacts 
• 88% of later outpatients, average 6.2 contacts 
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Parameter Assumptions conservative estimate Assumptions high estimate 
Nurse (CASIS, MOSAIC): 
• 46% of later inpatients, average 11.3 contacts 
• 56% of later outpatients, average 6.2 contacts 
Dietician (CASIS, MOSAIC):  
• 6% of later inpatients, average 6.4 contacts 
• 8% of later outpatients, average 6.4 contacts 
Productivity losses 
£13,892 per ESA claimant 
£22,492 per IB or SDA claimant 
Discount rate 3.5% 
Unemployment rate 4.2% 
• £13,892 per ESA claimant 
• £22,492 per IB or SDA claimant 
• Discount rate 3.5% 
• Unemployment rate 4.2% 
Years Lived with Disability and 
Years of Potential Life Lost 
N/A 
Disease modelling Chapter 7, following (Harbottle 
et al. 2008)  
• Mortality and life expectancy for AN based on 
ONS data 
• SMR anorexia 5.68 (Arcelus et al. 2011)  
• Discount rate 3.5% 
• Value per life year £30,000 (sensitivities: 
£15,000, £20,000)  
• Disability weight 0.54 (Kruijshaar et al. 2005)  
Benefit receipt (transfer 
payments) 
Proportion of benefit claimants attributable to AN vs other ED is 
the same as the proportion of ED admissions due to AN (71%,) 
Employment & Support Allowance (ESA); DWP data: 
810 claimants per quarter 
Average weekly amount £90.25 
Incapacity Benefit (IB)/Severe Disability Allowance (SDA); DWP 
data: 
1,308 claimants per quarter 
Average weekly amount £56.04 
• Odds ratio of disability is 6.3 for women with 
AN (BCS-70 study) 
• Female population of England is 26.97m (ONS 
figures) 
ESA, from DWP data:  
• 299.6k claimants per quarter  824 claimants 
with AN 
• Average weekly amount £76.75 
IB/SDA from DWP data:  
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Parameter Assumptions conservative estimate Assumptions high estimate 
• 850.3k claimants per quarter 2,399 claimants 
with AN 
• Average weekly amount £57.39 
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RESULTS 
Table 8-2 shows the results of the low and high estimates for 2010/11 by type of cost 
(direct, indirect, intangible or transfer payment) and cost category. 
Table 8-2: Conservative and high estimate of the annual costs of AN in England (2010/11 
prices) 
Type of cost Cost category Conservative* High* 
Direct costs 
ED inpatient adults £20,900,000 £27,000,000 
ED inpatient children £12,700,000 £16,300,000 
Private sector NHS funded £0 £14,800,000 
Privately funded £0 £1,600,000 
Outpatient adults £900,000 £13,700,000 
Outpatient children £600,000 £8,100,000 
A&E £0 £400,000 
Primary care £5,000,000 £7,000,000 
Indirect costs Productivity £40,700,000 £65,700,000 
Intangible costs YPLL £0 £97,100,000 
Transfer payments Benefits £4,900,000 £10,400,000 
*Rounded to nearest 100k 
Between the conservative and the high estimate, there is a £6 million difference between 
the estimates for adults, and over £3 million for children. But the difference in the cost of 
outpatient treatment is ever more striking, with £11.8 million for adults and £7.5 million 
for children. As a percentage change, the difference in productivity losses is relatively small, 
at a multiple of 1.6, and similarly, the estimated size transfer payments roughly doubles. 
Figure 8-1 illustrates the relative magnitudes of costs. Intangible costs are presented using 
a QALY valuation of £30,000. Using the alternative valuations of £15,000 and £20,000, the 
value reduces to £48,550,00 and £64,733,000, respectively. Years Lived with Disability are 
not included in this estimate.1  
                                                 
1 Assuming an estimated YLD of around 47,000 per year, the associated loss is around £1.1bn based on a 
disability weight of 0.224 (Salomon et al. 2015) for a valuation of a disability-adjusted life year of £30,000, 
with £550m and £730m at valuations of £15,000 and £20,000, respectively. Given the uncertainty 
surrounding the disability weight and the lack of methodological robustness stemming from the use of a 
QALY valuation to value DALYs, these figures should be treated with caution. 
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Table 8-3 and  
Table 8-4 show the annual costs associated with AN in 2010/11 for the conservative and 
high estimate, respectively, by cost perspective. Annual societal costs in the conservative 
estimate are £80.8 million, evenly split between healthcare costs and indirect costs, 
compared to £251.8 million in the high cost estimate where direct costs make up 30%, with 
22% going to indirect and 48% to intangible costs. Societal costs in the high cost scenario 
are 3.1 times as high as in the conservative estimate. 
Figure 8-1: Comparison of conservative and high cost estimate, by cost category 
 
Table 8-3: Annual costs associated with AN in 2010/11, conservative estimate 
 Perspective 
 Health system Government Patients Societal 
Direct costs £40,100,000 £40,100,000 £0 £40,100,000 
Indirect costs £0 £0 £40,700,000 £40,700,000 
Intangible costs £0 £0 £0 £0 
Transfers £0 £4,900,000 £0 £0 
Total £40,100,000 £45,000,000 £40,700,000 £80,800,000 
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Table 8-4: Annual costs associated with AN in 2010/11, high estimate 
 Perspective 
 Health system Government Patients Societal 
Direct costs £87,300,000 £87,300,000 £1,600,000 £89,000,000 
Indirect costs £0 £0 £65,700,000 £65,700,000 
Intangible costs £0 £0 £0 £97,100,0002 
Transfers £0 £10,400,000 £0 £0 
Total £87,300,000 £97,800,000 £67,300,000 £251,800,000 
 
In the conservative estimate, costs to the health care system are around £40 million, which 
more than doubles in the high estimate to £87 million where the costs of (potential) 
additional admissions, outpatient appointment and expenditure on private services are 
considered. Costs in the government perspective, which additionally includes transfer 
payments, also more than double from £45m to £97.8m. In addition to the doubling of 
health care costs, this is driven by the large increase in the estimated number of people 
receiving IB or SDA. From the perspective of patients and families (which is represented 
here in a very limited way), costs increase by 70%.  
In the conservative estimate, over 40% of costs are due to inpatient treatment (Figure 8-2). 
Outpatient treatment accounts for only 2%, or 4% of all healthcare costs. In our high 
estimate, outpatient treatment accounts for 8% of total costs (see Figure 8-3) and 25% of 
healthcare costs. The cost of outpatient treatment in the high cost scenario are over a third 
of the costs of inpatient treatment. 
                                                 
2 Using the alternative valuations of £15,000 and £20,000, the value reduces to £48,550,00 and £64,733,000, 
respectively. 
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Figure 8-2: Distribution of costs, conservative estimate 
 
Figure 8-3: Distribution of costs, high estimate 
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Figure 8-4 and Figure 8-5 show the impact of varying the cost-effectiveness threshold from 
£15,000 to £20,000 and £30,000. As expected, with an increasing valuation there is a linear 
increase in the estimate of intangible cost, and the contribution of intangible costs to total 
costs increases. 
Figure 8-4: Total societal costs by scenario 
 
Figure 8-5: Proportion of total costs attributable to cost categories, by scenario 
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DISCUSSION AND SUMMARY 
Any study of the social costs of AN is currently limited by poor data availability, in part due 
to the small number of cases that make it difficult to recruit sufficient numbers for research, 
and pose confidentiality issues in routinely collected data. Assumptions are therefore 
needed to come up with reasonable estimates. While there are many potential points of 
contention in the assumptions made to put together the estimate above, a few are likely to 
have a significant impact on results and are worth discussing. 
It is unclear how many people with AN receive treatment and in what setting. Our 
assumption focusses on the main treatment setting, while in reality, there will be overlaps, 
with people admitted for inpatient treatment who previously or subsequently receive 
outpatient treatment, and who may have concurrent input from their GP.  
Moreover, it is difficult to account for undetected cases. The ‘true’ prevalence of AN may 
be 2-3 times as high as estimated from either self-report or within services(Hoek 1991), and 
it is unclear what the cost implications of this may be. Similarly, it is currently not possible 
to estimate costs related to sub-threshold AN, as few data are available. In addition, there 
is a tendency in the literature to report research findings without distinguishing sub-
threshold anorexia and bulimia – which is in line with the current diagnostic manual for 
psychiatric conditions. 
Estimating the exact amount of benefits paid due to AN is difficult despite the availability 
of DWP data. While the majority of claimants received benefits for five or more years, this 
calculation may overestimate benefit receipt because the data do not show how many 
people start or stop claiming benefits within a quarter. The available data breakdown is not 
very precise due to the small number of claimants for AN, and the need to protect the 
identity of these individuals. 
Finally, there are uncertainties surrounding the data from Hospital Episode Statistics. Data 
are available by diagnosis, but admissions linked to AN may happen for various reasons, 
such as cardiac problems, self-harm or other medical problems. This is apparent from the 
Care Pathways data. Further, the average length of stay reported in HES is much lower than 
that reported by a recent RCP survey of ED services in the UK (Royal College of 
Psychiatrists 2012) which reported a length of stay of over 18 weeks, and a recent study on 
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the duration of stay in UK Specialist ED Units reported an average length of stay of 26 
weeks for adults and of 29 weeks for adolescents(Goddard et al. 2013a). One possible 
explanation is that HES conflates stays in psychiatric or ED units (typically for weight 
restoration or other mental health concerns such as self-harm) and stays in medical or 
paediatric units often linked to acute medical issues, which tend to be much shorter. In 
addition, HES data may not be entirely reliable(Brennan et al. 2012). To account for this, I 
assumed that inpatient treatment may be much more frequent that the diagnosis-based data 
suggest in our high cost scenario. Given that a high proportion of AN cases is likely treated 
on an outpatient basis, and given that the number of sessions required is generally high, the 
small contribution of outpatient costs in our conservative estimate is surprising, and it is 
possible that there are again issues with the underlying data. Here, I therefore estimated 
potential additional costs in the high cost scenario, but uncertainty remains.  
It is difficult to compare this estimate to the recent work by ProBono Economics (ProBono 
Economics 2012) because it did not distinguish costs by type of ED. However, some 
differences are due to different unit costs applied to incidents of service use and differences 
in data sources. For example, while HES showed around 8,000 outpatient contacts for 
2010/11, the ProBono Economics estimate cites unpublished data suggesting the number 
may be much higher (18,000). Other differences arise from the way private sector healthcare 
costs were treated. While HES reports data on both NHS beds and NHS commissioned 
private sector services, the ProBono Economics estimate assumed the HES data referred 
only to NHS beds, thus arriving at a much larger figure for additional private costs (£45m 
vs £1.6m). 
Two areas of costs outside the public sector should also be mentioned. While the study 
using BCS-70 data did not show an impact on earnings in adulthood, there is reason to 
believe that AN is associated with productivity losses both from absenteeism (time taken 
off due to illness) and presenteeism (lower productivity when at work due to illness), and 
that the impact may be large. While no estimate of the reduction in productivity associated 
with AN is available, Goetzel and colleagues (Goetzel et al. 2004) reported an average 
impairment of daily productivity due to depression, sadness or mental illness of 10.7%. 
Moreover, with an average length of stay of over 50 days, the impact of hospitalisation on 
the ability to attend work is clearly severe. These reductions in productivity likely not only 
288 
 
 
 
affect patients, but also carers and partners, who often experience high levels of 
psychological distress, depression and anxiety (Zabala et al. 2009). 
Cost related to informal care provided to people with AN by their family and friends have 
also been excluded from this estimate. The analysis of data collected in the CASIS study 
shows that up to three quarters of carers spent nearly a full day per week providing ED-
related care (Raenker et al. 2013), with potential impacts not only on their health and 
wellbeing but also on their capacity to engage in paid employment. This is a relevant impact 
that should not be ignored, especially in the context of service developments that shift 
provision from inpatient to outpatient treatment, where higher levels of informal care may 
replace formal provision. 
While I attempted to integrate findings from the ARIADNE studies into the estimate, the 
limited data available did not allow for a reliable estimate of total costs by ethnicity, gender 
and ED severity, although costs are distinguished by broad age group where possible. As 
more data from the ARIADNE studies and the large cohort studies become available, it 
may be possible to address the gaps in the estimate highlighted here. 
However, to my knowledge, this is the most comprehensive and detailed estimate of the 
societal costs of AN for England to date, and fills a significant gap in the literature that has 
been repeatedly highlighted (Striegel Weissman & Rosselli 2017). It improves upon existing 
estimates by incorporating data beyond what is available through routine collection. This 
approach means that costs can be stratified further, and additional cost categories can be 
included. A full comparison of this CoI estimate against existing estimates for England is 
provided in Chapter 9. 
While the data sources used in the conservative estimate are potentially more reliable, 
limiting a CoI estimate to such data is also likely to lead to an underestimation of actual 
costs. The high cost estimate incorporates a broader range of costs and is therefore more 
suited to capturing the complexities of AN. At the same time, these additional parameters 
may not be representative of the population with AN as a whole, as they are drawn from 
clinical studies. Another caveat is that there are still categories of costs that are omitted, 
such as caregiver burden, wider service use such as involvement of police or social care, 
travel costs necessary to attend for treatment, and out-of-pocket expenditure (e.g. for child 
care or additional foods or diet aids). There is also no estimate for males. On balance, both 
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estimates are likely to be ‘wrong’ in various ways, but the ‘high’ estimate is more likely to 
capture the broader burden of AN on individuals and society. 
This study combined the results from the preceding empirical chapters with publicly 
available data and previous findings from the literature to estimate the annual costs of 
Anorexia nervosa to society in England for 2010/11. This addresses RQ5: “What are the 
annual societal costs of AN in England?” and accomplishes the overarching aim of this 
thesis. 
In addition to carefully updating the evidence on the costs of AN to society, this study is 
the first in England to estimate costs of outpatient services beyond figures published in the 
Hospital Episode Statistics.  
• Direct costs ranged from £40.1 million to £89 million. 
• Indirect costs ranged from £40.7 million to £65.7 million. 
• Intangible costs in the high cost scenario were calculated at £49 million to £97.1 
million. 
• Transfer payments were estimated from £4.9 million to £10.4 million. 
• Total societal costs ranged from £80.8 million to £251.8 million. 
• In the conservative estimate, direct and indirect costs each account for 50% of costs. 
• In the high estimate, direct costs account for 30% of costs, indirect costs for 22% 
and intangible costs for 48%. 
The largest relative increase in costs from the conservative to the high estimate is seen in 
the costs associated with outpatient treatment, reflecting a large uncertainty regarding the 
data arising from a discrepancy between routine data sources and reporting in the literature. 
The ratio of costs associated with inpatient treatment to the costs associated with outpatient 
treatment in the conservative estimate is 22.4:1 (£33.6 million to £1.5 million), reducing to 
2.7:1 in the high estimate (£59.7 million to £21.8 million). This is a better representation of 
the English health care context than figures drawn from international studies. 
Several limitations remain. There is uncertainty around the magnitude of costs associated 
with outpatient services and wider service use. A cautious approach was taken to including 
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productivity losses and costs from excess mortality. Insufficient data were available to 
estimate costs associated with caregiving, travel or out-of-pocket expenditure. 
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CHAPTER 9  
Discussion and policy implications 
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CHAPTER INTRODUCTION 
The aim of this thesis was to present the annual societal costs associated with AN in 
England, and to explore why these costs may vary between individuals. The contribution 
of this thesis to the evidence base is an updated estimate of these societal costs, including a 
range of direct costs beyond hospital-based treatment, a more appropriate treatment of 
productivity losses based on analyses of economic outcomes using two major cohort studies 
and an estimate of costs associated with excess mortality using disease modelling 
techniques. 
My survey of the available literature – focussing on information for England – showed that 
there was a particular gap in information about the costs of treatment provided in an 
outpatient setting. Little was also known about what treatments and wider services people 
with AN receive, the costs associated with this service use, and why costs may vary. 
Using a range of econometric and economic modelling techniques, the thesis addressed 
each of these gaps in turn. The research questions were as follows: 
• RQ1: What treatments are provided for AN in an outpatient context, what are the 
associated unit costs, and why do these costs vary? 
• RQ2: What services do people use while being treated for AN on an outpatient 
basis, what are the associated costs, and why do these costs vary? 
• RQ3: What is the impact of AN on education, employment, income and related 
outcomes? 
• RQ4: What is the loss of life associated with AN in England? 
• RQ5: What are the annual societal costs of AN in England? 
The thesis is situated within the theoretical context of economic decision analysis. Three 
types of economic costs linked to health conditions are commonly distinguished, and my 
research questions map onto these types of costs as follows: 
• RQ1 and RQ2: Direct costs arising directly from a condition, such as health care 
expenditure; 
• RQ3: Indirect costs that are related to the condition but are not cash expenditure, 
such as productivity losses. 
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• RQ4: Intangible costs are those that are not easily quantified in monetary terms, for 
example the value of a life lost due to premature mortality. 
• RQ5 is an overarching question that ties together the three types of economic costs 
under the umbrella of societal costs. 
In this final chapter, I discuss my findings with regard to the societal costs of AN in England 
in the context of previous estimates and the wider literature to highlight the distinct 
contribution to knowledge. I summarise the strengths and limitations of the study and 
discuss the implications of my findings for policy, practice and future research. Concluding 
thoughts follow. 
294 
 
 
 
THE SOCIETAL COSTS OF ANOREXIA NERVOSA IN 
ENGLAND: WHAT HAVE WE LEARNED? 
The aim of this thesis was to present an estimate of the annual societal costs of AN in 
England. In Chapter 8, I presented the estimate for 2010/11: 
• Direct costs ranged from £40.1 million to £89 million. 
• Indirect costs ranged from £40.7 million to £65.7 million. 
• Intangible costs in the high cost scenario were calculated at £49 million to £97.1 
million. 
• Transfer payments were estimated from £4.9 million to £10.4 million. 
• Total societal costs ranged from £80.8 million to £251.8 million. 
Different cost perspectives were also considered. Notably, the cost to the health care system 
accounted for 50% of costs in the conservative estimate, and for 30% of costs in the high 
estimate. The implication is that a considerable burden of the cost of AN falls on 
individuals. 
Previous estimates of the costs of AN for England were uprated to 2010/11 prices using 
the Gross Domestic Product deflator to allow for a more direct comparison (see Table 9-1). 
Below, I compare the studies in terms of direct, indirect and intangible costs, with a 
particular focus on the most recent estimate (ProBono Economics 2012).. 
Table 9-1: Comparison of CoI estimates for England, 2010/11 prices (£million) 
Study Direct Indirect Intangible Total costs 
OHE 1994 £6 - - £6 
King's Fund 2007 £16 £35 - £51 
ProBono 2012 lo £79 £178 £158 £414 
ProBono 2012 hi £99 £2,219 £888 £3,205 
Bonin 2017, lo £40 £41 - £81 
Bonin 2017, hi £89 £66 £97 £525 
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DIRECT COSTS 
Estimates of direct costs per year increased from £6 million in 1994 to up to £99 million in 
2012, with my conservative scenario of £40 million falling approximately in the middle (see 
Figure 9-1). But what are the reasons for this heterogeneity? 
Figure 9-1: Comparison of estimates of direct costs of AN, 2010/11 prices (£million) 
 
COSTS OF INPATIENT CARE 
A closer look at the cost of inpatient care helps to illustrate the potential causes. All four 
estimates use routine data sources to estimate the costs of inpatient treatment, namely 
Hospital Episode Statistics (HES) or, in the case of the Office of Health Economics 
estimate, the Hospital Inpatient Enquiry. Comparing the three studies using HES-type data, 
I find the following differences and commonalities in the approach: 
All studies used inpatient bed days as the basis for their calculations. 
• King’s Fund: 73,153 bed days for AN and BN combined. The assumption was that 
95% of these were due to AN. 
• ProBono Economics: 98,000 bed days for AN and BN combined. 
• Bonin: 76,644 bed days in females with AN. 
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All studies made an assumption about the proportion of admissions occurring in younger 
vs older patients, although the age range of interest varied. This had implications for the 
unit cost applied (ProBono Economics, Bonin) and the proportion of total inpatient days 
included in the estimate (King’s Fund). 
• King’s Fund: ¾ of inpatient days occurred in people below age 35, who were the 
focus of the study. 
• ProBono Economics: Assumes that adult admissions cost about twice as much as 
children’s. 
• Bonin: 37% of FCEs for AN occur in patients aged under 18. 
All studies drew on publicly available unit costs for inpatient days (presented here in 
2010/11 prices): 
• King’s Fund: £213, based on the PSSRU unit cost volume 2006 (Curtis & Netten 
2006). 
• ProBono Economics: £503 based on the average of unit costs for specialist ED 
services and children’s specialist services from the PSSRU unit cost volume for 
2009/10 (Curtis 2010), which reports on NHS reference costs. 
• Bonin: £480, weighted cost of ED inpatient days based on NHS reference costs 
(Department of Health 2011). 
This analysis demonstrates that even though similar assumptions and data were used to 
derive these estimates, differences in assumptions can lead to a wide variation in costs – in 
this case, ranging from £11 million from the King’s Fund estimate to £49 million in the 
ProBono Economics estimate (although this includes inpatient costs for BN). 
COSTS OF OUTPATIENT CARE 
The largest relative increase in costs between my conservative and high estimates is seen in 
the costs associated with outpatient treatment, reflecting a large uncertainty regarding the 
data arising from a discrepancy between routine data sources and reporting in the literature. 
Here, estimation methods diverge between the three estimates compared above. While HES 
data on outpatient appointments have been published since 2003, they do not appear to 
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have been available at the time the King’s Fund’s estimate was put together, and their 
calculations are based on the ratio of outpatient costs to inpatient costs by Striegel-Moore 
(2000), 41%. The ProBono Economics estimate uses the same estimate as the King’s Fund 
for its lower bound estimate, while the higher bound is based on unpublished HES data 
(ProBono Economics 2012, p. 19). 
My estimate advances the approach. The ratio of costs associated with inpatient treatment 
to the costs associated with outpatient treatment in the conservative estimate is 22.4:1 
(£33.6 million to £1.5 million), reducing to 2.7:1 in the high estimate (£59.7 million to £21.8 
million). 
Given that HES data on outpatient appointments are now easily accessible, they form the 
basis for my conservative estimate. My high estimate, on the other hand, applies what may 
be termed the ‘ratio approach’ employed by the previous estimates (i.e., applying a ratio 
between inpatient and outpatient treatment costs found elsewhere in the literature to new 
data), but I use data from the CPS – an estimate more appropriate to the English context. 
However, the ratio is similar to the Striegel-Moore estimate: 38% in the CPS vs 41% in the 
American study (Striegel-Moore et al. 2000). For this reason, the lower-bound ProBono 
Economics estimate of £20 million is very similar to my higher-bound estimate of £21.8 
million. It should be noted, however, that patients in the Care Pathways Study where 
specifically entering for outpatient treatment, with the aim of preventing hospital 
admissions. It is unclear to what extent this cohort is representative of the population with 
AN as a whole, and it is possible that this cost ratio over-estimates outpatient treatment if 
scaled up to the national level. At the same time, HES data only report on outpatient 
appointment in hospital settings, so that there is likely a large amount of costs associated 
with treatment in community-based services that an estimate based on HES data would 
ignore.  
A related issue is that of unit costs. The process of deinstitutionalisation, as outlined in 
Chapter 2, is defined by a shifting of service provision from a hospital to a community 
setting. At the unit cost level, all else being equal, service provision in a hospital is more 
costly than in a community setting (see data in Curtis 2011). The weighted average cost of 
an outpatient attendance for paediatric services from the same source was £775. The cost 
of an MFDT session, the most intensive form of therapy provided within the outpatient 
services in our study, was around £325 per family. The most commonly provided 
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treatments, CBT and SFT, were significantly cheaper on a per-session basis - £136-£246 
and £205-£246, respectively. While there is some uncertainty around these estimates, given 
that the information available for costing was adapted from data intended for a different 
purpose, the costing methods followed best practice, and these are the most comprehensive 
estimates of the costs of ED treatment in outpatient services to date. 
While I was able to develop unit costs for a range of outpatient treatments (see Chapter 4), 
the lack of detail on the types of sessions provided, i.e. the nature of outpatient 
appointments for AN, and the lack of detailed data for community-based treatment, means 
that it was not possible to make good use of the new data available at this time. It is therefore 
uncertain whether my high estimate is too high or too low, pointing to a need for routine 
data collection in CAMHS. 
The reliance of estimates of the costs of inpatient care, and more recently also the costs of 
outpatient care on HES data warrants a closer look at these data. The Hospital Episode 
Statistics (Herbert et al. 2017) provide information on admissions to NHS hospitals in 
England and outpatient treatment in hospitals. Classification is based on ICD-10 diagnostic 
codes. Summary data are publicly available by primary diagnosis, and since 2013/14 also by 
all diagnosis, i.e. including diagnoses in addition to the primary one. It includes non-
residents treated in English hospitals and private patients treated in the NHS. 
Figure 9-2 shows finished consultant episodes (FCEs) for a primary diagnosis of AN from 
2010/11-2015/16. Note that inpatient data was not available for 2015/16 at the time of 
writing.  
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Figure 9-2: Inpatient and outpatient finished consultant episodes for primary diagnosis AN 
(F50.0), 2010/11-2015/16 
 
In 2010/11, there were 1,913 inpatient and 8,376 outpatient FCEs. However, data quality 
issues with the HES have long been recognised (Brennan et al. 2012), and a lack of clinician 
engagement with the data has been identified as a possible cause (Spencer & Davies 2012; 
Williams & Mann 2002). There is a particular issue with clinician-recorded diagnosis, with 
consistently over 95% of outpatient FCEs recorded without an ICD classification (ICD 
code R69.X). This can be illustrated by plotting the data on outpatient FCEs for full 
syndrome AN (F50.0), atypical AN (F50.1) and unspecified ED (F50.9). Figure 9-3 shows 
the trends for these categories: F50.9, the residual category, makes up a significant 
proportion of outpatient contacts for ED, and appears to increase over time, while visual 
inspection suggests a decreasing trend for outpatient appointments for full syndrome AN 
in recent years. 
8,376
9,282
9,956 9,627
8,203
7,480
1,913 2,046 2,249
2,786 2,763
0
2,000
4,000
6,000
8,000
10,000
12,000
2010/11 2011/12 2012/13 2013/14 2014/15 2015/16
Outpatient Inpatient
300 
 
 
 
Figure 9-3: Outpatient finished consultant episodes for primary diagnosis AN, 2010/11-
2015/16 
 
At the same time, there appears to have an uptick in admissions for both full syndrome AN 
and unspecified ED in 2013/14 (see Figure 9-4), which corresponds to the implementation 
of DSM-V criteria. As discussed above (Chapter 2), this tends to increase the likelihood of 
full syndrome AN being identified. However, these broad trends do not seem to reflect the 
shifting focus from inpatient towards outpatient treatment, at least not in a hospital setting. 
It is possible that overall demand for ED care increased, but data on activity in community-
based services would be required to assess this claim. 
Figure 9-4: Time trends in admissions for AN, atypical AN and unspecified, 2010/11 -
2014/2015 
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Summary data on FCEs for AN including additional diagnoses show that these are 2.6 times 
as high as admissions for the primary diagnosis (see Figure 9-5), and appeared to increase 
– although only data for two years can be shown. 
Figure 9-5: FCEs for AN (inpatient), primary diagnosis vs all diagnoses 
 
The increase in ED admissions was reported widely (Health and Social Care Information 
Centre 2014), and prompted a £150 million investment in service transformation over five 
years (Deputy Prime Minister’s Office et al. 2014). 
This brief analysis shows that HES data may not be entirely reliable. The general difficulties 
with data quality may be exacerbated by the fact that AN is a “disorder in transition” (Micali 
& Hebebrand 2015). At the same time, HES data are very influential, and in practice they 
are widely used in estimating CoI. 
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estimates of the cost of AN have sometimes included primary care costs (Office of Health 
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new information from my analysis of trial data (see Chapter 5, part 2), which allows me to 
include the costs of GP consultations as well as contacts with accident and emergency 
departments, nurses and dieticians, who play a prominent role in treating ED. I am also 
able to begin to look at the service use by patients in the time before entering different care 
pathways (inpatient vs outpatient treatment).  
Patients later admitted to inpatient care (CASIS trial) reported on average 8.9 GP contacts, 
while those later commencing treatments on an outpatient basis reported 6.2 contacts. This 
is in line with the data presented by Byford and colleagues (Byford et al. 2007a), who 
reported six to seven contacts for their participants. This provides further evidence that the 
consultation rate for patients with AN may be higher than previous cost estimates have 
assumed – at least for adolescents in the year prior to commencing treatment in higher tier 
services. The finding is also in line with previous work showing that people with AN consult 
their GP significantly more than others in the 5 years prior to diagnosis (Ogg et al. 1997), 
and a single consultation about eating or weight and shape concerns strongly predicts the 
subsequent emergence of AN (Lask et al. 2005).. 
While research into the service use and costs of people with AN has moved on considerably 
since the initial OHE estimate, and data availability for hospital-based services has 
improved, information is still lacking on community-based psychological treatment and 
primary care. The studies presented in this thesis represent a first step in addressing some 
of these data issues. The clinical trials providing data for the estimates of service use in 
primary care are some of the first larger-scale RCTs in AN, employed rigorous standards 
and were highly successful in collecting service use data from participants (Schmidt et al. 
2017). While it is difficult to assess the representativeness of the trial population in the 
absence of good knowledge on the population with AN as a whole, the strength of the 
underlying data and the application of best practice in economic costing are strengths of 
the studies informing these cost estimates. 
WIDER SERVICE COSTS 
One limitation that I am unable to overcome with the available data is the inclusion of a 
robust estimate of the costs of service use beyond health care.  
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As presented in Chapter 5, part 2, there is some evidence that people with AN do use 
services such as self-help and support groups (14% in the CASIS trial and 9% in the 
MOSAIC trial), CAB (8% in CASIS and 6% in MOSAIC) and helplines (10% in CASIS 
and 11% in MOSAIC), and that some are in touch with social workers (12% in CASIS and 
6% in MOSAIC). Costs associated with self-help and advice services were calculated at £32 
per participant (SD £99) for CASIS and at £59 (SD £394) for MOSAIC. The costs 
associated with social work were £95 (SD £397) and £70 (SD £383) for CASIS and 
MOSAIC, respectively. 
In order to include these figures in an estimate of the societal costs associated with AN, we 
would need to be able to establish causality between AN and service use, for example by 
comparing these figures to population norms. We would also need to establish whether 
these figures – calculated based on a 6-month period – should be ‘scaled up’ to an annual 
figure, i.e. whether the 6-month period is representative of any given 6-month period, or 
whether the period prior to commencing treatment for AN is qualitatively different in terms 
of contact with self-help services and social care. In addition, we would need to determine 
to what extent these figures are representative of the population with AN more generally, 
and how we could arrive at an average (or weighted average). Given that Byford and 
colleagues (2007a) find little evidence of contact with social care services in a younger 
cohort (aged 12-18), it is reasonable to assume some variation with age. 
There was little evidence in the data collected from the trials presented in Chapter 5 that 
people with AN are in contact with other services, such as the police. 
INDIRECT COSTS 
Comparing estimates of indirect costs, I find a wide range from £35 million to £2.2 billion. 
Both my estimates are significantly below the ProBono Economics estimates. 
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Figure 9-6: Comparison of estimates of indirect costs of AN, 2010/11 prices (£million) 
 
In my study using BCS-70 data (Chapter 6), I found no impact of AN on the likelihood of 
being in employment, education attainment or on wages. Similarly, my study of ALSPAC 
data did not show an effect of AN on GCSE-attainment. For this reason, I only include 
productivity losses based on the number of women with AN who received certain types of 
benefits, based on DWP data. This was justified because the BCS-70 analysis showed a 
significantly higher chance of being sick or disabled in terms of economic activity status. 
I was unable to explore questions related to under-employment, i.e. whether women with 
AN were more likely to be in an occupational class that was lower than expected, given 
their level of education. However, women with AN were more likely than those without an 
ED to be in occupational classes I or II, if they were employed. 
In addition, it is possible that there are weaknesses in the analysis approach beyond what 
has already been discussed: the amount of missing data with the possibility that these are 
not missing at random, the small sample size and the uncertainty about the predictor 
variable. Note that these limitations apply to both the analysis of ALSPAC and the BCS-
70.  
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Conceptually, the underlying relationships are perhaps better represented by Figure 9-7, as 
there are likely complex relationships between the variables entered into the regression 
models. 
Figure 9-7: Path model 
 
In addition to the question whether productivity losses in terms of lost employment should 
be included at all, there is an issue around valuation of productivity losses. As discussed in 
Chapter 2, the primary productivity-based approach (the human capital approach) has been 
criticised for bias against those with lower market wages. 
To avoid this pitfall at least in part, I used the median wage for women. Other acceptable 
choices would have been the average wage for women, the overall average or median, the 
minimum wage or the living wage. I did not assume that income would increase over time 
in line with long-term productivity growth, and did not make any assumptions that are often 
made in a human capital context regarding the inclusion of salary oncosts. 
In contrast, the ProBono Economics calculation drew on an estimate of the impact of 
emotional disorders in childhood on earnings, included 2% real wage growth, adjusted for 
the probability of being employed and then discounted to present value, which yielded a 
present value of lifetime earnings of £0.64 million per person. The alternative calculation 
was a 7% reduction in earnings, which then came to £45,000 per person (excluding any 
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additional overheads). Differences in the total estimate also arise from assumptions about 
prevalence, which I discuss below. 
INTANGIBLE COSTS 
Intangible costs make up the largest proportion of costs, both in my high estimate and in 
the ProBono Economics estimates. As with indirect costs, my high estimate is lower than 
the lower ProBono Economics estimate. 
I discussed the main approaches to valuing life years lost in Chapter 1. Several approaches 
are available, and I decided to base my estimate on the NICE WTP threshold for one 
quality-adjusted life year (£30,000; with sensitivity analyses using alternative estimates of 
£15,000 and £20,000) to ensure a better fit of the estimate within a health care context. I 
then adjusted for a disability weight for depression.  
The ProBono Economics study is based on the Value of Preventing Fatality of around £1.8 
million and calculated the number of excess fatalities based on a rate of fatalities per 
inpatient. This results in an estimate that is around eight times as high as mine. 
My method for calculating the number of fatalities is based on a disease modelling study 
(see Chapter 7) that combines population data for England with parameters on excess 
mortality, duration of illness and relapse for AN. This resulted in an estimate of ca. 2,000 
new cases per year, and a total of ca. 13,000 cases, with 69 fatalities from AN per year. The 
total present value of YPLL was around 6,000. Notably, the King’s Fund estimates 
prevalence at almost 27,000. 
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Figure 9-8: Comparison of estimates of intangible costs of AN, 2010/11 prices (£million) 
 
The question has been raised whether intangible costs should be included in CoI estimates 
at all, facing again the criticism that their inclusion discriminates against those receiving 
lower incomes. A striking recent example of such a bias is the fund compensating families 
of victims of the terrorist acts on 09/11/2001 in the USA, which, it has been reported, 
primarily bases compensation on lost future earnings, thus explicitly valuing loss of life 
differentially by income (Finkelstein & Corso 2014). A common recommendation is 
therefore first presenting a ‘neutral’ quantity (e.g. hours of work lost), which is then valued 
using a more equitable measure, such as average wages (Zhang et al. 2011, citing Drummond 
et al. 2005), and I have applied this recommendation to the estimate presented here. 
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WHY DO COSTS VARY? 
While it was not possible to relate the societal costs associated with AN to individual 
characteristics, some progress can be reported on the question of whether and why costs 
may vary. 
Chapter 5 discusses this in more detail with respect to direct costs. Costs appeared to be 
driven by care pathway and the associated risk of an inpatient admission, although it is 
unclear whether this is causal, or whether patients (to an extent) ‘self-select’ into care 
pathways owing to their clinical needs. Costs also vary based on some indicators of severity 
and some demographic characteristics. 
At the individual level, costs were positively associated with  
• Age and duration of illness in the CPS; 
• English as a first language, WHO health rating and DASS stress scale in CASIS. 
Costs were negatively associated with  
• Vomiting and a co-morbid medical condition in the CPS 
• The specialist-specialist pathway compared to the non-specialist-non-specialist 
pathway in the CPS; 
• Lowest ever BMI in CASIS; 
• Age and a diagnosis of AN (vs EDNOS-AN) in MOSAIC. 
These findings are broadly in line with the existing literature, which finds that: 
• Health care costs are higher for those with ED than for those without ED 
(Samnaliev et al. 2015); 
• Hospital costs associated with AN are higher than those associated with other ED 
(Haas et al. 2012a); 
• The presence of bingeing/purging behaviours is associated with higher outpatient 
costs (Stuhldreher et al. 2015); 
• Longer duration of illness is associated with higher outpatient care costs 
(Stuhldreher et al. 2015); 
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• Lower BMI at admission is associated with higher costs in AN and vice versa (Haas 
et al. 2012b, 2012a; Toulany et al. 2015); 
• Higher BMI following hospitalization is associated with higher retrospective costs, 
i.e. a longer inpatient stay is associated with a higher BMI (Stuhldreher et al. 2015); 
• Co-morbid mental health problems and conditions may be associated with higher 
costs in inpatients (Haas et al. 2012b, 2012a) and outpatients (Stuhldreher et al. 
2015), although some studies do not find this effect. 
The ‘missing link’ needed to be able to reflect these cost variations in a ‘bottom-up’ estimate 
of the societal costs of AN is a model showing receipt of treatment over the course of the 
illness. This can be illustrated using the simplified model shown as Figure 9-9:  
An incident case of AN is either detected or not detected. A detected case will (presumably) 
receive treatment. Both detected and un-detected cases will have an outcome (or an 
intermediate outcome) of recovery, relapse/chronic course of illness or mortality. What is 
missing in terms of data for an individual-level CoI estimate is information on a) course of 
illness and transitions between outcome states over a longer period of time (including 
number of relapses) and b) the link between this course of illness and treatment, including 
treatment settings (by ‘stage’ of illness) and transitions between settings of care. 
Figure 9-9: Schematic model of course of illness and treatment of AN 
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STRENGTHS AND LIMITATIONS OF THE STUDY 
The study of the cost of illness associated with AN has clear strengths and weaknesses. The 
study addresses a major gap in the literature. There is no other CoI estimate for England 
that provides the level of detail available here, and builds on such a breadth of data.  
And the strength of the study is in the quality of the data. The clinical trials providing data 
for the study were robustly run and returned data of a high standard. The two cohort 
studies, BCS-70 and ALSPAC, are well established data sources, representative of the 
British population, and have been widely used to inform policy and practice – but they have 
not been interrogated with regard to the link between AN and productivity-related 
outcomes.  
The studies on the costs of outpatient treatments, service use, costs and variations are 
among the first in England to provide this kind of information. Robust methods and best 
practices in economic costing were applied. 
But there are limitations as well. Currently, the CoI estimate only covers treatment seeking 
individuals – although an effort has been made to include assumptions about additional 
service use, especially in primary care. This is an important consideration, given that it is 
people with AN may be reluctant to seek help – and specifically help for their ED (Hart et 
al. 2011). 
Other methodological considerations highlight further gaps. While the current estimate 
covers a range of services beyond inpatient care, there are many potential cost categories 
that remain unexplored: 
• Carer time and distress; 
• Personal expenditure on food, medicines and other items; 
• Medications; 
• Presenteeism and; 
• The value of non-market production foregone. 
Missing data presents a potential problem, especially when it is likely that assumptions about 
the missing data mechanism may be violated – although I found no evidence for this. In 
addition, the analysis approach can be critiqued. Slightly different approaches were taken 
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for the analysis of ALSPAC and the BCS-70. To an extent, this reflects different conceptual 
models underpinning the analyses I used to build these studies, but it also reflects the large 
amount of time that has passed between the beginning and completion of this project. 
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IMPLICATIONS FOR POLICY AND PRACTICE 
POLICY DEVELOPMENTS FOLLOWING ‘NO HEALTH WITHOUT MENTAL 
HEALTH’ 
Since the publication of No Health Without Mental Health in 2011, there has been a lot of 
activity in the mental health policy field. A brief overview of major policy documents and 
events and the implication for mental health services generally or, where applicable, for ED 
specifically. Following the publication of statistics showing that ED inpatient admissions 
rose by 8% from 2013 (Health and Social Care Information Centre 2014), this figure has 
been quoted widely and can be found in many of the policy documents that referenced ED. 
The implementation of a waiting time standard for ED, backed by substantial funding 
commitments, is driving service development. The stated aim is to meet the standard by 
2020/21, i.e. that 95% of children receive treatment within one week or four weeks for 
urgent and routine cases, respectively. Baseline data collection is taking place in 2016/17. 
While the evidence base is still in development, recent developments following the 
publication of the Five Year Forward View in 2014 have seen £30 million annual funding 
was announced in 2014 to support capacity building for evidence-based Community Eating 
Disorders Services for Children and Young People (CEDS-CYP). The aim is to provide 
specialist care to release capacity in general CAMHS and to support the implementation of 
the waiting time standard for ED. 
Another aim, originating in the Five Year Forward View for Mental Health, is to reduce the 
number and duration of inpatient stays and end out-of-area placements. It envisioned that 
the use of inpatient beds overall will reduce, with potential larger reductions in specialist 
beds – and much of this reduction is expected to come from a reduction in bed days 
required by ED patients. 
The evidence cited for CEDS-CYP is limited to the TOuCAN trial and the CPS (National 
Collaborating Centre for Mental Health 2015, p. 21), indicating that there is still a need for 
developing the economic case for the two strategies for reducing waiting times and 
improving access to services: A shift from inpatient to outpatient services, and a shift from 
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general to specialist community-based services. The proposed CEDS-CYP therefore 
reflects the debates in the ED literature that were outlined in Chapter 2. 
THE ECONOMIC ARGUMENT FOR A SHIFT FROM INPATIENT TO 
OUTPATIENT SERVICES 
As highlighted in Chapter 2, treatment of AN needs to be considered in the broader context 
of deinstitutionalisation, as there is a shift from inpatient to outpatient treatment driven by 
both cost pressures and clinical considerations. The problems arising from this process that 
have been identified for mental health services generally, such as restrictive access and 
limited capacity, geographic clustering of inpatient beds, problems in the interplay between 
different service tiers (such as recognition in and referral onwards from primary care) and 
staff confidence and skill in providing treatment, are mirrored in the service landscape for 
ED. 
There is a consensus that treatment provision for ED needs to be improved, and this is 
reflected in the new waiting time standard for ED (National Collaborating Centre for 
Mental Health 2015). Assuming that existing services currently operate at (or above) 
capacity, and that there is no desire to see a ‘re-institutionalisation’ of ED treatment3, the 
economic question arising is whether it is ‘worth’ trying to improve provision by expanding 
outpatient services. 
Economic evaluation is concerned with both costs and outcomes, so to start answering this 
question, we need to look at the evidence relating to both: 
• How effective is outpatient treatment, compared to the alternative? 
• What is its cost, compared to the alternative? 
The question of effectiveness needs to be answered in the clinical realm. Evaluating service 
models in ED is difficult, as the experience from the TOuCAN trial (Gowers et al. 2010) 
has demonstrated, but there is a clinical consensus that inpatient admission should be 
reserved for the most severe and critical cases (National Institute for Health and Care 
                                                 
3 Interestingly, some European countries appear to be seeing an increase in available beds (Thornicroft & 
Tansella 2013). 
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Excellence 2017a). What is clear is that preventing hospitalisation will address the cost-
effectiveness question from both ends. 
But what are the costs? The King’s Fund (2008) estimated that, assuming that currently, 
34.6% of people with ED are accessing services, a 100% coverage by 2026 could be 
achieved at a cost of £6.6 million. Given that NICE estimates the costs of specialist ED 
services in 2015/16 to be in the region of £83 million (National Institute for Health and 
Care Excellence 2017b), it is likely that this was an underestimate. Assuming the same 
current coverage, a rough estimate would be in the region of £240 million.  
On the face of it, outpatient treatment is cheaper. The resource impact report 
accompanying the recently updated NICE guidance (National Institute for Health and Care 
Excellence 2017b), for example, cites NHS reference costs for 2015/16 that show the unit 
cost of an inpatient day for children to be £510, compared to £262 for an outpatient 
appointment and £191 for a community contact. The estimates presented in this thesis are 
even more favourable, with costs for the most commonly provided treatments ranging from 
£136-£246 per session (see Chapter 4, part 2). If these costs are accurate, expanding 
outpatient services would be cost saving (assuming equal outcomes) if twice the number of 
contacts per patient were required than if they had been admitted as inpatients. However, 
Knapp and colleagues (2011) find that deinstitutionalisation does not lead to cost savings. 
Thornicroft and Tansella (2013) confirm this finding and elaborate that quality of care is 
linked to expenditure, i.e. better acre is more expensive, and overall, community-based 
models are as expensive as institutional care. This finding is often replicated e.g. (Mansell et 
al. 2007). The TOuCAN trial (Byford et al. 2007a) seems to indicate that there is no 
difference in costs between inpatient and outpatient treatment overall, given the fact that 
inpatient admissions may be inevitable for some. 
The lack of cost savings overall, despite arguably lower unit costs of services may be 
explained by the need to – at least initially – build up community-based and outpatient 
capacity while still retaining inpatient capacity to continue treating existing cases (Gilburt & 
Peck 2014). 
So while the overall cost impact is unclear, these costs do not take into account a potential 
additional burden placed on carers. It is well established that the caregiving burden and 
carer distress in AN are high (Anastasiadou et al. 2014; Zabala et al. 2009), and the 
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Department of Health has explicitly acknowledged the role of caregivers in the 2014 
document ‘Closing the Gap: Priorities for Essential Change in Mental Health’. Raenker and 
colleagues (2013) found that carers spent most time providing emotional support, and more 
time spent caregiving was associated with higher distress. Social support, both from services 
and from informal sources, was found to alleviate distress. While we may not yet be able to 
quantify caregiving burden in AN for England, it is clear that in developing the economic 
argument for a shift towards outpatient treatment, the impact on carers needs to be 
considered, and it may be necessary to put in place services to in turn support caring for 
people with AN. Some interventions have been developed, and shown to have a positive 
effect (Treasure & Nazar 2016).  
THE ECONOMIC ARGUMENT FOR SERVICE SPECIALISATION 
Another current debate in ED is whether a higher degree of service specialisation in 
outpatient treatment is beneficial overall because highly specialist services may be more 
effective and better able to prevent hospitalisation, with the potential of treating between 
70%-90% of patients on an outpatient basis (House et al. 2012). 
Developing the economic argument for service specialisation again requires consideration 
of outcomes and costs. 
While it could be expected that treatment provision in non-specialist services would be 
cheaper, unit costs were similar across service types, and CBT was in fact cheaper in 
specialist ED services (see Chapter 4). 
Another argument might be that generic services provide more flexible capacity. Given that 
the prevalence of ED is low, specialist services need to cover larger catchment areas than 
general services with equivalent overall resources. This means that the argument for 
specialisation needs to consider how geographic distribution of services affects the cost of 
attending for treatment. A recent study estimated that the median productivity loss for 
caregivers was $673 and the value of lost leisure time associated with caregiving and travel 
to the hospital was $2,565 (Toulany et al. 2015). It is of course possible that an expansion 
of specialist services reduces the average travel time, but any economic argument needs to 
take this into account. 
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The CPS showed that the specialist pathway was associated with lower rates of admission 
and greater consistency of care (House et al. 2012). My analysis of showed that the S-S 
pathway had the lowest average cost (although differences in total costs were not 
significant), and inpatient costs contributed less than 50% to total costs, compared to over 
70% in the other pathways. This information seems to point towards lower costs due to 
lower hospitalisation rates, and better outcomes as indicated by these lower hospitalisation 
rates.  
The main limitations of the CPS were the small sample size and a bias towards specialist 
outpatient services, especially at the individual level – 63% of participants with economic 
data were on the S-S pathway. Moreover, as this was an observational study, it is difficult 
to establish causality between pathways and outcomes. This is an especially relevant point 
in this study, because it is possible that care pathways was determined by treatment success, 
e.g. those deteriorating or presenting with complex problems in non-specialist services may 
have been referred on to specialist services or admitted for inpatient care. 
The findings from the only RCT of inpatient vs outpatient care in the UK, the TOuCAN 
trial (Byford et al. 2007a), seem to support an economic argument for service specialisation 
to an extent: There was no significant difference in outcome nor in costs, but given the 
favourable trends in the data, specialist outpatient treatment had a higher probability of 
being considered cost-effective – at least at lower values of WTP (Byford et al. 2007a). 
IMPROVING DATA QUALITY IN CAMHS 
The Children and Young People’s Improving Access to Psychological Therapies 
programme (CYP IAPT) started in 2011. No new services are created, but the programme 
seeks to improve CAMHS by incorporating principles of outcomes monitoring. Linked 
initiatives are the CAMHS quality network and the support for data interpretation from 
CORC. While this has enabled some services to demonstrate their efficiency, funding cuts 
have been cited as a cause of limiting capacity for treatment but also capacity for 
implementing these principles (House of Commons Health Committee 2014, pp. 37-38). 
These principles are intended to underpin the development of the new ED community 
services from the start. As this thesis has demonstrated, there is still a dearth of detailed 
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information on CAMHS. Capacity for evaluation (and to be evaluated) will be key for 
achieving improvements in services. 
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RECOMMENDATIONS FOR FUTURE RESEARCH 
TOWARDS AN INCIDENCE-BASED ESTIMATE OF THE COSTS OF 
ANOREXIA NERVOSA  
The discussion of the usefulness of CoI estimates above concludes, they are most relevant 
when they are incidence-based and reflect variations between individuals, as this can be 
used to in scenario modelling and cost-effectiveness analysis. How far away are we from a 
robust incidence-based estimate for AN? 
 A decision-analytic model, used to combine evidence from different sources, would require 
information on the course of illness, including the probability of remission, relapse, 
recovery and mortality over the life course. While some information on these parameters is 
available, difficulty arises from a lack of data on individual patterns of remission and 
recovery.  
In addition, these patterns would need to be matched with appropriate cost data. The 
present study has advanced the evidence base somewhat, but the challenge remains to 
match the available unit cost data to robust service use data that reflect actual rather than 
estimated service use at the individual level. This is particularly true for service use beyond 
inpatient care, and treatment within private sector services. 
While some progress has been made in this study in exploring variations in costs, there are 
still some gaps that are difficult to fill. In particular, a difficulty arises from the low 
prevalence of AN, and especially the low prevalence in males that makes it unlikely that 
statistical testing of differences can succeed, and this is true to an even greater extent for 
formal sub-group analysis within males with AN. 
One strategy to increase sample size might be to follow the shift in thinking about ED in 
terms of behaviours discussed in Chapter 2, as individual behaviours are more common 
than any full syndrome or diagnostic category. However, this is still a relatively new concept 
and little research is available on life course, service use and costs. Issues around service use 
and costs rely on the implementation of principles and strategies that facilitate data 
collection and ultimately, service evaluation. While there are some promising efforts, such 
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as the children’s IAPT programme, it is unclear whether this will result in better and more 
data being publicly available down the line. 
CONSIDERATIONS FOR ECONOMIC EVALUATION OF INTERVENTIONS 
The findings from this study provide some implications for future economic evaluations of 
interventions for AN.  
If the finding from the studies using ALSPAC and BCS-70 data holds, namely that no effect 
of AN on education attainment or economic activity could be found, any economic 
argument focussing on investment in the present to be offset by savings later will need to 
focus on service costs alone because the increased costs of service provisions cannot be 
offset by increased future income – except from avoidable mortality. At the moment, the 
little evidence we have available suggests that changes in treatment models are unlikely to 
result in savings from lower direct costs. However, all else being equal, cost-effectiveness 
could be improved by increasing effectiveness of new interventions. 
As discussed above, the inclusion of the carer perspective in any cost-effectiveness study, 
especially of interventions for younger people, is crucial to avoid shifting costs from one 
element of society (e.g. the health service) to another (the individual). 
Similarly, the inclusion of travel costs is likely to be relevant given the current distribution 
of services. With the development and roll-out of group-based therapies, where the number 
of families attending each session is relevant not just in terms of unit costs but also in terms 
of clinical effectiveness (Eisler et al. 2016), recruitment and retention become even more 
important. The unit cost estimate for MCTAAN (see Chapter 4) does not include travel 
costs because this was considered a research cost, related to the requirements of the RCT. 
However, but with limited local availability of ED services, travel is – for the time being – 
a factor that needs to be acknowledged.4  
                                                 
4 It is worth mentioning that one strategy for improving access to therapies has been to develop online 
interventions. At this point, this for the most part offers alternative treatments for BN (Shingleton et al. 
2013), which tend to be CBT-based, and support for carers (Hibbs et al. 2015). However, an online version 
of the MANTRA intervention – now recommended by NICE – has been piloted to enhance relapse 
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Finally, there is a need for relevant outcome data, including utility data, that can be used 
together with cost data in economic evaluations of interventions and service models. The 
QALY is commonly measured using the EQ-5D (The EuroQol Group 1990), a generic 
measure of quality of life for which utility weights (needed to convert EQ-5D scores into 
QALYs) are readily available. However, it is generally accepted that generic measures of 
quality of life such as the are unlikely to be sensitive to changes in specific conditions, and 
in particular to changes in mental health problems (Adair et al. 2007; Chisholm et al. 1997). 
A factor that has arisen in the literature on quality of life in ED is that some people with 
ED may respond in ‘ego-syntonic’ ways, i.e. ways that are consistent with how they see 
themselves. This may lead to reporting of higher QoL than is actually experienced (de la 
Rie et al. 2005a). In a comparison with physical health conditions and healthy controls, an 
early study (Keilen et al. 1994) found the QoL profile for AN (measured on the Nottingham 
Health Profile, Hunt et al. 1981) to be quite different, especially when it came to ratings for 
mobility and broadly defined social functioning, drawing into question whether treatments 
for different conditions with very different needs profiles can be usefully compared on a 
single measure. In response to these concerns, a quality of life scale specific to ED (Eating 
Disorder Quality of Life Scale, EDQLS) was developed (Adair et al. 2007). The instrument 
consists of 40 self-report items in 12 domains rated on 5-point Likert scales. While changes 
in QoL can therefore be measured, there is no associated ‘utility tariff’ available that would 
allow for conversion of EDQLS scores into QALYs. This currently limits the usefulness of 
the EDQLS when it comes to comparison between interventions for different conditions, 
which is facilitated by the use of QALYs. 
Given the wide-ranging changes that can be expected in the landscape of ED services 
following implementation of CEDS-CYP, and the need to develop the evidence base for 
these services, presents an opportunity to build evaluation capacity into the service from 
the start, including data collection that can facilitate economic evaluation. The experience 
with the children’s IAPT programme can serve as a potential model, and the adoption of 
core models is recommended in the commissioning guidelines (National Collaborating 
Centre for Mental Health 2015). 
                                                 
prevention in AN (Schmidt et al. 2017), and a multi-national RCT is underway to test the effectiveness of 
the everybody intervention (ICare Consortium 2017). 
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THE IMPACT OF SPECIALISATION ON SKILLS, CONFIDENCE AND 
QUALITY OF CARE 
The study of CPS data (Chapter 5, part 1) generated hypotheses with regard to the impact 
of service specialisation. The literature on primary care (Currin 2006; Currin et al. 2007a) 
(Currin et al. 2006) suggests that confidence and experience play a role in choices about 
treatment and referral. The CPS (House 2011) found that the specialist – specialist (S-S) 
pathway was associated with greater continuity of care, while my study found that specialist 
services offered a wider range of ED treatments, and there was a trend for staff other than 
consultants to be involved in treatment, and it is hypothesised that this is due to greater 
specialist skills in all staff. The link between service specialisation, skills, confidence and 
quality of care should be explored, especially to support the evidence base for the new 
CEDS-CYP model. 
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CONCLUSIONS 
In this thesis, I have presented the costs of Anorexia nervosa to society in England: 
• Direct costs ranged from £40.1 million to £89 million. 
• Indirect costs ranged from £40.7 million to £65.7 million. 
• Intangible costs in the high cost scenario were calculated at £49 to £97.1 million. 
• Transfer payments were estimated from £4.9 million to £10.4 million. 
• Total societal costs ranged from £80.8 million to £251.8 million. 
While my approach was conservative, the fact remains that the costs of AN are high, and 
much of it may not be borne by the health service or indeed the public purse. For the time 
being, these remain as ‘blind spots’ within the CoI of Anorexia. 
Since the publication of ‘No Health Without Mental Health’, there have been significant 
policy developments that specifically affect the ED services landscape. In particular, the 
imminent introduction of community-based specialist ED services – aiming to improve 
access to treatment and relieve capacity in general CAMHS – means that going forward, 
there will be a need to improve the evidence base for ED treatment, and this will include 
economic evaluations. It will become even more important, then, that adequate and 
meaningful data are collected. 
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APPENDIX 1: SERVICE INFORMATION SCHEDULE FOR 
MULTI-FAMILY DAY TREATMENT 
Design Stage  
How much staff time was spent in tailoring your existing intervention to suit this specific 
client group? Please include any secretarial/admin support and volunteer time. 
Staff identifier (e.g. 
initials) 
Profession Grade No hours/days 
    
    
    
    
    
 
Were any special materials used in this design stage? YES NO 
If YES, please describe below. 
 
 
 
 
Preparing to hold the intervention 
For each activity listed below, please give hours of staff time absorbed, including volunteer 
time. Also list the identifier, profession and grade of staff not included in the table above. 
Please also describe materials used (or an approximate cost) and give one-off costs. 
 
Staff training 
Staff identifier (e.g. 
initials) 
Profession Grade No hours/days 
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Any other resources/materials? 
 
 
 
The intervention 
Preparation and/or purchase of intervention materials 
 
  
 
Staff travel time to and from the intervention venue (if applicable) 
 
 
 
Staff mileage to and from the intervention venue (if applicable) 
 
 
 
Staff time for giving the intervention 
Staff identifier (e.g. 
initials) 
Profession Grade No hours/days 
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Details on intervention 
Length of sessions (start & end times) 
Intensive programme  
One-day meetings  
Individual family meetings  
  
 
Number of participants at each session 
Intensive programme  
One-day meetings  
Individual family meetings  
  
 
Any other resources not mentioned above? 
 
 
366 
 
 
 
APPENDIX 2: SERVICE-LEVEL QUESTIONNAIRE FOR 
SERVICE MANAGERS 
            
ONE: STAFFING 
            
(a) What medical staff work in your service, and how much of their time is dedicated to 
working with adolescent* eating disorders? 
Level 
Total Whole Time 
Equivalents (WTE) 
Clinical 
sessions/programmed 
activities* dedicated to 
adolescent eating disorders 
Consultant   
Staff grade   
ST4-6   
ST1-3   
F1-F2   
Other (please specify)   
Other (please specify)   
 
*Please specify 
*Adolescent: 13 up to 18th birthday 
            
(b) What nursing staff work in your service, and how much of their time is dedicated to 
working with adolescent eating disorders? 
Agenda for Change Band 
Total Whole Time 
Equivalents (WTE) 
Time dedicated to 
adolescent eating disorders 
(WTE) 
1   
2   
3   
4   
5   
6   
7   
8a   
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8b   
8c   
8d   
9   
           (c) 
What other staff work in your service, and how much of their time is dedicated to working 
with adolescent eating disorders? 
 
Staff 
Agenda for Change 
Band 
Total Whole Time 
Equivalents 
Clinical 
sessions/WTE* 
dedicated to 
adolescent eating 
disorders 
Clinical/counselling 
psychologist 
   
Psychotherapist    
Family therapist    
Dietician    
Social worker    
Primary Mental 
Health Worker 
   
Administrative and 
clerical staff 
   
Other (please 
specify) 
   
Other (please 
specify) 
   
*Please specify 
            
TWO: REFERRALS, ASSESSMENT AND TREATMENT 
            
(a) How many referrals of adolescents with a primary diagnosis of an eating disorder did 
your service receive during the financial year 2007-2008? 
            
(b) How many of these were for cases of anorexia nervosa (and related eating disorders) 
and how many were for bulimia nervosa (and related eating disorders)? 
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AN-TYPE EATING DISORDERS: 
BN-TYPE EATING DISORDERS: 
           (c) 
During the financial year 2007-2008, what was the total number of adolescents seen by your 
service (i.e. overall, not just eating disorders)? 
Number assessed: 
Number treated: 
Total number seen (assessed and/or treated): 
           
THREE: EXPENDITURE 
Please attach a copy of your cost centre accounts or complete the table below to let us know 
a bit about your expenditure during the 2007-2008 financial year. 
Please be assured that any information provided in this questionnaire will be treated with 
the strictest confidence and all data will be anonymised. 
 
Category Expenditure 2007-2008 Notes/comments 
Medical staff (doctors, 
consultants) 
(salaries and on-costs) 
  
Nursing staff (salaries and 
on-costs) 
  
Managers (salaries and on-
costs) 
  
Clerical/domestic staff 
(salaries and on-costs) 
  
TOTAL STAFF (salaries 
and on-costs) 
  
Expenditure on sessional 
staff 
  
Other staff/user expenditure 
(e.g. travel, subsistence) 
  
Clinical 
expenditure/consumables 
(e.g. drugs, tests, patient 
supplies) 
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Office expenses (e.g. 
stationery, computers) 
  
Other costs (please 
describe) 
  
Building-related costs (e.g. 
power, cleaning, laundry, 
maintenance) 
  
Rent/capital charges   
Overhead costs/charges for 
managing agency 
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AGENDA FOR CHANGE BANDS 
£13,233 – £13, 944 
Administration, catering, domestic, portering staff 
 
£13,233 – £16, 588 
Administration, catering, clinical support worker, patient transport, pharmacy assistant 
 
£15, 190 – £18, 157 
Microbiology assistant, secretary, security 
 
£17,732 – £21,318 
Mortuary, radiography or occupational therapy assistant, operating department practitioner 
(during training or entry level), assistant psychologists, nursing auxiliaries and nursery nurses 
 
£20,710 – £26,839 
Nurse and midwife (old D and E grades), dental technician (entry level), 
Diagnostic/Therapeutic Radiographers, dietician, occupational therapist, paramedic, senior 
pharmacy technician, physiotherapist, assistant psychologists (higher grade), Clinical 
Psychologists, operating department practitioner (qualified) 
 
£24,831 – £33,436 
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Junior Sister/specialist senior staff nurse, Senior II Radiographer (diagnostic/therapeutic), 
Art therapist, specialist dental technician, health visitor, nurse specialist, trainee clinical 
psychologist, pharmacist, Senior Clinical Physiologists 
 
£29,789 – £39,273 
Senior sister, Senior I Radiographer (diagnostic/therapeutic team leader), Chief dental 
technician, management – clinical and administrative, qualified psychologist, specialist 
pharmacist, Chief Clinical Psychologists 
 
(a) £37,996 – £45,596 
(b) £44,258 – £54-714 
(c) £53,256 – £65,657 
(d) £63,833 – £79,031 
Advanced pharmacists, nurse and midwife consultants, Superintendent Radiographers 
(diagnostic/therapeutic), higher management, psychologists, senior therapists (divided into 
4 bands – a, b, c, d), Senior Chief Clinical Psychologists 
 
£75,383 – £95,333 
Consultant Psychologists who run large services 
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APPENDIX 3: SERVICE-LEVEL QUESTIONNAIRE FOR 
CLINICIANS 
 
QUESTIONNAIRE FOR CLINICIANS 
            
ONE: TYPE OF SERVICE 
            
(a) How would you describe your service? 
Outpatient: 
General child and adolescent mental health service 
Specialist child and adolescent eating disorder service 
Specialist adult eating disorder service 
Other (please specify) 
 
Inpatient: 
General child and adolescent mental health service 
Specialist child and adolescent eating disorder service 
Specialist adult eating disorder service 
Other (please specify) 
            
(b) Which Tier does your service come under? 
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Tier 3 
Tier 4 
N/A 
            
(c) Where is your service located? 
Community building 
Hospital building 
Other (please specify) 
            
 
(d) What is the age range of patients seen by your service? 
            
(e) Please provide a general description of your service: 
            
(f) Does your service specialise in treatment eating disorders? 
Yes (child and adolescent eating disorders) 
Yes (adult eating disorders) 
No 
            
(g) How would you describe the level of specialisation in adolescent* eating disorders within 
your service? 
*Adolescent: Aged 13 years up to 18th birthday 
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Service is entirely dedicated to the treatment of (child and) adolescent eating disorders 
Service is dedicated to the treatment of adult eating disorders but has specialisation in 
adolescent eating disorders within it 
Service is dedicated to general adolescent mental health but has specialisation in adolescent 
eating disorders within it 
Service is dedicated to general adolescent mental health and has no specialisation in 
adolescent eating disorders within it 
 
Notes: 
            
TWO:REFERRALS 
            
(a) Who can refer to your service? 
Patients (self-referrals) 
Schools 
Voluntary sector organisations (e.g. charities) 
Primary care (e.g. GPs) 
Hospitals (e.g. paediatric departments) 
Tier 2 mental health services 
Tier 3 mental health services 
Tier 4 mental health services 
Private/Independent services 
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• Other (please specify) 
            
(b) Which of the following statements best describes your usual practice with adolescent 
eating disorder referrals? 
AN-TYPE EATING DISORDERS: 
Referred for assessment and treatment elsewhere (referral not accepted by your service) 
Assessed in your service and referred elsewhere for treatment if eating disorder is diagnosed 
Assessed and treated within your service in the first instance (may be referred elsewhere if 
initial treatment is unsuccessful) 
BN-TYPE EATING DISORDERS: 
Referred for assessment and treatment elsewhere (referral not accepted by your service) 
Assessed in your service and referred elsewhere for treatment if eating disorder is diagnosed 
Assessed and treated within your service in the first instance (may be referred elsewhere if 
initial treatment is unsuccessful) 
            
(d) If you refer adolescent eating disorder cases elsewhere, please outline below where and 
under what circumstances you do this: 
For example: Cases of anorexia nervosa are treated within our general child and adolescent 
mental health service but are referred on for inpatient care in a specialist child and 
adolescent eating disorder unit if they drop below 70% weight for height. 
AN-TYPE EATING DISORDERS: 
BN-TYPE EATING DISORDERS: 
            
THREE: ASSESSMENT AND TREATMENT 
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(a) In your service, who are adolescents with eating disorders typically assessed by? 
Individual clinicians 
A number of clinicians (as a team) 
N/A 
            
(b) In your service, who are adolescents with eating disorders typically treated by? 
Individual clinicians 
A number of clinicians (as a team) 
A combination of individual and team work 
N/A 
            
(c) What services do you offer for adolescents with eating disorders? 
Inpatient programme 
Outpatient programme 
Day programme 
Outreach programme 
            
(d) What is the average length of each type of programme (in weeks)? 
Inpatient programme 
Outpatient programme 
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Day programme 
Outreach programme 
             
(e) Please fill in the spaces below to give us an idea of your assessment procedure and 
treatment provided for adolescents with eating disorders in your service: 
            
FOR AN-TYPE EATING DISORDERS 
Typical length of assessment: 
Professional(s) typically involved in assessment: 
FOR BN-TYPE EATING DISORDERS 
Typical length of assessment: 
Professional(s) typically involved in assessment: 
            
FOR AN-TYPE EATING DISORDERS: 
Type of treatment 
Typical length of  
one session 
Professional(s) typically 
responsible for providing 
the treatment 
CBT   
Interpersonal therapy   
Psychodynamic 
psychotherapy 
  
Family therapy   
Multi-family group therapy   
Group therapy (w/o 
families) 
  
Dietary regime   
Nurse counselling   
Medical monitoring   
Other (please specify)   
Other (please specify)   
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FOR BN-TYPE EATING DISORDERS 
Type of treatment 
Typical 
length of  
one session 
Professional(s) typically responsible for 
providing the treatment 
CBT   
Interpersonal therapy   
Psychodynamic 
psychotherapy 
  
Family therapy   
Multi-family group 
therapy 
  
Group therapy (w/o 
families) 
  
Dietary regime   
Nurse counselling   
Medical monitoring   
Other (please specify)   
Other (please specify)   
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APPENDIX 4: FULL MODELS FOR ALSPAC ANALYSIS 
1) Variable coding 
Variable name Level and meaning 
eb_ed_ed  Categorical variable: ED status 
0 No ED 
1 AN 
2 Other ED 
eb_bp_ed Binary: bingeing/purging; no vs yes 
eb_fh5312_abs Scale: Days of absence in last two weeks 
int1 Interaction term: eb_ed_ed * eb_bp_ed 
int2 Interaction term: eb_ed_ed * eb_fh5312_abs 
int3 Interaction term: eb_ed_ed * eb_bp_ed* eb_fh5312_abs 
sex Binary: female vs male 
soclass_set1_pred  Categorical: Parental social class 
II Class II 
III NM Class III non-manual 
III M Class III manual 
IV Class IV 
V Class V 
eb_ptlbw Binary: pre-term or low birth weigt; no vs yes 
mz028b_set1_pred Scale: Maternal age at delivery 
c645a_set1_pred  Categorical: parental qualifications 
Vocational Vocational qualification 
O level O-level qualification 
A level A-level qualification 
Degree Degrees-level qualification 
paritybi_set1_pred Binary: parity; no vs yes 
eb_b650_set1_pred Binary: Mother ever smoked; no vs yes 
eb_c804_set1_pred Binary: Child ethnic background; white vs other background 
eb_marital_set1_pred  Categorical: Maternal marital status 
0 Never married 
1 Married 
2 No longer married 
ks4_fsm_set2_pred Binary: eligible for free school meals; no vs yes 
ks4_idaci_set2_pred Scale: deprivation indicator 
ccxa180_set2_pred  Categorical: YP expectation of obtaining 5+ good GCSEs 
Fairly likely Fairly likely 
Not very likely Not very likely 
Not at all likely Not at all likely 
eb_se033a_set2_pred Binary: emotional and behavioural difficulties: no vs yes 
eb_a006_set2_pred  Categorical: Housing tenure 
380 
 
 
 
Variable name Level and meaning 
Social housing Social housing  
Privately rented Privately rented 
Other Other accommodation 
eb_sen_set2_pred Binary: School Action or School Action Plus (KS4); no vs yes 
eb_children_set2_pred Scale: Number of children in household 
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2) Full sample. Outcome: GCSE total score 
Model 1 
 
Model 2 
 
                                                                              
       _cons     411.7639   2.890248   142.47   0.000      406.059    417.4687
              
          2     -13.21774   5.167365    -2.56   0.012    -23.48491   -2.950566
          1      .4486387   14.02945     0.03   0.975     -27.4988    28.39608
    eb_ed_ed  
                                                                              
ks4_ptstne~t        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
                                                                                      
               _cons     240.6363   12.75982    18.86   0.000     215.6146    265.6581
                      
                  2     -5.367522   7.025783    -0.76   0.445    -19.14056    8.405518
                  1      35.36353   4.103855     8.62   0.000     27.31816     43.4089
eb_marital_set1_pred  
                      
   eb_c804_set1_pred    -3.916237   7.248526    -0.54   0.589    -18.13292    10.30045
   eb_b650_set1_pred     18.16031   2.929352     6.20   0.000      12.4175    23.90312
  paritybi_set1_pred     -35.6744   2.993219   -11.92   0.000    -41.54217   -29.80663
                      
             Degree      115.5552   6.125826    18.86   0.000     103.5458    127.5645
            A level      80.77058   4.628879    17.45   0.000     71.69612    89.84503
            O level      52.83203    4.04281    13.07   0.000     44.90546     60.7586
         Vocational      28.69391   5.403997     5.31   0.000     18.09933    39.28849
     c645a_set1_pred  
                      
    mz028b_set1_pred     3.154462   .3387753     9.31   0.000     2.490379    3.818544
            eb_ptlbw     -.567181    6.40443    -0.09   0.929    -13.12132    11.98696
                 sex    -41.23698    3.01941   -13.66   0.000    -47.15798   -35.31598
                      
                  V      74.95699   11.87594     6.31   0.000     51.66939    98.24459
                 IV      58.30731   8.085116     7.21   0.000      42.4367    74.17792
              III M      57.67176   7.689045     7.50   0.000     42.57815    72.76537
             III NM      28.03363   7.513879     3.73   0.000     13.28079    42.78647
                 II      16.31491    7.79965     2.09   0.037     1.003082    31.62674
   soclass_set1_pred  
                      
                  2     -19.15454   4.622817    -4.14   0.000    -28.32096   -9.988126
                  1     -9.377248    11.4054    -0.82   0.413    -32.02071    13.26621
            eb_ed_ed  
                                                                                      
    ks4_ptstnewe_out        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
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Model 3 
                                                                                        
                _cons     452.1144   14.15474    31.94   0.000     424.2483    479.9805
eb_children_set2_pred     1.114781    1.96222     0.57   0.571    -2.769274    4.998836
     eb_sen_set2_pred    -55.04573   5.217229   -10.55   0.000    -65.37898   -44.71248
                       
               Other      2.669588   9.131321     0.29   0.770    -15.39055    20.72973
    Privately rented     -18.00279   6.130533    -2.94   0.004    -30.09254   -5.913044
      Social housing     -32.00247   5.761247    -5.55   0.000    -43.42406   -20.58087
    eb_a006_set2_pred  
                       
  eb_se033a_set2_pred    -54.65698    9.13019    -5.99   0.000    -72.87904   -36.43491
                       
   Not at all likely     -254.2649   8.501742   -29.91   0.000    -271.1597   -237.3701
     Not very likely     -193.9128   6.360782   -30.49   0.000    -206.5251   -181.3004
       Fairly likely     -98.06653   3.257391   -30.11   0.000    -104.4906   -91.64246
    ccxa180_set2_pred  
                       
  ks4_idaci_set2_pred     34.90874   11.55954     3.02   0.003     12.07429    57.74318
    ks4_fsm_set2_pred    -18.54203   7.522272    -2.46   0.015    -33.43168   -3.652389
                       
                   2     -10.96303   7.114998    -1.54   0.125    -24.99589     3.06983
                   1      7.355795   4.342512     1.69   0.092      -1.2108    15.92239
 eb_marital_set1_pred  
                       
    eb_c804_set1_pred    -4.738713   7.224236    -0.66   0.513    -18.99778     9.52035
    eb_b650_set1_pred     12.56395   2.824627     4.45   0.000     7.001007    18.12689
   paritybi_set1_pred    -12.26779   2.967311    -4.13   0.000    -18.10419   -6.431381
                       
              Degree      51.01751    5.90405     8.64   0.000     39.39755    62.63747
             A level      25.54579    4.98123     5.13   0.000     15.71237    35.37921
             O level      12.53278   4.370387     2.87   0.005      3.89796    21.16759
          Vocational      9.609157   5.764857     1.67   0.098    -1.780953    20.99927
      c645a_set1_pred  
                       
     mz028b_set1_pred     1.228402   .3456006     3.55   0.000     .5479326    1.908871
             eb_ptlbw    -3.888842    5.63249    -0.69   0.490    -14.94892    7.171237
                  sex    -22.73634   2.963921    -7.67   0.000    -28.57985   -16.89283
                       
                   V      9.012674   11.33189     0.80   0.427    -13.31167    31.33702
                  IV      6.015526   7.978099     0.75   0.452    -9.745846     21.7769
               III M      8.461112   7.897974     1.07   0.286    -7.162472     24.0847
              III NM     -4.380838   7.899853    -0.55   0.580    -20.02821    11.26654
                  II     -6.598743   8.227468    -0.80   0.424    -22.89572    9.698237
    soclass_set1_pred  
                       
                   2     -9.206543   3.433771    -2.68   0.008    -16.00554    -2.40755
                   1     -1.660911    7.79531    -0.21   0.832    -17.07639    13.75457
             eb_ed_ed  
                                                                                       
     ks4_ptstnewe_out        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
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Model 4 
                                                                                           
                   _cons     455.3512   15.67704    29.05   0.000     424.4894     486.213
                      1      13.01698   13.48158     0.97   0.335    -13.45055    39.48451
eb_ks4_asco005_set3_pred  
                          
                      4     -32.21571   26.85156    -1.20   0.235    -85.99136    21.55994
                      3     -23.29834   8.789141    -2.65   0.010    -40.79644   -5.800244
                      2     -6.805089   4.175226    -1.63   0.107    -15.10256    1.492385
     eb_txa110_set3_pred  
                          
   eb_children_set2_pred     1.045885   1.974849     0.53   0.598    -2.873225    4.964994
        eb_sen_set2_pred    -55.10529    6.52516    -8.45   0.000    -67.97471   -42.23588
                          
                  Other      2.383843   9.463971     0.25   0.802    -16.35227    21.11995
       Privately rented     -17.55614   5.987716    -2.93   0.004    -29.39775   -5.714532
         Social housing     -32.42906   6.706045    -4.84   0.000    -45.69102   -19.16709
       eb_a006_set2_pred  
                          
     eb_se033a_set2_pred    -54.75443   9.556401    -5.73   0.000    -73.86458   -35.64428
                          
      Not at all likely     -250.4803   11.60364   -21.59   0.000    -273.4038   -227.5569
        Not very likely     -190.9634   8.464997   -22.56   0.000    -207.6713   -174.2556
          Fairly likely     -96.61238    4.30568   -22.44   0.000    -105.0884   -88.13637
       ccxa180_set2_pred  
                          
     ks4_idaci_set2_pred     40.13563   16.72687     2.40   0.017     7.227814    73.04345
       ks4_fsm_set2_pred    -18.32861     8.0511    -2.28   0.025    -34.27379   -2.383425
                          
                      2     -10.78241   7.290355    -1.48   0.141    -25.18447    3.619652
                      1       7.23652   4.310878     1.68   0.095    -1.286945    15.75999
    eb_marital_set1_pred  
                          
       eb_c804_set1_pred    -4.643236   8.176179    -0.57   0.571    -20.78036    11.49389
       eb_b650_set1_pred     12.29416   2.914126     4.22   0.000     6.549611    18.03872
      paritybi_set1_pred    -11.38923   2.983939    -3.82   0.000    -17.26603   -5.512436
                          
                 Degree      50.70585   5.940991     8.53   0.000     38.98786    62.42385
                A level      25.12888   5.289733     4.75   0.000     14.67459    35.58317
                O level      12.68875   4.278345     2.97   0.004     4.207442    21.17005
             Vocational      9.433634    5.77808     1.63   0.105    -2.013969    20.88124
         c645a_set1_pred  
                          
        mz028b_set1_pred     1.189282   .3767858     3.16   0.002     .4469191    1.931645
                eb_ptlbw    -3.914354   6.012663    -0.65   0.515     -15.7376    7.908887
                     sex    -22.11813    3.95051    -5.60   0.000    -29.88872   -14.34753
                          
                      V       8.93445   12.58738     0.71   0.479    -15.86678    33.73568
                     IV      6.459784   8.135769     0.79   0.429    -9.638907    22.55848
                  III M      9.203509    7.84822     1.17   0.244    -6.362926    24.76994
                 III NM     -3.614319   7.697142    -0.47   0.640    -18.91673     11.6881
                     II     -5.612258   8.004182    -0.70   0.485    -21.53141    10.30689
       soclass_set1_pred  
                          
                      2     -9.132773   3.503705    -2.61   0.011    -16.08281   -2.182731
                      1     -1.180544   7.970206    -0.15   0.883    -16.97524    14.61416
                eb_ed_ed  
                                                                                          
        ks4_ptstnewe_out        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
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Model 3b 
                                                                                        
                _cons     452.4309   14.14422    31.99   0.000     424.5866    480.2753
eb_children_set2_pred     1.101673   1.954381     0.56   0.574    -2.766329    4.969675
     eb_sen_set2_pred    -55.09033   5.243505   -10.51   0.000    -65.47704   -44.70362
                       
               Other      2.672833   9.140851     0.29   0.770     -15.4065    20.75216
    Privately rented     -17.98454   6.132576    -2.93   0.004    -30.07841   -5.890677
      Social housing     -31.96645   5.757993    -5.55   0.000    -43.38131    -20.5516
    eb_a006_set2_pred  
                       
  eb_se033a_set2_pred    -54.45053   9.212693    -5.91   0.000    -72.84044   -36.06062
                       
   Not at all likely     -254.1418   8.521254   -29.82   0.000     -271.076   -237.2075
     Not very likely     -193.8023   6.383706   -30.36   0.000    -206.4612   -181.1434
       Fairly likely     -98.01458   3.268898   -29.98   0.000     -104.462   -91.56716
    ccxa180_set2_pred  
                       
  ks4_idaci_set2_pred     34.97848   11.53419     3.03   0.003     12.19593    57.76102
    ks4_fsm_set2_pred     -18.5213   7.495449    -2.47   0.015    -33.35598   -3.686616
                       
                   2     -10.98092   7.123193    -1.54   0.125    -25.03036    3.068516
                   1      7.374027   4.346959     1.70   0.091     -1.20159    15.94964
 eb_marital_set1_pred  
                       
    eb_c804_set1_pred    -4.649366   7.221786    -0.64   0.521    -18.90326    9.604529
    eb_b650_set1_pred     12.51076   2.840488     4.40   0.000     6.915732    18.10579
   paritybi_set1_pred    -12.21767   2.978188    -4.10   0.000    -18.07598   -6.359366
                       
              Degree      50.97095    5.88554     8.66   0.000      39.3885    62.55339
             A level      25.54589   4.970919     5.14   0.000     15.73353    35.35826
             O level      12.45498   4.348525     2.86   0.005     3.864839    21.04512
          Vocational      9.463961   5.756145     1.64   0.102    -1.908144    20.83607
      c645a_set1_pred  
                       
     mz028b_set1_pred     1.223929   .3472657     3.52   0.001     .5400919    1.907766
             eb_ptlbw    -3.859177   5.634699    -0.68   0.494    -14.92366    7.205301
                  sex    -22.90575   3.012653    -7.60   0.000    -28.84718   -16.96431
                       
                   V      8.996562    11.2935     0.80   0.426    -13.24978     31.2429
                  IV      6.060566   7.949706     0.76   0.447    -9.642789    21.76392
               III M      8.514455   7.879285     1.08   0.282    -7.070856    24.09977
              III NM     -4.326852   7.891599    -0.55   0.585    -19.95725    11.30355
                  II      -6.54325   8.213606    -0.80   0.427    -22.81176     9.72526
    soclass_set1_pred  
                       
                   2      9.751518   17.82524     0.55   0.585    -25.33886     44.8419
                   1      14.30126   22.86003     0.63   0.532     -30.7217    59.32423
                 int1  
                       
             eb_bp_ed    -11.90053   18.10772    -0.66   0.512    -47.59017    23.78911
                       
                   2     -8.496155   3.759459    -2.26   0.025    -15.92892   -1.063391
                   1     -2.489117   8.468808    -0.29   0.769    -19.20074     14.2225
             eb_ed_ed  
                                                                                       
     ks4_ptstnewe_out        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                                       
385 
 
 
 
Model 3c 
                                                                                        
                _cons     450.9699   14.19674    31.77   0.000     423.0177    478.9221
eb_children_set2_pred     1.046737   1.950613     0.54   0.592     -2.81377    4.907244
     eb_sen_set2_pred    -54.28913   5.061412   -10.73   0.000    -64.30429   -44.27398
                       
               Other       2.54825    9.19729     0.28   0.782    -15.64725    20.74375
    Privately rented     -18.03973   6.113132    -2.95   0.004    -30.09458   -5.984871
      Social housing     -32.43137   5.761075    -5.63   0.000    -43.85299   -21.00975
    eb_a006_set2_pred  
                       
  eb_se033a_set2_pred    -54.65436   9.059814    -6.03   0.000      -72.733   -36.57573
                       
   Not at all likely     -251.9483   8.529112   -29.54   0.000    -268.8975   -234.9992
     Not very likely     -192.5858   6.424055   -29.98   0.000    -205.3272   -179.8445
       Fairly likely     -97.68473   3.262638   -29.94   0.000    -104.1197   -91.24981
    ccxa180_set2_pred  
                       
  ks4_idaci_set2_pred     35.81328   11.54564     3.10   0.002     13.00642    58.62014
    ks4_fsm_set2_pred    -18.92079   7.563377    -2.50   0.014    -33.89491   -3.946677
                       
                   2     -10.58517   7.068628    -1.50   0.136    -24.52424    3.353897
                   1      7.118393   4.384177     1.62   0.106    -1.533314     15.7701
 eb_marital_set1_pred  
                       
    eb_c804_set1_pred    -3.981806   7.174232    -0.56   0.580    -18.13948    10.17587
    eb_b650_set1_pred     12.76057   2.847062     4.48   0.000     7.151909    18.36922
   paritybi_set1_pred    -11.82545   2.972716    -3.98   0.000    -17.67291   -5.977992
                       
              Degree      51.14481   5.908455     8.66   0.000     39.51548    62.77414
             A level      25.75592   5.008592     5.14   0.000     15.86637    35.64547
             O level      12.80008   4.381667     2.92   0.004     4.141934    21.45822
          Vocational      9.833769   5.760774     1.71   0.090    -1.548469    21.21601
      c645a_set1_pred  
                       
     mz028b_set1_pred     1.224354   .3446222     3.55   0.000     .5458419    1.902866
             eb_ptlbw     -3.80014   5.611719    -0.68   0.499    -14.81885    7.218573
                  sex    -22.90439   2.958155    -7.74   0.000     -28.7364   -17.07238
                       
                   V      9.630144   11.43687     0.84   0.401     -12.9082    32.16849
                  IV       6.46418   8.060697     0.80   0.424    -9.466209    22.39457
               III M      8.820608   7.962029     1.11   0.270    -6.934347    24.57556
              III NM     -3.853974   7.994556    -0.48   0.631    -19.69538    11.98743
                  II     -6.031982   8.318115    -0.73   0.470    -22.51473    10.45077
    soclass_set1_pred  
                       
                 int2     .4894067   1.360944     0.36   0.720    -2.198158    3.176971
        eb_fh5312_abs    -5.408233   2.254551    -2.40   0.018     -9.86586   -.9506072
                       
                   2     -8.707375   3.454444    -2.52   0.013    -15.54855   -1.866202
                   1     -1.511382   7.761176    -0.19   0.846    -16.85788    13.83511
             eb_ed_ed  
                                                                                       
     ks4_ptstnewe_out        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                                       
386 
 
 
 
Model 3d 
                                                                                        
                _cons     451.1372   14.19397    31.78   0.000     423.1909    479.0835
eb_children_set2_pred      1.04331   1.947069     0.54   0.593    -2.809943    4.896563
     eb_sen_set2_pred    -54.32107   5.121705   -10.61   0.000    -64.45914   -44.18299
                       
               Other      2.583306   9.189289     0.28   0.779    -15.59583    20.76244
    Privately rented     -18.01815    6.10826    -2.95   0.004     -30.0631   -5.973207
      Social housing     -32.40942   5.772009    -5.61   0.000    -43.85334   -20.96551
    eb_a006_set2_pred  
                       
  eb_se033a_set2_pred    -54.52518   9.109329    -5.99   0.000    -72.70431   -36.34604
                       
   Not at all likely     -251.8748   8.554441   -29.44   0.000    -268.8754   -234.8741
     Not very likely     -192.5281   6.442694   -29.88   0.000    -205.3073   -179.7489
       Fairly likely     -97.64494   3.263686   -29.92   0.000    -104.0819   -91.20794
    ccxa180_set2_pred  
                       
  ks4_idaci_set2_pred     35.84569   11.58256     3.09   0.002     12.96372    58.72765
    ks4_fsm_set2_pred     -18.9219   7.529662    -2.51   0.013    -33.82707   -4.016724
                       
                   2     -10.57379   7.062855    -1.50   0.136    -24.50109    3.353514
                   1      7.132106   4.384002     1.63   0.106    -1.519246    15.78346
 eb_marital_set1_pred  
                       
    eb_c804_set1_pred    -3.919757   7.166693    -0.55   0.585    -18.06196    10.22244
    eb_b650_set1_pred     12.71564   2.862277     4.44   0.000     7.076174     18.3551
   paritybi_set1_pred    -11.79502   2.983937    -3.95   0.000    -17.66511   -5.924934
                       
              Degree      51.11033   5.888718     8.68   0.000     39.52098    62.69969
             A level      25.74073    4.98636     5.16   0.000     15.89648    35.58498
             O level       12.7337   4.368434     2.91   0.004     4.102618    21.36477
          Vocational      9.729331   5.755353     1.69   0.093    -1.641644    21.10031
      c645a_set1_pred  
                       
     mz028b_set1_pred      1.22085   .3460397     3.53   0.000     .5394701    1.902229
             eb_ptlbw    -3.746085    5.60872    -0.67   0.504    -14.75876    7.266588
                  sex    -23.04792   3.012547    -7.65   0.000    -28.98942   -17.10643
                       
                   V      9.586235   11.40865     0.84   0.402    -12.89479    32.06726
                  IV      6.477995   8.044909     0.81   0.422    -9.420117    22.37611
               III M      8.833118   7.953274     1.11   0.269    -6.903882    24.57012
              III NM     -3.843772   7.993332    -0.48   0.632    -19.68261    11.99506
                  II     -6.027756   8.306995    -0.73   0.470    -22.48769    10.43218
    soclass_set1_pred  
                       
                 int3     .5706085   1.319116     0.43   0.666    -2.033529    3.174746
        eb_fh5312_abs    -5.226734   1.806606    -2.89   0.005    -8.804365   -1.649103
           1.eb_bp_ed    -1.763856   4.956218    -0.36   0.723    -11.60389     8.07618
                       
                   2     -8.050023    3.76778    -2.14   0.035    -15.50561   -.5944386
                   1     -1.084685   7.830318    -0.14   0.890    -16.56771    14.39834
             eb_ed_ed  
                                                                                       
     ks4_ptstnewe_out        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                                       
387 
 
 
 
3) Full sample. Outcome: 5 ‘good’ GCSEs 
Model 1 
 
Model 2 
 
                                                                                   
            _cons     1.154255    .038969     4.25   0.000     1.080161    1.233431
                   
               2      .9682226   .0535377    -0.58   0.560     .8681838    1.079789
               1      1.129574   .1873473     0.73   0.464     .8129095    1.569594
         eb_ed_ed  
                                                                                   
ks4_level2_em_out   Odds Ratio   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                                   
                                                                                      
               _cons     .0669174   .0143281   -12.63   0.000     .0439816    .1018138
                      
                  2      1.167298   .1363008     1.32   0.185     .9285113    1.467494
                  1      1.658995   .1133887     7.41   0.000     1.450989     1.89682
eb_marital_set1_pred  
                      
   eb_c804_set1_pred     .8576129   .1026929    -1.28   0.200     .6781637    1.084546
   eb_b650_set1_pred     1.182147   .0564964     3.50   0.000      1.07644    1.298234
  paritybi_set1_pred     .6693046   .0333604    -8.06   0.000     .6070101     .737992
                      
             Degree      4.698686   .5159494    14.09   0.000     3.788767    5.827134
            A level      3.415603   .2593144    16.18   0.000     2.943345    3.963635
            O level      2.094662   .1393324    11.12   0.000     1.838579    2.386415
         Vocational      1.312184   .1158793     3.08   0.002     1.103619    1.560164
     c645a_set1_pred  
                      
    mz028b_set1_pred     1.049678   .0059324     8.58   0.000     1.038115     1.06137
            eb_ptlbw     1.073891   .1151219     0.67   0.506     .8703835    1.324982
                 sex     .6142169   .0304466    -9.83   0.000     .5573422    .6768954
                      
                  V      3.438408   .7644681     5.55   0.000     2.223597    5.316902
                 IV      2.916395   .3963791     7.88   0.000     2.234032     3.80718
              III M      2.950931     .38227     8.35   0.000     2.288901    3.804444
             III NM      1.693189   .2126109     4.19   0.000     1.323636     2.16592
                 II      1.448908    .188315     2.85   0.004     1.122968    1.869452
   soclass_set1_pred  
                      
                  2      .9075241   .0571763    -1.54   0.125     .8016095    1.027433
                  1      1.024455   .1763122     0.14   0.889     .7288953    1.439861
            eb_ed_ed  
                                                                                      
   ks4_level2_em_out   Odds Ratio   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                                      
388 
 
 
 
Model 3 
                                                                                        
                _cons     1.048262    .350304     0.14   0.888     .5438092     2.02066
eb_children_set2_pred      1.06664   .0486699     1.41   0.159     .9748118    1.167119
     eb_sen_set2_pred     .3007159   .0370768    -9.75   0.000     .2359323    .3832882
                       
               Other      .9840657   .1900353    -0.08   0.934     .6731779    1.438528
    Privately rented      .7496083   .1059793    -2.04   0.042       .56765    .9898927
      Social housing      .5912062   .0724303    -4.29   0.000     .4644414    .7525701
    eb_a006_set2_pred  
                       
  eb_se033a_set2_pred     .3636334   .0831922    -4.42   0.000     .2310759    .5722331
                       
   Not at all likely      .0180193   .0060195   -12.02   0.000     .0093187    .0348434
     Not very likely      .0312948   .0068901   -15.73   0.000     .0202239    .0484261
       Fairly likely      .1931218   .0160504   -19.79   0.000     .1638531    .2276188
    ccxa180_set2_pred  
                       
  ks4_idaci_set2_pred     .5602566   .1401183    -2.32   0.021     .3427867    .9156933
    ks4_fsm_set2_pred     .6217299   .1085992    -2.72   0.007     .4410947     .876338
                       
                   2      1.035689   .1675382     0.22   0.828     .7537074    1.423167
                   1      1.133565   .1096624     1.30   0.196     .9373581    1.370841
 eb_marital_set1_pred  
                       
    eb_c804_set1_pred     .8807082   .1410568    -0.79   0.428     .6428039    1.206662
    eb_b650_set1_pred     1.136291   .0731325     1.99   0.048     1.001372    1.289387
   paritybi_set1_pred     .8770817   .0603977    -1.90   0.057     .7662112    1.003995
                       
              Degree      2.294323   .3339926     5.70   0.000     1.723881    3.053528
             A level      2.016017   .2180713     6.48   0.000     1.629813    2.493738
             O level      1.398945   .1291834     3.64   0.000     1.166689    1.677435
          Vocational      1.067875   .1290065     0.54   0.587     .8422295    1.353973
      c645a_set1_pred  
                       
     mz028b_set1_pred     1.030532   .0084127     3.68   0.000     1.014137    1.047192
             eb_ptlbw     1.058154   .1431175     0.42   0.676      .811643    1.379534
                  sex      .704227   .0460036    -5.37   0.000     .6194446    .8006133
                       
                   V      1.318825   .3476558     1.05   0.294      .786362    2.211832
                  IV      1.565879   .2760251     2.54   0.011     1.107475    2.214023
               III M      1.745584   .2934356     3.31   0.001     1.254492    2.428921
              III NM      1.152869   .1909103     0.86   0.391     .8325208    1.596486
                  II      1.073008   .1945831     0.39   0.698     .7508692     1.53335
    soclass_set1_pred  
                       
                   2       1.03075   .0770365     0.41   0.686     .8896204    1.194269
                   1      1.195428   .2530916     0.84   0.401     .7860389    1.818036
             eb_ed_ed  
                                                                                       
    ks4_level2_em_out   Odds Ratio   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                                       
389 
 
 
 
Model 4 
                                                                                           
                   _cons     1.061927   .3416875     0.19   0.852     .5644184    1.997965
                      1      1.095193   .5624738     0.18   0.859      .400242    2.996809
eb_ks4_asco005_set3_pred  
                          
                      4      .5561302   .3450422    -0.95   0.346     .1628598    1.899062
                      3      .6994673   .1494237    -1.67   0.096     .4589081    1.066128
                      2      .9932623   .1210534    -0.06   0.956      .781832     1.26187
     eb_txa110_set3_pred  
                          
   eb_children_set2_pred     1.065837   .0485829     1.40   0.164     .9741558    1.166148
        eb_sen_set2_pred     .3010886   .0425698    -8.49   0.000      .228066    .3974917
                          
                  Other      .9808986   .2077626    -0.09   0.927     .6470694    1.486953
       Privately rented      .7552856   .1079669    -1.96   0.050     .5701905    1.000466
         Social housing      .5898561   .0732172    -4.25   0.000      .461909     .753244
       eb_a006_set2_pred  
                          
     eb_se033a_set2_pred     .3639436   .0865633    -4.25   0.000     .2273156    .5826919
                          
      Not at all likely      .0185607   .0062711   -11.80   0.000     .0095218    .0361801
        Not very likely      .0319545   .0073202   -15.03   0.000     .0202933    .0503165
          Fairly likely       .194438   .0212522   -14.98   0.000     .1568316    .2410619
       ccxa180_set2_pred  
                          
     ks4_idaci_set2_pred     .5890418   .2388345    -1.31   0.192     .2660046    1.304377
       ks4_fsm_set2_pred      .623311   .1124535    -2.62   0.009     .4372916    .8884613
                          
                      2      1.035405   .1709998     0.21   0.833     .7485822    1.432125
                      1      1.131288   .1120904     1.24   0.214     .9312484    1.374298
    eb_marital_set1_pred  
                          
       eb_c804_set1_pred     .8841363   .1466375    -0.74   0.458     .6381727    1.224899
       eb_b650_set1_pred     1.133491   .0841316     1.69   0.092     .9798756    1.311188
      paritybi_set1_pred     .8837946    .063372    -1.72   0.085     .7678078    1.017303
                          
                 Degree      2.295046   .7309858     2.61   0.009     1.229293    4.284768
                A level      2.010954   .2399455     5.85   0.000      1.59082    2.542045
                O level      1.400543   .1257164     3.75   0.000     1.173895    1.670951
             Vocational      1.067437   .1346819     0.52   0.605     .8331201    1.367655
         c645a_set1_pred  
                          
        mz028b_set1_pred     1.030133   .0090127     3.39   0.001     1.012589    1.047981
                eb_ptlbw     1.054445   .1450695     0.39   0.700     .8051233    1.380974
                     sex      .707004   .0597144    -4.11   0.000     .5990777    .8343736
                          
                      V      1.317895   .4066244     0.89   0.371     .7196724    2.413387
                     IV      1.573625   .2858196     2.50   0.013     1.101428     2.24826
                  III M      1.758941   .2789243     3.56   0.000     1.287742    2.402556
                 III NM       1.15932   .1942107     0.88   0.378     .8340535    1.611435
                     II      1.079823   .1930851     0.43   0.668     .7593261    1.535595
       soclass_set1_pred  
                          
                      2      1.031002   .0776507     0.41   0.686     .8888394    1.195903
                      1      1.195762   .2545105     0.84   0.403     .7844842    1.822658
                eb_ed_ed  
                                                                                          
       ks4_level2_em_out   Odds Ratio   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                                          
390 
 
 
 
Model 3b 
 
                                                                                       
                _cons     1.058155   .3574647     0.17   0.867     .5449425    2.054696
eb_children_set2_pred      1.06627   .0488736     1.40   0.163     .9740654    1.167203
     eb_sen_set2_pred     .3000781   .0370038    -9.76   0.000     .2354241    .3824879
                       
               Other      .9857017   .1905782    -0.07   0.941     .6739899    1.441576
    Privately rented      .7503123   .1061412    -2.03   0.043      .568089    .9909865
      Social housing      .5919163   .0725373    -4.28   0.000     .4649696    .7535221
    eb_a006_set2_pred  
                       
  eb_se033a_set2_pred     .3661036   .0842173    -4.37   0.000     .2320548     .577587
                       
   Not at all likely      .0180678   .0060355   -12.02   0.000     .0093441    .0349358
     Not very likely      .0313688   .0069031   -15.73   0.000     .0202762    .0485299
       Fairly likely      .1931888   .0160802   -19.75   0.000     .1638687     .227755
    ccxa180_set2_pred  
                       
  ks4_idaci_set2_pred     .5622846   .1407137    -2.30   0.022     .3439222    .9192894
    ks4_fsm_set2_pred     .6210934   .1086677    -2.72   0.007     .4403895    .8759452
                       
                   2      1.035764   .1678548     0.22   0.828     .7533189    1.424106
                   1      1.133691   .1094401     1.30   0.194     .9378543    1.370421
 eb_marital_set1_pred  
                       
    eb_c804_set1_pred     .8835688   .1421083    -0.77   0.442     .6440236    1.212213
    eb_b650_set1_pred      1.13462   .0734244     1.95   0.051      .999195    1.288399
   paritybi_set1_pred     .8785584   .0607441    -1.87   0.061      .767075    1.006244
                       
              Degree      2.291784   .3330881     5.71   0.000     1.722785     3.04871
             A level      2.017353   .2176651     6.50   0.000     1.631797    2.494007
             O level      1.397006   .1290363     3.62   0.000     1.165023    1.675182
          Vocational      1.064278   .1289921     0.51   0.607     .8387307    1.350479
      c645a_set1_pred  
                       
     mz028b_set1_pred     1.030332   .0084892     3.63   0.000     1.013785    1.047149
             eb_ptlbw     1.060042   .1434576     0.43   0.667     .8129648    1.382212
                  sex     .7000965   .0464723    -5.37   0.000     .6145195    .7975909
                       
                   V      1.321004   .3483956     1.06   0.291     .7874693    2.216026
                  IV      1.568811    .276751     2.55   0.011     1.109257    2.218753
               III M      1.749359   .2941987     3.33   0.001     1.257026    2.434522
              III NM      1.154357   .1915489     0.87   0.388     .8330271    1.599635
                  II      1.075093   .1952232     0.40   0.690     .7519617    1.537081
    soclass_set1_pred  
                       
                   2      1.233259   .6007401     0.43   0.667     .4721912    3.220999
                   1      1.245029   .7088668     0.38   0.701     .4063029    3.815128
                 int1  
                       
             eb_bp_ed     .7574413   .3690498    -0.57   0.569     .2897399    1.980111
                       
                   2      1.055361   .0927875     0.61   0.541     .8873924    1.255124
                   1      1.210265   .2818147     0.82   0.414     .7638395    1.917605
             eb_ed_ed  
                                                                                       
    ks4_level2_em_out   Odds Ratio   Std. Err.      t    P>|t|     [95% Conf. Interval]
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Model 3c 
                                                                                        
                _cons     1.034665   .3471246     0.10   0.919     .5353412     1.99972
eb_children_set2_pred      1.06622   .0484937     1.41   0.160      .974721    1.166307
     eb_sen_set2_pred     .3033921   .0372848    -9.71   0.000     .2382279    .3863812
                       
               Other      .9837906   .1911521    -0.08   0.933     .6713829    1.441568
    Privately rented      .7495736   .1057689    -2.04   0.042     .5679425    .9892913
      Social housing      .5874385       .072    -4.34   0.000     .4614351    .7478496
    eb_a006_set2_pred  
                       
  eb_se033a_set2_pred     .3634199   .0830286    -4.43   0.000     .2310903    .5715256
                       
   Not at all likely      .0184734   .0061762   -11.94   0.000     .0095486    .0357402
     Not very likely      .0317003   .0069748   -15.69   0.000     .0204922    .0490385
       Fairly likely      .1939193   .0161431   -19.70   0.000     .1644847    .2286211
    ccxa180_set2_pred  
                       
  ks4_idaci_set2_pred     .5644371   .1412633    -2.29   0.023      .345225    .9228451
    ks4_fsm_set2_pred      .618969    .108325    -2.74   0.006     .4388408    .8730334
                       
                   2       1.04054   .1682443     0.25   0.806     .7573596    1.429602
                   1      1.129559   .1097476     1.25   0.210     .9332629    1.367144
 eb_marital_set1_pred  
                       
    eb_c804_set1_pred     .8911326   .1423593    -0.72   0.471     .6509651    1.219908
    eb_b650_set1_pred     1.138919   .0736614     2.01   0.045     1.003054    1.293187
   paritybi_set1_pred     .8819744   .0609255    -1.82   0.069      .770154     1.01003
                       
              Degree      2.302148   .3357167     5.72   0.000     1.728887    3.065488
             A level       2.02251   .2193957     6.49   0.000     1.634054    2.503312
             O level      1.404236   .1296869     3.68   0.000     1.171082    1.683809
          Vocational      1.069602   .1290696     0.56   0.577     .8438265    1.355786
      c645a_set1_pred  
                       
     mz028b_set1_pred     1.030496   .0084347     3.67   0.000     1.014057    1.047201
             eb_ptlbw     1.059442   .1434725     0.43   0.670     .8123574    1.381678
                  sex     .7019101   .0459183    -5.41   0.000     .6172916    .7981281
                       
                   V      1.326211   .3503196     1.07   0.285     .7899187    2.226603
                  IV      1.572511   .2781375     2.56   0.011     1.110828    2.226079
               III M       1.74858   .2945715     3.32   0.001     1.255735    2.434854
              III NM      1.159287   .1926103     0.89   0.374     .8362312    1.607148
                  II       1.07891   .1961779     0.42   0.676     .7542614    1.543293
    soclass_set1_pred  
                       
                 int2     1.014925   .0384479     0.39   0.696     .9418597    1.093657
        eb_fh5312_abs     .9151465   .0533787    -1.52   0.130     .8157495    1.026655
                       
                   2      1.037643   .0770927     0.50   0.619       .89638    1.201167
                   1      1.198996   .2527061     0.86   0.391     .7899223    1.819914
             eb_ed_ed  
                                                                                       
    ks4_level2_em_out   Odds Ratio   Std. Err.      t    P>|t|     [95% Conf. Interval]
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Model 3d 
                                                                                        
                _cons     1.042897   .3526074     0.12   0.901     .5367806    2.026216
eb_children_set2_pred     1.065902   .0485996     1.40   0.163     .9742077    1.166226
     eb_sen_set2_pred     .3027475   .0372185    -9.72   0.000     .2377017    .3855927
                       
               Other      .9844864    .191149    -0.08   0.936     .6720513    1.442172
    Privately rented      .7500874   .1058382    -2.04   0.042     .5683371    .9899603
      Social housing      .5879018   .0720777    -4.33   0.000     .4617669    .7484914
    eb_a006_set2_pred  
                       
  eb_se033a_set2_pred     .3657131   .0838413    -4.39   0.000     .2321779    .5760498
                       
   Not at all likely      .0185127   .0061778   -11.95   0.000      .009581    .0357706
     Not very likely      .0317941   .0069939   -15.68   0.000      .020555    .0491785
       Fairly likely      .1940574   .0161775   -19.67   0.000     .1645626    .2288386
    ccxa180_set2_pred  
                       
  ks4_idaci_set2_pred     .5659835   .1419951    -2.27   0.024     .3457492     .926502
    ks4_fsm_set2_pred     .6182521    .108288    -2.75   0.006     .4382086    .8722689
                       
                   2       1.04237   .1690734     0.26   0.798     .7579134    1.433588
                   1      1.129918   .1098396     1.26   0.210     .9334641    1.367716
 eb_marital_set1_pred  
                       
    eb_c804_set1_pred     .8938381   .1435791    -0.70   0.485     .6517847    1.225783
    eb_b650_set1_pred     1.137314   .0738366     1.98   0.048     1.001148       1.292
   paritybi_set1_pred     .8831688   .0611842    -1.79   0.073       .77089    1.011801
                       
              Degree      2.298609   .3343005     5.72   0.000     1.727589    3.058368
             A level      2.022753   .2187625     6.51   0.000     1.635328    2.501962
             O level      1.401383   .1293676     3.66   0.000       1.1688    1.680249
          Vocational      1.065868   .1289175     0.53   0.598     .8404102    1.351809
      c645a_set1_pred  
                       
     mz028b_set1_pred     1.030278   .0084894     3.62   0.000     1.013731    1.047095
             eb_ptlbw     1.062022   .1437374     0.44   0.657     .8144663    1.384823
                  sex     .6978023   .0463273    -5.42   0.000     .6124936    .7949929
                       
                   V      1.328119   .3506128     1.07   0.283     .7913093     2.22909
                  IV      1.574938   .2780814     2.57   0.010     1.113237    2.228124
               III M       1.75128   .2944728     3.33   0.001      1.25848    2.437054
              III NM      1.160503   .1927856     0.90   0.371     .8371492    1.608754
                  II      1.080201    .196431     0.42   0.672       .75514    1.545188
    soclass_set1_pred  
                       
                 int3     1.010667   .0365009     0.29   0.769      .941297     1.08515
        eb_fh5312_abs     .9252961   .0379935    -1.89   0.059     .8535141    1.003115
           1.eb_bp_ed     .9311954   .1077551    -0.62   0.539     .7405657    1.170895
                       
                   2      1.065785   .0931713     0.73   0.467      .896963    1.266381
                   1      1.220266   .2621313     0.93   0.356     .7974229    1.867327
             eb_ed_ed  
                                                                                       
    ks4_level2_em_out   Odds Ratio   Std. Err.      t    P>|t|     [95% Conf. Interval]
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4) Females only. Outcome: GCSE total score 
Model 3 
                                                                                        
                _cons     454.9203   19.02782    23.91   0.000     417.5269    492.3138
eb_children_set2_pred     2.639637   2.610286     1.01   0.313     -2.51336    7.792634
     eb_sen_set2_pred     -61.9397    7.85336    -7.89   0.000    -77.44608   -46.43333
                       
               Other      8.769146   10.39887     0.84   0.400    -11.67942    29.21771
    Privately rented     -15.48568   8.154331    -1.90   0.058    -31.53097    .5596015
      Social housing     -35.15847   7.083176    -4.96   0.000    -49.13363    -21.1833
    eb_a006_set2_pred  
                       
  eb_se033a_set2_pred    -60.33303   13.97636    -4.32   0.000    -87.99311   -32.67295
                       
   Not at all likely     -260.7641   10.60248   -24.59   0.000    -281.7351   -239.7931
     Not very likely     -197.9369   8.142801   -24.31   0.000    -214.0141   -181.8597
       Fairly likely     -97.98427   4.370334   -22.42   0.000    -106.5894    -89.3791
    ccxa180_set2_pred  
                       
  ks4_idaci_set2_pred     26.55515   14.33156     1.85   0.065    -1.645469    54.75577
    ks4_fsm_set2_pred    -16.59601   9.882429    -1.68   0.095    -36.09987    2.907844
                       
                   2      1.009031   9.737115     0.10   0.918    -18.16345    20.18151
                   1      10.89722   5.815106     1.87   0.062    -.5521737    22.34662
 eb_marital_set1_pred  
                       
    eb_c804_set1_pred    -5.440013   9.401308    -0.58   0.563    -23.94575    13.06572
    eb_b650_set1_pred     13.74677   3.706023     3.71   0.000      6.46542    21.02813
   paritybi_set1_pred    -13.14667   3.889867    -3.38   0.001    -20.78251   -5.510829
                       
              Degree      51.05121    7.90515     6.46   0.000     35.52096    66.58146
             A level      18.98935   6.307415     3.01   0.003     6.584513    31.39418
             O level      6.395173   5.401123     1.18   0.237    -4.229284    17.01963
          Vocational      6.344878   7.071043     0.90   0.370    -7.561973    20.25173
      c645a_set1_pred  
                       
     mz028b_set1_pred     1.280821   .4708134     2.72   0.007     .3552205    2.206422
             eb_ptlbw    -7.205994   8.273514    -0.87   0.384    -23.45303    9.041038
                       
                   V      11.50411   14.92548     0.77   0.441    -17.84431    40.85253
                  IV      3.245698   10.06953     0.32   0.747    -16.57771    23.06911
               III M      10.65555   9.771635     1.09   0.277    -8.593611    29.90471
              III NM     -5.698794     9.8232    -0.58   0.563    -25.07796    13.68038
                  II     -5.702831   10.13482    -0.56   0.574    -25.69373    14.28807
    soclass_set1_pred  
                       
                   2     -11.59456   4.401383    -2.63   0.009    -20.28097   -2.908152
                   1     -.6479159   9.269097    -0.07   0.944    -18.92657    17.63074
             eb_ed_ed  
                                                                                       
     ks4_ptstnewe_out        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                                       
394 
 
 
 
Model 3b 
                                                                                        
                _cons     455.1293   19.02994    23.92   0.000     417.7322    492.5264
eb_children_set2_pred     2.636461   2.603818     1.01   0.313    -2.503235    7.776157
     eb_sen_set2_pred    -61.98151   7.848969    -7.90   0.000    -77.47853    -46.4845
                       
               Other      8.712531   10.40434     0.84   0.403    -11.74652    29.17158
    Privately rented     -15.47061   8.129777    -1.90   0.058    -31.46607    .5248404
      Social housing     -35.13963   7.096869    -4.95   0.000    -49.14245    -21.1368
    eb_a006_set2_pred  
                       
  eb_se033a_set2_pred    -60.20014   14.11703    -4.26   0.000    -88.14587    -32.2544
                       
   Not at all likely     -260.7009   10.60663   -24.58   0.000    -281.6794   -239.7223
     Not very likely     -197.8666   8.127353   -24.35   0.000    -213.9117   -181.8215
       Fairly likely     -97.97217    4.36366   -22.45   0.000    -106.5637   -89.38065
    ccxa180_set2_pred  
                       
  ks4_idaci_set2_pred     26.56412   14.34667     1.85   0.065    -1.666659     54.7949
    ks4_fsm_set2_pred    -16.58241   9.863287    -1.68   0.094    -36.04689    2.882074
                       
                   2      .9633887   9.754596     0.10   0.921    -18.24428    20.17106
                   1      10.89718   5.812911     1.87   0.062    -.5476693    22.34204
 eb_marital_set1_pred  
                       
    eb_c804_set1_pred    -5.402763   9.392625    -0.58   0.566    -23.89042     13.0849
    eb_b650_set1_pred     13.70519   3.726601     3.68   0.000     6.382626    21.02775
   paritybi_set1_pred    -13.13448   3.900449    -3.37   0.001    -20.79141   -5.477543
                       
              Degree      51.02244   7.903965     6.46   0.000      35.4947    66.55017
             A level      18.99079    6.29858     3.02   0.003     6.603926    31.37765
             O level      6.350366   5.387611     1.18   0.239    -4.246568     16.9473
          Vocational       6.25728    7.06782     0.89   0.377    -7.642641     20.1572
      c645a_set1_pred  
                       
     mz028b_set1_pred     1.279689   .4725954     2.71   0.007     .3504997    2.208879
             eb_ptlbw    -7.206352   8.299586    -0.87   0.386     -23.5056      9.0929
                       
                   V      11.50394   14.88397     0.77   0.440    -17.76046    40.76834
                  IV      3.275707   10.03027     0.33   0.744    -16.46786    23.01928
               III M      10.69004   9.732123     1.10   0.273    -8.478694    29.85877
              III NM     -5.645379   9.797722    -0.58   0.565    -24.97247    13.68172
                  II     -5.660843   10.12199    -0.56   0.577    -25.62536    14.30367
    soclass_set1_pred  
                       
                   2       10.6759   31.80106     0.34   0.737    -52.08614    73.43794
                   1      13.72134    36.3738     0.38   0.706    -58.05469    85.49737
                 int1  
                       
             eb_bp_ed    -11.55356   32.09577    -0.36   0.719    -74.94359    51.83647
                       
                   2     -11.34834   5.150399    -2.20   0.029    -21.51706   -1.179622
                   1     -1.506546   10.79677    -0.14   0.889    -22.78016    19.76707
             eb_ed_ed  
                                                                                       
     ks4_ptstnewe_out        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
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Model 3c 
                                                                                        
                _cons     453.6899   18.98727    23.89   0.000     416.3772    491.0026
eb_children_set2_pred     2.628274    2.58729     1.02   0.311     -2.47807    7.734618
     eb_sen_set2_pred    -61.06861   7.747587    -7.88   0.000     -76.3595   -45.77771
                       
               Other      8.565181     10.457     0.82   0.413    -12.00144     29.1318
    Privately rented     -15.60172   8.154832    -1.91   0.057    -31.64853    .4450867
      Social housing     -35.51966   7.070298    -5.02   0.000    -49.46907   -21.57024
    eb_a006_set2_pred  
                       
  eb_se033a_set2_pred    -59.95002   13.87379    -4.32   0.000    -87.40134    -32.4987
                       
   Not at all likely     -258.5446   10.76216   -24.02   0.000    -279.8396   -237.2496
     Not very likely     -196.6634   8.185988   -24.02   0.000    -212.8282   -180.4985
       Fairly likely     -97.63815    4.37154   -22.33   0.000     -106.246   -89.03031
    ccxa180_set2_pred  
                       
  ks4_idaci_set2_pred     27.70193   14.30603     1.94   0.054    -.4477055    55.85157
    ks4_fsm_set2_pred    -17.09057   9.975215    -1.71   0.089    -36.78403    2.602901
                       
                   2      1.497926   9.701977     0.15   0.877     -17.6039    20.59975
                   1       10.4459   5.823583     1.79   0.074    -1.020963    21.91276
 eb_marital_set1_pred  
                       
    eb_c804_set1_pred    -4.507899   9.414326    -0.48   0.632    -23.04035    14.02455
    eb_b650_set1_pred     13.97745   3.730515     3.75   0.000     6.646592    21.30831
   paritybi_set1_pred    -12.67638   3.907619    -3.24   0.001     -20.3479   -5.004861
                       
              Degree      51.11548   7.927781     6.45   0.000     35.53918    66.69178
             A level      19.45565   6.338278     3.07   0.002     6.988065    31.92323
             O level      6.886867   5.420987     1.27   0.205    -3.778016    17.55175
          Vocational      6.581664   7.038156     0.94   0.350    -7.259173     20.4225
      c645a_set1_pred  
                       
     mz028b_set1_pred     1.273593   .4671578     2.73   0.007     .3553367    2.191849
             eb_ptlbw    -7.101053   8.224118    -0.86   0.388    -23.24938    9.047278
                       
                   V       12.2135   14.98557     0.82   0.416    -17.25725    41.68425
                  IV      3.613261   10.12505     0.36   0.721    -16.32337    23.54989
               III M      10.92266   9.843916     1.11   0.268    -8.473967    30.31928
              III NM     -5.171362   9.911008    -0.52   0.602    -24.72991    14.38719
                  II     -5.136796   10.28049    -0.50   0.618    -25.42488    15.15129
    soclass_set1_pred  
                       
                 int2     .0717871   2.163231     0.03   0.974    -4.198518    4.342092
        eb_fh5312_abs    -4.797223   3.735762    -1.28   0.201    -12.16667    2.572223
                       
                   2     -11.03081   4.415298    -2.50   0.013    -19.74553   -2.316093
                   1     -.6115731   9.222929    -0.07   0.947    -18.79706    17.57391
             eb_ed_ed  
                                                                                       
     ks4_ptstnewe_out        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
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Model 3d 
                                                                                       
                _cons     453.7484   18.99201    23.89   0.000     416.4263    491.0706
eb_children_set2_pred     2.630429   2.584455     1.02   0.310    -2.470084    7.730941
     eb_sen_set2_pred    -61.04913   7.774175    -7.85   0.000    -76.39393   -45.70433
                       
               Other      8.584377   10.43869     0.82   0.411    -11.94521    29.11397
    Privately rented     -15.61008   8.151812    -1.91   0.056    -31.65079    .4306341
      Social housing     -35.52106   7.079392    -5.02   0.000    -49.48891   -21.55321
    eb_a006_set2_pred  
                       
  eb_se033a_set2_pred    -59.91093   14.00397    -4.28   0.000    -87.62668   -32.19517
                       
   Not at all likely     -258.5512   10.77587   -23.99   0.000    -279.8736   -237.2288
     Not very likely     -196.6622   8.170047   -24.07   0.000     -212.794   -180.5303
       Fairly likely     -97.63459   4.369117   -22.35   0.000    -106.2374   -89.03176
    ccxa180_set2_pred  
                       
  ks4_idaci_set2_pred     27.62827   14.32761     1.93   0.055    -.5648064    55.82136
    ks4_fsm_set2_pred    -17.09896   9.966636    -1.72   0.088    -36.77481    2.576895
                       
                   2      1.457302    9.65889     0.15   0.880     -17.5571    20.47171
                   1      10.46163    5.80374     1.80   0.073     -.965003    21.88827
 eb_marital_set1_pred  
                       
    eb_c804_set1_pred    -4.479122   9.383914    -0.48   0.634    -22.94961    13.99137
    eb_b650_set1_pred     13.95188    3.75366     3.72   0.000     6.574579    21.32918
   paritybi_set1_pred    -12.67944   3.923412    -3.23   0.001    -20.38256   -4.976325
                       
              Degree      51.08354   7.921916     6.45   0.000     35.51906    66.64802
             A level      19.44113   6.332136     3.07   0.002     6.985997    31.89626
             O level      6.850471   5.411848     1.27   0.206    -3.795799    17.49674
          Vocational      6.533565   7.029154     0.93   0.353    -7.288768     20.3559
      c645a_set1_pred  
                       
     mz028b_set1_pred     1.272802   .4671931     2.72   0.007      .354478    2.191126
             eb_ptlbw    -7.070654   8.233669    -0.86   0.391    -23.23811    9.096801
                       
                   V      12.12602   14.98562     0.81   0.419    -17.34473    41.59676
                  IV      3.595181   10.09381     0.36   0.722      -16.278    23.46837
               III M      10.90948   9.815801     1.11   0.268     -8.42992    30.24889
              III NM     -5.194643   9.907087    -0.52   0.601    -24.74513    14.35584
                  II     -5.154467   10.26224    -0.50   0.616    -25.40527    15.09633
    soclass_set1_pred  
                       
                 int3      .273007   1.899187     0.14   0.886    -3.485523    4.031537
        eb_fh5312_abs     -5.00313   2.877041    -1.74   0.085    -10.70604    .6997758
           1.eb_bp_ed    -.3714487   5.514523    -0.07   0.946    -11.28285    10.53995
                       
                   2     -10.88028   4.926403    -2.21   0.028    -20.60011   -1.160458
                   1     -.4849142   9.375611    -0.05   0.959    -18.97278    18.00296
             eb_ed_ed  
                                                                                       
     ks4_ptstnewe_out        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
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5) Females only. Outcome: 5 ‘good’ GCSEs 
Model 3/3a 
 
                                                                                       
                _cons     1.100383   .5073046     0.21   0.836     .4452253    2.719618
eb_children_set2_pred      1.07812   .0688101     1.18   0.240     .9507181    1.222594
     eb_sen_set2_pred     .2659282   .0513998    -6.85   0.000     .1819484    .3886695
                       
               Other      .9908625     .24682    -0.04   0.971     .6077194    1.615562
    Privately rented      .6747322   .1303266    -2.04   0.042     .4616909    .9860784
      Social housing        .57511   .0897336    -3.55   0.000     .4232157    .7815201
    eb_a006_set2_pred  
                       
  eb_se033a_set2_pred     .3330453   .1437147    -2.55   0.012      .142162    .7802309
                       
   Not at all likely      .0161644    .007469    -8.93   0.000     .0064884    .0402699
     Not very likely      .0258646   .0070877   -13.34   0.000     .0150541    .0444382
       Fairly likely       .179004   .0196559   -15.67   0.000     .1441611    .2222682
    ccxa180_set2_pred  
                       
  ks4_idaci_set2_pred     .5597807   .1842088    -1.76   0.078     .2934997    1.067648
    ks4_fsm_set2_pred     .5227826   .1242425    -2.73   0.007     .3277945    .8337591
                       
                   2      .9266107   .2091658    -0.34   0.736     .5947663    1.443605
                   1       1.03058   .1395927     0.22   0.824      .789865    1.344653
 eb_marital_set1_pred  
                       
    eb_c804_set1_pred     .9210092   .2034149    -0.37   0.710     .5969124    1.421076
    eb_b650_set1_pred      1.31906   .1186217     3.08   0.002     1.105637    1.573679
   paritybi_set1_pred     .9639028   .0939317    -0.38   0.706     .7961664    1.166978
                       
              Degree      3.139941   .6794659     5.29   0.000     2.053824    4.800426
             A level      1.976235   .2828801     4.76   0.000     1.492189    2.617298
             O level      1.435747   .1726184     3.01   0.003     1.133934    1.817893
          Vocational      1.160069   .1795525     0.96   0.338     .8562689    1.571657
      c645a_set1_pred  
                       
     mz028b_set1_pred     1.022138    .011466     1.95   0.051     .9998814    1.044889
             eb_ptlbw     1.155551   .2322123     0.72   0.472     .7790977    1.713904
                       
                   V      1.881568   .7928675     1.50   0.134     .8231678    4.300824
                  IV      1.775638   .4153089     2.45   0.014      1.12199    2.810088
               III M      1.740984   .3852012     2.51   0.012     1.127621    2.687983
              III NM      1.153093   .2530001     0.65   0.516     .7493621    1.774341
                  II      1.139873   .2634547     0.57   0.571     .7238096    1.795099
    soclass_set1_pred  
                       
                   2      1.073214   .1107276     0.68   0.494     .8759719    1.314869
                   1      1.227312   .3314719     0.76   0.450     .7191122    2.094659
             eb_ed_ed  
                                                                                       
    ks4_level2_em_out   Odds Ratio   Std. Err.      t    P>|t|     [95% Conf. Interval]
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Model 3b 
 
                                                                                       
                _cons     1.105954   .5127126     0.22   0.828      .445193    2.747424
eb_children_set2_pred     1.077561   .0689823     1.17   0.244     .9498577    1.222433
     eb_sen_set2_pred      .265141   .0515284    -6.83   0.000     .1810261    .3883406
                       
               Other      .9927222   .2477096    -0.03   0.977     .6083452    1.619964
    Privately rented      .6749466   .1302045    -2.04   0.042     .4620654    .9859057
      Social housing      .5760823   .0900707    -3.53   0.000     .4236593    .7833437
    eb_a006_set2_pred  
                       
  eb_se033a_set2_pred     .3350838   .1459919    -2.51   0.013      .141831    .7916542
                       
   Not at all likely      .0161837   .0074834    -8.92   0.000     .0064918    .0403453
     Not very likely      .0258839   .0070897   -13.34   0.000     .0150695    .0444592
       Fairly likely      .1788641   .0196324   -15.68   0.000     .1440626    .2220727
    ccxa180_set2_pred  
                       
  ks4_idaci_set2_pred     .5611358   .1843804    -1.76   0.079     .2945021    1.069172
    ks4_fsm_set2_pred     .5215457   .1238531    -2.74   0.006     .3271431    .8314706
                       
                   2      .9267938   .2097695    -0.34   0.737     .5941657    1.445635
                   1       1.02993   .1393356     0.22   0.828     .7896311    1.343356
 eb_marital_set1_pred  
                       
    eb_c804_set1_pred     .9248673   .2052275    -0.35   0.725     .5981733    1.429986
    eb_b650_set1_pred     1.316763   .1190651     3.04   0.002     1.102628    1.572484
   paritybi_set1_pred     .9647241   .0940587    -0.37   0.713     .7967706    1.168081
                       
              Degree      3.135973   .6792667     5.28   0.000     2.050378    4.796351
             A level      1.976852   .2823936     4.77   0.000     1.493533    2.616576
             O level      1.433731   .1726005     2.99   0.003     1.131992      1.8159
          Vocational      1.156952    .179319     0.94   0.347     .8536075    1.568096
      c645a_set1_pred  
                       
     mz028b_set1_pred     1.022067   .0115482     1.93   0.054     .9996499    1.044986
             eb_ptlbw     1.157365   .2331323     0.73   0.468     .7795797    1.718225
                       
                   V      1.884664    .794632     1.50   0.133     .8241343    4.309925
                  IV      1.778551    .417128     2.46   0.014     1.122399     2.81829
               III M      1.744031   .3871654     2.51   0.012     1.127927    2.696667
              III NM       1.15406   .2542074     0.65   0.516     .7486947    1.778901
                  II      1.141012   .2646571     0.57   0.570     .7233384    1.799862
    soclass_set1_pred  
                       
                   2      1.186134   .9457544     0.21   0.831     .2463203     5.71173
                   1      1.143093   1.011473     0.15   0.880     .2001004    6.530029
                 int1  
                       
             eb_bp_ed     .8068297   .6332137    -0.27   0.785     .1717579    3.790068
                       
                   2      1.092755   .1311233     0.74   0.460     .8628507    1.383916
                   1      1.258821   .4067208     0.71   0.477     .6642841    2.385472
             eb_ed_ed  
                                                                                       
    ks4_level2_em_out   Odds Ratio   Std. Err.      t    P>|t|     [95% Conf. Interval]
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Model 3c 
                 _cons     1.088595   .5026909     0.18   0.854     .4397992      2.6945
eb_children_set2_pred     1.078545   .0686356     1.19   0.236     .9514577    1.222608
     eb_sen_set2_pred     .2690692   .0519447    -6.80   0.000     .1841854    .3930727
                       
               Other      .9886553   .2478143    -0.05   0.964     .6044784    1.616996
    Privately rented      .6727449   .1299471    -2.05   0.041     .4603311    .9831745
      Social housing       .570631   .0890225    -3.60   0.000     .4199433    .7753897
    eb_a006_set2_pred  
                       
  eb_se033a_set2_pred     .3336707   .1437259    -2.55   0.012     .1426534    .7804659
                       
   Not at all likely      .0165129   .0076449    -8.86   0.000     .0066164    .0412123
     Not very likely      .0261651   .0071591   -13.32   0.000     .0152423    .0449152
       Fairly likely      .1795145   .0196609   -15.68   0.000     .1446567     .222772
    ccxa180_set2_pred  
                       
  ks4_idaci_set2_pred     .5656776   .1865454    -1.73   0.084     .2961819    1.080387
    ks4_fsm_set2_pred     .5190773   .1239795    -2.75   0.006      .324698    .8298212
                       
                   2      .9317942   .2103011    -0.31   0.754      .598153    1.451536
                   1      1.022353   .1387909     0.16   0.871     .7830865    1.334726
 eb_marital_set1_pred  
                       
    eb_c804_set1_pred     .9357813   .2065254    -0.30   0.764     .6066974    1.443367
    eb_b650_set1_pred     1.323761   .1196672     3.10   0.002     1.108538    1.580769
   paritybi_set1_pred     .9702791   .0950105    -0.31   0.758     .8006839    1.175797
                       
              Degree      3.137655   .6798753     5.28   0.000     2.051161    4.799659
             A level      1.988861   .2855655     4.79   0.000     1.500407    2.636331
             O level      1.444861   .1738472     3.06   0.002     1.140929    1.829758
          Vocational      1.162467   .1793885     0.98   0.329     .8588325     1.57345
      c645a_set1_pred  
                       
     mz028b_set1_pred     1.021955   .0114615     1.94   0.053     .9997082    1.044697
             eb_ptlbw     1.157925   .2324535     0.73   0.465     .7810191    1.716719
                       
                   V      1.898867    .802487     1.52   0.129     .8287188     4.35093
                  IV      1.783797   .4175414     2.47   0.014     1.126742    2.824011
               III M      1.744852   .3865798     2.51   0.012     1.129453     2.69556
              III NM      1.159948   .2548952     0.68   0.500     .7533109    1.786088
                  II      1.146959   .2659675     0.59   0.555      .727198    1.809019
    soclass_set1_pred  
                       
                 int2     .9938983   .0563638    -0.11   0.914     .8887999    1.111424
        eb_fh5312_abs     .9396748   .0910778    -0.64   0.522     .7763374    1.137377
                       
                   2      1.081828   .1110301     0.77   0.444     .8839828    1.323954
                   1      1.228844   .3311221     0.76   0.446     .7209349    2.094582
             eb_ed_ed  
                                                                                       
    ks4_level2_em_out   Odds Ratio   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                                       
400 
 
 
 
Model 3d 
                                                                                        
                _cons     1.090349   .5037676     0.19   0.852      .440295    2.700145
eb_children_set2_pred      1.07797   .0687915     1.18   0.241     .9506075    1.222396
     eb_sen_set2_pred     .2684731   .0519547    -6.80   0.000     .1836064    .3925671
                       
               Other      .9907236   .2476795    -0.04   0.970     .6065463    1.618233
    Privately rented        .67332    .129932    -2.05   0.041     .4608982    .9836442
      Social housing      .5712103   .0891528    -3.59   0.000     .4203115    .7762843
    eb_a006_set2_pred  
                       
  eb_se033a_set2_pred     .3355035   .1448725    -2.53   0.012     .1431295    .7864384
                       
   Not at all likely      .0165157   .0076496    -8.86   0.000     .0066148    .0412362
     Not very likely      .0262089   .0071665   -13.32   0.000     .0152735    .0449738
       Fairly likely      .1796228   .0196754   -15.67   0.000     .1447401    .2229123
    ccxa180_set2_pred  
                       
  ks4_idaci_set2_pred     .5661682   .1863969    -1.73   0.084      .296766    1.080132
    ks4_fsm_set2_pred      .517918   .1237273    -2.75   0.006     .3239438     .828042
                       
                   2      .9344403   .2111171    -0.30   0.764     .5995727    1.456335
                   1      1.022532   .1387841     0.16   0.870     .7832718    1.334876
 eb_marital_set1_pred  
                       
    eb_c804_set1_pred     .9397908   .2083563    -0.28   0.779     .6080747    1.452464
    eb_b650_set1_pred     1.321653   .1198539     3.08   0.002     1.106145    1.579148
   paritybi_set1_pred     .9716154   .0952774    -0.29   0.769     .8015641    1.177743
                       
              Degree      3.135914   .6784522     5.28   0.000     2.051391    4.793797
             A level      1.991471   .2850967     4.81   0.000     1.503654    2.637545
             O level      1.442914   .1735954     3.05   0.002     1.139422    1.827242
          Vocational       1.15961   .1791379     0.96   0.338     .8564449    1.570089
      c645a_set1_pred  
                       
     mz028b_set1_pred     1.021878   .0114832     1.93   0.054     .9995881    1.044664
             eb_ptlbw     1.159986   .2327676     0.74   0.460     .7825468    1.719471
                       
                   V      1.897735   .8018669     1.52   0.130     .8283598    4.347624
                  IV      1.785433   .4181104     2.48   0.014     1.127541    2.827187
               III M      1.744956   .3870801     2.51   0.012     1.128903    2.697196
              III NM      1.159845   .2551761     0.67   0.501     .7528483    1.786868
                  II      1.147839   .2664261     0.59   0.553     .7274313    1.811214
    soclass_set1_pred  
                       
                 int3      1.01205   .0477294     0.25   0.800     .9222629    1.110579
        eb_fh5312_abs     .9204033   .0607633    -1.26   0.210     .8081141    1.048295
           1.eb_bp_ed     .9554229   .1246506    -0.35   0.727     .7385659    1.235953
                       
                   2      1.103588   .1308476     0.83   0.407     .8738045    1.393799
                   1      1.248328   .3455652     0.80   0.425       .72164    2.159419
             eb_ed_ed  
                                                                                       
    ks4_level2_em_out   Odds Ratio   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                                       
